data_2mbu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mbu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.293 0 N-CA-C 109.154 -1.578 . . . . 10.0 109.154 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.71 0.15 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.116 2.166 . . . . 10.0 110.357 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.01 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.081 2.153 . . . . 10.0 113.029 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.46 157.69 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.013 1.725 . . . . 10.0 108.047 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.19 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.7 148.45 49.23 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.63 52.08 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.702 1.144 . . . . 10.0 113.437 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 -63.04 0.98 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.788 1.794 . . . . 10.0 107.817 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -98.42 -25.95 14.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.405 1.482 . . . . 10.0 110.506 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.58 167.06 31.38 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.254 -0.904 . . . . 10.0 111.687 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.86 115.91 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.848 1.259 . . . . 10.0 109.054 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.39 20.27 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 119.895 -1.753 . . . . 10.0 110.479 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.56 40.64 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.254 1.022 . . . . 10.0 108.83 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.29 -9.47 41.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.794 0.838 . . . . 10.0 113.19 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 m -129.27 74.4 81.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.163 0.985 . . . . 10.0 108.646 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.58 -179.07 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 125.073 3.849 . . . . 10.0 112.221 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.61 138.88 34.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.698 1.199 . . . . 10.0 107.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -73.01 179.1 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.481 2.121 . . . . 10.0 112.598 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.5 168.27 20.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.804 2.042 . . . . 10.0 108.937 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.809 2.044 . . . . 10.0 110.488 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.83 165.4 21.08 Favored Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 127.315 2.246 . . . . 10.0 105.359 163.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.89 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.55 2.167 . . . . 10.0 110.24 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.58 2.43 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 106.338 -2.705 . . . . 10.0 106.338 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.53 133.71 46.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.116 0.966 . . . . 10.0 108.718 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.59 140.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.25 139.2 35.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.521 -1.288 . . . . 10.0 107.521 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.0 t -128.57 130.39 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.15 108.1 14.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.01 143.36 54.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.271 1.028 . . . . 10.0 108.533 162.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.72 131.12 53.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 158.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.37 176.81 7.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.417 1.087 . . . . 10.0 110.398 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.82 11.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.098 1.359 . . . . 10.0 109.511 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.51 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.607 1.163 . . . . 10.0 112.879 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.89 51.99 4.53 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.775 1.178 . . . . 10.0 110.38 -171.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.45 84.8 8.13 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 127.457 2.303 . . . . 10.0 106.098 -163.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.58 23.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.308 2.672 . . . . 10.0 109.253 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.476 1.911 . . . . 10.0 112.083 -165.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.78 -53.14 12.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.704 2.001 . . . . 10.0 110.572 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.463 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.91 -49.9 76.05 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.327 1.451 . . . . 10.0 110.884 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -13.47 61.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.713 0.635 . . . . 10.0 112.713 -171.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.74 -16.76 27.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.722 1.609 . . . . 10.0 112.118 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.24 0.41 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.094 1.315 . . . . 10.0 112.593 -172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.04 -9.2 25.7 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.988 1.746 . . . . 10.0 114.403 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.87 -43.15 69.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.797 1.18 . . . . 10.0 108.813 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.27 -28.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 -164.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 t -46.46 -60.35 3.82 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.711 1.205 . . . . 10.0 109.471 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.77 -35.42 79.4 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.272 1.133 . . . . 10.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -57.17 -51.66 68.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.418 0.687 . . . . 10.0 110.367 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.94 -39.13 80.68 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.182 0.515 . . . . 10.0 110.258 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.94 -25.54 64.62 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.117 -0.99 . . . . 10.0 111.418 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.68 10.05 39.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.568 1.147 . . . . 10.0 112.897 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 151.26 75.17 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-N 119.513 1.051 . . . . 10.0 110.922 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.13 169.71 21.52 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 124.042 3.161 . . . . 10.0 110.471 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.11 -4.26 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.004 1.322 . . . . 10.0 113.397 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.58 8.35 43.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.744 1.618 . . . . 10.0 110.653 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.48 164.71 31.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 O-C-N 121.161 -0.962 . . . . 10.0 108.834 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -145.98 134.65 22.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.534 -1.212 . . . . 10.0 108.448 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -114.48 135.52 54.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.854 0.359 . . . . 10.0 111.621 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.71 138.91 41.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 10.0 109.685 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -104.91 118.5 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.8 mt -118.75 138.51 26.03 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 112.726 0.639 . . . . 10.0 112.726 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.28 152.86 24.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.933 2.422 . . . . 10.0 112.188 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 97.47 8.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.391 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.88 76.79 8.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.389 -0.369 . . . . 10.0 111.861 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.53 20.16 1.15 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.165 1.542 . . . . 10.0 115.165 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.11 3.42 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 119.939 -1.725 . . . . 10.0 112.793 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.53 -152.08 1.57 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.327 0.965 . . . . 10.0 110.779 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.84 -30.81 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.077 0.951 . . . . 10.0 112.047 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.38 -27.43 6.33 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.079 1.752 . . . . 10.0 113.327 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.95 -36.35 64.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.656 1.116 . . . . 10.0 110.515 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.8 t -73.9 -55.1 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.93 31.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.545 3.138 . . . . 10.0 112.186 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.16 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.33 1.443 . . . . 10.0 111.217 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.57 -41.82 70.3 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.476 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.33 8.46 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 114.181 1.178 . . . . 10.0 114.181 -173.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.85 -45.78 92.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 123.639 0.587 . . . . 10.0 110.241 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -45.24 95.17 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 116.7 -1.619 . . . . 10.0 109.197 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.418 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.46 -45.6 92.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.61 1.55 . . . . 10.0 110.778 -176.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -60.59 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.082 1.753 . . . . 10.0 109.415 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.71 -29.0 66.29 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.796 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.16 48.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.365 1.066 . . . . 10.0 110.703 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.9 -22.42 56.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.663 -170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.44 61.9 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.867 0.746 . . . . 10.0 112.97 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.31 130.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 124.929 1.292 . . . . 10.0 109.337 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.55 75.95 1.37 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.2 -5.47 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.091 2.256 . . . . 10.0 117.091 -170.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 52.0 7.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.329 1.852 . . . . 10.0 112.086 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.93 -47.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 117.452 -1.261 . . . . 10.0 113.403 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.9 34.83 1.31 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.57 1.532 . . . . 10.0 113.084 -176.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.4 -44.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.447 0 O-C-N 120.762 -1.211 . . . . 10.0 108.891 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.55 45.41 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.56 1.318 . . . . 10.0 114.56 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.43 -65.64 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 117.601 -1.19 . . . . 10.0 108.671 166.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.53 -46.81 73.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.324 1.42 . . . . 10.0 112.025 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.56 82.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.479 1.511 . . . . 10.0 110.182 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.22 4.57 5.5 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.774 1.63 . . . . 10.0 112.867 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.28 2.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.706 0.803 . . . . 10.0 112.635 -173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.463 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.32 -21.19 64.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.112 0.869 . . . . 10.0 112.171 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.47 3.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.557 1.143 . . . . 10.0 108.79 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.4 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.544 1.538 . . . . 10.0 110.666 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.25 13.74 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.362 1.065 . . . . 10.0 113.34 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.03 -64.27 0.36 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 128.166 2.586 . . . . 10.0 109.57 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.4 mt 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.73 1.612 . . . . 10.0 112.522 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.49 20.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.282 1.433 . . . . 10.0 114.192 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.07 155.41 29.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 127.888 2.475 . . . . 10.0 107.643 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.18 -44.96 10.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.532 2.155 . . . . 10.0 110.012 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.34 67.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.259 1.024 . . . . 10.0 111.19 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.08 70.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.965 1.306 . . . . 10.0 110.344 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.9 -48.56 17.91 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.16 0.984 . . . . 10.0 108.875 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.25 84.57 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 122.761 0.425 . . . . 10.0 111.36 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.86 78.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.279 1.432 . . . . 10.0 112.605 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.69 60.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.609 0.763 . . . . 10.0 111.423 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.376 -0.827 . . . . 10.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.46 -41.73 30.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.788 0.835 . . . . 10.0 110.15 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.08 54.46 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.953 -1.471 . . . . 10.0 114.811 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.33 8.87 6.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.394 2.597 . . . . 10.0 112.604 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.9 49.26 4.12 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.678 -1.369 . . . . 10.0 109.678 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.53 132.89 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.167 -2.16 . . . . 10.0 105.167 169.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.66 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.666 0.786 . . . . 10.0 110.03 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.804 -0.617 . . . . 10.0 110.416 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.14 -26.73 66.81 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.682 0.674 . . . . 10.0 111.706 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.09 4.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.359 -1.719 . . . . 10.0 106.359 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.9 -59.44 4.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.819 1.248 . . . . 10.0 112.169 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.56 -33.7 64.8 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.254 -0.276 . . . . 10.0 110.254 -170.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.25 -49.48 75.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.38 92.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.592 1.157 . . . . 10.0 110.23 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.1 -48.77 44.17 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 119.701 1.137 . . . . 10.0 110.845 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.9 1.02 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.637 0.775 . . . . 10.0 111.181 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.3 8.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.387 1.475 . . . . 10.0 111.69 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.13 -40.4 86.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.262 . . . . 10.0 110.487 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.82 54.94 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.718 0.807 . . . . 10.0 110.505 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.4 mm -69.57 -38.78 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.23 1.012 . . . . 10.0 111.268 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.26 63.78 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.002 0.921 . . . . 10.0 110.963 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.39 19.59 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.837 -0.905 . . . . 10.0 110.837 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.07 82.52 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.762 -0.846 . . . . 10.0 109.611 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.0 76.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.771 -1.109 . . . . 10.0 111.495 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.69 -2.24 35.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.557 0.617 . . . . 10.0 111.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -93.48 -48.32 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.622 0.248 . . . . 10.0 110.953 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.65 58.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.407 . . . . 10.0 111.793 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -79.17 -45.05 20.7 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.818 0.342 . . . . 10.0 110.597 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -18.64 60.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.004 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--O 1.226 -0.163 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.146 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.769 0.319 . . . . 10.0 111.511 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.86 79.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.649 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 4.97 1.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.1 1.76 . . . . 10.0 113.545 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.45 36.8 26.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.888 2.075 . . . . 10.0 112.077 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.679 -1.23 . . . . 10.0 107.679 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.13 4.05 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.757 2.023 . . . . 10.0 110.316 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.32 -170.83 33.52 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.933 1.73 . . . . 10.0 112.777 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.53 153.0 61.54 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 127.286 2.234 . . . . 10.0 108.304 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.58 152.7 71.59 Favored 'Cis proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.6 -1.0 . . . . 10.0 113.087 -6.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.0 m -145.89 144.24 30.07 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.264 1.425 . . . . 10.0 108.537 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.98 158.4 32.15 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.77 1.628 . . . . 10.0 108.174 163.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.05 135.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.04 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 1 C-N-CA 133.17 4.588 . . . . 10.0 117.552 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.19 60.38 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.807 -1.552 . . . . 10.0 115.526 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.88 -41.27 1.04 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.967 1.883 . . . . 10.0 114.349 -170.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.77 107.55 16.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.98 113.45 24.52 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 126.528 1.931 . . . . 10.0 106.738 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.57 169.62 17.41 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.333 -1.479 . . . . 10.0 107.154 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.94 -178.8 1.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.631 0.373 . . . . 10.0 110.191 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.27 -50.16 5.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 128.527 2.731 . . . . 10.0 107.715 160.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.07 16.53 4.45 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.856 1.693 . . . . 10.0 114.435 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.32 -51.11 1.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.735 1.267 . . . . 10.0 109.628 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.56 72.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.076 1.351 . . . . 10.0 112.251 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.57 -5.88 9.89 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.443 -1.199 . . . . 10.0 114.752 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.85 174.32 35.22 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.71 1.755 . . . . 10.0 109.93 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.98 -52.53 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.397 2.065 . . . . 10.0 111.752 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.31 -28.71 69.92 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.965 -1.084 . . . . 10.0 111.526 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.39 -27.24 66.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.144 0.578 . . . . 10.0 110.333 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.65 -42.84 33.36 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.051 -1.031 . . . . 10.0 110.961 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.83 -31.82 73.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.923 0.783 . . . . 10.0 111.014 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.49 -56.4 8.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.59 1.956 . . . . 10.0 108.076 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.56 -41.32 93.1 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 116.928 -1.51 . . . . 10.0 111.542 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.72 69.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.931 1.696 . . . . 10.0 111.698 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.07 65.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.905 0.482 . . . . 10.0 110.637 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.48 -42.61 96.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.605 0.762 . . . . 10.0 111.272 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.1 mt -67.04 -37.42 84.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.881 -1.137 . . . . 10.0 111.278 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.28 -51.93 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 119.239 0.927 . . . . 10.0 108.574 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.01 -43.08 63.49 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.573 1.149 . . . . 10.0 110.021 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.65 -0.32 33.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.144 -175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.11 -33.32 9.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.672 1.589 . . . . 10.0 114.461 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -55.75 4.98 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.37 -1.344 . . . . 10.0 107.37 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.28 -20.34 66.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.121 -0.945 . . . . 10.0 111.811 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.73 -35.46 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 130.087 3.355 . . . . 10.0 113.712 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.17 13.48 34.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.701 1.2 . . . . 10.0 113.145 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.82 0.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.92 2.088 . . . . 10.0 109.823 -163.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.058 1.743 . . . . 10.0 108.788 -179.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.234 -1.546 . . . . 10.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.23 73.64 0.16 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.046 2.138 . . . . 10.0 110.379 -175.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.25 11.97 0.65 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.429 -2.169 . . . . 10.0 113.011 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -146.41 157.74 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.033 1.733 . . . . 10.0 108.052 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 m -131.25 132.8 44.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.47 49.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.56 51.91 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.632 1.11 . . . . 10.0 113.432 -167.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.09 0.98 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 119.863 1.832 . . . . 10.0 107.727 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.363 1.465 . . . . 10.0 110.488 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.6 167.07 31.36 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.231 -0.918 . . . . 10.0 111.623 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.85 116.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.879 1.272 . . . . 10.0 109.064 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.34 20.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.869 -1.77 . . . . 10.0 110.478 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.56 40.72 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.312 1.045 . . . . 10.0 108.864 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.38 40.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.808 0.843 . . . . 10.0 113.215 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 m -129.3 74.38 81.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.209 1.003 . . . . 10.0 108.62 -176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.62 -179.1 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 125.114 3.876 . . . . 10.0 112.198 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.54 138.87 34.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.732 1.213 . . . . 10.0 107.993 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.09 179.08 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.456 2.104 . . . . 10.0 112.626 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.5 168.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.862 2.065 . . . . 10.0 108.947 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.06 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.778 2.031 . . . . 10.0 110.514 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.77 165.39 21.2 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 10.0 105.388 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.94 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.585 2.19 . . . . 10.0 110.248 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.12 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.343 -2.703 . . . . 10.0 106.343 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.46 133.66 45.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.081 0.952 . . . . 10.0 108.758 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.55 140.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.335 -1.728 . . . . 10.0 106.335 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.3 139.23 35.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.855 -1.905 . . . . 10.0 105.855 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.19 108.13 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.07 143.35 54.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.305 1.042 . . . . 10.0 108.515 162.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 4.9 mp -121.69 131.03 53.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 158.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.3 176.77 7.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.438 1.095 . . . . 10.0 110.427 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.05 175.81 11.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.965 1.306 . . . . 10.0 109.479 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.44 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.688 1.195 . . . . 10.0 112.903 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.0 4.53 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.873 1.225 . . . . 10.0 110.379 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' HG21 ' A' ' 153' ' ' VAL . 35.7 t -113.52 84.83 8.3 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 127.427 2.291 . . . . 10.0 106.101 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.56 168.53 24.14 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.365 2.71 . . . . 10.0 109.215 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.03 -45.74 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.538 1.935 . . . . 10.0 112.046 -165.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.82 -53.06 12.81 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.69 1.996 . . . . 10.0 110.618 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.92 -49.9 76.05 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.368 1.467 . . . . 10.0 110.865 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.44 61.57 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.732 0.642 . . . . 10.0 112.732 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.8 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.709 1.604 . . . . 10.0 112.031 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.83 -67.18 0.41 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 120.124 1.329 . . . . 10.0 112.581 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.94 -9.26 25.84 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 122.141 1.8 . . . . 10.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.21 68.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.795 1.18 . . . . 10.0 108.774 167.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.88 1.067 . . . . 10.0 113.88 -164.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.45 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.799 1.24 . . . . 10.0 109.499 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.88 -35.42 78.17 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.277 1.135 . . . . 10.0 112.928 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -57.11 -51.64 68.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.407 0.683 . . . . 10.0 110.389 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.14 80.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.126 0.489 . . . . 10.0 110.252 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.64 64.67 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.11 -0.993 . . . . 10.0 111.375 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.1 39.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.487 1.115 . . . . 10.0 112.948 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.9 151.23 74.7 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 119.467 1.031 . . . . 10.0 111.002 174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.09 169.64 21.67 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.013 3.142 . . . . 10.0 110.505 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 -4.22 4.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.994 1.318 . . . . 10.0 113.452 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.72 8.43 43.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.687 1.595 . . . . 10.0 110.606 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.78 31.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 O-C-N 121.19 -0.944 . . . . 10.0 108.865 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -146.13 134.86 22.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.551 -1.204 . . . . 10.0 108.399 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -114.38 139.9 49.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.869 0.366 . . . . 10.0 111.538 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.45 143.54 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.692 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.368 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 16.3 mt -124.21 138.66 31.21 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.66 152.76 22.86 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.069 2.513 . . . . 10.0 112.207 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.67 98.2 9.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.405 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.92 76.75 8.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.826 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.13 1.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.11 1.522 . . . . 10.0 115.11 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.14 3.42 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 119.97 -1.706 . . . . 10.0 112.824 168.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.02 1.52 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.335 0.969 . . . . 10.0 110.766 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.96 -30.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.14 0.976 . . . . 10.0 111.976 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.32 -27.54 6.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.103 1.761 . . . . 10.0 113.331 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.86 -36.4 64.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.679 1.127 . . . . 10.0 110.501 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.9 t -73.95 -55.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.923 -1.14 . . . . 10.0 107.923 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.84 31.89 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.495 3.118 . . . . 10.0 112.257 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.14 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 125.314 1.435 . . . . 10.0 111.173 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.44 -41.95 70.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.81 -1.091 . . . . 10.0 112.463 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.45 8.37 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -173.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.77 -45.8 92.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.639 0.587 . . . . 10.0 110.3 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.39 -45.23 95.23 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.738 -1.601 . . . . 10.0 109.226 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.65 92.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.611 1.55 . . . . 10.0 110.874 -177.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.977 1.711 . . . . 10.0 109.48 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.75 -28.95 66.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 118.922 -0.561 . . . . 10.0 111.768 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.19 49.72 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.38 1.072 . . . . 10.0 110.655 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.79 -22.56 56.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.621 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.43 61.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.82 0.724 . . . . 10.0 112.871 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.34 130.26 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.973 1.309 . . . . 10.0 109.313 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.5 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 -165.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.22 -5.52 54.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.118 2.266 . . . . 10.0 117.118 -170.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.42 52.03 7.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.348 1.859 . . . . 10.0 112.064 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.04 -47.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 117.444 -1.265 . . . . 10.0 113.355 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.95 34.8 1.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.628 1.558 . . . . 10.0 113.079 -176.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.56 0.62 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 120.758 -1.214 . . . . 10.0 108.845 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.49 44.89 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.547 1.314 . . . . 10.0 114.547 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.49 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.549 -1.215 . . . . 10.0 108.661 166.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.57 -46.83 73.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.397 1.453 . . . . 10.0 112.031 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.43 -40.66 83.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.433 1.493 . . . . 10.0 110.135 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.06 4.5 5.43 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.683 1.593 . . . . 10.0 112.888 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.22 -57.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.0 -2.222 . . . . 10.0 105.0 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.56 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.664 0.786 . . . . 10.0 112.716 -173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.31 -21.22 64.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.099 0.863 . . . . 10.0 112.199 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.49 3.9 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.535 1.134 . . . . 10.0 108.81 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 58.42 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.517 1.527 . . . . 10.0 110.695 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.31 13.71 15.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.357 1.063 . . . . 10.0 113.28 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.95 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 128.223 2.609 . . . . 10.0 109.546 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt 54.52 44.61 28.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.729 1.612 . . . . 10.0 112.542 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.75 14.59 20.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.299 1.44 . . . . 10.0 114.154 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.045 2.538 . . . . 10.0 107.704 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.16 -45.0 10.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.539 2.16 . . . . 10.0 109.973 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.03 -29.34 67.47 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.263 1.025 . . . . 10.0 111.119 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.52 -42.16 70.5 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.022 1.329 . . . . 10.0 110.292 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.92 -48.5 18.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.169 0.988 . . . . 10.0 108.877 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.21 84.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 123.387 0.43 . . . . 10.0 111.369 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.12 -46.83 79.0 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.262 1.425 . . . . 10.0 112.569 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.9 t80 -74.3 -41.59 60.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.6 0.76 . . . . 10.0 111.439 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.99 -14.8 59.8 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.357 -0.839 . . . . 10.0 110.384 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 -41.85 30.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.827 0.851 . . . . 10.0 110.114 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.15 53.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.944 -1.475 . . . . 10.0 114.883 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.39 8.85 6.56 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.333 2.567 . . . . 10.0 112.625 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 49.3 4.12 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.67 -1.372 . . . . 10.0 109.67 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.6 132.94 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.144 -2.169 . . . . 10.0 105.144 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.69 35.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.673 0.789 . . . . 10.0 110.009 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.59 -37.01 86.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.788 -0.625 . . . . 10.0 110.352 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.04 -26.75 66.92 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.707 0.685 . . . . 10.0 111.772 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.07 4.01 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.36 -1.719 . . . . 10.0 106.36 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.94 -59.42 4.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.821 1.249 . . . . 10.0 112.154 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.58 -33.73 64.77 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.205 -0.294 . . . . 10.0 110.205 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -62.27 -49.41 75.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.284 -0.636 . . . . 10.0 109.284 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.76 -41.29 92.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.524 1.13 . . . . 10.0 110.216 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.21 -48.71 45.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.686 1.13 . . . . 10.0 110.773 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.63 38.82 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.709 0.804 . . . . 10.0 111.147 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.28 8.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.426 1.49 . . . . 10.0 111.701 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.08 -40.41 87.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.842 1.257 . . . . 10.0 110.54 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.85 55.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.695 0.798 . . . . 10.0 110.495 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.6 mm -69.49 -38.77 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.224 1.009 . . . . 10.0 111.322 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.28 63.8 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 10.0 111.018 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.39 19.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.16 82.79 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.806 -0.82 . . . . 10.0 109.569 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -33.64 75.97 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.749 -1.119 . . . . 10.0 111.527 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.67 -0.89 33.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.592 0.633 . . . . 10.0 112.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.37 -48.41 5.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.701 0.286 . . . . 10.0 110.709 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.86 -5.98 59.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.815 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -81.35 -43.81 18.51 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.874 0.369 . . . . 10.0 110.891 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -17.77 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 69.3 mt . . . . . 0 C--O 1.225 -0.186 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.96 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.6 mtm . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.832 0.349 . . . . 10.0 111.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.91 81.12 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.595 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -69.97 5.0 1.74 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.175 1.79 . . . . 10.0 113.539 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 54.37 36.81 26.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.877 2.071 . . . . 10.0 112.146 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.37 135.13 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.717 -1.216 . . . . 10.0 107.717 172.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.37 -16.09 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.717 2.007 . . . . 10.0 110.254 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.88 33.61 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.954 1.74 . . . . 10.0 112.821 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.444 HG21 ' SG ' ' A' ' 37' ' ' CYS . 14.8 m -142.46 152.99 61.76 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.262 2.225 . . . . 10.0 108.359 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.59 152.65 71.56 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.592 -1.003 . . . . 10.0 113.078 -6.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.7 m -145.86 144.22 30.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 125.294 1.438 . . . . 10.0 108.562 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.93 158.35 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.847 1.659 . . . . 10.0 108.208 163.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.06 136.53 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.955 -1.498 . . . . 10.0 106.955 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.07 135.13 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.1 10.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 133.159 4.584 . . . . 10.0 117.542 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.6 20.19 60.47 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.806 -1.552 . . . . 10.0 115.601 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -131.88 -41.28 1.04 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.916 1.858 . . . . 10.0 114.38 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.81 107.53 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.99 113.39 24.46 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 126.506 1.922 . . . . 10.0 106.808 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -136.45 169.65 17.34 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 120.393 -1.442 . . . . 10.0 107.172 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.84 1.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.617 0.367 . . . . 10.0 110.123 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.31 -50.09 5.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 128.469 2.708 . . . . 10.0 107.771 160.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.08 16.56 4.44 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.946 1.736 . . . . 10.0 114.368 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.38 -51.16 1.29 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.814 1.307 . . . . 10.0 109.609 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.62 72.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.143 1.377 . . . . 10.0 112.274 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 118.529 -1.151 . . . . 10.0 114.73 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.3 35.22 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.738 1.769 . . . . 10.0 110.015 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.437 2.092 . . . . 10.0 111.72 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.33 -28.65 69.89 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.904 -1.122 . . . . 10.0 111.523 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.15 66.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.058 0.543 . . . . 10.0 110.333 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.67 -43.01 32.65 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.062 -1.024 . . . . 10.0 110.905 -169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.91 73.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.889 0.768 . . . . 10.0 111.076 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.5 8.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.65 1.98 . . . . 10.0 108.018 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.56 -41.29 93.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 116.959 -1.496 . . . . 10.0 111.538 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 120.946 1.703 . . . . 10.0 111.74 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.49 -47.12 64.89 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.898 0.479 . . . . 10.0 110.635 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.46 -42.55 96.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.616 0.767 . . . . 10.0 111.251 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.45 83.97 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 120.917 -1.114 . . . . 10.0 111.257 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.0 mt -58.15 -51.98 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.217 0.917 . . . . 10.0 108.647 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.05 -43.03 63.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.483 1.113 . . . . 10.0 110.018 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.69 -0.36 33.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.12 -1.419 . . . . 10.0 113.072 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.14 -33.26 9.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.618 1.567 . . . . 10.0 114.458 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -55.69 5.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.413 -1.329 . . . . 10.0 107.413 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.38 66.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.177 -0.919 . . . . 10.0 111.738 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.053 3.341 . . . . 10.0 113.741 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.19 13.51 34.9 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.677 1.191 . . . . 10.0 113.113 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.35 76.84 0.27 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.895 2.078 . . . . 10.0 109.816 -163.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.135 1.774 . . . . 10.0 108.822 -179.291 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.166 -1.573 . . . . 10.0 109.166 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.18 73.72 0.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 127.088 2.155 . . . . 10.0 110.359 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.38 12.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.094 2.158 . . . . 10.0 112.981 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CD2' HD11 ' A' ' 178' ' ' LEU . 14.5 m-85 -146.46 157.72 43.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.029 1.731 . . . . 10.0 108.086 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m -131.2 132.79 44.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.63 148.37 49.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.186 -1.042 . . . . 10.0 108.186 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.68 52.35 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.731 1.158 . . . . 10.0 113.415 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -63.07 0.98 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.825 1.813 . . . . 10.0 107.854 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.9 14.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.369 1.467 . . . . 10.0 110.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.1 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.242 -0.911 . . . . 10.0 111.718 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.95 115.98 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.819 1.248 . . . . 10.0 108.99 -171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -80.43 167.39 20.24 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 119.963 -1.71 . . . . 10.0 110.489 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.24 124.61 40.79 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.309 1.044 . . . . 10.0 108.839 172.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.42 41.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.806 0.842 . . . . 10.0 113.176 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.198 0.999 . . . . 10.0 108.664 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.63 -179.11 2.63 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.987 3.792 . . . . 10.0 112.235 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 138.91 34.1 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.723 1.209 . . . . 10.0 107.948 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.99 179.12 5.67 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.453 2.102 . . . . 10.0 112.643 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.51 168.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.824 2.049 . . . . 10.0 108.946 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 m -47.08 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.855 2.062 . . . . 10.0 110.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.35 21.34 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 127.385 2.274 . . . . 10.0 105.433 163.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.83 -164.73 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.676 2.25 . . . . 10.0 110.248 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.6 2.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.71 45.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.138 0.975 . . . . 10.0 108.706 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.66 140.78 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.24 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.523 -1.288 . . . . 10.0 107.523 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.59 130.32 68.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.89 -1.892 . . . . 10.0 105.89 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.09 108.12 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.06 143.42 54.26 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.292 1.037 . . . . 10.0 108.516 162.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.84 131.11 53.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 158.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.31 176.81 7.14 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.465 1.106 . . . . 10.0 110.472 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.84 11.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.063 1.345 . . . . 10.0 109.498 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.2 t80 -61.53 -73.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.63 1.172 . . . . 10.0 112.905 172.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.99 52.0 4.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.76 1.171 . . . . 10.0 110.376 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.46 84.77 8.12 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 127.452 2.301 . . . . 10.0 106.118 -163.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.51 24.18 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.306 2.671 . . . . 10.0 109.234 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.07 -45.73 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.409 1.883 . . . . 10.0 112.064 -165.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.09 12.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.774 2.029 . . . . 10.0 110.564 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.9 -49.93 75.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.36 1.464 . . . . 10.0 110.888 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.78 -13.52 61.55 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.744 0.646 . . . . 10.0 112.744 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.69 -16.82 27.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.712 1.605 . . . . 10.0 112.038 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 120.122 1.328 . . . . 10.0 112.576 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.03 -9.22 25.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 CA-C-N 122.063 1.773 . . . . 10.0 114.358 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.22 69.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.832 1.196 . . . . 10.0 108.829 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.18 -28.47 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.825 1.046 . . . . 10.0 113.825 -164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -46.48 -60.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.713 1.205 . . . . 10.0 109.448 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.38 79.04 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-N 120.299 1.142 . . . . 10.0 113.004 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -57.17 -51.6 68.65 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.322 0.649 . . . . 10.0 110.421 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.24 80.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.186 0.517 . . . . 10.0 110.211 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.55 64.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.1 -1.0 . . . . 10.0 111.427 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.02 39.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.563 1.145 . . . . 10.0 112.862 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.91 151.26 74.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 119.52 1.054 . . . . 10.0 111.029 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.14 169.68 21.57 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.067 3.178 . . . . 10.0 110.419 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 -4.24 4.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.044 1.338 . . . . 10.0 113.473 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.67 8.38 43.39 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.737 1.615 . . . . 10.0 110.642 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.45 164.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 121.212 -0.93 . . . . 10.0 108.824 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -145.56 135.75 23.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.445 -1.252 . . . . 10.0 108.335 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -115.46 134.57 54.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.904 0.383 . . . . 10.0 111.573 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.64 140.42 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.548 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.0 mtt85 -107.74 123.36 48.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.298 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 mt -124.99 138.76 32.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 112.916 0.71 . . . . 10.0 112.916 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.27 152.95 24.13 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.06 2.507 . . . . 10.0 112.339 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.68 98.47 9.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.369 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.92 76.76 8.61 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.791 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.62 20.28 1.15 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.07 -48.1 3.42 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 119.879 -1.763 . . . . 10.0 112.808 168.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.13 1.55 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.316 0.96 . . . . 10.0 110.74 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.071 0.948 . . . . 10.0 112.089 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.3 -27.52 6.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.098 1.759 . . . . 10.0 113.319 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.9 -36.39 64.74 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 119.693 1.133 . . . . 10.0 110.513 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.8 t -73.88 -55.21 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.93 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.459 3.104 . . . . 10.0 112.193 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.2 -42.46 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 125.346 1.451 . . . . 10.0 111.26 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.65 -41.77 70.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.774 -1.108 . . . . 10.0 112.462 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -44.33 8.52 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.91 -45.69 92.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.639 0.587 . . . . 10.0 110.275 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.34 -45.33 94.84 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 116.784 -1.579 . . . . 10.0 109.211 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.44 -45.57 92.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.609 1.55 . . . . 10.0 110.812 -176.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -60.61 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.988 1.715 . . . . 10.0 109.399 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.64 -28.92 66.31 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 118.966 -0.54 . . . . 10.0 111.825 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.18 49.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.318 1.047 . . . . 10.0 110.699 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.85 -22.42 56.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.671 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.38 14.51 61.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.874 0.749 . . . . 10.0 113.016 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.28 130.28 26.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.95 1.3 . . . . 10.0 109.324 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.58 75.9 1.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.977 -0.749 . . . . 10.0 108.977 -165.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.22 -5.42 54.27 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.038 2.236 . . . . 10.0 117.038 -170.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.35 51.95 7.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.312 1.845 . . . . 10.0 112.118 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.94 -47.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.417 -1.277 . . . . 10.0 113.398 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.89 34.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.628 1.558 . . . . 10.0 113.095 -176.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.52 0.62 Allowed 'General case' 0 C--O 1.22 -0.468 0 O-C-N 120.814 -1.179 . . . . 10.0 108.901 172.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 -16.54 44.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 10.0 114.569 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.53 -65.51 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 117.478 -1.249 . . . . 10.0 108.676 166.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.58 -46.88 73.81 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 120.42 1.464 . . . . 10.0 112.031 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.451 1.5 . . . . 10.0 110.244 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.14 4.49 5.53 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.776 1.63 . . . . 10.0 112.853 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -115.19 -57.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.6 -61.26 2.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.694 0.798 . . . . 10.0 112.63 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.32 -21.22 64.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.086 0.857 . . . . 10.0 112.199 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.43 -53.6 3.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.601 1.16 . . . . 10.0 108.795 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.487 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.46 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.587 1.555 . . . . 10.0 110.659 -169.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.23 13.73 15.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 10.0 113.306 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.96 -64.28 0.36 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 128.239 2.616 . . . . 10.0 109.479 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.2 mt 54.55 44.55 28.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.746 1.618 . . . . 10.0 112.526 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.65 20.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.208 1.403 . . . . 10.0 114.184 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 155.33 28.98 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 127.897 2.479 . . . . 10.0 107.679 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.22 -44.89 10.93 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.537 2.158 . . . . 10.0 110.003 -173.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.33 67.49 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.191 0.996 . . . . 10.0 111.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.55 -42.07 70.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.965 1.306 . . . . 10.0 110.361 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.9 -48.61 17.76 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.2 1.0 . . . . 10.0 108.884 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.2 84.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 123.426 0.453 . . . . 10.0 111.432 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.93 78.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.318 1.447 . . . . 10.0 112.542 172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.9 t80 -74.16 -41.81 60.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.601 0.761 . . . . 10.0 111.382 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.9 -14.74 59.84 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.401 -0.812 . . . . 10.0 110.421 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.76 30.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.871 0.868 . . . . 10.0 110.143 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.09 54.51 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.926 -1.486 . . . . 10.0 114.836 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.27 8.75 6.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.386 2.593 . . . . 10.0 112.649 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.0 49.26 4.1 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.65 132.84 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.176 -2.157 . . . . 10.0 105.176 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.71 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.679 0.791 . . . . 10.0 110.0 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.68 -36.9 85.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.738 -0.649 . . . . 10.0 110.367 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.8 66.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.744 0.702 . . . . 10.0 111.673 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.59 -57.09 4.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.363 -1.718 . . . . 10.0 106.363 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.9 -59.45 4.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.795 1.238 . . . . 10.0 112.161 -166.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.53 -33.7 64.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 -170.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 m -62.36 -49.31 76.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.75 -41.33 92.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.557 1.143 . . . . 10.0 110.269 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -49.09 -48.78 44.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.673 1.124 . . . . 10.0 110.809 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.88 1.02 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.678 0.791 . . . . 10.0 111.179 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.78 172.32 8.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.474 1.509 . . . . 10.0 111.658 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.42 86.71 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.825 1.25 . . . . 10.0 110.487 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.82 54.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.757 0.823 . . . . 10.0 110.501 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.53 -38.85 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.23 1.012 . . . . 10.0 111.213 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.61 -33.2 63.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.026 0.93 . . . . 10.0 110.987 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.26 -48.39 19.43 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.872 -0.891 . . . . 10.0 110.872 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.03 82.38 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.792 -0.828 . . . . 10.0 109.656 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -34.14 77.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.663 -1.16 . . . . 10.0 111.45 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.01 7.23 41.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.613 0.642 . . . . 10.0 112.045 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -101.09 -48.26 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.645 0.259 . . . . 10.0 110.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.48 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.7 tmtt? -77.16 -44.28 30.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.878 0.371 . . . . 10.0 110.829 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -16.88 57.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.298 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 C--O 1.225 -0.194 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.233 179.686 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 57.7 mtm . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.796 0.331 . . . . 10.0 111.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.86 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.688 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.07 5.09 1.75 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.081 1.752 . . . . 10.0 113.53 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 54.34 36.85 26.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.99 2.116 . . . . 10.0 112.082 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.25 -16.2 4.02 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.779 2.032 . . . . 10.0 110.295 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.982 1.753 . . . . 10.0 112.802 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.45 153.06 61.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.192 2.197 . . . . 10.0 108.27 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.7 71.46 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.535 -1.027 . . . . 10.0 113.109 -6.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.5 m -145.91 144.22 30.04 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.287 1.435 . . . . 10.0 108.534 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.86 158.41 31.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.844 1.657 . . . . 10.0 108.221 163.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.936 -1.505 . . . . 10.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.9 t -104.0 135.18 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.065 -1.457 . . . . 10.0 107.065 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 1 C-N-CA 133.131 4.572 . . . . 10.0 117.471 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.18 60.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 117.752 -1.582 . . . . 10.0 115.498 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.37 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.975 1.887 . . . . 10.0 114.373 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -112.7 107.61 16.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.4 24.41 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.51 1.924 . . . . 10.0 106.768 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.53 169.59 17.44 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 120.316 -1.49 . . . . 10.0 107.087 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.78 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.601 0.36 . . . . 10.0 110.184 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.29 -50.15 5.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 128.615 2.766 . . . . 10.0 107.689 160.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.06 16.48 4.48 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.92 1.724 . . . . 10.0 114.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 m -128.32 -51.14 1.29 Allowed 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.768 1.284 . . . . 10.0 109.654 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.62 72.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.04 1.336 . . . . 10.0 112.252 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.416 -1.213 . . . . 10.0 114.741 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.78 174.27 35.12 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.717 1.758 . . . . 10.0 110.017 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.419 2.079 . . . . 10.0 111.753 -169.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.63 69.86 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.9 -1.125 . . . . 10.0 111.58 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.46 -27.14 66.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.069 0.548 . . . . 10.0 110.368 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.59 -43.05 32.93 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.014 -1.054 . . . . 10.0 110.894 -169.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.71 -31.86 73.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.937 0.79 . . . . 10.0 111.066 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.52 -56.5 8.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.628 1.971 . . . . 10.0 107.984 168.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' A' ' 6' ' ' TYR . 4.1 mm? -65.43 -41.42 93.53 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 116.905 -1.522 . . . . 10.0 111.503 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.66 69.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.965 1.712 . . . . 10.0 111.705 -175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.51 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.964 0.505 . . . . 10.0 110.617 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.41 -42.68 96.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.585 0.754 . . . . 10.0 111.257 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.03 -37.44 84.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.948 -1.095 . . . . 10.0 111.251 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.32 -51.92 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.99 -43.03 63.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.577 1.151 . . . . 10.0 110.037 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.73 -0.31 33.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.144 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.21 9.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.614 1.566 . . . . 10.0 114.399 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -55.79 4.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.345 -1.354 . . . . 10.0 107.345 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.29 66.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.766 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 130.082 3.353 . . . . 10.0 113.679 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.03 13.33 35.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.759 1.224 . . . . 10.0 113.153 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.4 tttm 56.42 76.78 0.28 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.939 2.096 . . . . 10.0 109.855 -163.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.122 1.769 . . . . 10.0 108.815 -179.251 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 109.135 -1.586 . . . . 10.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.12 73.72 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.144 2.178 . . . . 10.0 110.313 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.428 -2.169 . . . . 10.0 113.023 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.42 157.77 43.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.964 1.706 . . . . 10.0 107.991 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.29 132.76 44.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.671 -1.233 . . . . 10.0 107.671 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.57 148.43 49.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.65 13.69 52.11 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.767 1.175 . . . . 10.0 113.398 -167.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -62.98 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.767 1.783 . . . . 10.0 107.78 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -98.52 -25.89 14.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.353 1.461 . . . . 10.0 110.46 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.55 167.12 31.16 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.249 -0.907 . . . . 10.0 111.694 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.88 115.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.781 1.232 . . . . 10.0 109.002 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.31 167.32 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.001 -1.687 . . . . 10.0 110.508 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.67 40.98 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.271 1.028 . . . . 10.0 108.853 172.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.4 41.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.21 0.819 . . . . 10.0 113.21 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.195 0.998 . . . . 10.0 108.676 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.53 -179.08 2.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 125.047 3.831 . . . . 10.0 112.266 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.87 34.04 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.739 1.215 . . . . 10.0 107.944 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.1 179.04 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.415 2.076 . . . . 10.0 112.58 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.8 m -127.35 168.3 20.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 126.866 2.067 . . . . 10.0 108.949 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.11 -61.8 1.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.812 2.045 . . . . 10.0 110.493 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.85 165.37 21.14 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 127.305 2.242 . . . . 10.0 105.394 163.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.91 -164.61 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.608 2.206 . . . . 10.0 110.201 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.75 2.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.45 133.76 45.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.01 0.924 . . . . 10.0 108.77 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.65 140.79 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.24 139.08 35.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.47 130.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.939 -1.874 . . . . 10.0 105.939 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.13 108.06 14.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.94 143.32 54.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.303 1.041 . . . . 10.0 108.58 162.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.8 131.1 53.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 158.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.34 176.86 7.11 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.376 1.07 . . . . 10.0 110.391 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.06 175.79 11.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.028 1.331 . . . . 10.0 109.525 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.3 t80 -61.47 -73.14 0.1 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.563 1.145 . . . . 10.0 112.937 172.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.95 4.53 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 124.858 1.218 . . . . 10.0 110.336 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.49 84.74 8.15 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.532 2.333 . . . . 10.0 106.102 -163.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.54 168.58 24.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.296 2.664 . . . . 10.0 109.217 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.93 -45.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.538 1.935 . . . . 10.0 112.064 -164.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.88 -53.03 13.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.754 2.022 . . . . 10.0 110.569 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.518 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.6 t80 -58.96 -49.94 75.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.472 1.509 . . . . 10.0 110.784 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.43 61.6 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.73 -16.85 27.74 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.727 1.611 . . . . 10.0 112.074 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.81 -67.21 0.41 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.115 1.325 . . . . 10.0 112.559 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.02 -9.17 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 122.076 1.777 . . . . 10.0 114.518 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.16 68.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.766 1.167 . . . . 10.0 108.806 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.17 -28.59 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.348 1.059 . . . . 10.0 113.85 -164.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.36 -60.29 3.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.79 1.236 . . . . 10.0 109.544 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.89 -35.38 78.34 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 CA-C-N 120.243 1.122 . . . . 10.0 112.918 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -57.28 -51.54 68.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.412 0.685 . . . . 10.0 110.34 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -59.01 -39.17 81.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.128 0.49 . . . . 10.0 110.231 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.81 -25.63 64.77 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.153 -0.967 . . . . 10.0 111.445 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.66 9.99 39.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.625 1.17 . . . . 10.0 112.868 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.94 151.17 75.3 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 119.488 1.04 . . . . 10.0 110.994 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.07 169.7 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.982 3.121 . . . . 10.0 110.484 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.1 -4.1 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.024 1.33 . . . . 10.0 113.372 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.8 8.37 43.26 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.765 1.626 . . . . 10.0 110.532 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.44 164.33 32.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 O-C-N 121.164 -0.96 . . . . 10.0 108.863 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.93 140.91 28.59 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.435 -1.257 . . . . 10.0 108.29 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -120.84 134.13 55.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.759 0.314 . . . . 10.0 111.549 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.25 136.94 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.803 -0.635 . . . . 10.0 109.66 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -103.66 119.71 39.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.402 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.26 138.45 28.08 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.859 0.688 . . . . 10.0 112.859 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.5 152.81 23.38 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.027 2.485 . . . . 10.0 112.222 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.07 97.22 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.94 76.77 8.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.827 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.15 1.15 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.1 -48.1 3.41 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 119.903 -1.748 . . . . 10.0 112.787 168.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.51 -152.12 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.294 0.949 . . . . 10.0 110.783 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.81 -30.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.074 0.95 . . . . 10.0 112.003 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.4 -27.44 6.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.068 1.747 . . . . 10.0 113.367 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.86 -36.42 64.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.629 1.104 . . . . 10.0 110.485 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.93 -55.21 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.81 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.492 3.117 . . . . 10.0 112.21 170.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.352 1.453 . . . . 10.0 111.176 173.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.53 -41.81 70.13 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.789 -1.101 . . . . 10.0 112.535 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.53 -44.33 8.61 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.136 1.161 . . . . 10.0 114.136 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.8 -45.78 92.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.528 0.604 . . . . 10.0 110.304 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.32 -45.35 94.79 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 116.836 -1.554 . . . . 10.0 109.234 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.3 -45.69 92.14 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.552 1.523 . . . . 10.0 110.839 -176.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.978 1.711 . . . . 10.0 109.413 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.7 -28.91 66.24 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 118.881 -0.58 . . . . 10.0 111.806 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.72 -37.15 49.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.347 1.059 . . . . 10.0 110.699 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.5 56.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.653 -0.689 . . . . 10.0 111.634 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.6 61.71 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.974 0.797 . . . . 10.0 113.023 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.35 130.28 26.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.997 1.319 . . . . 10.0 109.315 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.57 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.981 -0.748 . . . . 10.0 108.981 -165.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.704 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.2 -5.4 54.19 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 117.137 2.273 . . . . 10.0 117.137 -170.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.37 51.97 7.49 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.284 1.834 . . . . 10.0 112.113 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.91 -47.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.487 -1.244 . . . . 10.0 113.461 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.704 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.77 34.92 1.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.532 1.514 . . . . 10.0 113.067 -176.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.749 -1.219 . . . . 10.0 108.929 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.2 -16.42 44.7 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.576 1.325 . . . . 10.0 114.576 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.52 -65.65 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.552 -1.213 . . . . 10.0 108.625 166.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.57 -46.78 73.77 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.391 1.451 . . . . 10.0 111.997 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.39 -40.62 82.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.459 1.503 . . . . 10.0 110.207 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.1 4.46 5.53 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.736 1.615 . . . . 10.0 112.884 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.23 -57.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.049 -2.204 . . . . 10.0 105.049 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.68 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.704 0.801 . . . . 10.0 112.618 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.518 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -68.28 -21.26 64.8 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.06 0.845 . . . . 10.0 112.147 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.43 3.91 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.591 1.157 . . . . 10.0 108.802 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.426 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.41 87.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.476 1.51 . . . . 10.0 110.698 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.79 15.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.408 1.083 . . . . 10.0 113.372 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.97 -64.2 0.36 Allowed 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 128.226 2.61 . . . . 10.0 109.581 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.52 44.63 28.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.789 1.635 . . . . 10.0 112.449 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.69 14.64 20.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 10.0 114.148 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.2 155.38 28.98 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 127.907 2.483 . . . . 10.0 107.643 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.27 -44.88 10.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.543 2.162 . . . . 10.0 109.972 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.09 -29.32 67.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.222 1.009 . . . . 10.0 111.124 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.53 -42.1 70.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.945 1.298 . . . . 10.0 110.353 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.93 -48.54 17.87 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.071 0.948 . . . . 10.0 108.901 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.2 84.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 123.45 0.469 . . . . 10.0 111.412 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.95 78.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.285 1.434 . . . . 10.0 112.532 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.21 -41.66 61.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.559 0.744 . . . . 10.0 111.443 -177.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.38 -0.825 . . . . 10.0 110.411 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.75 30.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.766 0.826 . . . . 10.0 110.102 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.14 54.36 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.958 -1.468 . . . . 10.0 114.827 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.75 6.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.327 2.563 . . . . 10.0 112.604 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.98 49.24 4.11 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.54 132.93 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.177 -2.157 . . . . 10.0 105.177 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.76 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.642 0.777 . . . . 10.0 109.983 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.64 -37.04 86.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.732 -0.651 . . . . 10.0 110.375 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.92 -26.86 67.06 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.681 0.673 . . . . 10.0 111.732 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.7 -57.05 4.02 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.375 -1.713 . . . . 10.0 106.375 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.8 -59.56 4.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.846 1.258 . . . . 10.0 112.172 -166.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.55 -33.66 64.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -49.38 75.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.8 -41.3 92.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.587 1.155 . . . . 10.0 110.229 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.668 1.122 . . . . 10.0 110.831 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -92.68 38.98 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.674 0.789 . . . . 10.0 111.129 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.92 172.3 8.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.396 1.479 . . . . 10.0 111.569 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.2 -40.4 86.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.814 1.246 . . . . 10.0 110.439 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.5 -49.91 54.32 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.765 0.826 . . . . 10.0 110.445 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.49 -38.84 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.256 1.022 . . . . 10.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 1.7 mtmt -55.52 -33.34 63.68 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.025 0.93 . . . . 10.0 111.017 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.11 -48.47 19.8 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.854 -0.898 . . . . 10.0 110.854 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.42 -36.14 82.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.702 -0.881 . . . . 10.0 109.502 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.693 -1.146 . . . . 10.0 111.478 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 12.7 pt-20 -104.29 10.65 35.48 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.72 0.637 . . . . 10.0 111.853 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.3 tmtt? -102.65 -51.02 3.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.686 0.279 . . . . 10.0 110.495 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.74 -4.81 59.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.844 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -77.79 -45.38 24.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.852 0.358 . . . . 10.0 110.848 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.84 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.324 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 36.7 mt . . . . . 0 C--O 1.227 -0.113 0 CA-C-N 116.38 -0.373 . . . . 10.0 110.856 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 63.6 mtm . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 10.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.86 79.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.623 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.05 5.03 1.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.125 1.77 . . . . 10.0 113.493 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.43 36.75 26.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.93 2.092 . . . . 10.0 112.12 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.35 135.04 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.24 -16.18 4.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.737 2.015 . . . . 10.0 110.277 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.3 -170.86 33.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.928 1.727 . . . . 10.0 112.772 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.54 152.97 61.44 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 127.253 2.221 . . . . 10.0 108.308 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.59 152.68 71.58 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.585 -1.006 . . . . 10.0 113.035 -6.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.87 144.27 30.11 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.272 1.429 . . . . 10.0 108.551 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.95 158.35 32.21 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.906 1.682 . . . . 10.0 108.218 163.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.934 -1.506 . . . . 10.0 106.934 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.06 135.16 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 168.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.17 10.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 133.175 4.59 . . . . 10.0 117.505 171.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.23 60.26 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.667 -1.629 . . . . 10.0 115.446 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.89 -41.28 1.04 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.989 1.895 . . . . 10.0 114.315 -170.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -112.78 107.62 16.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.315 -0.995 . . . . 10.0 108.315 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.07 113.42 24.55 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.495 1.918 . . . . 10.0 106.764 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.48 169.59 17.44 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 120.277 -1.514 . . . . 10.0 107.198 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.98 -178.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.62 0.368 . . . . 10.0 110.171 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.35 -50.09 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 128.552 2.741 . . . . 10.0 107.733 160.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 16.52 4.48 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.868 1.699 . . . . 10.0 114.373 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.27 -51.16 1.3 Allowed 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.825 1.313 . . . . 10.0 109.656 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.54 72.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.072 1.349 . . . . 10.0 112.174 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.62 -6.03 9.83 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.535 -1.147 . . . . 10.0 114.802 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.27 35.22 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.667 1.733 . . . . 10.0 109.929 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.92 -52.52 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.355 2.037 . . . . 10.0 111.736 -169.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -28.6 69.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.946 -1.096 . . . . 10.0 111.568 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.16 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.095 0.558 . . . . 10.0 110.351 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.71 -42.86 32.96 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.014 -1.054 . . . . 10.0 110.898 -169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.93 -31.77 73.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.908 0.776 . . . . 10.0 110.985 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.46 8.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.589 1.956 . . . . 10.0 108.103 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.47 -41.33 93.47 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 116.945 -1.502 . . . . 10.0 111.58 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.69 69.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.902 1.683 . . . . 10.0 111.746 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.06 65.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.902 0.481 . . . . 10.0 110.619 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.55 -42.57 96.82 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 10.0 111.217 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.14 -37.38 83.72 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.877 -1.139 . . . . 10.0 111.26 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.23 -51.94 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.284 0.947 . . . . 10.0 108.561 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.02 -43.06 63.53 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.618 1.167 . . . . 10.0 110.052 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.7 -0.27 33.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.173 -1.394 . . . . 10.0 113.188 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.25 9.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.679 1.591 . . . . 10.0 114.436 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -55.69 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.35 -20.32 66.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.115 -0.948 . . . . 10.0 111.772 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.46 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.108 3.363 . . . . 10.0 113.707 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.06 13.38 35.36 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.732 1.213 . . . . 10.0 113.151 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.92 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.942 2.097 . . . . 10.0 109.78 -163.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.138 1.775 . . . . 10.0 108.82 -179.321 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.194 -1.563 . . . . 10.0 109.194 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.08 73.77 0.15 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 127.131 2.172 . . . . 10.0 110.357 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.37 12.06 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.459 -2.155 . . . . 10.0 112.998 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.47 157.7 43.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.984 1.714 . . . . 10.0 108.041 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.18 132.82 44.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.735 -1.209 . . . . 10.0 107.735 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.38 49.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.62 52.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.67 1.128 . . . . 10.0 113.423 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -63.0 0.98 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.763 1.782 . . . . 10.0 107.77 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.38 -25.97 14.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 10.0 110.501 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -154.59 167.02 31.51 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.27 -0.894 . . . . 10.0 111.624 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.89 115.97 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.797 1.239 . . . . 10.0 108.996 -171.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.36 20.31 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 119.948 -1.72 . . . . 10.0 110.473 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.66 40.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.168 0.987 . . . . 10.0 108.815 172.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 m -67.25 -9.46 40.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.832 0.853 . . . . 10.0 113.219 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 m -129.32 74.37 81.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.195 0.998 . . . . 10.0 108.612 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.49 -179.12 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 125.139 3.892 . . . . 10.0 112.213 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.57 138.96 34.21 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.729 1.211 . . . . 10.0 107.934 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.13 179.17 5.67 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.369 2.046 . . . . 10.0 112.569 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.5 168.3 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.832 2.053 . . . . 10.0 108.947 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.89 1.67 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.834 2.054 . . . . 10.0 110.457 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.74 165.43 21.11 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.283 2.233 . . . . 10.0 105.397 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.99 -164.61 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.571 2.181 . . . . 10.0 110.213 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.68 2.45 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.269 -2.733 . . . . 10.0 106.269 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.47 133.79 45.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.137 0.975 . . . . 10.0 108.723 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.73 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.348 -1.723 . . . . 10.0 106.348 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.15 139.16 35.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.55 130.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.906 -1.887 . . . . 10.0 105.906 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.11 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.393 -1.336 . . . . 10.0 107.393 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.04 143.39 54.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.275 1.03 . . . . 10.0 108.583 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 158.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.27 176.85 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.433 1.093 . . . . 10.0 110.459 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.89 11.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.071 1.349 . . . . 10.0 109.502 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HD1' ' CG2' ' A' ' 98' ' ' ILE . 40.2 t80 -61.59 -73.09 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.615 1.166 . . . . 10.0 112.912 172.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.01 4.54 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.828 1.204 . . . . 10.0 110.392 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 153' ' ' VAL . 35.9 t -113.57 84.8 8.37 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 127.471 2.308 . . . . 10.0 106.086 -163.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.56 168.6 23.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.279 2.653 . . . . 10.0 109.203 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.03 -45.75 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.46 1.904 . . . . 10.0 112.093 -165.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.79 -53.14 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.672 1.989 . . . . 10.0 110.597 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.42 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.88 -49.93 75.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.471 1.508 . . . . 10.0 110.817 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.54 61.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.68 -16.85 27.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.687 1.595 . . . . 10.0 112.071 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.2 0.41 Allowed Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 120.09 1.314 . . . . 10.0 112.621 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.09 -9.11 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 CA-C-N 121.994 1.748 . . . . 10.0 114.45 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.18 68.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.772 1.169 . . . . 10.0 108.827 167.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.23 -28.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.33 1.052 . . . . 10.0 113.816 -164.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 t -46.48 -60.25 3.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.763 1.225 . . . . 10.0 109.483 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.88 -35.35 78.57 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.348 1.16 . . . . 10.0 112.918 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -57.29 -51.59 68.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.349 0.659 . . . . 10.0 110.372 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.12 80.69 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.168 0.509 . . . . 10.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.6 64.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.094 -1.004 . . . . 10.0 111.39 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.13 39.65 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.535 1.134 . . . . 10.0 112.908 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.97 151.25 75.17 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 119.45 1.023 . . . . 10.0 110.968 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.1 169.69 21.57 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 124.053 3.169 . . . . 10.0 110.458 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.09 -4.16 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.024 1.33 . . . . 10.0 113.457 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.76 8.39 43.29 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.622 1.569 . . . . 10.0 110.587 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.46 164.85 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 O-C-N 121.117 -0.989 . . . . 10.0 108.884 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -145.66 136.18 24.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.477 -1.238 . . . . 10.0 108.413 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -115.4 137.65 51.82 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.778 0.323 . . . . 10.0 111.572 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.98 140.24 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.692 -0.686 . . . . 10.0 109.832 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -106.34 120.87 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 14.9 mt -121.83 138.76 29.05 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 112.692 0.627 . . . . 10.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.69 152.82 22.81 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.911 2.407 . . . . 10.0 112.287 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.16 98.05 9.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.21 76.8 8.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.751 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.17 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.161 1.541 . . . . 10.0 115.161 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.09 -48.09 3.41 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 119.897 -1.752 . . . . 10.0 112.801 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.52 -152.06 1.56 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.317 0.961 . . . . 10.0 110.75 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.83 -30.76 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.108 0.963 . . . . 10.0 112.12 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.46 -27.39 6.42 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.064 1.745 . . . . 10.0 113.374 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.9 -36.48 64.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.606 1.094 . . . . 10.0 110.472 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.6 t -73.83 -55.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.495 3.118 . . . . 10.0 112.148 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.15 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 125.407 1.479 . . . . 10.0 111.294 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.59 -41.84 70.37 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 117.757 -1.116 . . . . 10.0 112.457 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.43 -44.32 8.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 114.186 1.18 . . . . 10.0 114.186 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.93 -45.71 92.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.685 0.615 . . . . 10.0 110.272 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.2 95.32 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 116.702 -1.618 . . . . 10.0 109.204 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.418 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.4 -45.7 91.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.628 1.558 . . . . 10.0 110.764 -176.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 126.004 1.722 . . . . 10.0 109.42 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.71 -28.89 66.21 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 118.887 -0.578 . . . . 10.0 111.8 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.78 -37.1 50.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.329 1.052 . . . . 10.0 110.625 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.89 -22.43 56.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.802 -0.618 . . . . 10.0 111.702 -170.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.33 14.55 61.84 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.897 0.761 . . . . 10.0 113.0 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.962 1.305 . . . . 10.0 109.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.704 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.36 -5.35 54.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 117.059 2.244 . . . . 10.0 117.059 -170.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.28 52.05 7.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.347 1.859 . . . . 10.0 112.092 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.98 -47.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.425 -1.274 . . . . 10.0 113.328 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.704 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.9 34.79 1.3 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.586 1.539 . . . . 10.0 113.175 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.33 -44.51 0.62 Allowed 'General case' 0 C--O 1.221 -0.44 0 O-C-N 120.805 -1.185 . . . . 10.0 108.948 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.51 45.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.541 1.311 . . . . 10.0 114.541 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.5 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.6 -1.19 . . . . 10.0 108.637 166.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.6 -46.78 73.88 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.347 1.43 . . . . 10.0 112.006 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.37 -40.51 82.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.468 1.507 . . . . 10.0 110.24 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.24 4.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.766 1.626 . . . . 10.0 112.847 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.412 ' CG2' ' HD1' ' A' ' 35' ' ' TYR . 61.4 mt -115.26 -57.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.033 -2.21 . . . . 10.0 105.033 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.62 -61.37 1.99 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.694 0.798 . . . . 10.0 112.6 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -68.34 -21.12 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.073 0.851 . . . . 10.0 112.157 -177.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.5 3.88 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.508 1.123 . . . . 10.0 108.758 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.545 1.538 . . . . 10.0 110.614 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.68 15.67 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.367 1.067 . . . . 10.0 113.322 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.5 tttm 70.07 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 128.17 2.588 . . . . 10.0 109.557 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.2 mt 54.47 44.59 28.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.768 1.627 . . . . 10.0 112.475 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.59 20.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.295 1.438 . . . . 10.0 114.177 -173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 155.36 29.0 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 127.959 2.503 . . . . 10.0 107.655 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 -44.96 10.95 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 10.0 110.017 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.0 -29.36 67.54 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.191 0.997 . . . . 10.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.51 -42.15 70.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.983 1.313 . . . . 10.0 110.314 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.9 -48.58 17.84 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.145 0.978 . . . . 10.0 108.876 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.16 84.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.408 0.443 . . . . 10.0 111.4 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.13 -46.85 79.04 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.328 1.451 . . . . 10.0 112.558 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.57 60.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.537 0.735 . . . . 10.0 111.466 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -77.02 -14.74 59.79 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.414 -0.804 . . . . 10.0 110.365 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.79 30.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.777 0.831 . . . . 10.0 110.115 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.99 10.12 54.07 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 117.981 -1.455 . . . . 10.0 114.847 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.31 8.71 6.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.365 2.583 . . . . 10.0 112.673 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.97 49.23 4.11 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.68 -1.368 . . . . 10.0 109.68 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.53 132.88 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.233 -2.136 . . . . 10.0 105.233 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -92.32 133.64 35.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.63 0.772 . . . . 10.0 110.021 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.59 -36.88 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.811 -0.614 . . . . 10.0 110.445 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.83 66.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.694 0.679 . . . . 10.0 111.687 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.64 -57.02 4.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.88 -59.54 4.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.826 1.25 . . . . 10.0 112.093 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.56 -33.64 64.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 -170.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 m -62.35 -49.38 75.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -65.68 -41.36 92.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.554 1.141 . . . . 10.0 110.212 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.17 -48.8 44.76 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.691 1.132 . . . . 10.0 110.789 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.58 38.97 1.02 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.639 0.776 . . . . 10.0 111.202 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.24 8.6 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 10.0 111.666 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.36 86.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.837 1.255 . . . . 10.0 110.512 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.88 55.05 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.719 0.808 . . . . 10.0 110.477 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.52 -38.79 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.209 1.004 . . . . 10.0 111.262 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.58 -33.23 63.73 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.009 0.923 . . . . 10.0 111.029 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.47 19.33 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.831 -0.908 . . . . 10.0 110.831 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.3 -36.16 82.77 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.703 -0.88 . . . . 10.0 109.616 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -33.87 76.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.661 -1.162 . . . . 10.0 111.488 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.59 -5.46 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.619 0.645 . . . . 10.0 112.127 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.1 mmtt -92.0 -48.74 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.52 0.2 . . . . 10.0 111.01 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.48 -9.02 59.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.818 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -79.36 -45.01 20.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.672 0.273 . . . . 10.0 110.629 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -19.43 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.203 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 51.4 mt . . . . . 0 C--O 1.225 -0.233 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.056 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 59.1 mtm . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.869 0.366 . . . . 10.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.85 80.28 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.929 -0.578 . . . . 10.0 109.666 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.02 5.04 1.75 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.093 1.757 . . . . 10.0 113.5 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.38 36.82 26.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.935 2.094 . . . . 10.0 112.029 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.31 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.26 -16.16 4.02 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 126.783 2.033 . . . . 10.0 110.267 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.86 33.57 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.979 1.752 . . . . 10.0 112.791 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 37' ' ' CYS . 14.6 m -142.57 152.98 61.37 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 127.282 2.233 . . . . 10.0 108.325 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.55 152.66 71.42 Favored 'Cis proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.61 -0.996 . . . . 10.0 113.082 -6.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.282 1.433 . . . . 10.0 108.581 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.92 158.39 32.08 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.779 1.632 . . . . 10.0 108.146 163.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.55 29.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 t -104.14 135.19 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.085 -1.45 . . . . 10.0 107.085 168.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.13 10.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.142 4.577 . . . . 10.0 117.517 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.73 20.1 60.42 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 117.753 -1.582 . . . . 10.0 115.531 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.84 -41.35 1.04 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.998 1.899 . . . . 10.0 114.365 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.81 107.58 16.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.277 -1.009 . . . . 10.0 108.277 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 126.511 1.924 . . . . 10.0 106.741 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.54 169.56 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.362 -1.461 . . . . 10.0 107.22 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.96 -178.79 1.28 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.606 0.362 . . . . 10.0 110.14 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.3 mt -46.23 -50.11 4.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 128.528 2.731 . . . . 10.0 107.778 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.1 16.52 4.49 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.927 1.727 . . . . 10.0 114.352 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.29 -51.16 1.3 Allowed 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.851 1.326 . . . . 10.0 109.692 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.5 72.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.068 1.347 . . . . 10.0 112.3 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.53 -5.9 9.92 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-O 118.542 -1.144 . . . . 10.0 114.774 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.81 174.24 35.11 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.672 1.736 . . . . 10.0 109.945 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.86 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.397 2.065 . . . . 10.0 111.73 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.06 -1.025 . . . . 10.0 111.561 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.16 66.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.094 0.558 . . . . 10.0 110.342 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.99 32.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.969 -1.082 . . . . 10.0 110.89 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.4 mt -63.77 -31.86 73.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.876 0.762 . . . . 10.0 110.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.45 -56.44 8.24 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.636 1.974 . . . . 10.0 108.036 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.59 -41.3 92.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 116.922 -1.513 . . . . 10.0 111.555 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.78 69.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 120.984 1.72 . . . . 10.0 111.7 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.47 -47.06 65.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.939 0.496 . . . . 10.0 110.643 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.55 -42.54 96.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.513 0.725 . . . . 10.0 111.228 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.02 -37.49 84.23 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 120.899 -1.126 . . . . 10.0 111.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.27 -51.89 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.234 0.925 . . . . 10.0 108.589 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.0 -43.09 63.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.567 1.147 . . . . 10.0 110.045 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.61 -0.37 33.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.11 -1.424 . . . . 10.0 113.164 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.3 9.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.62 1.568 . . . . 10.0 114.392 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.82 4.93 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.35 66.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 10.0 111.759 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.47 6.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 130.172 3.389 . . . . 10.0 113.689 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.11 13.34 35.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.724 1.21 . . . . 10.0 113.166 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.9 0.27 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.973 2.109 . . . . 10.0 109.806 -163.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.126 1.77 . . . . 10.0 108.834 -179.27 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.232 0 N-CA-C 109.179 -1.568 . . . . 10.0 109.179 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.69 0.15 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 127.152 2.181 . . . . 10.0 110.355 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 112.392 -2.185 . . . . 10.0 113.039 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.43 157.76 43.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.944 1.698 . . . . 10.0 108.057 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 m -131.25 132.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.39 49.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.57 52.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.67 1.129 . . . . 10.0 113.43 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 -63.02 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.86 1.83 . . . . 10.0 107.768 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.4 -25.88 14.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.409 1.483 . . . . 10.0 110.572 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.68 167.0 31.64 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.234 -0.916 . . . . 10.0 111.614 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.82 115.98 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.816 1.246 . . . . 10.0 109.01 -171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.4 167.33 20.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.948 -1.72 . . . . 10.0 110.435 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.2 124.64 40.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.254 1.022 . . . . 10.0 108.883 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.48 41.69 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.816 0.846 . . . . 10.0 113.216 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 m -129.19 74.43 81.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.222 1.009 . . . . 10.0 108.667 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.57 -179.07 2.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 125.111 3.874 . . . . 10.0 112.261 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.91 34.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 124.716 1.207 . . . . 10.0 107.898 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.08 179.11 5.71 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.38 2.054 . . . . 10.0 112.665 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.52 168.26 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.828 2.051 . . . . 10.0 108.902 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -47.1 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.834 2.053 . . . . 10.0 110.45 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.4 21.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 127.37 2.268 . . . . 10.0 105.39 163.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.97 -164.59 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.576 2.184 . . . . 10.0 110.206 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.09 -112.66 2.45 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 106.382 -2.687 . . . . 10.0 106.382 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.15 0.98 . . . . 10.0 108.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.55 140.75 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.323 -1.732 . . . . 10.0 106.323 169.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -99.19 139.13 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -128.51 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.858 -1.905 . . . . 10.0 105.858 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.13 108.03 14.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.93 143.32 54.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.316 1.046 . . . . 10.0 108.573 162.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 158.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.419 1.088 . . . . 10.0 110.396 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.02 175.84 11.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.969 1.308 . . . . 10.0 109.471 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.3 t80 -61.51 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.625 1.17 . . . . 10.0 112.884 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.03 4.54 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.823 1.201 . . . . 10.0 110.312 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.58 84.81 8.4 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.412 2.285 . . . . 10.0 106.087 -163.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.47 168.49 24.18 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.4 2.733 . . . . 10.0 109.25 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.06 -45.69 0.28 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.447 1.899 . . . . 10.0 112.051 -165.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.13 12.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.764 2.026 . . . . 10.0 110.572 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.84 -49.98 75.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.389 1.476 . . . . 10.0 110.874 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.8 -13.49 61.57 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -171.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.7 -16.91 27.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 10.0 112.045 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.083 1.31 . . . . 10.0 112.554 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.92 -9.32 25.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.063 1.773 . . . . 10.0 114.466 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.1 69.24 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.746 1.157 . . . . 10.0 108.851 167.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.26 -28.58 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.846 1.054 . . . . 10.0 113.846 -164.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.37 -60.31 3.84 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.782 1.233 . . . . 10.0 109.524 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.44 78.62 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 120.266 1.131 . . . . 10.0 112.917 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.19 -51.65 68.46 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.382 0.673 . . . . 10.0 110.378 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.1 80.63 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.154 0.502 . . . . 10.0 110.265 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.97 -25.45 64.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.124 -0.985 . . . . 10.0 111.453 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.74 10.07 39.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.576 1.15 . . . . 10.0 112.887 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.95 151.23 75.1 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.511 1.05 . . . . 10.0 110.977 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.04 169.62 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 124.054 3.17 . . . . 10.0 110.477 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.03 -4.2 4.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.02 1.328 . . . . 10.0 113.434 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.66 8.43 43.36 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.688 1.595 . . . . 10.0 110.63 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.66 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 O-C-N 121.241 -0.912 . . . . 10.0 108.827 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -145.6 136.82 24.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.501 -1.227 . . . . 10.0 108.507 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -114.65 135.88 53.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.96 0.41 . . . . 10.0 111.704 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.26 139.81 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.425 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -108.8 121.62 45.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.191 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 18.7 mt -121.76 138.21 28.24 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 112.787 0.662 . . . . 10.0 112.787 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.71 152.85 22.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.0 2.467 . . . . 10.0 112.395 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.37 98.08 9.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.502 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.0 76.74 8.56 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.913 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.54 20.23 1.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.04 -48.12 3.43 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.879 -1.763 . . . . 10.0 112.827 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.48 -152.06 1.54 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.279 0.943 . . . . 10.0 110.791 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.79 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.04 0.936 . . . . 10.0 112.07 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.49 6.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.093 1.757 . . . . 10.0 113.336 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.85 -36.43 64.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.642 1.11 . . . . 10.0 110.573 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.89 -55.17 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.9 31.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.49 3.116 . . . . 10.0 112.192 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.19 -42.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 125.383 1.468 . . . . 10.0 111.23 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.55 -41.87 70.29 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 117.721 -1.133 . . . . 10.0 112.45 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.44 8.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 114.129 1.159 . . . . 10.0 114.129 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.87 -45.71 92.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.525 0.602 . . . . 10.0 110.26 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.45 -45.24 95.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 116.71 -1.614 . . . . 10.0 109.257 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.67 92.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.628 1.558 . . . . 10.0 110.835 -177.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.029 1.732 . . . . 10.0 109.448 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.72 -28.94 66.23 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 118.909 -0.567 . . . . 10.0 111.805 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.68 -37.2 49.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.33 1.052 . . . . 10.0 110.677 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.88 -22.44 56.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.63 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.43 14.47 61.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.85 0.738 . . . . 10.0 112.955 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.32 130.23 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.994 1.318 . . . . 10.0 109.261 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.54 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.574 0.75 . . . . 10.0 109.011 -165.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.707 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.29 -5.4 54.35 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 117.067 2.247 . . . . 10.0 117.067 -170.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.99 7.49 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.332 1.853 . . . . 10.0 112.072 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.96 -47.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 117.413 -1.28 . . . . 10.0 113.431 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.707 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.84 34.85 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.599 1.545 . . . . 10.0 113.183 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.44 -44.43 0.61 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.814 -1.179 . . . . 10.0 108.938 172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.57 45.68 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.484 1.291 . . . . 10.0 114.484 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.47 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 117.588 -1.196 . . . . 10.0 108.654 166.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.63 -46.75 73.96 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.368 1.44 . . . . 10.0 111.98 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.53 -40.54 83.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.458 1.503 . . . . 10.0 110.14 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.12 4.49 5.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 112.883 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.24 -57.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.002 -2.221 . . . . 10.0 105.002 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.57 -61.29 2.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.764 0.825 . . . . 10.0 112.621 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.36 -21.27 64.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.09 0.859 . . . . 10.0 112.136 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.41 -53.48 3.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.571 1.148 . . . . 10.0 108.799 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.483 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.46 88.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.556 1.542 . . . . 10.0 110.618 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.29 13.73 15.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.411 1.084 . . . . 10.0 113.328 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.96 -64.29 0.36 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.26 2.624 . . . . 10.0 109.537 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.6 mt 54.54 44.73 28.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.768 1.627 . . . . 10.0 112.417 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.73 14.51 21.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.267 1.427 . . . . 10.0 114.137 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.05 155.45 29.21 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 127.983 2.513 . . . . 10.0 107.679 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.27 -44.99 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 10.0 109.936 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.97 -29.41 67.62 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.175 0.99 . . . . 10.0 111.182 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.08 70.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.981 1.313 . . . . 10.0 110.386 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.98 -48.52 17.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.15 0.98 . . . . 10.0 108.895 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.21 84.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 123.396 0.435 . . . . 10.0 111.357 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.12 -46.9 79.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.235 1.414 . . . . 10.0 112.506 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.2 -41.73 60.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.543 0.737 . . . . 10.0 111.388 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.89 -14.75 59.84 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.31 -0.869 . . . . 10.0 110.378 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.78 30.72 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.766 0.827 . . . . 10.0 110.1 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.97 10.14 53.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.93 -1.483 . . . . 10.0 114.85 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.41 8.88 6.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.389 2.595 . . . . 10.0 112.601 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 49.3 4.12 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.638 -1.385 . . . . 10.0 109.638 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.6 132.96 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.39 133.73 35.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.615 0.766 . . . . 10.0 109.993 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.66 -36.96 85.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.729 -0.653 . . . . 10.0 110.375 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.01 -26.81 66.97 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.692 0.678 . . . . 10.0 111.75 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.04 4.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.328 -1.73 . . . . 10.0 106.328 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.9 -59.48 4.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.831 1.252 . . . . 10.0 112.156 -166.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.57 -33.63 64.74 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.296 -0.261 . . . . 10.0 110.296 -170.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 m -62.32 -49.43 75.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.34 92.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.571 1.148 . . . . 10.0 110.264 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.24 -48.71 45.46 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.658 1.117 . . . . 10.0 110.837 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.61 38.92 1.02 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.66 0.784 . . . . 10.0 111.278 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.29 8.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.372 1.469 . . . . 10.0 111.694 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.31 86.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.775 1.23 . . . . 10.0 110.562 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.92 54.54 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.677 0.791 . . . . 10.0 110.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.44 -38.83 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.191 0.997 . . . . 10.0 111.269 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.26 63.72 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.059 0.944 . . . . 10.0 110.974 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.3 -48.38 19.3 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.17 82.8 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.766 -0.844 . . . . 10.0 109.582 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 117.802 -1.094 . . . . 10.0 111.557 178.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.78 3.86 37.28 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.698 0.624 . . . . 10.0 112.09 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -99.06 -45.95 5.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.714 0.292 . . . . 10.0 110.697 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.63 -8.69 55.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.738 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -77.28 -44.31 30.22 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.753 0.311 . . . . 10.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -18.27 58.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.157 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 C--O 1.226 -0.144 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.201 179.661 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 mtm . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.776 0.322 . . . . 10.0 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.91 78.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.615 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -69.98 4.96 1.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.142 1.777 . . . . 10.0 113.518 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.5 36.73 26.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.976 2.11 . . . . 10.0 112.064 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.39 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.23 -16.08 4.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.672 1.989 . . . . 10.0 110.284 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.34 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.959 1.742 . . . . 10.0 112.744 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.5 153.02 61.67 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.329 2.252 . . . . 10.0 108.336 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.56 152.74 71.52 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.57 -1.012 . . . . 10.0 113.086 -6.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.9 m -145.95 144.22 30.0 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.281 1.432 . . . . 10.0 108.562 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.86 158.42 31.91 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.832 1.653 . . . . 10.0 108.294 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.975 -1.491 . . . . 10.0 106.975 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.97 135.2 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 168.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 t30 47.02 10.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 1 C-N-CA 133.145 4.578 . . . . 10.0 117.546 171.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.66 20.13 60.48 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.839 -1.534 . . . . 10.0 115.605 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.81 -41.31 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.897 1.849 . . . . 10.0 114.353 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -112.87 107.59 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.46 24.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 126.54 1.936 . . . . 10.0 106.713 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.58 169.61 17.42 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.297 -1.502 . . . . 10.0 107.162 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.81 1.28 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.643 0.377 . . . . 10.0 110.175 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.25 -50.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 128.557 2.743 . . . . 10.0 107.687 160.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.04 16.53 4.43 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.952 1.739 . . . . 10.0 114.354 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.772 1.286 . . . . 10.0 109.689 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.47 -34.49 72.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.098 1.359 . . . . 10.0 112.283 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.5 -5.9 9.95 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-O 118.554 -1.137 . . . . 10.0 114.852 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.28 35.23 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.614 1.707 . . . . 10.0 109.913 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.54 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.378 2.052 . . . . 10.0 111.816 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.39 -28.63 69.92 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.006 -1.059 . . . . 10.0 111.488 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.47 -27.15 66.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.104 0.562 . . . . 10.0 110.344 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.7 -42.84 33.05 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.971 -1.081 . . . . 10.0 110.928 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.8 -31.91 73.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.926 0.784 . . . . 10.0 110.975 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.45 8.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.637 1.975 . . . . 10.0 108.079 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.6 -41.3 92.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 116.898 -1.525 . . . . 10.0 111.53 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.74 69.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.987 1.721 . . . . 10.0 111.693 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.04 65.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 10.0 110.592 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.45 -42.63 96.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.604 0.762 . . . . 10.0 111.254 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.12 -37.43 83.86 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.958 -1.089 . . . . 10.0 111.219 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.7 mt -58.23 -51.93 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.265 0.939 . . . . 10.0 108.604 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.97 -43.08 63.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.579 1.151 . . . . 10.0 110.07 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.64 -0.37 33.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.183 -1.389 . . . . 10.0 113.157 -175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.05 -33.33 9.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.656 1.582 . . . . 10.0 114.442 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -55.72 5.02 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.445 -1.317 . . . . 10.0 107.445 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.34 -20.32 66.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 10.0 111.756 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.36 6.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.08 3.352 . . . . 10.0 113.694 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 13.39 35.29 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.729 1.212 . . . . 10.0 113.111 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.31 76.93 0.27 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.886 2.075 . . . . 10.0 109.827 -163.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.13 1.772 . . . . 10.0 108.878 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 109.175 -1.57 . . . . 10.0 109.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.22 73.71 0.15 Allowed 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 127.046 2.138 . . . . 10.0 110.324 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.467 -2.151 . . . . 10.0 113.053 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.47 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.995 1.718 . . . . 10.0 108.063 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.18 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.44 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.66 52.29 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.67 1.129 . . . . 10.0 113.405 -167.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.11 0.97 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.794 1.797 . . . . 10.0 107.745 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.37 -25.94 14.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.383 1.473 . . . . 10.0 110.528 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.08 31.3 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.345 -0.847 . . . . 10.0 111.694 -171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.87 115.85 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.874 1.27 . . . . 10.0 109.07 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.33 167.37 20.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 119.924 -1.735 . . . . 10.0 110.5 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.64 40.88 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.261 1.024 . . . . 10.0 108.9 172.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.29 -9.55 41.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.816 0.846 . . . . 10.0 113.22 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.1 m -129.23 74.39 81.07 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.255 1.022 . . . . 10.0 108.692 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.53 -179.0 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 125.084 3.856 . . . . 10.0 112.231 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.69 138.91 34.13 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.685 1.194 . . . . 10.0 107.905 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.05 179.12 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.474 2.116 . . . . 10.0 112.593 176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.57 168.24 21.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.845 2.058 . . . . 10.0 108.902 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -46.99 -61.88 1.67 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.817 2.047 . . . . 10.0 110.489 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.37 21.27 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 127.319 2.248 . . . . 10.0 105.378 163.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.91 -164.64 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.524 2.149 . . . . 10.0 110.237 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.16 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.355 -2.698 . . . . 10.0 106.355 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.49 133.76 46.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.03 0.932 . . . . 10.0 108.744 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.78 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.312 -1.736 . . . . 10.0 106.312 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.16 139.14 35.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.3 t -128.5 130.35 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.11 108.13 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.42 54.36 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.219 1.008 . . . . 10.0 108.524 162.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.86 131.1 53.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 158.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.28 176.78 7.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.515 1.126 . . . . 10.0 110.414 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.0 175.83 11.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.008 1.323 . . . . 10.0 109.469 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.3 t80 -61.48 -73.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 10.0 112.905 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.08 4.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.824 1.202 . . . . 10.0 110.322 -171.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.55 84.73 8.26 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 127.472 2.309 . . . . 10.0 106.115 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.5 168.6 23.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.281 2.654 . . . . 10.0 109.252 171.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.446 1.898 . . . . 10.0 112.068 -165.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.73 -53.22 12.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.736 2.015 . . . . 10.0 110.542 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.89 -49.88 76.13 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.349 1.46 . . . . 10.0 110.877 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.88 -13.4 61.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.683 0.623 . . . . 10.0 112.683 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.83 -16.73 27.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.659 1.584 . . . . 10.0 112.029 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.72 -67.26 0.41 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.081 1.309 . . . . 10.0 112.569 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.08 -9.13 25.49 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 122.031 1.761 . . . . 10.0 114.411 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.29 68.97 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 10.0 108.781 167.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.46 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.906 1.076 . . . . 10.0 113.906 -164.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.37 -60.39 3.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 10.0 109.505 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.18 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.255 1.127 . . . . 10.0 112.996 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -57.18 -51.64 68.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.407 0.683 . . . . 10.0 110.367 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.2 80.74 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.171 0.51 . . . . 10.0 110.279 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.53 64.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.211 -0.931 . . . . 10.0 111.393 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.7 10.13 39.62 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.613 1.165 . . . . 10.0 112.905 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.99 151.25 75.4 Favored Pre-proline 0 C--O 1.237 0.416 0 CA-C-N 119.483 1.038 . . . . 10.0 110.953 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.13 169.75 21.44 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.003 3.135 . . . . 10.0 110.509 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -4.14 4.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.973 1.309 . . . . 10.0 113.394 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.41 43.33 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.671 1.588 . . . . 10.0 110.61 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.49 164.97 30.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 121.141 -0.974 . . . . 10.0 108.809 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -145.81 137.25 24.94 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.497 -1.229 . . . . 10.0 108.402 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -115.45 137.07 52.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.913 0.387 . . . . 10.0 111.553 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.08 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.468 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -109.17 126.75 53.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.255 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -127.07 139.19 34.42 Favored Pre-proline 0 N--CA 1.462 0.172 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.23 153.16 21.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.974 2.449 . . . . 10.0 112.241 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.87 99.02 10.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.296 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.18 76.9 8.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.757 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.69 20.26 1.17 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.122 1.527 . . . . 10.0 115.122 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.1 3.43 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 119.886 -1.759 . . . . 10.0 112.852 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.08 1.53 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.292 0.949 . . . . 10.0 110.78 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.83 -30.78 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.088 0.955 . . . . 10.0 112.057 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.43 -27.44 6.45 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.124 1.77 . . . . 10.0 113.337 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.87 -36.37 64.81 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.661 1.119 . . . . 10.0 110.588 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.6 t -73.88 -55.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.533 3.133 . . . . 10.0 112.171 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.13 -42.5 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 125.336 1.446 . . . . 10.0 111.239 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.59 -41.9 70.43 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.778 -1.106 . . . . 10.0 112.471 -175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.38 -44.34 8.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 114.183 1.179 . . . . 10.0 114.183 -173.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.9 -45.77 92.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.49 0.586 . . . . 10.0 110.201 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -45.31 94.95 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 116.761 -1.59 . . . . 10.0 109.205 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.7 92.0 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.601 1.546 . . . . 10.0 110.789 -176.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -60.59 3.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.015 1.726 . . . . 10.0 109.35 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.7 -28.92 66.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 118.963 -0.542 . . . . 10.0 111.767 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.63 -37.22 49.24 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.401 1.081 . . . . 10.0 110.71 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.86 -22.46 56.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.606 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.34 14.54 61.84 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.906 0.765 . . . . 10.0 113.0 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.37 130.28 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.932 1.293 . . . . 10.0 109.326 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -123.54 75.96 1.37 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -165.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.706 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.27 -5.37 54.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.11 2.263 . . . . 10.0 117.11 -170.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.32 52.02 7.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.343 1.857 . . . . 10.0 112.071 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 117.484 -1.246 . . . . 10.0 113.368 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.706 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.83 34.91 1.3 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.565 1.529 . . . . 10.0 113.14 -176.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.42 -44.5 0.61 Allowed 'General case' 0 C--O 1.219 -0.505 0 O-C-N 120.822 -1.174 . . . . 10.0 108.899 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.44 44.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.45 -65.62 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 117.654 -1.165 . . . . 10.0 108.673 166.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.61 -46.81 73.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.255 1.389 . . . . 10.0 111.98 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.56 82.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.406 1.482 . . . . 10.0 110.186 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.11 4.5 5.47 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.76 1.624 . . . . 10.0 112.896 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.21 -57.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.071 -2.196 . . . . 10.0 105.071 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.65 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.706 0.802 . . . . 10.0 112.615 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.34 -21.1 64.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.115 0.87 . . . . 10.0 112.217 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.52 -53.48 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.591 1.157 . . . . 10.0 108.772 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.56 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.44 87.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.571 1.548 . . . . 10.0 110.671 -169.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.18 13.75 15.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.399 1.08 . . . . 10.0 113.389 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.94 -64.25 0.36 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.207 2.603 . . . . 10.0 109.567 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.7 mt 54.61 44.53 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.764 1.626 . . . . 10.0 112.504 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.56 20.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.269 1.428 . . . . 10.0 114.208 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.33 28.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 127.921 2.488 . . . . 10.0 107.682 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.11 -45.04 10.87 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.575 2.183 . . . . 10.0 109.968 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.3 67.39 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.232 1.013 . . . . 10.0 111.175 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.56 -42.08 70.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.941 1.297 . . . . 10.0 110.336 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.92 -48.55 17.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.208 1.003 . . . . 10.0 108.886 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.2 84.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 122.76 0.424 . . . . 10.0 111.418 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.93 78.75 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.279 1.432 . . . . 10.0 112.569 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.65 61.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.535 0.734 . . . . 10.0 111.448 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.371 -0.83 . . . . 10.0 110.366 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.79 30.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.893 0.877 . . . . 10.0 110.095 172.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.09 54.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.917 -1.49 . . . . 10.0 114.773 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.84 6.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 121.358 2.579 . . . . 10.0 112.652 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.25 4.12 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.629 -1.388 . . . . 10.0 109.629 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.57 132.95 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 105.161 -2.163 . . . . 10.0 105.161 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.65 35.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.611 0.764 . . . . 10.0 110.005 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.53 -37.03 86.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.791 -0.623 . . . . 10.0 110.366 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.06 -26.8 66.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.733 0.697 . . . . 10.0 111.717 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.03 4.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.95 -59.45 4.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.829 1.252 . . . . 10.0 112.192 -166.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.56 -33.69 64.79 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.226 -0.287 . . . . 10.0 110.226 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 m -62.2 -49.49 75.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.75 -41.27 92.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.518 1.127 . . . . 10.0 110.255 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.15 -48.71 44.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.723 1.147 . . . . 10.0 110.84 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.66 38.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.697 0.799 . . . . 10.0 111.191 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.31 8.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.413 1.485 . . . . 10.0 111.624 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.19 -40.36 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.852 1.261 . . . . 10.0 110.473 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.84 55.59 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.682 0.793 . . . . 10.0 110.46 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.5 -38.84 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.244 1.018 . . . . 10.0 111.261 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.23 63.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 10.0 111.001 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.41 19.48 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.2 82.93 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.732 -0.863 . . . . 10.0 109.553 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.32 -34.15 77.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.74 -1.124 . . . . 10.0 111.432 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.12 1.76 39.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.749 0.704 . . . . 10.0 111.922 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.5 -52.91 3.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.587 0.232 . . . . 10.0 110.533 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.31 -5.88 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.137 0.421 . . . . 10.0 112.137 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.0 tmmt? -79.1 -45.92 19.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.938 0.399 . . . . 10.0 110.821 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -19.59 59.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.164 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 54.6 mt . . . . . 0 C--O 1.227 -0.084 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.605 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.74 0.305 . . . . 10.0 111.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.87 82.97 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.631 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 5.04 1.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.158 1.783 . . . . 10.0 113.558 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.41 36.74 26.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.916 2.086 . . . . 10.0 112.077 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.3 135.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.729 -1.211 . . . . 10.0 107.729 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.2 -16.08 4.06 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.637 1.975 . . . . 10.0 110.261 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -170.89 33.64 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.036 1.779 . . . . 10.0 112.853 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.49 153.02 61.71 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.271 2.228 . . . . 10.0 108.299 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.57 152.65 71.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.561 -1.016 . . . . 10.0 113.152 -6.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.6 m -145.81 144.3 30.19 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.317 1.447 . . . . 10.0 108.583 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.96 158.39 32.15 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.837 1.655 . . . . 10.0 108.19 163.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.5 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.6 t -104.08 135.16 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 107.117 -1.438 . . . . 10.0 107.117 168.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.09 10.97 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 133.19 4.596 . . . . 10.0 117.463 171.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.11 60.57 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.77 -1.572 . . . . 10.0 115.57 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.89 -41.31 1.04 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.976 1.888 . . . . 10.0 114.325 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.77 107.58 16.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.01 113.37 24.46 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 126.549 1.94 . . . . 10.0 106.765 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.53 169.62 17.39 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 120.344 -1.473 . . . . 10.0 107.159 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.92 -178.82 1.3 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.603 0.361 . . . . 10.0 110.171 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.28 -50.06 5.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 128.483 2.713 . . . . 10.0 107.811 160.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.53 4.5 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.849 1.69 . . . . 10.0 114.365 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.25 -51.25 1.3 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.759 1.28 . . . . 10.0 109.697 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.6 72.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.1 1.36 . . . . 10.0 112.238 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.51 -5.87 9.94 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.489 -1.173 . . . . 10.0 114.844 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.79 174.31 35.17 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.699 1.749 . . . . 10.0 110.012 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.86 -52.57 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.391 2.061 . . . . 10.0 111.81 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.37 -28.66 69.92 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.907 -1.121 . . . . 10.0 111.478 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.16 66.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.044 0.538 . . . . 10.0 110.406 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.63 -42.94 33.08 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.079 -1.013 . . . . 10.0 110.938 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.96 73.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.941 0.791 . . . . 10.0 111.01 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.47 8.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.604 1.962 . . . . 10.0 108.057 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.61 -41.27 92.94 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 116.888 -1.53 . . . . 10.0 111.508 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.81 69.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 121.017 1.735 . . . . 10.0 111.663 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.46 -47.01 65.33 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.844 0.458 . . . . 10.0 110.661 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.5 -42.64 96.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.581 0.752 . . . . 10.0 111.245 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.07 -37.39 83.94 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.922 -1.111 . . . . 10.0 111.247 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.26 -51.92 65.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 119.265 0.939 . . . . 10.0 108.553 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.03 -43.1 63.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.622 1.169 . . . . 10.0 109.972 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.69 -0.29 33.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.15 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.38 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.647 1.579 . . . . 10.0 114.425 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -55.77 4.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.833 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.71 -35.54 6.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.174 3.389 . . . . 10.0 113.65 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.08 13.42 35.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.682 1.193 . . . . 10.0 113.105 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.34 76.87 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.93 2.092 . . . . 10.0 109.837 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.113 1.765 . . . . 10.0 108.797 -179.227 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.254 0 N-CA-C 109.17 -1.572 . . . . 10.0 109.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.15 73.76 0.15 Allowed 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 127.166 2.186 . . . . 10.0 110.312 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.96 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 112.4 -2.182 . . . . 10.0 113.047 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.44 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.09 1.756 . . . . 10.0 108.037 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.21 132.85 44.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.676 -1.231 . . . . 10.0 107.676 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.41 49.34 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.79 52.37 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.734 1.159 . . . . 10.0 113.375 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 -63.05 0.97 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 119.857 1.828 . . . . 10.0 107.69 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.46 -25.93 14.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.406 1.482 . . . . 10.0 110.517 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.53 167.12 31.15 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.275 -0.891 . . . . 10.0 111.789 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.0 115.98 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.775 1.23 . . . . 10.0 108.968 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.41 20.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.908 -1.745 . . . . 10.0 110.457 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.29 124.64 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.238 1.015 . . . . 10.0 108.822 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.28 -9.5 41.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.86 0.864 . . . . 10.0 113.197 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 m -129.32 74.52 80.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 10.0 108.633 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.63 -179.09 2.62 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 125.095 3.863 . . . . 10.0 112.217 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.82 33.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.716 1.206 . . . . 10.0 107.928 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.97 179.13 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.406 2.071 . . . . 10.0 112.616 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.48 168.2 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 126.926 2.09 . . . . 10.0 108.906 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.76 1.73 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.785 2.034 . . . . 10.0 110.503 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.86 165.32 21.32 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.37 2.268 . . . . 10.0 105.435 163.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.8 -164.72 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.631 2.221 . . . . 10.0 110.249 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.18 -112.72 2.46 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.277 -2.729 . . . . 10.0 106.277 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.37 133.66 45.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.142 0.977 . . . . 10.0 108.739 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.62 140.84 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.355 -1.72 . . . . 10.0 106.355 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.27 139.14 35.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.53 130.42 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.828 -1.916 . . . . 10.0 105.828 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.16 108.07 14.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.335 . . . . 10.0 107.394 -172.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.99 143.37 54.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.292 1.037 . . . . 10.0 108.568 162.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.77 131.05 53.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.898 -0.779 . . . . 10.0 108.898 158.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.475 1.11 . . . . 10.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.79 11.78 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.111 1.364 . . . . 10.0 109.533 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.2 t80 -61.46 -73.15 0.1 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.694 1.198 . . . . 10.0 112.891 172.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.96 52.02 4.54 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.813 1.197 . . . . 10.0 110.307 -171.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.57 84.83 8.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.437 2.295 . . . . 10.0 106.03 -163.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.55 168.51 24.2 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.33 2.687 . . . . 10.0 109.246 171.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.1 -45.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.457 1.903 . . . . 10.0 112.091 -165.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.76 -53.14 12.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 10.0 110.577 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.86 -50.05 75.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.332 1.453 . . . . 10.0 110.824 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.7 -13.55 61.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.71 -16.92 27.64 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.764 1.625 . . . . 10.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.59 -67.3 0.4 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 120.11 1.323 . . . . 10.0 112.587 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.21 25.72 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-N 122.052 1.768 . . . . 10.0 114.469 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.9 -43.12 68.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.734 1.152 . . . . 10.0 108.765 167.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 tt -105.27 -28.48 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -164.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.7 t -46.44 -60.33 3.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.817 1.247 . . . . 10.0 109.475 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.2 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.277 1.135 . . . . 10.0 113.002 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.25 -51.61 68.66 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.356 0.663 . . . . 10.0 110.366 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.99 -39.12 80.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.091 0.472 . . . . 10.0 110.223 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.84 -25.64 64.75 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.178 -0.951 . . . . 10.0 111.431 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.01 39.77 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.607 1.163 . . . . 10.0 112.923 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.99 151.25 75.38 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 119.493 1.042 . . . . 10.0 110.938 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.1 169.74 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.967 3.111 . . . . 10.0 110.541 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -4.2 4.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.018 1.327 . . . . 10.0 113.428 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.39 43.34 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.705 1.602 . . . . 10.0 110.533 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.53 164.87 30.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 121.245 -0.909 . . . . 10.0 108.796 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.53 135.0 21.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.568 -1.196 . . . . 10.0 108.431 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -113.82 138.98 49.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.855 0.359 . . . . 10.0 111.733 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.23 142.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.484 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -109.09 122.34 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.186 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.7 mt -121.59 138.29 28.18 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.76 153.14 22.76 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.937 2.425 . . . . 10.0 112.211 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.69 97.78 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.433 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.12 76.78 8.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.798 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.64 20.31 1.15 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.176 1.547 . . . . 10.0 115.176 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.02 -48.13 3.43 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.937 -1.727 . . . . 10.0 112.88 168.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 -152.14 1.53 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.342 0.973 . . . . 10.0 110.737 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.82 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.154 0.982 . . . . 10.0 112.029 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.48 6.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.093 1.757 . . . . 10.0 113.347 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.88 -36.47 64.8 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.631 1.105 . . . . 10.0 110.464 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.79 -55.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -65.83 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.56 3.144 . . . . 10.0 112.237 170.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.22 -42.47 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 125.409 1.48 . . . . 10.0 111.226 173.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.62 -41.8 70.43 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.744 -1.122 . . . . 10.0 112.461 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.56 -44.26 8.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.119 1.155 . . . . 10.0 114.119 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -61.87 -45.8 92.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.568 0.622 . . . . 10.0 110.252 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.24 95.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 116.74 -1.6 . . . . 10.0 109.16 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.4 -45.69 91.99 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.637 1.562 . . . . 10.0 110.775 -177.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -60.6 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.017 1.727 . . . . 10.0 109.38 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.59 -29.02 66.47 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.962 -0.542 . . . . 10.0 111.855 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.64 -37.28 49.58 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.325 1.05 . . . . 10.0 110.669 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.6 mtp -75.74 -22.49 56.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.72 -0.657 . . . . 10.0 111.709 -170.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.44 61.85 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.844 0.735 . . . . 10.0 112.995 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.3 130.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.957 1.303 . . . . 10.0 109.314 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.59 75.95 1.38 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.572 0.749 . . . . 10.0 108.982 -165.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.33 -5.36 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.077 2.251 . . . . 10.0 117.077 -170.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.39 51.91 7.54 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.352 1.861 . . . . 10.0 112.127 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.92 -47.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.42 -1.276 . . . . 10.0 113.419 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.78 34.84 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.589 1.541 . . . . 10.0 113.131 -176.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.454 0 O-C-N 120.813 -1.179 . . . . 10.0 108.974 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.53 45.52 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -71.47 -65.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 117.556 -1.211 . . . . 10.0 108.698 166.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.75 74.06 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.389 1.45 . . . . 10.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.41 -40.6 82.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.478 1.511 . . . . 10.0 110.156 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.18 4.58 5.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.719 1.608 . . . . 10.0 112.871 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.08 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.56 -61.35 2.0 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.678 0.791 . . . . 10.0 112.671 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.2 64.8 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.045 0.839 . . . . 10.0 112.152 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.63 3.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.614 1.166 . . . . 10.0 108.772 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.569 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.55 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.543 1.537 . . . . 10.0 110.647 -169.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.61 15.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.421 1.088 . . . . 10.0 113.331 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.0 -64.19 0.36 Allowed 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 128.266 2.626 . . . . 10.0 109.513 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt 54.52 44.58 28.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.764 1.625 . . . . 10.0 112.498 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.65 14.56 20.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.324 1.45 . . . . 10.0 114.224 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.42 29.11 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 127.984 2.514 . . . . 10.0 107.629 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.2 -44.92 10.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.551 2.167 . . . . 10.0 110.038 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.35 67.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.229 1.012 . . . . 10.0 111.133 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.48 -42.14 70.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.027 1.331 . . . . 10.0 110.333 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.86 -48.57 18.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.155 0.982 . . . . 10.0 108.908 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.24 84.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 123.402 0.439 . . . . 10.0 111.292 -172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.03 -46.9 78.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.378 1.471 . . . . 10.0 112.565 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.9 t80 -74.2 -41.69 61.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.556 0.742 . . . . 10.0 111.489 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.0 -14.72 59.8 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.367 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.76 30.65 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.86 0.864 . . . . 10.0 110.135 172.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.06 54.19 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 117.969 -1.462 . . . . 10.0 114.906 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.74 6.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.355 2.577 . . . . 10.0 112.674 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.95 49.35 4.08 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.67 132.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.138 -2.171 . . . . 10.0 105.138 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.26 133.7 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.63 0.772 . . . . 10.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.57 -37.0 86.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.375 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.76 66.87 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.721 0.691 . . . . 10.0 111.721 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.65 -57.1 4.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.796 1.238 . . . . 10.0 112.201 -166.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.57 -33.64 64.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.4 m -62.29 -49.5 75.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.28 92.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.522 1.129 . . . . 10.0 110.232 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.28 -48.72 45.79 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.726 1.148 . . . . 10.0 110.721 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.57 38.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.712 0.805 . . . . 10.0 111.195 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.84 172.32 8.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.361 1.464 . . . . 10.0 111.59 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.17 -40.45 86.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.824 1.25 . . . . 10.0 110.444 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.86 54.68 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.745 0.818 . . . . 10.0 110.495 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.47 -38.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.287 1.035 . . . . 10.0 111.321 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.32 63.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.07 0.948 . . . . 10.0 111.003 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.37 19.6 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.12 82.65 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.817 -0.814 . . . . 10.0 109.608 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -33.98 76.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.729 -1.129 . . . . 10.0 111.46 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.41 1.58 38.53 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.627 0.649 . . . . 10.0 112.136 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 11.7 mmtt -96.89 -47.14 5.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 10.0 110.91 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.13 -6.04 58.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -79.44 -44.96 20.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.923 0.392 . . . . 10.0 110.751 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -74.53 -21.21 59.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 37.8 mt . . . . . 0 C--O 1.225 -0.208 0 CA-C-N 116.207 -0.452 . . . . 10.0 111.1 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.1 mtm . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.763 0.316 . . . . 10.0 111.582 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.93 78.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.612 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.0 5.05 1.73 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 113.49 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.3 36.78 26.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.897 2.079 . . . . 10.0 112.127 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.36 135.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.33 -16.04 4.01 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.701 2.0 . . . . 10.0 110.255 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.48 -170.92 33.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.892 1.71 . . . . 10.0 112.72 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.45 153.01 61.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.242 2.217 . . . . 10.0 108.309 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.53 152.67 71.37 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.599 -1.0 . . . . 10.0 113.07 -6.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.1 m -145.86 144.26 30.12 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.351 1.46 . . . . 10.0 108.634 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.94 158.39 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.823 1.649 . . . . 10.0 108.204 163.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.14 136.48 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.06 135.06 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.123 -1.436 . . . . 10.0 107.123 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.08 10.96 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.148 4.579 . . . . 10.0 117.561 171.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.57 20.28 60.34 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.803 -1.554 . . . . 10.0 115.52 -170.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.9 -41.4 1.03 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.962 1.881 . . . . 10.0 114.346 -170.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.69 107.58 16.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.553 1.941 . . . . 10.0 106.765 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -136.59 169.54 17.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.141 -1.429 . . . . 10.0 107.141 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.8 1.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.585 0.354 . . . . 10.0 110.193 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.26 -50.1 5.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 128.569 2.748 . . . . 10.0 107.717 160.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.13 16.57 4.48 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.834 1.683 . . . . 10.0 114.4 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -128.28 -51.21 1.3 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.793 1.297 . . . . 10.0 109.692 168.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.59 72.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.037 1.335 . . . . 10.0 112.298 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.54 -5.98 9.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 118.496 -1.169 . . . . 10.0 114.754 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.36 35.26 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 119.75 1.775 . . . . 10.0 110.046 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 -52.62 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.354 2.036 . . . . 10.0 111.724 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.27 -28.7 69.9 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.999 -1.063 . . . . 10.0 111.539 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.12 66.81 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.07 0.548 . . . . 10.0 110.409 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.69 -42.9 32.92 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.014 -1.054 . . . . 10.0 110.939 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.76 -31.83 73.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.91 0.777 . . . . 10.0 111.04 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.56 -56.4 8.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.502 1.921 . . . . 10.0 108.053 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.56 -41.33 93.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 116.917 -1.516 . . . . 10.0 111.509 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.65 69.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.996 1.725 . . . . 10.0 111.729 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.58 -47.04 64.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.863 0.465 . . . . 10.0 110.58 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.45 -42.63 96.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.608 0.763 . . . . 10.0 111.256 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.08 -37.38 83.89 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 120.94 -1.1 . . . . 10.0 111.266 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.31 -51.89 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.261 0.937 . . . . 10.0 108.582 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.06 63.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.543 1.137 . . . . 10.0 110.064 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.63 -0.46 33.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 117.145 -1.407 . . . . 10.0 113.123 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.03 -33.37 9.29 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.627 1.571 . . . . 10.0 114.429 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -55.8 4.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.372 -1.344 . . . . 10.0 107.372 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.32 66.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.159 -0.928 . . . . 10.0 111.795 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.41 6.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 130.122 3.369 . . . . 10.0 113.73 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.16 13.51 34.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.653 1.181 . . . . 10.0 113.153 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.977 2.111 . . . . 10.0 109.819 -163.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.085 1.754 . . . . 10.0 108.787 -179.16 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.292 0 N-CA-C 109.203 -1.559 . . . . 10.0 109.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.66 0.15 Allowed 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 127.081 2.152 . . . . 10.0 110.423 -175.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.2 11.9 0.66 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 112.45 -2.159 . . . . 10.0 112.997 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.41 157.75 43.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.028 1.731 . . . . 10.0 108.009 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.25 132.81 44.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.48 49.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.187 -1.042 . . . . 10.0 108.187 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.6 13.73 52.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.713 1.149 . . . . 10.0 113.423 -166.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.03 0.98 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.858 1.829 . . . . 10.0 107.853 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.4 -26.07 14.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.427 1.491 . . . . 10.0 110.45 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.5 167.14 31.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.25 -0.906 . . . . 10.0 111.702 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.91 115.98 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.802 1.241 . . . . 10.0 109.036 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.41 167.25 20.42 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.927 -1.733 . . . . 10.0 110.534 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.62 40.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.213 1.005 . . . . 10.0 108.835 172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 m -67.32 -9.39 40.61 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.228 0.825 . . . . 10.0 113.228 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -129.35 74.39 81.0 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.14 0.976 . . . . 10.0 108.574 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.53 -179.08 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 125.095 3.864 . . . . 10.0 112.246 -172.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.91 34.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.681 1.193 . . . . 10.0 107.932 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.08 179.08 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.457 2.105 . . . . 10.0 112.601 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.48 168.23 20.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.801 2.04 . . . . 10.0 108.931 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.0 -61.8 1.71 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.808 2.043 . . . . 10.0 110.531 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.03 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.321 2.248 . . . . 10.0 105.34 163.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.9 -164.62 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.576 2.184 . . . . 10.0 110.229 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.67 2.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.323 -2.711 . . . . 10.0 106.323 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.51 133.79 46.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.075 0.95 . . . . 10.0 108.697 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.65 140.76 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.16 35.3 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.5 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.962 -1.866 . . . . 10.0 105.962 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.12 108.16 14.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -172.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.14 143.37 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.305 1.042 . . . . 10.0 108.463 162.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.73 131.14 53.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 158.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.42 176.82 7.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 10.0 110.381 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.82 11.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.0 109.464 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.47 -73.22 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.66 1.184 . . . . 10.0 112.842 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.06 4.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.778 1.18 . . . . 10.0 110.326 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.52 84.76 8.23 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 127.464 2.306 . . . . 10.0 106.111 -163.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.5 168.49 24.2 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.339 2.693 . . . . 10.0 109.239 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.07 -45.7 0.28 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.431 1.892 . . . . 10.0 112.081 -165.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.87 -53.09 12.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.767 2.027 . . . . 10.0 110.518 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.6 t80 -59.05 -49.87 76.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.423 1.489 . . . . 10.0 110.796 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.47 61.63 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -171.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.85 27.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.69 1.596 . . . . 10.0 112.046 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.6 -67.31 0.4 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.174 1.352 . . . . 10.0 112.56 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.0 -9.18 25.67 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 121.986 1.745 . . . . 10.0 114.425 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.2 69.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.812 1.187 . . . . 10.0 108.837 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.22 -28.49 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 113.874 1.065 . . . . 10.0 113.874 -164.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.43 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.746 1.218 . . . . 10.0 109.48 173.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.85 -35.39 78.65 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.273 1.133 . . . . 10.0 112.897 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.24 -51.66 68.47 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.431 0.693 . . . . 10.0 110.304 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.89 -39.22 80.79 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.169 0.509 . . . . 10.0 110.25 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.79 -25.71 64.84 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.096 -1.002 . . . . 10.0 111.415 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.07 39.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.513 1.125 . . . . 10.0 112.923 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.86 151.17 74.5 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 119.485 1.039 . . . . 10.0 110.971 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.07 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.987 3.125 . . . . 10.0 110.49 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.12 -4.19 4.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.011 1.324 . . . . 10.0 113.395 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.62 8.34 43.45 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.743 1.617 . . . . 10.0 110.627 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.52 164.94 30.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 O-C-N 121.189 -0.945 . . . . 10.0 108.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -146.08 137.07 24.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.402 -1.272 . . . . 10.0 108.444 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -117.3 135.64 53.68 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.804 0.335 . . . . 10.0 111.725 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.92 138.67 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.81 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -104.42 118.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.02 138.44 27.01 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.88 152.89 25.32 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.028 2.485 . . . . 10.0 112.4 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 96.96 8.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.271 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.1 76.8 8.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.363 -0.38 . . . . 10.0 111.776 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.22 1.16 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.132 1.53 . . . . 10.0 115.132 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.11 -48.18 3.42 Favored Glycine 0 N--CA 1.467 0.723 0 O-C-N 119.933 -1.729 . . . . 10.0 112.752 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.39 -152.13 1.52 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.389 0.995 . . . . 10.0 110.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.86 -30.75 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.077 0.951 . . . . 10.0 112.081 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.34 -27.52 6.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.049 1.74 . . . . 10.0 113.396 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.86 -36.46 64.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.66 1.118 . . . . 10.0 110.478 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.9 t -73.88 -55.14 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.94 31.91 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.519 3.128 . . . . 10.0 112.137 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.19 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 125.332 1.444 . . . . 10.0 111.196 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.47 -41.86 70.0 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.53 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.32 8.45 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.121 1.156 . . . . 10.0 114.121 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.89 -45.67 92.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.503 0.592 . . . . 10.0 110.335 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.38 -45.33 94.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.786 -1.578 . . . . 10.0 109.251 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.63 92.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.592 1.542 . . . . 10.0 110.829 -177.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.6 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.99 1.716 . . . . 10.0 109.483 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.64 -29.03 66.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.919 -0.562 . . . . 10.0 111.789 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.57 -37.24 48.79 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.362 1.065 . . . . 10.0 110.701 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.8 -22.46 56.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.695 -170.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.46 61.83 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.871 0.748 . . . . 10.0 112.986 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.41 130.32 26.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 124.916 1.286 . . . . 10.0 109.277 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.87 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.605 0.762 . . . . 10.0 109.022 -165.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.704 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.26 -5.39 54.26 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.103 2.26 . . . . 10.0 117.103 -170.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 51.96 7.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.313 1.845 . . . . 10.0 112.114 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.93 -47.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.455 -1.26 . . . . 10.0 113.381 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.704 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.93 34.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.576 1.535 . . . . 10.0 113.199 -176.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.41 -44.57 0.61 Allowed 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.832 -1.167 . . . . 10.0 108.84 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.48 44.7 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.605 1.335 . . . . 10.0 114.605 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -71.53 -65.49 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 117.518 -1.23 . . . . 10.0 108.695 166.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.72 74.04 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.407 1.458 . . . . 10.0 112.048 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.49 -40.48 82.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.388 1.475 . . . . 10.0 110.241 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.3 4.65 5.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.818 1.647 . . . . 10.0 112.826 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.29 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.991 -2.225 . . . . 10.0 104.991 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.62 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.713 0.805 . . . . 10.0 112.625 -173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.502 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.26 -21.22 64.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.093 0.86 . . . . 10.0 112.189 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.42 -53.51 3.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.58 1.152 . . . . 10.0 108.831 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.38 88.03 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 10.0 110.656 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.63 15.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.382 1.073 . . . . 10.0 113.325 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.01 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 128.217 2.607 . . . . 10.0 109.57 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.0 mt 54.43 44.71 28.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.815 1.646 . . . . 10.0 112.436 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.6 20.63 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.284 1.434 . . . . 10.0 114.189 -173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 155.39 29.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 127.933 2.493 . . . . 10.0 107.643 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.2 -45.01 10.7 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.576 2.184 . . . . 10.0 109.937 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.36 67.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.208 1.003 . . . . 10.0 111.161 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.15 70.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.981 1.313 . . . . 10.0 110.322 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.89 -48.53 18.03 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.165 0.986 . . . . 10.0 108.909 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.16 84.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.461 0.476 . . . . 10.0 111.349 -172.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.11 -46.89 78.95 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.324 1.45 . . . . 10.0 112.51 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.62 60.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.549 0.74 . . . . 10.0 111.412 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.95 -14.71 59.82 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.36 -0.838 . . . . 10.0 110.418 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.52 -41.73 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.814 0.846 . . . . 10.0 110.098 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.07 10.1 54.52 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.0 -1.445 . . . . 10.0 114.845 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.32 8.79 6.59 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.313 2.556 . . . . 10.0 112.64 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.16 4.15 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.696 -1.362 . . . . 10.0 109.696 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.54 132.88 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.165 -2.161 . . . . 10.0 105.165 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -92.26 133.76 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.561 0.744 . . . . 10.0 110.022 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.63 -36.96 85.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.768 -0.634 . . . . 10.0 110.37 174.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.09 -26.79 66.89 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.637 0.653 . . . . 10.0 111.719 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.06 4.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.334 -1.728 . . . . 10.0 106.334 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.776 1.23 . . . . 10.0 112.241 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.51 -33.65 64.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.3 m -62.34 -49.37 75.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.76 -41.33 92.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.555 1.142 . . . . 10.0 110.207 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.1 -48.73 44.18 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.768 1.167 . . . . 10.0 110.83 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.65 38.84 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.714 0.806 . . . . 10.0 111.116 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.461 1.504 . . . . 10.0 111.657 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.18 -40.35 86.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.782 1.233 . . . . 10.0 110.521 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.82 55.38 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.723 0.809 . . . . 10.0 110.489 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.49 -38.78 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.241 1.016 . . . . 10.0 111.324 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.31 63.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.995 0.918 . . . . 10.0 111.016 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.46 19.72 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.851 -0.899 . . . . 10.0 110.851 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.35 -36.21 82.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.751 -0.852 . . . . 10.0 109.53 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -33.63 75.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.751 -1.118 . . . . 10.0 111.542 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.6 -0.87 34.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.581 0.628 . . . . 10.0 112.373 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 54.2 mmtt -95.26 -44.92 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 10.0 110.8 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.34 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.584 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -79.24 -45.75 19.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.692 0.282 . . . . 10.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -16.58 60.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 45.8 mt . . . . . 0 C--O 1.227 -0.093 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.293 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.763 0.315 . . . . 10.0 111.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.89 78.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.69 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.0 5.02 1.75 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.148 1.779 . . . . 10.0 113.524 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.4 36.8 26.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.885 2.074 . . . . 10.0 112.075 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.17 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.793 2.037 . . . . 10.0 110.319 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.39 -170.96 33.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 126.024 1.773 . . . . 10.0 112.865 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.38 152.99 62.04 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 127.316 2.246 . . . . 10.0 108.341 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.63 152.71 71.76 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.569 -1.013 . . . . 10.0 113.103 -6.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 57.2 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.325 1.45 . . . . 10.0 108.538 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.6 mmm -123.94 158.44 31.99 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.733 1.613 . . . . 10.0 108.225 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.16 136.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.862 -1.533 . . . . 10.0 106.862 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.0 135.2 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.091 -1.448 . . . . 10.0 107.091 168.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 46.99 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 133.151 4.58 . . . . 10.0 117.53 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.67 20.08 60.57 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.778 -1.568 . . . . 10.0 115.552 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.41 1.04 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.954 1.877 . . . . 10.0 114.333 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.72 107.57 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.53 24.55 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.471 1.908 . . . . 10.0 106.79 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.63 169.58 17.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.304 -1.497 . . . . 10.0 107.09 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.91 -178.76 1.29 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.36 -50.08 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 128.482 2.713 . . . . 10.0 107.724 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.54 4.5 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.963 1.744 . . . . 10.0 114.377 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.9 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 118.726 1.263 . . . . 10.0 109.651 168.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.065 1.346 . . . . 10.0 112.247 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.49 -5.68 9.99 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 118.57 -1.128 . . . . 10.0 114.83 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.74 174.25 35.07 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.639 1.719 . . . . 10.0 109.963 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.88 -52.6 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.407 2.072 . . . . 10.0 111.766 -169.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.015 -1.053 . . . . 10.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.41 -27.2 66.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.138 0.575 . . . . 10.0 110.38 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.64 -43.04 32.67 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.097 -1.002 . . . . 10.0 110.822 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.71 -31.87 73.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.965 0.802 . . . . 10.0 111.036 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.48 8.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.537 1.935 . . . . 10.0 108.074 168.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -41.37 93.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.896 -1.526 . . . . 10.0 111.496 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.952 1.705 . . . . 10.0 111.735 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.15 64.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.934 0.494 . . . . 10.0 110.591 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.43 -42.52 96.24 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.584 0.754 . . . . 10.0 111.301 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.18 -37.38 83.61 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.93 -1.106 . . . . 10.0 111.242 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.18 -52.0 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.232 0.924 . . . . 10.0 108.583 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.96 -43.06 63.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.596 1.158 . . . . 10.0 110.016 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.7 -0.4 33.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.154 -1.403 . . . . 10.0 113.139 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.08 -33.25 9.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.637 1.575 . . . . 10.0 114.466 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -55.73 4.99 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.763 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.5 6.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 130.244 3.418 . . . . 10.0 113.638 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.12 13.43 35.19 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.717 1.207 . . . . 10.0 113.117 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.33 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.872 2.069 . . . . 10.0 109.845 -163.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.039 1.736 . . . . 10.0 108.768 -179.272 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.296 0 N-CA-C 109.284 -1.526 . . . . 10.0 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.7 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 127.087 2.155 . . . . 10.0 110.406 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.24 11.86 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.07 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.012 1.725 . . . . 10.0 108.081 -175.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.32 132.75 44.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 148.42 49.48 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.7 13.61 52.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.623 1.106 . . . . 10.0 113.42 -167.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -63.04 0.98 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 119.871 1.835 . . . . 10.0 107.769 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.348 1.459 . . . . 10.0 110.521 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.68 167.02 31.57 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.271 -0.893 . . . . 10.0 111.719 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.82 115.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.836 1.254 . . . . 10.0 109.023 -171.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.45 167.32 20.31 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 119.993 -1.692 . . . . 10.0 110.497 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.69 41.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.29 1.036 . . . . 10.0 108.823 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.44 -9.36 41.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.768 0.827 . . . . 10.0 113.116 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.29 74.34 81.06 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.254 1.022 . . . . 10.0 108.647 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.43 -179.11 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 125.121 3.881 . . . . 10.0 112.29 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.92 34.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.769 1.227 . . . . 10.0 107.948 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.14 179.14 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.427 2.085 . . . . 10.0 112.538 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.54 168.18 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.78 2.032 . . . . 10.0 108.938 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -47.0 -61.87 1.67 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.851 2.06 . . . . 10.0 110.44 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.05 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 127.228 2.211 . . . . 10.0 105.301 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.91 -164.56 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.585 2.19 . . . . 10.0 110.304 173.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.07 -112.7 2.46 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.36 -2.696 . . . . 10.0 106.36 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.48 133.71 45.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.07 0.948 . . . . 10.0 108.785 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.64 140.82 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.305 -1.739 . . . . 10.0 106.305 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.31 139.22 35.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.8 t -128.54 130.43 69.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.901 -1.888 . . . . 10.0 105.901 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 HG12 HD13 ' A' ' 63' ' ' LEU . 11.3 t -131.15 108.09 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -172.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.11 143.39 54.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.236 1.014 . . . . 10.0 108.544 162.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.14 53.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 158.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.36 176.87 7.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.391 1.076 . . . . 10.0 110.365 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.05 175.82 11.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.049 1.34 . . . . 10.0 109.555 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.673 1.189 . . . . 10.0 112.882 172.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.98 52.11 4.56 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.78 1.181 . . . . 10.0 110.293 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.492 ' SG ' HG21 ' A' ' 153' ' ' VAL . 35.7 t -113.57 84.83 8.38 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 127.371 2.268 . . . . 10.0 106.147 -163.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.56 168.55 24.08 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.32 2.68 . . . . 10.0 109.253 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.0 -45.68 0.28 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.482 1.913 . . . . 10.0 112.06 -164.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.81 -53.17 12.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.745 2.018 . . . . 10.0 110.556 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.92 -49.81 76.41 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.349 1.459 . . . . 10.0 110.91 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.52 61.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.63 -16.86 27.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.793 1.637 . . . . 10.0 112.118 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.73 -67.25 0.41 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 120.064 1.302 . . . . 10.0 112.557 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.23 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.066 1.774 . . . . 10.0 114.431 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.85 -43.2 68.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.83 1.195 . . . . 10.0 108.774 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.16 -28.56 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 t -46.35 -60.42 3.68 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.668 1.187 . . . . 10.0 109.492 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.79 -35.42 79.18 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 CA-C-N 120.244 1.123 . . . . 10.0 112.908 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.18 -51.67 68.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.422 0.689 . . . . 10.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -58.92 -39.08 80.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.128 0.489 . . . . 10.0 110.291 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.52 64.61 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.15 -0.969 . . . . 10.0 111.441 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.08 39.81 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.563 1.145 . . . . 10.0 112.834 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.93 151.28 74.72 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 119.52 1.055 . . . . 10.0 110.982 174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.13 169.67 21.59 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.985 3.124 . . . . 10.0 110.537 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.05 -4.19 4.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.969 1.308 . . . . 10.0 113.461 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.72 8.46 43.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.706 1.602 . . . . 10.0 110.6 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.56 165.56 29.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 121.213 -0.929 . . . . 10.0 108.798 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -146.63 135.79 22.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.573 -1.194 . . . . 10.0 108.458 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.87 136.81 52.47 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 t -140.02 139.57 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.022 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -106.33 120.2 41.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.044 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 10.8 mt -118.23 136.45 23.93 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.73 154.64 26.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.502 2.135 . . . . 10.0 112.307 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.78 96.74 7.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.247 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.41 76.77 8.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.757 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.55 20.23 1.15 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.204 1.557 . . . . 10.0 115.204 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.04 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.863 -1.773 . . . . 10.0 112.827 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.54 -152.11 1.58 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.351 0.977 . . . . 10.0 110.759 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.201 1.0 . . . . 10.0 112.002 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.36 -27.44 6.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.123 1.769 . . . . 10.0 113.346 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.96 -36.4 64.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 119.589 1.086 . . . . 10.0 110.498 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.6 t -73.8 -55.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.031 -1.1 . . . . 10.0 108.031 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.532 3.133 . . . . 10.0 112.182 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.12 -42.56 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 125.405 1.479 . . . . 10.0 111.296 173.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.5 -41.86 70.09 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.768 -1.11 . . . . 10.0 112.499 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.5 -44.33 8.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 114.137 1.162 . . . . 10.0 114.137 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.84 -45.77 92.38 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.514 0.597 . . . . 10.0 110.3 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.2 mt -61.39 -45.26 95.1 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 116.744 -1.598 . . . . 10.0 109.209 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.37 -45.7 91.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.652 1.569 . . . . 10.0 110.771 -176.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.005 1.722 . . . . 10.0 109.474 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.66 -29.03 66.4 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 118.955 -0.545 . . . . 10.0 111.767 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.22 49.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.325 1.05 . . . . 10.0 110.748 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 31.0 mtp -75.77 -22.49 56.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.644 -0.693 . . . . 10.0 111.632 -170.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.32 14.54 61.87 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.914 0.768 . . . . 10.0 112.985 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.39 130.28 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.012 1.325 . . . . 10.0 109.272 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.56 76.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.955 -0.758 . . . . 10.0 108.955 -165.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.706 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.35 -5.33 54.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.092 2.256 . . . . 10.0 117.092 -170.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 44.35 51.99 7.45 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.284 1.833 . . . . 10.0 112.11 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.97 -47.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.448 -1.263 . . . . 10.0 113.364 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.706 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.85 34.81 1.29 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.627 1.558 . . . . 10.0 113.159 -176.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.46 0.62 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 120.835 -1.165 . . . . 10.0 108.898 172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.51 45.49 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.542 1.312 . . . . 10.0 114.542 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.42 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 117.67 -1.157 . . . . 10.0 108.756 166.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.48 -46.93 73.5 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.378 1.444 . . . . 10.0 112.033 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.32 -40.65 82.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.473 1.509 . . . . 10.0 110.194 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.07 4.51 5.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.808 1.643 . . . . 10.0 112.899 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.31 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.3 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.683 0.793 . . . . 10.0 112.615 -173.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.33 -21.16 64.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.149 0.886 . . . . 10.0 112.171 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.48 -53.46 3.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.519 1.127 . . . . 10.0 108.781 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.43 88.07 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.541 1.536 . . . . 10.0 110.626 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.39 13.83 15.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.395 1.078 . . . . 10.0 113.267 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.91 -64.24 0.36 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 128.206 2.602 . . . . 10.0 109.591 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.2 mt 54.46 44.63 28.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.734 1.614 . . . . 10.0 112.534 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.63 20.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.228 1.411 . . . . 10.0 114.179 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 155.25 28.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.944 2.498 . . . . 10.0 107.676 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.1 -45.01 10.96 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.525 2.15 . . . . 10.0 109.955 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.22 67.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.193 0.997 . . . . 10.0 111.212 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.13 70.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.02 1.328 . . . . 10.0 110.327 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.89 -48.51 18.07 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.211 1.004 . . . . 10.0 108.93 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.09 84.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.405 0.441 . . . . 10.0 111.367 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.09 -46.94 78.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.307 1.443 . . . . 10.0 112.536 172.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.7 t80 -74.2 -41.78 60.87 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.597 0.759 . . . . 10.0 111.406 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.86 -14.79 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.35 -0.844 . . . . 10.0 110.39 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.39 -41.79 29.97 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.801 0.84 . . . . 10.0 110.18 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.0 10.12 54.13 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 117.931 -1.483 . . . . 10.0 114.846 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.38 8.84 6.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.367 2.583 . . . . 10.0 112.615 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.25 4.13 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.672 -1.371 . . . . 10.0 109.672 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.49 132.94 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.134 -2.173 . . . . 10.0 105.134 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.41 133.72 35.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.608 0.763 . . . . 10.0 109.915 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.63 -36.96 85.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.8 -0.619 . . . . 10.0 110.406 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.96 -26.86 67.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.748 0.704 . . . . 10.0 111.719 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.69 -57.03 4.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.378 -1.712 . . . . 10.0 106.378 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.87 -59.51 4.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.85 1.26 . . . . 10.0 112.164 -166.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.55 -33.67 64.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.5 m -62.28 -49.43 75.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.327 -0.62 . . . . 10.0 109.327 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.73 -41.33 92.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.645 1.178 . . . . 10.0 110.237 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.694 1.133 . . . . 10.0 110.883 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.682 0.793 . . . . 10.0 111.178 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.392 1.477 . . . . 10.0 111.716 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.1 -40.44 86.92 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.911 1.284 . . . . 10.0 110.523 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.9 54.69 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.754 0.822 . . . . 10.0 110.484 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.48 -38.8 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.158 0.983 . . . . 10.0 111.274 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.28 63.73 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.002 0.921 . . . . 10.0 110.99 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.34 19.88 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.861 -0.896 . . . . 10.0 110.861 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.38 -36.21 82.96 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.712 -0.875 . . . . 10.0 109.583 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.36 77.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.767 -1.111 . . . . 10.0 111.517 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -94.95 -15.05 23.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.607 0.639 . . . . 10.0 112.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.482 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 72.3 mmtt -86.9 -47.25 9.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 10.0 110.845 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.79 -9.4 59.01 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.11 -42.47 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.684 0.278 . . . . 10.0 110.989 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -19.45 57.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 68.8 mt . . . . . 0 C--O 1.227 -0.094 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.118 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.852 0.358 . . . . 10.0 111.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.29 -43.87 80.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.664 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.08 5.05 1.77 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.142 1.777 . . . . 10.0 113.477 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 54.38 36.77 26.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.875 2.07 . . . . 10.0 112.142 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.39 135.04 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.682 -1.229 . . . . 10.0 107.682 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.2 -16.14 4.05 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.766 2.026 . . . . 10.0 110.31 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.91 33.64 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.968 1.747 . . . . 10.0 112.769 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.492 HG21 ' SG ' ' A' ' 37' ' ' CYS . 14.7 m -142.51 152.99 61.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 127.216 2.206 . . . . 10.0 108.283 175.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.65 71.41 Favored 'Cis proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.646 -0.981 . . . . 10.0 113.07 -6.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.1 m -145.86 144.3 30.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.331 1.452 . . . . 10.0 108.59 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.94 158.38 32.14 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.792 1.637 . . . . 10.0 108.211 163.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.08 136.41 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.943 -1.502 . . . . 10.0 106.943 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.4 t -104.05 135.21 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.054 -1.462 . . . . 10.0 107.054 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.0 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.132 4.573 . . . . 10.0 117.582 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.1 60.58 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.844 -1.531 . . . . 10.0 115.568 -170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.85 -41.26 1.04 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.931 1.866 . . . . 10.0 114.348 -170.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.76 107.61 16.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 -171.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.97 113.4 24.46 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.522 1.929 . . . . 10.0 106.8 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.51 169.57 17.48 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 120.408 -1.433 . . . . 10.0 107.141 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.95 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.587 0.355 . . . . 10.0 110.11 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.34 -50.01 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 128.466 2.707 . . . . 10.0 107.764 160.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.56 4.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.881 1.705 . . . . 10.0 114.429 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.28 -51.2 1.3 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.724 1.262 . . . . 10.0 109.667 168.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.66 72.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.102 1.361 . . . . 10.0 112.202 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.64 -5.92 9.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.796 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.31 35.23 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.693 1.747 . . . . 10.0 109.96 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.93 -52.57 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.359 2.039 . . . . 10.0 111.758 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.46 -28.58 69.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.977 -1.077 . . . . 10.0 111.486 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.45 -27.1 66.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.101 0.56 . . . . 10.0 110.392 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.96 32.67 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.959 -1.088 . . . . 10.0 110.904 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.7 -31.88 73.19 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.922 0.783 . . . . 10.0 111.026 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.51 -56.4 8.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.557 1.943 . . . . 10.0 108.075 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.54 -41.36 93.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 116.883 -1.532 . . . . 10.0 111.494 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.73 69.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.985 1.721 . . . . 10.0 111.728 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.05 65.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.975 0.51 . . . . 10.0 110.613 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.57 -42.47 96.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.592 0.757 . . . . 10.0 111.263 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.27 -37.32 83.27 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 120.946 -1.096 . . . . 10.0 111.236 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.3 -51.87 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.28 0.945 . . . . 10.0 108.654 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.08 63.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.573 1.149 . . . . 10.0 110.016 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.71 -0.34 33.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.08 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.33 9.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.671 1.589 . . . . 10.0 114.42 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.74 4.99 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.33 -1.359 . . . . 10.0 107.33 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.37 -20.3 66.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.743 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 130.183 3.393 . . . . 10.0 113.639 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.21 13.45 35.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.667 1.187 . . . . 10.0 113.114 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.87 0.27 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.903 2.081 . . . . 10.0 109.799 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.079 1.751 . . . . 10.0 108.805 -179.276 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.293 0 N-CA-C 109.154 -1.578 . . . . 10.0 109.154 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.71 0.15 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.116 2.166 . . . . 10.0 110.357 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.01 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.081 2.153 . . . . 10.0 113.029 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.46 157.69 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.013 1.725 . . . . 10.0 108.047 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.19 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.7 148.45 49.23 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.63 52.08 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.702 1.144 . . . . 10.0 113.437 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 -63.04 0.98 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.788 1.794 . . . . 10.0 107.817 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -98.42 -25.95 14.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.405 1.482 . . . . 10.0 110.506 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.58 167.06 31.38 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.254 -0.904 . . . . 10.0 111.687 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.86 115.91 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.848 1.259 . . . . 10.0 109.054 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.39 20.27 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 119.895 -1.753 . . . . 10.0 110.479 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.56 40.64 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.254 1.022 . . . . 10.0 108.83 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.29 -9.47 41.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.794 0.838 . . . . 10.0 113.19 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 m -129.27 74.4 81.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.163 0.985 . . . . 10.0 108.646 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.58 -179.07 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 125.073 3.849 . . . . 10.0 112.221 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.61 138.88 34.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.698 1.199 . . . . 10.0 107.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -73.01 179.1 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.481 2.121 . . . . 10.0 112.598 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.5 168.27 20.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.804 2.042 . . . . 10.0 108.937 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.809 2.044 . . . . 10.0 110.488 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.83 165.4 21.08 Favored Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 127.315 2.246 . . . . 10.0 105.359 163.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.89 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.55 2.167 . . . . 10.0 110.24 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.58 2.43 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 106.338 -2.705 . . . . 10.0 106.338 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.53 133.71 46.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.116 0.966 . . . . 10.0 108.718 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.59 140.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.25 139.2 35.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.521 -1.288 . . . . 10.0 107.521 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.0 t -128.57 130.39 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.15 108.1 14.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.01 143.36 54.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.271 1.028 . . . . 10.0 108.533 162.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.72 131.12 53.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 158.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.37 176.81 7.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.417 1.087 . . . . 10.0 110.398 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.82 11.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.098 1.359 . . . . 10.0 109.511 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.51 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.607 1.163 . . . . 10.0 112.879 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.89 51.99 4.53 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.775 1.178 . . . . 10.0 110.38 -171.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.45 84.8 8.13 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 127.457 2.303 . . . . 10.0 106.098 -163.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.58 23.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.308 2.672 . . . . 10.0 109.253 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.476 1.911 . . . . 10.0 112.083 -165.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.78 -53.14 12.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.704 2.001 . . . . 10.0 110.572 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.463 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.91 -49.9 76.05 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.327 1.451 . . . . 10.0 110.884 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -13.47 61.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.713 0.635 . . . . 10.0 112.713 -171.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.74 -16.76 27.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.722 1.609 . . . . 10.0 112.118 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.24 0.41 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.094 1.315 . . . . 10.0 112.593 -172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.04 -9.2 25.7 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.988 1.746 . . . . 10.0 114.403 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.87 -43.15 69.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.797 1.18 . . . . 10.0 108.813 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.27 -28.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 -164.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 t -46.46 -60.35 3.82 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.711 1.205 . . . . 10.0 109.471 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.77 -35.42 79.4 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.272 1.133 . . . . 10.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -57.17 -51.66 68.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.418 0.687 . . . . 10.0 110.367 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.94 -39.13 80.68 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.182 0.515 . . . . 10.0 110.258 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.94 -25.54 64.62 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.117 -0.99 . . . . 10.0 111.418 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.68 10.05 39.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.568 1.147 . . . . 10.0 112.897 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.7 mt -60.97 151.26 75.17 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-N 119.513 1.051 . . . . 10.0 110.922 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.13 169.71 21.52 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 124.042 3.161 . . . . 10.0 110.471 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.11 -4.26 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.004 1.322 . . . . 10.0 113.397 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.58 8.35 43.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.744 1.618 . . . . 10.0 110.653 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.48 164.71 31.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 O-C-N 121.161 -0.962 . . . . 10.0 108.834 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -145.98 134.65 22.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.534 -1.212 . . . . 10.0 108.448 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -114.48 135.52 54.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.854 0.359 . . . . 10.0 111.621 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.71 138.91 41.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 10.0 109.685 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -104.91 118.5 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.8 mt -118.75 138.51 26.03 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 112.726 0.639 . . . . 10.0 112.726 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.28 152.86 24.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.933 2.422 . . . . 10.0 112.188 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 97.47 8.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.391 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.88 76.79 8.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.389 -0.369 . . . . 10.0 111.861 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.53 20.16 1.15 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.165 1.542 . . . . 10.0 115.165 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.11 3.42 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 119.939 -1.725 . . . . 10.0 112.793 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.53 -152.08 1.57 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.327 0.965 . . . . 10.0 110.779 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.84 -30.81 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.077 0.951 . . . . 10.0 112.047 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.38 -27.43 6.33 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.079 1.752 . . . . 10.0 113.327 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.95 -36.35 64.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.656 1.116 . . . . 10.0 110.515 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.8 t -73.9 -55.1 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.93 31.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.545 3.138 . . . . 10.0 112.186 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.16 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.33 1.443 . . . . 10.0 111.217 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.57 -41.82 70.3 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.476 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.33 8.46 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 114.181 1.178 . . . . 10.0 114.181 -173.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.85 -45.78 92.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 123.639 0.587 . . . . 10.0 110.241 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -45.24 95.17 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 116.7 -1.619 . . . . 10.0 109.197 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.418 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.46 -45.6 92.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.61 1.55 . . . . 10.0 110.778 -176.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -60.59 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.082 1.753 . . . . 10.0 109.415 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.71 -29.0 66.29 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.796 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.16 48.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.365 1.066 . . . . 10.0 110.703 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.9 -22.42 56.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.663 -170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.44 61.9 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.867 0.746 . . . . 10.0 112.97 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.31 130.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 124.929 1.292 . . . . 10.0 109.337 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.55 75.95 1.37 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.2 -5.47 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.091 2.256 . . . . 10.0 117.091 -170.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 52.0 7.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.329 1.852 . . . . 10.0 112.086 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.93 -47.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 117.452 -1.261 . . . . 10.0 113.403 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.9 34.83 1.31 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.57 1.532 . . . . 10.0 113.084 -176.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.4 -44.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.447 0 O-C-N 120.762 -1.211 . . . . 10.0 108.891 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.55 45.41 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.56 1.318 . . . . 10.0 114.56 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.43 -65.64 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 117.601 -1.19 . . . . 10.0 108.671 166.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.53 -46.81 73.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.324 1.42 . . . . 10.0 112.025 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.56 82.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.479 1.511 . . . . 10.0 110.182 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.22 4.57 5.5 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.774 1.63 . . . . 10.0 112.867 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.28 2.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.706 0.803 . . . . 10.0 112.635 -173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.32 -21.19 64.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.112 0.869 . . . . 10.0 112.171 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.47 3.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.557 1.143 . . . . 10.0 108.79 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.4 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.544 1.538 . . . . 10.0 110.666 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.25 13.74 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.362 1.065 . . . . 10.0 113.34 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.03 -64.27 0.36 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 128.166 2.586 . . . . 10.0 109.57 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.4 mt 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.73 1.612 . . . . 10.0 112.522 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.49 20.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.282 1.433 . . . . 10.0 114.192 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.07 155.41 29.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 127.888 2.475 . . . . 10.0 107.643 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.18 -44.96 10.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.532 2.155 . . . . 10.0 110.012 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.34 67.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.259 1.024 . . . . 10.0 111.19 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.08 70.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.965 1.306 . . . . 10.0 110.344 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.9 -48.56 17.91 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.16 0.984 . . . . 10.0 108.875 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.25 84.57 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 122.761 0.425 . . . . 10.0 111.36 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.86 78.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.279 1.432 . . . . 10.0 112.605 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.69 60.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.609 0.763 . . . . 10.0 111.423 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.376 -0.827 . . . . 10.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.46 -41.73 30.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.788 0.835 . . . . 10.0 110.15 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.08 54.46 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.953 -1.471 . . . . 10.0 114.811 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.33 8.87 6.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.394 2.597 . . . . 10.0 112.604 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.9 49.26 4.12 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.678 -1.369 . . . . 10.0 109.678 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.53 132.89 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.167 -2.16 . . . . 10.0 105.167 169.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.66 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.666 0.786 . . . . 10.0 110.03 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.804 -0.617 . . . . 10.0 110.416 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.14 -26.73 66.81 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.682 0.674 . . . . 10.0 111.706 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.09 4.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.359 -1.719 . . . . 10.0 106.359 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.9 -59.44 4.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.819 1.248 . . . . 10.0 112.169 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.56 -33.7 64.8 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.254 -0.276 . . . . 10.0 110.254 -170.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.25 -49.48 75.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.38 92.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.592 1.157 . . . . 10.0 110.23 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.1 -48.77 44.17 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 119.701 1.137 . . . . 10.0 110.845 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.9 1.02 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.637 0.775 . . . . 10.0 111.181 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.3 8.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.387 1.475 . . . . 10.0 111.69 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.13 -40.4 86.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.262 . . . . 10.0 110.487 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.82 54.94 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.718 0.807 . . . . 10.0 110.505 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.4 mm -69.57 -38.78 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.23 1.012 . . . . 10.0 111.268 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.26 63.78 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.002 0.921 . . . . 10.0 110.963 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.39 19.59 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.837 -0.905 . . . . 10.0 110.837 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.07 82.52 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.762 -0.846 . . . . 10.0 109.611 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.0 76.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.771 -1.109 . . . . 10.0 111.495 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.69 -2.24 35.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.557 0.617 . . . . 10.0 111.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -93.48 -48.32 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.622 0.248 . . . . 10.0 110.953 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.65 58.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.407 . . . . 10.0 111.793 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -79.17 -45.05 20.7 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.818 0.342 . . . . 10.0 110.597 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -18.64 60.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.004 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.72 -40.23 63.72 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.146 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.19 79.06 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.055 0.391 . . . . 10.0 112.055 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.44 -30.03 66.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.366 -0.379 . . . . 10.0 111.511 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.86 79.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.649 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 4.97 1.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.1 1.76 . . . . 10.0 113.545 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.45 36.8 26.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.888 2.075 . . . . 10.0 112.077 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.679 -1.23 . . . . 10.0 107.679 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.13 4.05 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.757 2.023 . . . . 10.0 110.316 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.32 -170.83 33.52 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.933 1.73 . . . . 10.0 112.777 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.53 153.0 61.54 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 127.286 2.234 . . . . 10.0 108.304 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.58 152.7 71.59 Favored 'Cis proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.6 -1.0 . . . . 10.0 113.087 -6.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.0 m -145.89 144.24 30.07 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.264 1.425 . . . . 10.0 108.537 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.98 158.4 32.15 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.77 1.628 . . . . 10.0 108.174 163.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.05 135.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.04 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 1 C-N-CA 133.17 4.588 . . . . 10.0 117.552 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.19 60.38 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.807 -1.552 . . . . 10.0 115.526 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.88 -41.27 1.04 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.967 1.883 . . . . 10.0 114.349 -170.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.77 107.55 16.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.98 113.45 24.52 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 126.528 1.931 . . . . 10.0 106.738 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.57 169.62 17.41 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.333 -1.479 . . . . 10.0 107.154 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.94 -178.8 1.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.631 0.373 . . . . 10.0 110.191 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.27 -50.16 5.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 128.527 2.731 . . . . 10.0 107.715 160.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.07 16.53 4.45 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.856 1.693 . . . . 10.0 114.435 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.32 -51.11 1.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.735 1.267 . . . . 10.0 109.628 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.56 72.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.076 1.351 . . . . 10.0 112.251 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.57 -5.88 9.89 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.443 -1.199 . . . . 10.0 114.752 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.85 174.32 35.22 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.71 1.755 . . . . 10.0 109.93 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.98 -52.53 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.397 2.065 . . . . 10.0 111.752 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.31 -28.71 69.92 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.965 -1.084 . . . . 10.0 111.526 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.39 -27.24 66.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.144 0.578 . . . . 10.0 110.333 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.65 -42.84 33.36 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.051 -1.031 . . . . 10.0 110.961 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.83 -31.82 73.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.923 0.783 . . . . 10.0 111.014 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.49 -56.4 8.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.59 1.956 . . . . 10.0 108.076 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.56 -41.32 93.1 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 116.928 -1.51 . . . . 10.0 111.542 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.72 69.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.931 1.696 . . . . 10.0 111.698 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.07 65.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.905 0.482 . . . . 10.0 110.637 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.48 -42.61 96.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.605 0.762 . . . . 10.0 111.272 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.1 mt -67.04 -37.42 84.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.881 -1.137 . . . . 10.0 111.278 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.28 -51.93 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 119.239 0.927 . . . . 10.0 108.574 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.01 -43.08 63.49 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.573 1.149 . . . . 10.0 110.021 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.65 -0.32 33.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.144 -175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.11 -33.32 9.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.672 1.589 . . . . 10.0 114.461 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -55.75 4.98 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.37 -1.344 . . . . 10.0 107.37 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.28 -20.34 66.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.121 -0.945 . . . . 10.0 111.811 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.73 -35.46 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 130.087 3.355 . . . . 10.0 113.712 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.17 13.48 34.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.701 1.2 . . . . 10.0 113.145 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.82 0.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.92 2.088 . . . . 10.0 109.823 -163.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.058 1.743 . . . . 10.0 108.788 -179.276 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.234 -1.546 . . . . 10.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.23 73.64 0.16 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.046 2.138 . . . . 10.0 110.379 -175.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.25 11.97 0.65 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.429 -2.169 . . . . 10.0 113.011 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -146.41 157.74 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.033 1.733 . . . . 10.0 108.052 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 m -131.25 132.8 44.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.47 49.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.56 51.91 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.632 1.11 . . . . 10.0 113.432 -167.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.09 0.98 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 119.863 1.832 . . . . 10.0 107.727 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.363 1.465 . . . . 10.0 110.488 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.6 167.07 31.36 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.231 -0.918 . . . . 10.0 111.623 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.85 116.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.879 1.272 . . . . 10.0 109.064 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.34 20.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.869 -1.77 . . . . 10.0 110.478 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.56 40.72 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.312 1.045 . . . . 10.0 108.864 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.38 40.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.808 0.843 . . . . 10.0 113.215 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 m -129.3 74.38 81.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.209 1.003 . . . . 10.0 108.62 -176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.62 -179.1 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 125.114 3.876 . . . . 10.0 112.198 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.54 138.87 34.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.732 1.213 . . . . 10.0 107.993 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.09 179.08 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.456 2.104 . . . . 10.0 112.626 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.5 168.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.862 2.065 . . . . 10.0 108.947 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.06 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.778 2.031 . . . . 10.0 110.514 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.77 165.39 21.2 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 10.0 105.388 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.94 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.585 2.19 . . . . 10.0 110.248 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.12 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.343 -2.703 . . . . 10.0 106.343 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.46 133.66 45.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.081 0.952 . . . . 10.0 108.758 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.55 140.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.335 -1.728 . . . . 10.0 106.335 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.3 139.23 35.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.855 -1.905 . . . . 10.0 105.855 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.19 108.13 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.07 143.35 54.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.305 1.042 . . . . 10.0 108.515 162.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 4.9 mp -121.69 131.03 53.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 158.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.3 176.77 7.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.438 1.095 . . . . 10.0 110.427 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.05 175.81 11.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.965 1.306 . . . . 10.0 109.479 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.44 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.688 1.195 . . . . 10.0 112.903 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.0 4.53 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.873 1.225 . . . . 10.0 110.379 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.444 ' SG ' HG21 ' A' ' 153' ' ' VAL . 35.7 t -113.52 84.83 8.3 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 127.427 2.291 . . . . 10.0 106.101 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.56 168.53 24.14 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.365 2.71 . . . . 10.0 109.215 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.03 -45.74 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.538 1.935 . . . . 10.0 112.046 -165.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.82 -53.06 12.81 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.69 1.996 . . . . 10.0 110.618 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.92 -49.9 76.05 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.368 1.467 . . . . 10.0 110.865 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.44 61.57 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.732 0.642 . . . . 10.0 112.732 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.8 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.709 1.604 . . . . 10.0 112.031 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.83 -67.18 0.41 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 120.124 1.329 . . . . 10.0 112.581 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.94 -9.26 25.84 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 122.141 1.8 . . . . 10.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.21 68.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.795 1.18 . . . . 10.0 108.774 167.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.88 1.067 . . . . 10.0 113.88 -164.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.45 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.799 1.24 . . . . 10.0 109.499 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.88 -35.42 78.17 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.277 1.135 . . . . 10.0 112.928 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -57.11 -51.64 68.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.407 0.683 . . . . 10.0 110.389 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.14 80.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.126 0.489 . . . . 10.0 110.252 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.64 64.67 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.11 -0.993 . . . . 10.0 111.375 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.1 39.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.487 1.115 . . . . 10.0 112.948 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.9 151.23 74.7 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 119.467 1.031 . . . . 10.0 111.002 174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.09 169.64 21.67 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.013 3.142 . . . . 10.0 110.505 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 -4.22 4.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.994 1.318 . . . . 10.0 113.452 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.72 8.43 43.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.687 1.595 . . . . 10.0 110.606 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.78 31.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 O-C-N 121.19 -0.944 . . . . 10.0 108.865 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -146.13 134.86 22.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.551 -1.204 . . . . 10.0 108.399 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -114.38 139.9 49.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.869 0.366 . . . . 10.0 111.538 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.45 143.54 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.692 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.368 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 16.3 mt -124.21 138.66 31.21 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.66 152.76 22.86 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.069 2.513 . . . . 10.0 112.207 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.67 98.2 9.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.405 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.92 76.75 8.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.826 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.13 1.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.11 1.522 . . . . 10.0 115.11 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.14 3.42 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 119.97 -1.706 . . . . 10.0 112.824 168.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.02 1.52 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.335 0.969 . . . . 10.0 110.766 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.96 -30.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.14 0.976 . . . . 10.0 111.976 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.32 -27.54 6.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.103 1.761 . . . . 10.0 113.331 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.86 -36.4 64.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.679 1.127 . . . . 10.0 110.501 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.9 t -73.95 -55.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.923 -1.14 . . . . 10.0 107.923 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.84 31.89 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.495 3.118 . . . . 10.0 112.257 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.14 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 125.314 1.435 . . . . 10.0 111.173 173.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.44 -41.95 70.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.81 -1.091 . . . . 10.0 112.463 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.45 8.37 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -173.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.77 -45.8 92.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.639 0.587 . . . . 10.0 110.3 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.39 -45.23 95.23 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.738 -1.601 . . . . 10.0 109.226 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.65 92.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.611 1.55 . . . . 10.0 110.874 -177.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.977 1.711 . . . . 10.0 109.48 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.75 -28.95 66.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 118.922 -0.561 . . . . 10.0 111.768 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.19 49.72 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.38 1.072 . . . . 10.0 110.655 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.79 -22.56 56.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.621 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.43 61.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.82 0.724 . . . . 10.0 112.871 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.34 130.26 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.973 1.309 . . . . 10.0 109.313 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.5 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 -165.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.22 -5.52 54.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.118 2.266 . . . . 10.0 117.118 -170.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.42 52.03 7.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.348 1.859 . . . . 10.0 112.064 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.04 -47.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 117.444 -1.265 . . . . 10.0 113.355 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.95 34.8 1.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.628 1.558 . . . . 10.0 113.079 -176.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.56 0.62 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 120.758 -1.214 . . . . 10.0 108.845 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.49 44.89 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.547 1.314 . . . . 10.0 114.547 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.49 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.549 -1.215 . . . . 10.0 108.661 166.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.57 -46.83 73.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.397 1.453 . . . . 10.0 112.031 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.43 -40.66 83.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.433 1.493 . . . . 10.0 110.135 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.06 4.5 5.43 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.683 1.593 . . . . 10.0 112.888 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.22 -57.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.0 -2.222 . . . . 10.0 105.0 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.56 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.664 0.786 . . . . 10.0 112.716 -173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.31 -21.22 64.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.099 0.863 . . . . 10.0 112.199 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.49 3.9 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.535 1.134 . . . . 10.0 108.81 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 58.42 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.517 1.527 . . . . 10.0 110.695 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.31 13.71 15.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.357 1.063 . . . . 10.0 113.28 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.95 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 128.223 2.609 . . . . 10.0 109.546 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt 54.52 44.61 28.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.729 1.612 . . . . 10.0 112.542 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.75 14.59 20.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.299 1.44 . . . . 10.0 114.154 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.045 2.538 . . . . 10.0 107.704 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.16 -45.0 10.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.539 2.16 . . . . 10.0 109.973 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.03 -29.34 67.47 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.263 1.025 . . . . 10.0 111.119 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.52 -42.16 70.5 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.022 1.329 . . . . 10.0 110.292 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.92 -48.5 18.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.169 0.988 . . . . 10.0 108.877 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.21 84.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 123.387 0.43 . . . . 10.0 111.369 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.12 -46.83 79.0 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.262 1.425 . . . . 10.0 112.569 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.9 t80 -74.3 -41.59 60.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.6 0.76 . . . . 10.0 111.439 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.99 -14.8 59.8 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.357 -0.839 . . . . 10.0 110.384 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 -41.85 30.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.827 0.851 . . . . 10.0 110.114 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.15 53.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.944 -1.475 . . . . 10.0 114.883 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.39 8.85 6.56 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.333 2.567 . . . . 10.0 112.625 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 49.3 4.12 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.67 -1.372 . . . . 10.0 109.67 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.6 132.94 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.144 -2.169 . . . . 10.0 105.144 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.69 35.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.673 0.789 . . . . 10.0 110.009 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.59 -37.01 86.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.788 -0.625 . . . . 10.0 110.352 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.04 -26.75 66.92 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.707 0.685 . . . . 10.0 111.772 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.07 4.01 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.36 -1.719 . . . . 10.0 106.36 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.94 -59.42 4.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.821 1.249 . . . . 10.0 112.154 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.58 -33.73 64.77 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.205 -0.294 . . . . 10.0 110.205 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -62.27 -49.41 75.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.284 -0.636 . . . . 10.0 109.284 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.76 -41.29 92.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.524 1.13 . . . . 10.0 110.216 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.21 -48.71 45.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.686 1.13 . . . . 10.0 110.773 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.63 38.82 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.709 0.804 . . . . 10.0 111.147 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.28 8.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.426 1.49 . . . . 10.0 111.701 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.08 -40.41 87.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.842 1.257 . . . . 10.0 110.54 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.85 55.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.695 0.798 . . . . 10.0 110.495 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.6 mm -69.49 -38.77 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.224 1.009 . . . . 10.0 111.322 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.28 63.8 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 10.0 111.018 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.39 19.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.16 82.79 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.806 -0.82 . . . . 10.0 109.569 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -33.64 75.97 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.749 -1.119 . . . . 10.0 111.527 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.67 -0.89 33.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.592 0.633 . . . . 10.0 112.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.37 -48.41 5.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.701 0.286 . . . . 10.0 110.709 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.86 -5.98 59.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.815 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -81.35 -43.81 18.51 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.874 0.369 . . . . 10.0 110.891 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -17.77 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 69.3 mt -75.89 -38.55 57.71 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.96 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.26 80.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.6 mtm -71.2 -29.2 64.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.91 81.12 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.595 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -69.97 5.0 1.74 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.175 1.79 . . . . 10.0 113.539 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 54.37 36.81 26.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.877 2.071 . . . . 10.0 112.146 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.5 t -69.37 135.13 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.717 -1.216 . . . . 10.0 107.717 172.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.37 -16.09 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.717 2.007 . . . . 10.0 110.254 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.88 33.61 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.954 1.74 . . . . 10.0 112.821 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.444 HG21 ' SG ' ' A' ' 37' ' ' CYS . 14.8 m -142.46 152.99 61.76 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.262 2.225 . . . . 10.0 108.359 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.59 152.65 71.56 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.592 -1.003 . . . . 10.0 113.078 -6.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.7 m -145.86 144.22 30.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 125.294 1.438 . . . . 10.0 108.562 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.93 158.35 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.847 1.659 . . . . 10.0 108.208 163.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.06 136.53 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.955 -1.498 . . . . 10.0 106.955 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.07 135.13 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.1 10.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 133.159 4.584 . . . . 10.0 117.542 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.6 20.19 60.47 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.806 -1.552 . . . . 10.0 115.601 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -131.88 -41.28 1.04 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.916 1.858 . . . . 10.0 114.38 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.81 107.53 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.99 113.39 24.46 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 126.506 1.922 . . . . 10.0 106.808 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -136.45 169.65 17.34 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 120.393 -1.442 . . . . 10.0 107.172 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.84 1.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.617 0.367 . . . . 10.0 110.123 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.31 -50.09 5.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 128.469 2.708 . . . . 10.0 107.771 160.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.08 16.56 4.44 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.946 1.736 . . . . 10.0 114.368 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.38 -51.16 1.29 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.814 1.307 . . . . 10.0 109.609 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.62 72.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.143 1.377 . . . . 10.0 112.274 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 118.529 -1.151 . . . . 10.0 114.73 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.3 35.22 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.738 1.769 . . . . 10.0 110.015 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.437 2.092 . . . . 10.0 111.72 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.33 -28.65 69.89 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.904 -1.122 . . . . 10.0 111.523 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.15 66.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.058 0.543 . . . . 10.0 110.333 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.67 -43.01 32.65 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.062 -1.024 . . . . 10.0 110.905 -169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.91 73.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.889 0.768 . . . . 10.0 111.076 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.5 8.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.65 1.98 . . . . 10.0 108.018 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.56 -41.29 93.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 116.959 -1.496 . . . . 10.0 111.538 176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 120.946 1.703 . . . . 10.0 111.74 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.49 -47.12 64.89 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.898 0.479 . . . . 10.0 110.635 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.46 -42.55 96.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.616 0.767 . . . . 10.0 111.251 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.45 83.97 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 120.917 -1.114 . . . . 10.0 111.257 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.0 mt -58.15 -51.98 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.217 0.917 . . . . 10.0 108.647 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.05 -43.03 63.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.483 1.113 . . . . 10.0 110.018 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.69 -0.36 33.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.12 -1.419 . . . . 10.0 113.072 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.14 -33.26 9.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.618 1.567 . . . . 10.0 114.458 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -55.69 5.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.413 -1.329 . . . . 10.0 107.413 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.38 66.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.177 -0.919 . . . . 10.0 111.738 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.053 3.341 . . . . 10.0 113.741 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.19 13.51 34.9 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.677 1.191 . . . . 10.0 113.113 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.35 76.84 0.27 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.895 2.078 . . . . 10.0 109.816 -163.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.135 1.774 . . . . 10.0 108.822 -179.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.166 -1.573 . . . . 10.0 109.166 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.18 73.72 0.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 127.088 2.155 . . . . 10.0 110.359 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.38 12.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.094 2.158 . . . . 10.0 112.981 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CD2' HD11 ' A' ' 178' ' ' LEU . 14.5 m-85 -146.46 157.72 43.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.029 1.731 . . . . 10.0 108.086 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m -131.2 132.79 44.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.63 148.37 49.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.186 -1.042 . . . . 10.0 108.186 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.68 52.35 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.731 1.158 . . . . 10.0 113.415 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -63.07 0.98 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.825 1.813 . . . . 10.0 107.854 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.9 14.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.369 1.467 . . . . 10.0 110.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.1 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.242 -0.911 . . . . 10.0 111.718 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.95 115.98 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.819 1.248 . . . . 10.0 108.99 -171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -80.43 167.39 20.24 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 119.963 -1.71 . . . . 10.0 110.489 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.24 124.61 40.79 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.309 1.044 . . . . 10.0 108.839 172.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.42 41.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.806 0.842 . . . . 10.0 113.176 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.198 0.999 . . . . 10.0 108.664 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.63 -179.11 2.63 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.987 3.792 . . . . 10.0 112.235 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 138.91 34.1 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.723 1.209 . . . . 10.0 107.948 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.99 179.12 5.67 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.453 2.102 . . . . 10.0 112.643 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.51 168.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.824 2.049 . . . . 10.0 108.946 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 m -47.08 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.855 2.062 . . . . 10.0 110.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.35 21.34 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 127.385 2.274 . . . . 10.0 105.433 163.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.83 -164.73 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.676 2.25 . . . . 10.0 110.248 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.6 2.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.71 45.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.138 0.975 . . . . 10.0 108.706 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.66 140.78 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.24 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.523 -1.288 . . . . 10.0 107.523 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.59 130.32 68.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.89 -1.892 . . . . 10.0 105.89 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.09 108.12 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.06 143.42 54.26 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.292 1.037 . . . . 10.0 108.516 162.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.84 131.11 53.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 158.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.31 176.81 7.14 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.465 1.106 . . . . 10.0 110.472 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.84 11.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.063 1.345 . . . . 10.0 109.498 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.2 t80 -61.53 -73.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.63 1.172 . . . . 10.0 112.905 172.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.99 52.0 4.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.76 1.171 . . . . 10.0 110.376 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.46 84.77 8.12 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 127.452 2.301 . . . . 10.0 106.118 -163.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.51 24.18 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.306 2.671 . . . . 10.0 109.234 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.07 -45.73 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.409 1.883 . . . . 10.0 112.064 -165.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.09 12.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.774 2.029 . . . . 10.0 110.564 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.9 -49.93 75.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.36 1.464 . . . . 10.0 110.888 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.78 -13.52 61.55 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.744 0.646 . . . . 10.0 112.744 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.69 -16.82 27.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.712 1.605 . . . . 10.0 112.038 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 120.122 1.328 . . . . 10.0 112.576 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.03 -9.22 25.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 CA-C-N 122.063 1.773 . . . . 10.0 114.358 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.22 69.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.832 1.196 . . . . 10.0 108.829 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.18 -28.47 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.825 1.046 . . . . 10.0 113.825 -164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -46.48 -60.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.713 1.205 . . . . 10.0 109.448 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.38 79.04 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-N 120.299 1.142 . . . . 10.0 113.004 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -57.17 -51.6 68.65 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.322 0.649 . . . . 10.0 110.421 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.24 80.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.186 0.517 . . . . 10.0 110.211 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.55 64.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.1 -1.0 . . . . 10.0 111.427 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.02 39.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.563 1.145 . . . . 10.0 112.862 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.91 151.26 74.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 119.52 1.054 . . . . 10.0 111.029 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.14 169.68 21.57 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.067 3.178 . . . . 10.0 110.419 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 -4.24 4.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.044 1.338 . . . . 10.0 113.473 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.67 8.38 43.39 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.737 1.615 . . . . 10.0 110.642 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.45 164.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 121.212 -0.93 . . . . 10.0 108.824 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -145.56 135.75 23.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.445 -1.252 . . . . 10.0 108.335 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -115.46 134.57 54.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.904 0.383 . . . . 10.0 111.573 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.64 140.42 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.548 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.0 mtt85 -107.74 123.36 48.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.298 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 mt -124.99 138.76 32.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 112.916 0.71 . . . . 10.0 112.916 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.27 152.95 24.13 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.06 2.507 . . . . 10.0 112.339 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.68 98.47 9.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.369 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.92 76.76 8.61 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.791 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.62 20.28 1.15 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.07 -48.1 3.42 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 119.879 -1.763 . . . . 10.0 112.808 168.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.13 1.55 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.316 0.96 . . . . 10.0 110.74 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.071 0.948 . . . . 10.0 112.089 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.3 -27.52 6.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.098 1.759 . . . . 10.0 113.319 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.9 -36.39 64.74 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 119.693 1.133 . . . . 10.0 110.513 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.8 t -73.88 -55.21 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.93 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.459 3.104 . . . . 10.0 112.193 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.2 -42.46 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 125.346 1.451 . . . . 10.0 111.26 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.65 -41.77 70.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.774 -1.108 . . . . 10.0 112.462 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -44.33 8.52 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.91 -45.69 92.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.639 0.587 . . . . 10.0 110.275 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.34 -45.33 94.84 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 116.784 -1.579 . . . . 10.0 109.211 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.44 -45.57 92.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.609 1.55 . . . . 10.0 110.812 -176.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -60.61 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.988 1.715 . . . . 10.0 109.399 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.64 -28.92 66.31 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 118.966 -0.54 . . . . 10.0 111.825 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.18 49.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.318 1.047 . . . . 10.0 110.699 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.85 -22.42 56.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.671 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.38 14.51 61.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.874 0.749 . . . . 10.0 113.016 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.28 130.28 26.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.95 1.3 . . . . 10.0 109.324 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.58 75.9 1.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.977 -0.749 . . . . 10.0 108.977 -165.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.22 -5.42 54.27 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.038 2.236 . . . . 10.0 117.038 -170.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.35 51.95 7.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.312 1.845 . . . . 10.0 112.118 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.94 -47.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.417 -1.277 . . . . 10.0 113.398 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.89 34.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.628 1.558 . . . . 10.0 113.095 -176.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.52 0.62 Allowed 'General case' 0 C--O 1.22 -0.468 0 O-C-N 120.814 -1.179 . . . . 10.0 108.901 172.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 -16.54 44.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 10.0 114.569 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.53 -65.51 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 117.478 -1.249 . . . . 10.0 108.676 166.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.58 -46.88 73.81 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 120.42 1.464 . . . . 10.0 112.031 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.451 1.5 . . . . 10.0 110.244 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.14 4.49 5.53 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.776 1.63 . . . . 10.0 112.853 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -115.19 -57.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.6 -61.26 2.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.694 0.798 . . . . 10.0 112.63 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.32 -21.22 64.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.086 0.857 . . . . 10.0 112.199 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.43 -53.6 3.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.601 1.16 . . . . 10.0 108.795 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.487 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.46 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.587 1.555 . . . . 10.0 110.659 -169.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.23 13.73 15.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 10.0 113.306 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.96 -64.28 0.36 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 128.239 2.616 . . . . 10.0 109.479 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.2 mt 54.55 44.55 28.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.746 1.618 . . . . 10.0 112.526 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.65 20.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.208 1.403 . . . . 10.0 114.184 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 155.33 28.98 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 127.897 2.479 . . . . 10.0 107.679 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.22 -44.89 10.93 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.537 2.158 . . . . 10.0 110.003 -173.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.33 67.49 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.191 0.996 . . . . 10.0 111.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.55 -42.07 70.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.965 1.306 . . . . 10.0 110.361 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.9 -48.61 17.76 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.2 1.0 . . . . 10.0 108.884 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.2 84.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 123.426 0.453 . . . . 10.0 111.432 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.93 78.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.318 1.447 . . . . 10.0 112.542 172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.9 t80 -74.16 -41.81 60.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.601 0.761 . . . . 10.0 111.382 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.9 -14.74 59.84 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.401 -0.812 . . . . 10.0 110.421 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.76 30.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.871 0.868 . . . . 10.0 110.143 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.09 54.51 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.926 -1.486 . . . . 10.0 114.836 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.27 8.75 6.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.386 2.593 . . . . 10.0 112.649 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.0 49.26 4.1 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.65 132.84 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.176 -2.157 . . . . 10.0 105.176 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.71 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.679 0.791 . . . . 10.0 110.0 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.68 -36.9 85.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.738 -0.649 . . . . 10.0 110.367 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.8 66.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.744 0.702 . . . . 10.0 111.673 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.59 -57.09 4.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.363 -1.718 . . . . 10.0 106.363 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.9 -59.45 4.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.795 1.238 . . . . 10.0 112.161 -166.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.53 -33.7 64.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 -170.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 m -62.36 -49.31 76.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.75 -41.33 92.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.557 1.143 . . . . 10.0 110.269 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -49.09 -48.78 44.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.673 1.124 . . . . 10.0 110.809 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.88 1.02 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.678 0.791 . . . . 10.0 111.179 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.78 172.32 8.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.474 1.509 . . . . 10.0 111.658 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.42 86.71 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.825 1.25 . . . . 10.0 110.487 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.82 54.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.757 0.823 . . . . 10.0 110.501 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.53 -38.85 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.23 1.012 . . . . 10.0 111.213 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.61 -33.2 63.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.026 0.93 . . . . 10.0 110.987 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.26 -48.39 19.43 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.872 -0.891 . . . . 10.0 110.872 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.03 82.38 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.792 -0.828 . . . . 10.0 109.656 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -34.14 77.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.663 -1.16 . . . . 10.0 111.45 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.01 7.23 41.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.613 0.642 . . . . 10.0 112.045 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -101.09 -48.26 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.645 0.259 . . . . 10.0 110.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.48 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.7 tmtt? -77.16 -44.28 30.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.878 0.371 . . . . 10.0 110.829 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -16.88 57.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.298 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.4 mt -74.97 -37.63 61.87 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.233 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.34 82.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.974 0.361 . . . . 10.0 111.974 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 57.7 mtm -71.59 -28.89 64.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.86 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.688 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.07 5.09 1.75 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.081 1.752 . . . . 10.0 113.53 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 54.34 36.85 26.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.99 2.116 . . . . 10.0 112.082 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.25 -16.2 4.02 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.779 2.032 . . . . 10.0 110.295 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.982 1.753 . . . . 10.0 112.802 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.45 153.06 61.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.192 2.197 . . . . 10.0 108.27 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.7 71.46 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.535 -1.027 . . . . 10.0 113.109 -6.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.5 m -145.91 144.22 30.04 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.287 1.435 . . . . 10.0 108.534 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.86 158.41 31.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.844 1.657 . . . . 10.0 108.221 163.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.936 -1.505 . . . . 10.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.9 t -104.0 135.18 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.065 -1.457 . . . . 10.0 107.065 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 1 C-N-CA 133.131 4.572 . . . . 10.0 117.471 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.18 60.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 117.752 -1.582 . . . . 10.0 115.498 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.37 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.975 1.887 . . . . 10.0 114.373 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -112.7 107.61 16.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.4 24.41 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.51 1.924 . . . . 10.0 106.768 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.53 169.59 17.44 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 120.316 -1.49 . . . . 10.0 107.087 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.78 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.601 0.36 . . . . 10.0 110.184 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.29 -50.15 5.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 128.615 2.766 . . . . 10.0 107.689 160.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.06 16.48 4.48 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.92 1.724 . . . . 10.0 114.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 m -128.32 -51.14 1.29 Allowed 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.768 1.284 . . . . 10.0 109.654 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.62 72.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.04 1.336 . . . . 10.0 112.252 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.416 -1.213 . . . . 10.0 114.741 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.78 174.27 35.12 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.717 1.758 . . . . 10.0 110.017 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.419 2.079 . . . . 10.0 111.753 -169.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.63 69.86 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.9 -1.125 . . . . 10.0 111.58 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.46 -27.14 66.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.069 0.548 . . . . 10.0 110.368 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.59 -43.05 32.93 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.014 -1.054 . . . . 10.0 110.894 -169.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.71 -31.86 73.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.937 0.79 . . . . 10.0 111.066 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.52 -56.5 8.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.628 1.971 . . . . 10.0 107.984 168.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' A' ' 6' ' ' TYR . 4.1 mm? -65.43 -41.42 93.53 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 116.905 -1.522 . . . . 10.0 111.503 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.66 69.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.965 1.712 . . . . 10.0 111.705 -175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.51 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.964 0.505 . . . . 10.0 110.617 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.41 -42.68 96.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.585 0.754 . . . . 10.0 111.257 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.03 -37.44 84.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.948 -1.095 . . . . 10.0 111.251 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.32 -51.92 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.99 -43.03 63.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.577 1.151 . . . . 10.0 110.037 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.73 -0.31 33.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.144 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.21 9.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.614 1.566 . . . . 10.0 114.399 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -55.79 4.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.345 -1.354 . . . . 10.0 107.345 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.29 66.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.766 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 130.082 3.353 . . . . 10.0 113.679 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.03 13.33 35.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.759 1.224 . . . . 10.0 113.153 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.4 tttm 56.42 76.78 0.28 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.939 2.096 . . . . 10.0 109.855 -163.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.122 1.769 . . . . 10.0 108.815 -179.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 109.135 -1.586 . . . . 10.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.12 73.72 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.144 2.178 . . . . 10.0 110.313 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.428 -2.169 . . . . 10.0 113.023 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.42 157.77 43.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.964 1.706 . . . . 10.0 107.991 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.29 132.76 44.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.671 -1.233 . . . . 10.0 107.671 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.57 148.43 49.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.65 13.69 52.11 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.767 1.175 . . . . 10.0 113.398 -167.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -62.98 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.767 1.783 . . . . 10.0 107.78 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -98.52 -25.89 14.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.353 1.461 . . . . 10.0 110.46 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.55 167.12 31.16 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.249 -0.907 . . . . 10.0 111.694 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.88 115.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.781 1.232 . . . . 10.0 109.002 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.31 167.32 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.001 -1.687 . . . . 10.0 110.508 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.67 40.98 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.271 1.028 . . . . 10.0 108.853 172.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.4 41.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.21 0.819 . . . . 10.0 113.21 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.195 0.998 . . . . 10.0 108.676 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.53 -179.08 2.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 125.047 3.831 . . . . 10.0 112.266 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.87 34.04 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.739 1.215 . . . . 10.0 107.944 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.1 179.04 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.415 2.076 . . . . 10.0 112.58 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.8 m -127.35 168.3 20.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 126.866 2.067 . . . . 10.0 108.949 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.11 -61.8 1.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.812 2.045 . . . . 10.0 110.493 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.85 165.37 21.14 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 127.305 2.242 . . . . 10.0 105.394 163.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.91 -164.61 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.608 2.206 . . . . 10.0 110.201 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.75 2.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.45 133.76 45.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.01 0.924 . . . . 10.0 108.77 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.65 140.79 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.24 139.08 35.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.47 130.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.939 -1.874 . . . . 10.0 105.939 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.13 108.06 14.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.94 143.32 54.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.303 1.041 . . . . 10.0 108.58 162.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.8 131.1 53.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 158.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.34 176.86 7.11 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.376 1.07 . . . . 10.0 110.391 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.06 175.79 11.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.028 1.331 . . . . 10.0 109.525 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.3 t80 -61.47 -73.14 0.1 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.563 1.145 . . . . 10.0 112.937 172.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.95 4.53 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 124.858 1.218 . . . . 10.0 110.336 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.49 84.74 8.15 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.532 2.333 . . . . 10.0 106.102 -163.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.54 168.58 24.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.296 2.664 . . . . 10.0 109.217 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.93 -45.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.538 1.935 . . . . 10.0 112.064 -164.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.88 -53.03 13.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.754 2.022 . . . . 10.0 110.569 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.518 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.6 t80 -58.96 -49.94 75.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.472 1.509 . . . . 10.0 110.784 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.43 61.6 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.73 -16.85 27.74 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.727 1.611 . . . . 10.0 112.074 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.81 -67.21 0.41 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.115 1.325 . . . . 10.0 112.559 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.02 -9.17 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 122.076 1.777 . . . . 10.0 114.518 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.16 68.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.766 1.167 . . . . 10.0 108.806 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.17 -28.59 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.348 1.059 . . . . 10.0 113.85 -164.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.36 -60.29 3.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.79 1.236 . . . . 10.0 109.544 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.89 -35.38 78.34 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 CA-C-N 120.243 1.122 . . . . 10.0 112.918 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -57.28 -51.54 68.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.412 0.685 . . . . 10.0 110.34 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -59.01 -39.17 81.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.128 0.49 . . . . 10.0 110.231 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.81 -25.63 64.77 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.153 -0.967 . . . . 10.0 111.445 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.66 9.99 39.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.625 1.17 . . . . 10.0 112.868 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.94 151.17 75.3 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 119.488 1.04 . . . . 10.0 110.994 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.07 169.7 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.982 3.121 . . . . 10.0 110.484 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.1 -4.1 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.024 1.33 . . . . 10.0 113.372 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.8 8.37 43.26 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.765 1.626 . . . . 10.0 110.532 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.44 164.33 32.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 O-C-N 121.164 -0.96 . . . . 10.0 108.863 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.93 140.91 28.59 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.435 -1.257 . . . . 10.0 108.29 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -120.84 134.13 55.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.759 0.314 . . . . 10.0 111.549 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.25 136.94 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.803 -0.635 . . . . 10.0 109.66 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -103.66 119.71 39.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.402 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.26 138.45 28.08 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.859 0.688 . . . . 10.0 112.859 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.5 152.81 23.38 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.027 2.485 . . . . 10.0 112.222 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.07 97.22 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.94 76.77 8.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.827 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.15 1.15 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.1 -48.1 3.41 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 119.903 -1.748 . . . . 10.0 112.787 168.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.51 -152.12 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.294 0.949 . . . . 10.0 110.783 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.81 -30.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.074 0.95 . . . . 10.0 112.003 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.4 -27.44 6.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.068 1.747 . . . . 10.0 113.367 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.86 -36.42 64.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.629 1.104 . . . . 10.0 110.485 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.93 -55.21 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.81 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.492 3.117 . . . . 10.0 112.21 170.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.352 1.453 . . . . 10.0 111.176 173.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.53 -41.81 70.13 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.789 -1.101 . . . . 10.0 112.535 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.53 -44.33 8.61 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.136 1.161 . . . . 10.0 114.136 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.8 -45.78 92.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.528 0.604 . . . . 10.0 110.304 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.32 -45.35 94.79 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 116.836 -1.554 . . . . 10.0 109.234 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.3 -45.69 92.14 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.552 1.523 . . . . 10.0 110.839 -176.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.978 1.711 . . . . 10.0 109.413 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.7 -28.91 66.24 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 118.881 -0.58 . . . . 10.0 111.806 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.72 -37.15 49.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.347 1.059 . . . . 10.0 110.699 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.5 56.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.653 -0.689 . . . . 10.0 111.634 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.6 61.71 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.974 0.797 . . . . 10.0 113.023 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.35 130.28 26.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.997 1.319 . . . . 10.0 109.315 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.57 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.981 -0.748 . . . . 10.0 108.981 -165.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.704 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.2 -5.4 54.19 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 117.137 2.273 . . . . 10.0 117.137 -170.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.37 51.97 7.49 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.284 1.834 . . . . 10.0 112.113 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.91 -47.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.487 -1.244 . . . . 10.0 113.461 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.704 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.77 34.92 1.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.532 1.514 . . . . 10.0 113.067 -176.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.749 -1.219 . . . . 10.0 108.929 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.2 -16.42 44.7 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.576 1.325 . . . . 10.0 114.576 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.52 -65.65 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.552 -1.213 . . . . 10.0 108.625 166.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.57 -46.78 73.77 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.391 1.451 . . . . 10.0 111.997 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.39 -40.62 82.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.459 1.503 . . . . 10.0 110.207 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.1 4.46 5.53 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.736 1.615 . . . . 10.0 112.884 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.23 -57.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.049 -2.204 . . . . 10.0 105.049 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.68 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.704 0.801 . . . . 10.0 112.618 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.518 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -68.28 -21.26 64.8 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.06 0.845 . . . . 10.0 112.147 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.43 3.91 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.591 1.157 . . . . 10.0 108.802 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.426 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.41 87.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.476 1.51 . . . . 10.0 110.698 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.79 15.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.408 1.083 . . . . 10.0 113.372 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.97 -64.2 0.36 Allowed 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 128.226 2.61 . . . . 10.0 109.581 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.52 44.63 28.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.789 1.635 . . . . 10.0 112.449 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.69 14.64 20.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 10.0 114.148 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.2 155.38 28.98 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 127.907 2.483 . . . . 10.0 107.643 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.27 -44.88 10.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.543 2.162 . . . . 10.0 109.972 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.09 -29.32 67.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.222 1.009 . . . . 10.0 111.124 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.53 -42.1 70.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.945 1.298 . . . . 10.0 110.353 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.93 -48.54 17.87 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.071 0.948 . . . . 10.0 108.901 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.2 84.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 123.45 0.469 . . . . 10.0 111.412 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.95 78.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.285 1.434 . . . . 10.0 112.532 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.21 -41.66 61.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.559 0.744 . . . . 10.0 111.443 -177.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.38 -0.825 . . . . 10.0 110.411 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.75 30.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.766 0.826 . . . . 10.0 110.102 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.14 54.36 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.958 -1.468 . . . . 10.0 114.827 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.75 6.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.327 2.563 . . . . 10.0 112.604 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.98 49.24 4.11 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.54 132.93 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.177 -2.157 . . . . 10.0 105.177 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.76 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.642 0.777 . . . . 10.0 109.983 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.64 -37.04 86.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.732 -0.651 . . . . 10.0 110.375 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.92 -26.86 67.06 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.681 0.673 . . . . 10.0 111.732 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.7 -57.05 4.02 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.375 -1.713 . . . . 10.0 106.375 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.8 -59.56 4.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.846 1.258 . . . . 10.0 112.172 -166.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.55 -33.66 64.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -49.38 75.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.8 -41.3 92.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.587 1.155 . . . . 10.0 110.229 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.668 1.122 . . . . 10.0 110.831 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -92.68 38.98 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.674 0.789 . . . . 10.0 111.129 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.92 172.3 8.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.396 1.479 . . . . 10.0 111.569 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.2 -40.4 86.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.814 1.246 . . . . 10.0 110.439 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.5 -49.91 54.32 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.765 0.826 . . . . 10.0 110.445 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.49 -38.84 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.256 1.022 . . . . 10.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 1.7 mtmt -55.52 -33.34 63.68 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.025 0.93 . . . . 10.0 111.017 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.11 -48.47 19.8 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.854 -0.898 . . . . 10.0 110.854 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.42 -36.14 82.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.702 -0.881 . . . . 10.0 109.502 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.693 -1.146 . . . . 10.0 111.478 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 12.7 pt-20 -104.29 10.65 35.48 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.72 0.637 . . . . 10.0 111.853 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.45 ' HZ2' ' CAN' ' A' ' 201' ' ' 1YO . 6.3 tmtt? -102.65 -51.02 3.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.686 0.279 . . . . 10.0 110.495 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.74 -4.81 59.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.844 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -77.79 -45.38 24.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.852 0.358 . . . . 10.0 110.848 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.84 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.324 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 36.7 mt -75.14 -38.57 60.97 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.38 -0.373 . . . . 10.0 110.856 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.69 83.75 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.083 0.401 . . . . 10.0 112.083 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 63.6 mtm -69.35 -30.1 68.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 10.0 111.436 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.86 79.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.623 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.05 5.03 1.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.125 1.77 . . . . 10.0 113.493 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.43 36.75 26.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.93 2.092 . . . . 10.0 112.12 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.35 135.04 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.24 -16.18 4.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.737 2.015 . . . . 10.0 110.277 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.3 -170.86 33.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.928 1.727 . . . . 10.0 112.772 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.54 152.97 61.44 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 127.253 2.221 . . . . 10.0 108.308 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.59 152.68 71.58 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.585 -1.006 . . . . 10.0 113.035 -6.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.87 144.27 30.11 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.272 1.429 . . . . 10.0 108.551 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.95 158.35 32.21 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.906 1.682 . . . . 10.0 108.218 163.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.934 -1.506 . . . . 10.0 106.934 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.06 135.16 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 168.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.17 10.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 133.175 4.59 . . . . 10.0 117.505 171.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.23 60.26 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.667 -1.629 . . . . 10.0 115.446 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.89 -41.28 1.04 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.989 1.895 . . . . 10.0 114.315 -170.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -112.78 107.62 16.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.315 -0.995 . . . . 10.0 108.315 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.07 113.42 24.55 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.495 1.918 . . . . 10.0 106.764 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.48 169.59 17.44 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 120.277 -1.514 . . . . 10.0 107.198 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.98 -178.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.62 0.368 . . . . 10.0 110.171 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.35 -50.09 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 128.552 2.741 . . . . 10.0 107.733 160.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 16.52 4.48 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.868 1.699 . . . . 10.0 114.373 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.27 -51.16 1.3 Allowed 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.825 1.313 . . . . 10.0 109.656 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.54 72.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.072 1.349 . . . . 10.0 112.174 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.62 -6.03 9.83 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.535 -1.147 . . . . 10.0 114.802 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.27 35.22 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.667 1.733 . . . . 10.0 109.929 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.92 -52.52 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.355 2.037 . . . . 10.0 111.736 -169.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -28.6 69.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.946 -1.096 . . . . 10.0 111.568 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.16 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.095 0.558 . . . . 10.0 110.351 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.71 -42.86 32.96 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.014 -1.054 . . . . 10.0 110.898 -169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.93 -31.77 73.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.908 0.776 . . . . 10.0 110.985 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.46 8.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.589 1.956 . . . . 10.0 108.103 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.47 -41.33 93.47 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 116.945 -1.502 . . . . 10.0 111.58 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.69 69.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.902 1.683 . . . . 10.0 111.746 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.06 65.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.902 0.481 . . . . 10.0 110.619 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.55 -42.57 96.82 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 10.0 111.217 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.14 -37.38 83.72 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.877 -1.139 . . . . 10.0 111.26 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.23 -51.94 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.284 0.947 . . . . 10.0 108.561 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.02 -43.06 63.53 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.618 1.167 . . . . 10.0 110.052 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.7 -0.27 33.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.173 -1.394 . . . . 10.0 113.188 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.25 9.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.679 1.591 . . . . 10.0 114.436 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -55.69 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.35 -20.32 66.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.115 -0.948 . . . . 10.0 111.772 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.46 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.108 3.363 . . . . 10.0 113.707 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.06 13.38 35.36 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.732 1.213 . . . . 10.0 113.151 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.92 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.942 2.097 . . . . 10.0 109.78 -163.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.138 1.775 . . . . 10.0 108.82 -179.321 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . 0.45 ' CAN' ' HZ2' ' A' ' 140' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.194 -1.563 . . . . 10.0 109.194 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.08 73.77 0.15 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 127.131 2.172 . . . . 10.0 110.357 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.37 12.06 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.459 -2.155 . . . . 10.0 112.998 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.47 157.7 43.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.984 1.714 . . . . 10.0 108.041 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.18 132.82 44.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.735 -1.209 . . . . 10.0 107.735 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.38 49.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.62 52.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.67 1.128 . . . . 10.0 113.423 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -63.0 0.98 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.763 1.782 . . . . 10.0 107.77 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.38 -25.97 14.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 10.0 110.501 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -154.59 167.02 31.51 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.27 -0.894 . . . . 10.0 111.624 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.89 115.97 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.797 1.239 . . . . 10.0 108.996 -171.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.36 20.31 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 119.948 -1.72 . . . . 10.0 110.473 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.66 40.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.168 0.987 . . . . 10.0 108.815 172.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 m -67.25 -9.46 40.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.832 0.853 . . . . 10.0 113.219 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 m -129.32 74.37 81.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.195 0.998 . . . . 10.0 108.612 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.49 -179.12 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 125.139 3.892 . . . . 10.0 112.213 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.57 138.96 34.21 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.729 1.211 . . . . 10.0 107.934 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.13 179.17 5.67 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.369 2.046 . . . . 10.0 112.569 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.5 168.3 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.832 2.053 . . . . 10.0 108.947 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.89 1.67 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.834 2.054 . . . . 10.0 110.457 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.74 165.43 21.11 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.283 2.233 . . . . 10.0 105.397 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.99 -164.61 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.571 2.181 . . . . 10.0 110.213 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.68 2.45 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.269 -2.733 . . . . 10.0 106.269 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.47 133.79 45.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.137 0.975 . . . . 10.0 108.723 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.73 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.348 -1.723 . . . . 10.0 106.348 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.15 139.16 35.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.55 130.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.906 -1.887 . . . . 10.0 105.906 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.11 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.393 -1.336 . . . . 10.0 107.393 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.04 143.39 54.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.275 1.03 . . . . 10.0 108.583 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 158.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.27 176.85 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.433 1.093 . . . . 10.0 110.459 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.89 11.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.071 1.349 . . . . 10.0 109.502 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HD1' ' CG2' ' A' ' 98' ' ' ILE . 40.2 t80 -61.59 -73.09 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.615 1.166 . . . . 10.0 112.912 172.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.01 4.54 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.828 1.204 . . . . 10.0 110.392 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 153' ' ' VAL . 35.9 t -113.57 84.8 8.37 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 127.471 2.308 . . . . 10.0 106.086 -163.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.56 168.6 23.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.279 2.653 . . . . 10.0 109.203 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.03 -45.75 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.46 1.904 . . . . 10.0 112.093 -165.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.79 -53.14 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.672 1.989 . . . . 10.0 110.597 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.42 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.88 -49.93 75.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.471 1.508 . . . . 10.0 110.817 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.54 61.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.68 -16.85 27.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.687 1.595 . . . . 10.0 112.071 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.2 0.41 Allowed Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 120.09 1.314 . . . . 10.0 112.621 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.09 -9.11 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 CA-C-N 121.994 1.748 . . . . 10.0 114.45 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.18 68.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.772 1.169 . . . . 10.0 108.827 167.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.23 -28.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.33 1.052 . . . . 10.0 113.816 -164.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 t -46.48 -60.25 3.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.763 1.225 . . . . 10.0 109.483 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.88 -35.35 78.57 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.348 1.16 . . . . 10.0 112.918 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -57.29 -51.59 68.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.349 0.659 . . . . 10.0 110.372 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.12 80.69 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.168 0.509 . . . . 10.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.6 64.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.094 -1.004 . . . . 10.0 111.39 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.13 39.65 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.535 1.134 . . . . 10.0 112.908 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.97 151.25 75.17 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 119.45 1.023 . . . . 10.0 110.968 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.1 169.69 21.57 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 124.053 3.169 . . . . 10.0 110.458 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.09 -4.16 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.024 1.33 . . . . 10.0 113.457 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.76 8.39 43.29 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.622 1.569 . . . . 10.0 110.587 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.46 164.85 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 O-C-N 121.117 -0.989 . . . . 10.0 108.884 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -145.66 136.18 24.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.477 -1.238 . . . . 10.0 108.413 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -115.4 137.65 51.82 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.778 0.323 . . . . 10.0 111.572 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.98 140.24 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.692 -0.686 . . . . 10.0 109.832 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -106.34 120.87 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 14.9 mt -121.83 138.76 29.05 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 112.692 0.627 . . . . 10.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.69 152.82 22.81 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.911 2.407 . . . . 10.0 112.287 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.16 98.05 9.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.21 76.8 8.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.751 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.17 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.161 1.541 . . . . 10.0 115.161 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.09 -48.09 3.41 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 119.897 -1.752 . . . . 10.0 112.801 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.52 -152.06 1.56 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.317 0.961 . . . . 10.0 110.75 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.83 -30.76 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.108 0.963 . . . . 10.0 112.12 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.46 -27.39 6.42 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.064 1.745 . . . . 10.0 113.374 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.9 -36.48 64.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.606 1.094 . . . . 10.0 110.472 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.6 t -73.83 -55.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.495 3.118 . . . . 10.0 112.148 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.15 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 125.407 1.479 . . . . 10.0 111.294 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.59 -41.84 70.37 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 117.757 -1.116 . . . . 10.0 112.457 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.43 -44.32 8.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 114.186 1.18 . . . . 10.0 114.186 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.93 -45.71 92.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.685 0.615 . . . . 10.0 110.272 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.2 95.32 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 116.702 -1.618 . . . . 10.0 109.204 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.418 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.4 -45.7 91.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.628 1.558 . . . . 10.0 110.764 -176.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 126.004 1.722 . . . . 10.0 109.42 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.71 -28.89 66.21 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 118.887 -0.578 . . . . 10.0 111.8 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.78 -37.1 50.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.329 1.052 . . . . 10.0 110.625 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.89 -22.43 56.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.802 -0.618 . . . . 10.0 111.702 -170.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.33 14.55 61.84 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.897 0.761 . . . . 10.0 113.0 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.962 1.305 . . . . 10.0 109.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.704 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.36 -5.35 54.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 117.059 2.244 . . . . 10.0 117.059 -170.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.28 52.05 7.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.347 1.859 . . . . 10.0 112.092 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.98 -47.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.425 -1.274 . . . . 10.0 113.328 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.704 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.9 34.79 1.3 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.586 1.539 . . . . 10.0 113.175 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.33 -44.51 0.62 Allowed 'General case' 0 C--O 1.221 -0.44 0 O-C-N 120.805 -1.185 . . . . 10.0 108.948 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.51 45.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.541 1.311 . . . . 10.0 114.541 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.5 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.6 -1.19 . . . . 10.0 108.637 166.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.6 -46.78 73.88 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.347 1.43 . . . . 10.0 112.006 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.37 -40.51 82.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.468 1.507 . . . . 10.0 110.24 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.24 4.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.766 1.626 . . . . 10.0 112.847 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.412 ' CG2' ' HD1' ' A' ' 35' ' ' TYR . 61.4 mt -115.26 -57.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.033 -2.21 . . . . 10.0 105.033 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.62 -61.37 1.99 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.694 0.798 . . . . 10.0 112.6 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -68.34 -21.12 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.073 0.851 . . . . 10.0 112.157 -177.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.5 3.88 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.508 1.123 . . . . 10.0 108.758 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.545 1.538 . . . . 10.0 110.614 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.68 15.67 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.367 1.067 . . . . 10.0 113.322 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.5 tttm 70.07 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 128.17 2.588 . . . . 10.0 109.557 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.2 mt 54.47 44.59 28.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.768 1.627 . . . . 10.0 112.475 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.59 20.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.295 1.438 . . . . 10.0 114.177 -173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 155.36 29.0 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 127.959 2.503 . . . . 10.0 107.655 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 -44.96 10.95 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 10.0 110.017 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.0 -29.36 67.54 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.191 0.997 . . . . 10.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.51 -42.15 70.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.983 1.313 . . . . 10.0 110.314 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.9 -48.58 17.84 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.145 0.978 . . . . 10.0 108.876 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.16 84.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.408 0.443 . . . . 10.0 111.4 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.13 -46.85 79.04 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.328 1.451 . . . . 10.0 112.558 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.57 60.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.537 0.735 . . . . 10.0 111.466 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -77.02 -14.74 59.79 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.414 -0.804 . . . . 10.0 110.365 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.79 30.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.777 0.831 . . . . 10.0 110.115 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.99 10.12 54.07 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 117.981 -1.455 . . . . 10.0 114.847 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.31 8.71 6.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.365 2.583 . . . . 10.0 112.673 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.97 49.23 4.11 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.68 -1.368 . . . . 10.0 109.68 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.53 132.88 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.233 -2.136 . . . . 10.0 105.233 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -92.32 133.64 35.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.63 0.772 . . . . 10.0 110.021 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.59 -36.88 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.811 -0.614 . . . . 10.0 110.445 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.83 66.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.694 0.679 . . . . 10.0 111.687 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.64 -57.02 4.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.88 -59.54 4.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.826 1.25 . . . . 10.0 112.093 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.56 -33.64 64.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 -170.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 m -62.35 -49.38 75.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -65.68 -41.36 92.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.554 1.141 . . . . 10.0 110.212 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.17 -48.8 44.76 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.691 1.132 . . . . 10.0 110.789 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.58 38.97 1.02 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.639 0.776 . . . . 10.0 111.202 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.24 8.6 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 10.0 111.666 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.36 86.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.837 1.255 . . . . 10.0 110.512 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.88 55.05 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.719 0.808 . . . . 10.0 110.477 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.52 -38.79 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.209 1.004 . . . . 10.0 111.262 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.58 -33.23 63.73 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.009 0.923 . . . . 10.0 111.029 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.47 19.33 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.831 -0.908 . . . . 10.0 110.831 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.3 -36.16 82.77 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.703 -0.88 . . . . 10.0 109.616 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -33.87 76.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.661 -1.162 . . . . 10.0 111.488 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.59 -5.46 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.619 0.645 . . . . 10.0 112.127 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.1 mmtt -92.0 -48.74 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.52 0.2 . . . . 10.0 111.01 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.48 -9.02 59.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.818 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -79.36 -45.01 20.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.672 0.273 . . . . 10.0 110.629 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -19.43 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.203 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 51.4 mt -74.02 -40.57 62.79 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.12 78.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.949 0.352 . . . . 10.0 111.949 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.08 -29.99 65.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 10.0 111.482 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.85 80.28 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.929 -0.578 . . . . 10.0 109.666 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.02 5.04 1.75 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.093 1.757 . . . . 10.0 113.5 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.38 36.82 26.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.935 2.094 . . . . 10.0 112.029 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.31 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.26 -16.16 4.02 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 126.783 2.033 . . . . 10.0 110.267 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.86 33.57 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.979 1.752 . . . . 10.0 112.791 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 37' ' ' CYS . 14.6 m -142.57 152.98 61.37 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 127.282 2.233 . . . . 10.0 108.325 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.55 152.66 71.42 Favored 'Cis proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.61 -0.996 . . . . 10.0 113.082 -6.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.282 1.433 . . . . 10.0 108.581 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.92 158.39 32.08 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.779 1.632 . . . . 10.0 108.146 163.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.55 29.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.3 t -104.14 135.19 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.085 -1.45 . . . . 10.0 107.085 168.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.13 10.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.142 4.577 . . . . 10.0 117.517 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.73 20.1 60.42 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 117.753 -1.582 . . . . 10.0 115.531 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.84 -41.35 1.04 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.998 1.899 . . . . 10.0 114.365 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.81 107.58 16.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.277 -1.009 . . . . 10.0 108.277 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 126.511 1.924 . . . . 10.0 106.741 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.54 169.56 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.362 -1.461 . . . . 10.0 107.22 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.96 -178.79 1.28 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.606 0.362 . . . . 10.0 110.14 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.3 mt -46.23 -50.11 4.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 128.528 2.731 . . . . 10.0 107.778 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.1 16.52 4.49 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.927 1.727 . . . . 10.0 114.352 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.29 -51.16 1.3 Allowed 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.851 1.326 . . . . 10.0 109.692 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.5 72.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.068 1.347 . . . . 10.0 112.3 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.53 -5.9 9.92 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-O 118.542 -1.144 . . . . 10.0 114.774 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.81 174.24 35.11 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.672 1.736 . . . . 10.0 109.945 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.86 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.397 2.065 . . . . 10.0 111.73 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.06 -1.025 . . . . 10.0 111.561 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.16 66.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.094 0.558 . . . . 10.0 110.342 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.99 32.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.969 -1.082 . . . . 10.0 110.89 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.4 mt -63.77 -31.86 73.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.876 0.762 . . . . 10.0 110.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.45 -56.44 8.24 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.636 1.974 . . . . 10.0 108.036 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.59 -41.3 92.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 116.922 -1.513 . . . . 10.0 111.555 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.78 69.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 120.984 1.72 . . . . 10.0 111.7 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.47 -47.06 65.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.939 0.496 . . . . 10.0 110.643 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.55 -42.54 96.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.513 0.725 . . . . 10.0 111.228 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.02 -37.49 84.23 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 120.899 -1.126 . . . . 10.0 111.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.27 -51.89 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.234 0.925 . . . . 10.0 108.589 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.0 -43.09 63.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.567 1.147 . . . . 10.0 110.045 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.61 -0.37 33.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.11 -1.424 . . . . 10.0 113.164 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.3 9.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.62 1.568 . . . . 10.0 114.392 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.82 4.93 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.35 66.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 10.0 111.759 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.47 6.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 130.172 3.389 . . . . 10.0 113.689 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.11 13.34 35.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.724 1.21 . . . . 10.0 113.166 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.9 0.27 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.973 2.109 . . . . 10.0 109.806 -163.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.126 1.77 . . . . 10.0 108.834 -179.27 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.232 0 N-CA-C 109.179 -1.568 . . . . 10.0 109.179 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.69 0.15 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 127.152 2.181 . . . . 10.0 110.355 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 112.392 -2.185 . . . . 10.0 113.039 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.43 157.76 43.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.944 1.698 . . . . 10.0 108.057 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 m -131.25 132.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.39 49.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.57 52.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.67 1.129 . . . . 10.0 113.43 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 -63.02 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.86 1.83 . . . . 10.0 107.768 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.4 -25.88 14.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.409 1.483 . . . . 10.0 110.572 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.68 167.0 31.64 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.234 -0.916 . . . . 10.0 111.614 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.82 115.98 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.816 1.246 . . . . 10.0 109.01 -171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.4 167.33 20.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.948 -1.72 . . . . 10.0 110.435 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.2 124.64 40.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.254 1.022 . . . . 10.0 108.883 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.48 41.69 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.816 0.846 . . . . 10.0 113.216 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 m -129.19 74.43 81.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.222 1.009 . . . . 10.0 108.667 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.57 -179.07 2.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 125.111 3.874 . . . . 10.0 112.261 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.91 34.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 124.716 1.207 . . . . 10.0 107.898 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.08 179.11 5.71 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.38 2.054 . . . . 10.0 112.665 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.52 168.26 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.828 2.051 . . . . 10.0 108.902 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -47.1 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.834 2.053 . . . . 10.0 110.45 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.4 21.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 127.37 2.268 . . . . 10.0 105.39 163.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.97 -164.59 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.576 2.184 . . . . 10.0 110.206 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.09 -112.66 2.45 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 106.382 -2.687 . . . . 10.0 106.382 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.15 0.98 . . . . 10.0 108.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.55 140.75 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.323 -1.732 . . . . 10.0 106.323 169.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -99.19 139.13 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -128.51 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.858 -1.905 . . . . 10.0 105.858 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.13 108.03 14.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.93 143.32 54.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.316 1.046 . . . . 10.0 108.573 162.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 158.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.419 1.088 . . . . 10.0 110.396 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.02 175.84 11.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.969 1.308 . . . . 10.0 109.471 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.3 t80 -61.51 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.625 1.17 . . . . 10.0 112.884 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.03 4.54 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.823 1.201 . . . . 10.0 110.312 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.58 84.81 8.4 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.412 2.285 . . . . 10.0 106.087 -163.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.47 168.49 24.18 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.4 2.733 . . . . 10.0 109.25 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.06 -45.69 0.28 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.447 1.899 . . . . 10.0 112.051 -165.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.13 12.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.764 2.026 . . . . 10.0 110.572 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.84 -49.98 75.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.389 1.476 . . . . 10.0 110.874 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.8 -13.49 61.57 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -171.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.7 -16.91 27.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 10.0 112.045 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.083 1.31 . . . . 10.0 112.554 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.92 -9.32 25.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.063 1.773 . . . . 10.0 114.466 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.1 69.24 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.746 1.157 . . . . 10.0 108.851 167.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.26 -28.58 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.846 1.054 . . . . 10.0 113.846 -164.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.37 -60.31 3.84 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.782 1.233 . . . . 10.0 109.524 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.44 78.62 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 120.266 1.131 . . . . 10.0 112.917 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.19 -51.65 68.46 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.382 0.673 . . . . 10.0 110.378 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.1 80.63 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.154 0.502 . . . . 10.0 110.265 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.97 -25.45 64.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.124 -0.985 . . . . 10.0 111.453 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.74 10.07 39.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.576 1.15 . . . . 10.0 112.887 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.95 151.23 75.1 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.511 1.05 . . . . 10.0 110.977 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.04 169.62 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 124.054 3.17 . . . . 10.0 110.477 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.03 -4.2 4.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.02 1.328 . . . . 10.0 113.434 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.66 8.43 43.36 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.688 1.595 . . . . 10.0 110.63 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.66 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 O-C-N 121.241 -0.912 . . . . 10.0 108.827 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -145.6 136.82 24.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.501 -1.227 . . . . 10.0 108.507 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -114.65 135.88 53.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.96 0.41 . . . . 10.0 111.704 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.26 139.81 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.425 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -108.8 121.62 45.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.191 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 18.7 mt -121.76 138.21 28.24 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 112.787 0.662 . . . . 10.0 112.787 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.71 152.85 22.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.0 2.467 . . . . 10.0 112.395 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.37 98.08 9.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.502 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.0 76.74 8.56 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.913 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.54 20.23 1.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.04 -48.12 3.43 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.879 -1.763 . . . . 10.0 112.827 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.48 -152.06 1.54 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.279 0.943 . . . . 10.0 110.791 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.79 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.04 0.936 . . . . 10.0 112.07 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.49 6.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.093 1.757 . . . . 10.0 113.336 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.85 -36.43 64.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.642 1.11 . . . . 10.0 110.573 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.89 -55.17 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.9 31.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.49 3.116 . . . . 10.0 112.192 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.19 -42.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 125.383 1.468 . . . . 10.0 111.23 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.55 -41.87 70.29 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 117.721 -1.133 . . . . 10.0 112.45 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.44 8.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 114.129 1.159 . . . . 10.0 114.129 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.87 -45.71 92.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.525 0.602 . . . . 10.0 110.26 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.45 -45.24 95.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 116.71 -1.614 . . . . 10.0 109.257 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.67 92.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.628 1.558 . . . . 10.0 110.835 -177.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.029 1.732 . . . . 10.0 109.448 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.72 -28.94 66.23 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 118.909 -0.567 . . . . 10.0 111.805 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.68 -37.2 49.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.33 1.052 . . . . 10.0 110.677 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.88 -22.44 56.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.63 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.43 14.47 61.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.85 0.738 . . . . 10.0 112.955 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.32 130.23 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.994 1.318 . . . . 10.0 109.261 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.54 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.574 0.75 . . . . 10.0 109.011 -165.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.707 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.29 -5.4 54.35 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 117.067 2.247 . . . . 10.0 117.067 -170.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.99 7.49 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.332 1.853 . . . . 10.0 112.072 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.96 -47.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 117.413 -1.28 . . . . 10.0 113.431 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.707 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.84 34.85 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.599 1.545 . . . . 10.0 113.183 -176.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.44 -44.43 0.61 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.814 -1.179 . . . . 10.0 108.938 172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.57 45.68 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.484 1.291 . . . . 10.0 114.484 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.47 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 117.588 -1.196 . . . . 10.0 108.654 166.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.63 -46.75 73.96 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.368 1.44 . . . . 10.0 111.98 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.53 -40.54 83.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.458 1.503 . . . . 10.0 110.14 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.12 4.49 5.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 112.883 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.24 -57.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.002 -2.221 . . . . 10.0 105.002 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.57 -61.29 2.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.764 0.825 . . . . 10.0 112.621 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.36 -21.27 64.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.09 0.859 . . . . 10.0 112.136 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.41 -53.48 3.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.571 1.148 . . . . 10.0 108.799 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.483 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.46 88.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.556 1.542 . . . . 10.0 110.618 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.29 13.73 15.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.411 1.084 . . . . 10.0 113.328 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.96 -64.29 0.36 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.26 2.624 . . . . 10.0 109.537 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.6 mt 54.54 44.73 28.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.768 1.627 . . . . 10.0 112.417 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.73 14.51 21.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.267 1.427 . . . . 10.0 114.137 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.05 155.45 29.21 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 127.983 2.513 . . . . 10.0 107.679 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.27 -44.99 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 10.0 109.936 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.97 -29.41 67.62 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.175 0.99 . . . . 10.0 111.182 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.08 70.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.981 1.313 . . . . 10.0 110.386 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.98 -48.52 17.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.15 0.98 . . . . 10.0 108.895 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.21 84.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 123.396 0.435 . . . . 10.0 111.357 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.12 -46.9 79.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.235 1.414 . . . . 10.0 112.506 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.2 -41.73 60.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.543 0.737 . . . . 10.0 111.388 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.89 -14.75 59.84 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.31 -0.869 . . . . 10.0 110.378 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.78 30.72 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.766 0.827 . . . . 10.0 110.1 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.97 10.14 53.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.93 -1.483 . . . . 10.0 114.85 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.41 8.88 6.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.389 2.595 . . . . 10.0 112.601 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 49.3 4.12 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.638 -1.385 . . . . 10.0 109.638 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.6 132.96 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.39 133.73 35.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.615 0.766 . . . . 10.0 109.993 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.66 -36.96 85.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.729 -0.653 . . . . 10.0 110.375 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.01 -26.81 66.97 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.692 0.678 . . . . 10.0 111.75 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.04 4.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.328 -1.73 . . . . 10.0 106.328 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.9 -59.48 4.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.831 1.252 . . . . 10.0 112.156 -166.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.57 -33.63 64.74 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.296 -0.261 . . . . 10.0 110.296 -170.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 m -62.32 -49.43 75.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.34 92.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.571 1.148 . . . . 10.0 110.264 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.24 -48.71 45.46 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.658 1.117 . . . . 10.0 110.837 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.61 38.92 1.02 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.66 0.784 . . . . 10.0 111.278 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.29 8.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.372 1.469 . . . . 10.0 111.694 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.31 86.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.775 1.23 . . . . 10.0 110.562 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.92 54.54 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.677 0.791 . . . . 10.0 110.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.44 -38.83 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.191 0.997 . . . . 10.0 111.269 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.26 63.72 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.059 0.944 . . . . 10.0 110.974 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.3 -48.38 19.3 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.17 82.8 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.766 -0.844 . . . . 10.0 109.582 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 117.802 -1.094 . . . . 10.0 111.557 178.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.78 3.86 37.28 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.698 0.624 . . . . 10.0 112.09 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -99.06 -45.95 5.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.714 0.292 . . . . 10.0 110.697 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.63 -8.69 55.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.738 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -77.28 -44.31 30.22 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.753 0.311 . . . . 10.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -18.27 58.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.157 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.9 mt -74.08 -36.88 64.33 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.201 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.01 -46.53 82.24 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 mtm -71.86 -28.86 63.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.91 78.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.615 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -69.98 4.96 1.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.142 1.777 . . . . 10.0 113.518 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.5 36.73 26.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.976 2.11 . . . . 10.0 112.064 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.39 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.23 -16.08 4.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.672 1.989 . . . . 10.0 110.284 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.34 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.959 1.742 . . . . 10.0 112.744 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.5 153.02 61.67 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.329 2.252 . . . . 10.0 108.336 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.56 152.74 71.52 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.57 -1.012 . . . . 10.0 113.086 -6.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.9 m -145.95 144.22 30.0 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.281 1.432 . . . . 10.0 108.562 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.86 158.42 31.91 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.832 1.653 . . . . 10.0 108.294 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.975 -1.491 . . . . 10.0 106.975 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.97 135.2 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 168.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 t30 47.02 10.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 1 C-N-CA 133.145 4.578 . . . . 10.0 117.546 171.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.66 20.13 60.48 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.839 -1.534 . . . . 10.0 115.605 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.81 -41.31 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.897 1.849 . . . . 10.0 114.353 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -112.87 107.59 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.46 24.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 126.54 1.936 . . . . 10.0 106.713 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.58 169.61 17.42 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.297 -1.502 . . . . 10.0 107.162 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.81 1.28 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.643 0.377 . . . . 10.0 110.175 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.25 -50.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 128.557 2.743 . . . . 10.0 107.687 160.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.04 16.53 4.43 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.952 1.739 . . . . 10.0 114.354 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.772 1.286 . . . . 10.0 109.689 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.47 -34.49 72.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.098 1.359 . . . . 10.0 112.283 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.5 -5.9 9.95 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-O 118.554 -1.137 . . . . 10.0 114.852 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.28 35.23 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.614 1.707 . . . . 10.0 109.913 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.54 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.378 2.052 . . . . 10.0 111.816 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.39 -28.63 69.92 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.006 -1.059 . . . . 10.0 111.488 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.47 -27.15 66.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.104 0.562 . . . . 10.0 110.344 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.7 -42.84 33.05 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.971 -1.081 . . . . 10.0 110.928 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.8 -31.91 73.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.926 0.784 . . . . 10.0 110.975 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.45 8.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.637 1.975 . . . . 10.0 108.079 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.6 -41.3 92.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 116.898 -1.525 . . . . 10.0 111.53 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.74 69.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.987 1.721 . . . . 10.0 111.693 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.04 65.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 10.0 110.592 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.45 -42.63 96.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.604 0.762 . . . . 10.0 111.254 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.12 -37.43 83.86 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.958 -1.089 . . . . 10.0 111.219 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.7 mt -58.23 -51.93 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.265 0.939 . . . . 10.0 108.604 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.97 -43.08 63.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.579 1.151 . . . . 10.0 110.07 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.64 -0.37 33.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.183 -1.389 . . . . 10.0 113.157 -175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.05 -33.33 9.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.656 1.582 . . . . 10.0 114.442 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -55.72 5.02 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.445 -1.317 . . . . 10.0 107.445 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.34 -20.32 66.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 10.0 111.756 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.36 6.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.08 3.352 . . . . 10.0 113.694 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 13.39 35.29 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.729 1.212 . . . . 10.0 113.111 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.31 76.93 0.27 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.886 2.075 . . . . 10.0 109.827 -163.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.13 1.772 . . . . 10.0 108.878 -179.272 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 109.175 -1.57 . . . . 10.0 109.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.22 73.71 0.15 Allowed 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 127.046 2.138 . . . . 10.0 110.324 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.467 -2.151 . . . . 10.0 113.053 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.47 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.995 1.718 . . . . 10.0 108.063 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.18 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.44 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.66 52.29 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.67 1.129 . . . . 10.0 113.405 -167.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.11 0.97 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.794 1.797 . . . . 10.0 107.745 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.37 -25.94 14.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.383 1.473 . . . . 10.0 110.528 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.08 31.3 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.345 -0.847 . . . . 10.0 111.694 -171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.87 115.85 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.874 1.27 . . . . 10.0 109.07 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.33 167.37 20.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 119.924 -1.735 . . . . 10.0 110.5 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.64 40.88 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.261 1.024 . . . . 10.0 108.9 172.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.29 -9.55 41.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.816 0.846 . . . . 10.0 113.22 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.1 m -129.23 74.39 81.07 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.255 1.022 . . . . 10.0 108.692 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.53 -179.0 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 125.084 3.856 . . . . 10.0 112.231 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.69 138.91 34.13 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.685 1.194 . . . . 10.0 107.905 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.05 179.12 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.474 2.116 . . . . 10.0 112.593 176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.57 168.24 21.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.845 2.058 . . . . 10.0 108.902 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -46.99 -61.88 1.67 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.817 2.047 . . . . 10.0 110.489 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.37 21.27 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 127.319 2.248 . . . . 10.0 105.378 163.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.91 -164.64 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.524 2.149 . . . . 10.0 110.237 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.16 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.355 -2.698 . . . . 10.0 106.355 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.49 133.76 46.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.03 0.932 . . . . 10.0 108.744 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.78 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.312 -1.736 . . . . 10.0 106.312 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.16 139.14 35.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.3 t -128.5 130.35 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.11 108.13 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.42 54.36 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.219 1.008 . . . . 10.0 108.524 162.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.86 131.1 53.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 158.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.28 176.78 7.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.515 1.126 . . . . 10.0 110.414 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.0 175.83 11.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.008 1.323 . . . . 10.0 109.469 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.3 t80 -61.48 -73.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 10.0 112.905 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.08 4.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.824 1.202 . . . . 10.0 110.322 -171.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.55 84.73 8.26 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 127.472 2.309 . . . . 10.0 106.115 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.5 168.6 23.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.281 2.654 . . . . 10.0 109.252 171.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.446 1.898 . . . . 10.0 112.068 -165.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.73 -53.22 12.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.736 2.015 . . . . 10.0 110.542 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.89 -49.88 76.13 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.349 1.46 . . . . 10.0 110.877 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.88 -13.4 61.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.683 0.623 . . . . 10.0 112.683 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.83 -16.73 27.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.659 1.584 . . . . 10.0 112.029 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.72 -67.26 0.41 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.081 1.309 . . . . 10.0 112.569 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.08 -9.13 25.49 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 122.031 1.761 . . . . 10.0 114.411 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.29 68.97 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 10.0 108.781 167.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.46 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.906 1.076 . . . . 10.0 113.906 -164.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.37 -60.39 3.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 10.0 109.505 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.18 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.255 1.127 . . . . 10.0 112.996 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -57.18 -51.64 68.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.407 0.683 . . . . 10.0 110.367 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.2 80.74 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.171 0.51 . . . . 10.0 110.279 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.53 64.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.211 -0.931 . . . . 10.0 111.393 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.7 10.13 39.62 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.613 1.165 . . . . 10.0 112.905 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.99 151.25 75.4 Favored Pre-proline 0 C--O 1.237 0.416 0 CA-C-N 119.483 1.038 . . . . 10.0 110.953 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.13 169.75 21.44 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.003 3.135 . . . . 10.0 110.509 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -4.14 4.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.973 1.309 . . . . 10.0 113.394 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.41 43.33 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.671 1.588 . . . . 10.0 110.61 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.49 164.97 30.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 121.141 -0.974 . . . . 10.0 108.809 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -145.81 137.25 24.94 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.497 -1.229 . . . . 10.0 108.402 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -115.45 137.07 52.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.913 0.387 . . . . 10.0 111.553 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.08 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.468 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -109.17 126.75 53.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.255 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -127.07 139.19 34.42 Favored Pre-proline 0 N--CA 1.462 0.172 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.23 153.16 21.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.974 2.449 . . . . 10.0 112.241 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.87 99.02 10.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.296 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.18 76.9 8.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.757 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.69 20.26 1.17 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.122 1.527 . . . . 10.0 115.122 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.1 3.43 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 119.886 -1.759 . . . . 10.0 112.852 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.08 1.53 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.292 0.949 . . . . 10.0 110.78 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.83 -30.78 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.088 0.955 . . . . 10.0 112.057 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.43 -27.44 6.45 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.124 1.77 . . . . 10.0 113.337 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.87 -36.37 64.81 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.661 1.119 . . . . 10.0 110.588 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.6 t -73.88 -55.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 174.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.533 3.133 . . . . 10.0 112.171 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.13 -42.5 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 125.336 1.446 . . . . 10.0 111.239 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.59 -41.9 70.43 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.778 -1.106 . . . . 10.0 112.471 -175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.38 -44.34 8.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 114.183 1.179 . . . . 10.0 114.183 -173.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.9 -45.77 92.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.49 0.586 . . . . 10.0 110.201 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -45.31 94.95 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 116.761 -1.59 . . . . 10.0 109.205 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.7 92.0 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.601 1.546 . . . . 10.0 110.789 -176.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -60.59 3.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.015 1.726 . . . . 10.0 109.35 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.7 -28.92 66.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 118.963 -0.542 . . . . 10.0 111.767 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.63 -37.22 49.24 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.401 1.081 . . . . 10.0 110.71 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.86 -22.46 56.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.606 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.34 14.54 61.84 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.906 0.765 . . . . 10.0 113.0 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.37 130.28 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.932 1.293 . . . . 10.0 109.326 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -123.54 75.96 1.37 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -165.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.706 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.27 -5.37 54.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.11 2.263 . . . . 10.0 117.11 -170.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.32 52.02 7.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.343 1.857 . . . . 10.0 112.071 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 117.484 -1.246 . . . . 10.0 113.368 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.706 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.83 34.91 1.3 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.565 1.529 . . . . 10.0 113.14 -176.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.42 -44.5 0.61 Allowed 'General case' 0 C--O 1.219 -0.505 0 O-C-N 120.822 -1.174 . . . . 10.0 108.899 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.44 44.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.45 -65.62 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 117.654 -1.165 . . . . 10.0 108.673 166.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.61 -46.81 73.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.255 1.389 . . . . 10.0 111.98 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.56 82.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.406 1.482 . . . . 10.0 110.186 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.11 4.5 5.47 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.76 1.624 . . . . 10.0 112.896 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.21 -57.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.071 -2.196 . . . . 10.0 105.071 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.65 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.706 0.802 . . . . 10.0 112.615 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.34 -21.1 64.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.115 0.87 . . . . 10.0 112.217 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.52 -53.48 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.591 1.157 . . . . 10.0 108.772 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.56 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.44 87.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.571 1.548 . . . . 10.0 110.671 -169.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.18 13.75 15.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.399 1.08 . . . . 10.0 113.389 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.94 -64.25 0.36 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.207 2.603 . . . . 10.0 109.567 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.7 mt 54.61 44.53 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.764 1.626 . . . . 10.0 112.504 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.56 20.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.269 1.428 . . . . 10.0 114.208 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.33 28.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 127.921 2.488 . . . . 10.0 107.682 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.11 -45.04 10.87 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.575 2.183 . . . . 10.0 109.968 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.3 67.39 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.232 1.013 . . . . 10.0 111.175 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.56 -42.08 70.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.941 1.297 . . . . 10.0 110.336 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.92 -48.55 17.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.208 1.003 . . . . 10.0 108.886 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.2 84.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 122.76 0.424 . . . . 10.0 111.418 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.93 78.75 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.279 1.432 . . . . 10.0 112.569 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.65 61.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.535 0.734 . . . . 10.0 111.448 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.371 -0.83 . . . . 10.0 110.366 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.79 30.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.893 0.877 . . . . 10.0 110.095 172.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.09 54.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.917 -1.49 . . . . 10.0 114.773 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.84 6.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 121.358 2.579 . . . . 10.0 112.652 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.25 4.12 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.629 -1.388 . . . . 10.0 109.629 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.57 132.95 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 105.161 -2.163 . . . . 10.0 105.161 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.65 35.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.611 0.764 . . . . 10.0 110.005 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.53 -37.03 86.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.791 -0.623 . . . . 10.0 110.366 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.06 -26.8 66.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.733 0.697 . . . . 10.0 111.717 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.03 4.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.95 -59.45 4.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.829 1.252 . . . . 10.0 112.192 -166.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.56 -33.69 64.79 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.226 -0.287 . . . . 10.0 110.226 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 m -62.2 -49.49 75.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.75 -41.27 92.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.518 1.127 . . . . 10.0 110.255 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.15 -48.71 44.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.723 1.147 . . . . 10.0 110.84 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.66 38.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.697 0.799 . . . . 10.0 111.191 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.31 8.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.413 1.485 . . . . 10.0 111.624 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.19 -40.36 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.852 1.261 . . . . 10.0 110.473 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.84 55.59 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.682 0.793 . . . . 10.0 110.46 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.5 -38.84 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.244 1.018 . . . . 10.0 111.261 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.23 63.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 10.0 111.001 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.41 19.48 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.2 82.93 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.732 -0.863 . . . . 10.0 109.553 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.32 -34.15 77.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.74 -1.124 . . . . 10.0 111.432 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.12 1.76 39.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.749 0.704 . . . . 10.0 111.922 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.5 -52.91 3.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.587 0.232 . . . . 10.0 110.533 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.31 -5.88 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.137 0.421 . . . . 10.0 112.137 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.0 tmmt? -79.1 -45.92 19.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.938 0.399 . . . . 10.0 110.821 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -19.59 59.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.164 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 54.6 mt -71.87 -37.82 70.14 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.605 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.47 80.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.015 0.376 . . . . 10.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.39 -29.37 64.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.74 0.305 . . . . 10.0 111.464 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.87 82.97 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.631 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 5.04 1.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.158 1.783 . . . . 10.0 113.558 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.41 36.74 26.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.916 2.086 . . . . 10.0 112.077 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.3 135.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.729 -1.211 . . . . 10.0 107.729 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.2 -16.08 4.06 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.637 1.975 . . . . 10.0 110.261 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -170.89 33.64 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.036 1.779 . . . . 10.0 112.853 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.49 153.02 61.71 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.271 2.228 . . . . 10.0 108.299 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.57 152.65 71.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.561 -1.016 . . . . 10.0 113.152 -6.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.6 m -145.81 144.3 30.19 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.317 1.447 . . . . 10.0 108.583 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.96 158.39 32.15 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.837 1.655 . . . . 10.0 108.19 163.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.5 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.6 t -104.08 135.16 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 107.117 -1.438 . . . . 10.0 107.117 168.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.09 10.97 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 133.19 4.596 . . . . 10.0 117.463 171.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.11 60.57 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.77 -1.572 . . . . 10.0 115.57 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.89 -41.31 1.04 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.976 1.888 . . . . 10.0 114.325 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.77 107.58 16.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.01 113.37 24.46 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 126.549 1.94 . . . . 10.0 106.765 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.53 169.62 17.39 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 120.344 -1.473 . . . . 10.0 107.159 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.92 -178.82 1.3 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.603 0.361 . . . . 10.0 110.171 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.28 -50.06 5.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 128.483 2.713 . . . . 10.0 107.811 160.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.53 4.5 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.849 1.69 . . . . 10.0 114.365 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.25 -51.25 1.3 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.759 1.28 . . . . 10.0 109.697 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.6 72.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.1 1.36 . . . . 10.0 112.238 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.51 -5.87 9.94 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.489 -1.173 . . . . 10.0 114.844 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.79 174.31 35.17 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.699 1.749 . . . . 10.0 110.012 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.86 -52.57 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.391 2.061 . . . . 10.0 111.81 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.37 -28.66 69.92 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.907 -1.121 . . . . 10.0 111.478 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.16 66.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.044 0.538 . . . . 10.0 110.406 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.63 -42.94 33.08 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.079 -1.013 . . . . 10.0 110.938 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.96 73.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.941 0.791 . . . . 10.0 111.01 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.47 8.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.604 1.962 . . . . 10.0 108.057 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.61 -41.27 92.94 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 116.888 -1.53 . . . . 10.0 111.508 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.81 69.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 121.017 1.735 . . . . 10.0 111.663 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.46 -47.01 65.33 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.844 0.458 . . . . 10.0 110.661 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.5 -42.64 96.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.581 0.752 . . . . 10.0 111.245 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.07 -37.39 83.94 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.922 -1.111 . . . . 10.0 111.247 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.26 -51.92 65.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 119.265 0.939 . . . . 10.0 108.553 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.03 -43.1 63.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.622 1.169 . . . . 10.0 109.972 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.69 -0.29 33.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.15 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.38 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.647 1.579 . . . . 10.0 114.425 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -55.77 4.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.833 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.71 -35.54 6.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.174 3.389 . . . . 10.0 113.65 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.08 13.42 35.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.682 1.193 . . . . 10.0 113.105 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.34 76.87 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.93 2.092 . . . . 10.0 109.837 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.113 1.765 . . . . 10.0 108.797 -179.227 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . 0.452 ' CAA' ' SAK' ' A' ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.254 0 N-CA-C 109.17 -1.572 . . . . 10.0 109.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.15 73.76 0.15 Allowed 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 127.166 2.186 . . . . 10.0 110.312 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.96 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 112.4 -2.182 . . . . 10.0 113.047 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.44 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.09 1.756 . . . . 10.0 108.037 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.21 132.85 44.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.676 -1.231 . . . . 10.0 107.676 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.41 49.34 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.79 52.37 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.734 1.159 . . . . 10.0 113.375 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 -63.05 0.97 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 119.857 1.828 . . . . 10.0 107.69 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.46 -25.93 14.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.406 1.482 . . . . 10.0 110.517 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.53 167.12 31.15 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.275 -0.891 . . . . 10.0 111.789 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.0 115.98 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.775 1.23 . . . . 10.0 108.968 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.41 20.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.908 -1.745 . . . . 10.0 110.457 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.29 124.64 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.238 1.015 . . . . 10.0 108.822 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.28 -9.5 41.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.86 0.864 . . . . 10.0 113.197 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 m -129.32 74.52 80.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 10.0 108.633 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.63 -179.09 2.62 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 125.095 3.863 . . . . 10.0 112.217 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.82 33.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.716 1.206 . . . . 10.0 107.928 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.97 179.13 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.406 2.071 . . . . 10.0 112.616 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.48 168.2 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 126.926 2.09 . . . . 10.0 108.906 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.76 1.73 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.785 2.034 . . . . 10.0 110.503 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.86 165.32 21.32 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.37 2.268 . . . . 10.0 105.435 163.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.8 -164.72 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.631 2.221 . . . . 10.0 110.249 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.18 -112.72 2.46 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.277 -2.729 . . . . 10.0 106.277 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.37 133.66 45.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.142 0.977 . . . . 10.0 108.739 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.62 140.84 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.355 -1.72 . . . . 10.0 106.355 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.27 139.14 35.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.53 130.42 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.828 -1.916 . . . . 10.0 105.828 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.16 108.07 14.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.335 . . . . 10.0 107.394 -172.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.99 143.37 54.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.292 1.037 . . . . 10.0 108.568 162.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.77 131.05 53.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.898 -0.779 . . . . 10.0 108.898 158.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.475 1.11 . . . . 10.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.79 11.78 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.111 1.364 . . . . 10.0 109.533 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.2 t80 -61.46 -73.15 0.1 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.694 1.198 . . . . 10.0 112.891 172.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.96 52.02 4.54 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.813 1.197 . . . . 10.0 110.307 -171.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.57 84.83 8.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.437 2.295 . . . . 10.0 106.03 -163.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.55 168.51 24.2 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.33 2.687 . . . . 10.0 109.246 171.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.1 -45.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.457 1.903 . . . . 10.0 112.091 -165.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.76 -53.14 12.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 10.0 110.577 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.86 -50.05 75.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.332 1.453 . . . . 10.0 110.824 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.7 -13.55 61.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.71 -16.92 27.64 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.764 1.625 . . . . 10.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.59 -67.3 0.4 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 120.11 1.323 . . . . 10.0 112.587 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.21 25.72 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-N 122.052 1.768 . . . . 10.0 114.469 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.9 -43.12 68.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.734 1.152 . . . . 10.0 108.765 167.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 tt -105.27 -28.48 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -164.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.7 t -46.44 -60.33 3.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.817 1.247 . . . . 10.0 109.475 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.2 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.277 1.135 . . . . 10.0 113.002 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.25 -51.61 68.66 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.356 0.663 . . . . 10.0 110.366 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.99 -39.12 80.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.091 0.472 . . . . 10.0 110.223 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.84 -25.64 64.75 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.178 -0.951 . . . . 10.0 111.431 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.01 39.77 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.607 1.163 . . . . 10.0 112.923 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.99 151.25 75.38 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 119.493 1.042 . . . . 10.0 110.938 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.1 169.74 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.967 3.111 . . . . 10.0 110.541 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -4.2 4.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.018 1.327 . . . . 10.0 113.428 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.39 43.34 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.705 1.602 . . . . 10.0 110.533 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.53 164.87 30.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 121.245 -0.909 . . . . 10.0 108.796 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.53 135.0 21.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.568 -1.196 . . . . 10.0 108.431 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -113.82 138.98 49.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.855 0.359 . . . . 10.0 111.733 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.23 142.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.484 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -109.09 122.34 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.186 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.7 mt -121.59 138.29 28.18 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.76 153.14 22.76 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.937 2.425 . . . . 10.0 112.211 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.69 97.78 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.433 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.12 76.78 8.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.798 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.64 20.31 1.15 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.176 1.547 . . . . 10.0 115.176 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.02 -48.13 3.43 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.937 -1.727 . . . . 10.0 112.88 168.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 -152.14 1.53 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.342 0.973 . . . . 10.0 110.737 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.82 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.154 0.982 . . . . 10.0 112.029 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.48 6.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.093 1.757 . . . . 10.0 113.347 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.88 -36.47 64.8 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.631 1.105 . . . . 10.0 110.464 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.79 -55.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -65.83 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.56 3.144 . . . . 10.0 112.237 170.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.22 -42.47 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 125.409 1.48 . . . . 10.0 111.226 173.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.62 -41.8 70.43 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.744 -1.122 . . . . 10.0 112.461 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.56 -44.26 8.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.119 1.155 . . . . 10.0 114.119 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -61.87 -45.8 92.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.568 0.622 . . . . 10.0 110.252 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.24 95.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 116.74 -1.6 . . . . 10.0 109.16 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.4 -45.69 91.99 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.637 1.562 . . . . 10.0 110.775 -177.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -60.6 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.017 1.727 . . . . 10.0 109.38 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.59 -29.02 66.47 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.962 -0.542 . . . . 10.0 111.855 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.64 -37.28 49.58 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.325 1.05 . . . . 10.0 110.669 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.6 mtp -75.74 -22.49 56.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.72 -0.657 . . . . 10.0 111.709 -170.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.44 61.85 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.844 0.735 . . . . 10.0 112.995 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.3 130.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.957 1.303 . . . . 10.0 109.314 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.59 75.95 1.38 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.572 0.749 . . . . 10.0 108.982 -165.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.33 -5.36 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.077 2.251 . . . . 10.0 117.077 -170.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.39 51.91 7.54 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.352 1.861 . . . . 10.0 112.127 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.92 -47.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.42 -1.276 . . . . 10.0 113.419 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.705 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.78 34.84 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.589 1.541 . . . . 10.0 113.131 -176.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.454 0 O-C-N 120.813 -1.179 . . . . 10.0 108.974 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.53 45.52 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -71.47 -65.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 117.556 -1.211 . . . . 10.0 108.698 166.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.75 74.06 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.389 1.45 . . . . 10.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.41 -40.6 82.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.478 1.511 . . . . 10.0 110.156 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.18 4.58 5.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.719 1.608 . . . . 10.0 112.871 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.08 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.56 -61.35 2.0 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.678 0.791 . . . . 10.0 112.671 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.2 64.8 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.045 0.839 . . . . 10.0 112.152 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.63 3.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.614 1.166 . . . . 10.0 108.772 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.569 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.55 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.543 1.537 . . . . 10.0 110.647 -169.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.61 15.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.421 1.088 . . . . 10.0 113.331 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.0 -64.19 0.36 Allowed 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 128.266 2.626 . . . . 10.0 109.513 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt 54.52 44.58 28.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.764 1.625 . . . . 10.0 112.498 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.65 14.56 20.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.324 1.45 . . . . 10.0 114.224 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.42 29.11 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 127.984 2.514 . . . . 10.0 107.629 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.2 -44.92 10.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.551 2.167 . . . . 10.0 110.038 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.35 67.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.229 1.012 . . . . 10.0 111.133 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.48 -42.14 70.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.027 1.331 . . . . 10.0 110.333 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.86 -48.57 18.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.155 0.982 . . . . 10.0 108.908 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.24 84.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 123.402 0.439 . . . . 10.0 111.292 -172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.03 -46.9 78.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.378 1.471 . . . . 10.0 112.565 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.9 t80 -74.2 -41.69 61.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.556 0.742 . . . . 10.0 111.489 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.0 -14.72 59.8 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.367 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.76 30.65 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.86 0.864 . . . . 10.0 110.135 172.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.06 54.19 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 117.969 -1.462 . . . . 10.0 114.906 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.74 6.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.355 2.577 . . . . 10.0 112.674 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.95 49.35 4.08 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.67 132.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.138 -2.171 . . . . 10.0 105.138 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.26 133.7 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.63 0.772 . . . . 10.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.57 -37.0 86.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.375 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.76 66.87 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.721 0.691 . . . . 10.0 111.721 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.65 -57.1 4.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.796 1.238 . . . . 10.0 112.201 -166.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.57 -33.64 64.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.4 m -62.29 -49.5 75.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.28 92.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.522 1.129 . . . . 10.0 110.232 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.28 -48.72 45.79 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.726 1.148 . . . . 10.0 110.721 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.57 38.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.712 0.805 . . . . 10.0 111.195 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.84 172.32 8.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.361 1.464 . . . . 10.0 111.59 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.17 -40.45 86.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.824 1.25 . . . . 10.0 110.444 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.86 54.68 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.745 0.818 . . . . 10.0 110.495 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.47 -38.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.287 1.035 . . . . 10.0 111.321 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.32 63.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.07 0.948 . . . . 10.0 111.003 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.37 19.6 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.12 82.65 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.817 -0.814 . . . . 10.0 109.608 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -33.98 76.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.729 -1.129 . . . . 10.0 111.46 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.41 1.58 38.53 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.627 0.649 . . . . 10.0 112.136 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 11.7 mmtt -96.89 -47.14 5.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 10.0 110.91 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.13 -6.04 58.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -79.44 -44.96 20.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.923 0.392 . . . . 10.0 110.751 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -74.53 -21.21 59.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 37.8 mt -71.93 -37.89 69.95 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.207 -0.452 . . . . 10.0 111.1 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.33 78.0 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.001 0.371 . . . . 10.0 112.001 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.1 mtm -72.79 -28.64 62.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.582 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.93 78.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.612 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.0 5.05 1.73 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 113.49 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.3 36.78 26.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.897 2.079 . . . . 10.0 112.127 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.36 135.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.33 -16.04 4.01 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.701 2.0 . . . . 10.0 110.255 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.48 -170.92 33.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.892 1.71 . . . . 10.0 112.72 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.45 153.01 61.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.242 2.217 . . . . 10.0 108.309 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.53 152.67 71.37 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.599 -1.0 . . . . 10.0 113.07 -6.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.1 m -145.86 144.26 30.12 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.351 1.46 . . . . 10.0 108.634 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.94 158.39 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.823 1.649 . . . . 10.0 108.204 163.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.14 136.48 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.06 135.06 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.123 -1.436 . . . . 10.0 107.123 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.08 10.96 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.148 4.579 . . . . 10.0 117.561 171.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.57 20.28 60.34 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.803 -1.554 . . . . 10.0 115.52 -170.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.9 -41.4 1.03 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.962 1.881 . . . . 10.0 114.346 -170.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.69 107.58 16.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.553 1.941 . . . . 10.0 106.765 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -136.59 169.54 17.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.141 -1.429 . . . . 10.0 107.141 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.8 1.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.585 0.354 . . . . 10.0 110.193 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.26 -50.1 5.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 128.569 2.748 . . . . 10.0 107.717 160.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.13 16.57 4.48 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.834 1.683 . . . . 10.0 114.4 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -128.28 -51.21 1.3 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.793 1.297 . . . . 10.0 109.692 168.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.59 72.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.037 1.335 . . . . 10.0 112.298 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.54 -5.98 9.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 118.496 -1.169 . . . . 10.0 114.754 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.36 35.26 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 119.75 1.775 . . . . 10.0 110.046 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 -52.62 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.354 2.036 . . . . 10.0 111.724 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.27 -28.7 69.9 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.999 -1.063 . . . . 10.0 111.539 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.12 66.81 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.07 0.548 . . . . 10.0 110.409 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.69 -42.9 32.92 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.014 -1.054 . . . . 10.0 110.939 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.76 -31.83 73.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.91 0.777 . . . . 10.0 111.04 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.56 -56.4 8.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.502 1.921 . . . . 10.0 108.053 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.56 -41.33 93.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 116.917 -1.516 . . . . 10.0 111.509 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.65 69.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.996 1.725 . . . . 10.0 111.729 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.58 -47.04 64.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.863 0.465 . . . . 10.0 110.58 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.45 -42.63 96.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.608 0.763 . . . . 10.0 111.256 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.08 -37.38 83.89 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 120.94 -1.1 . . . . 10.0 111.266 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.31 -51.89 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.261 0.937 . . . . 10.0 108.582 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.06 63.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.543 1.137 . . . . 10.0 110.064 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.63 -0.46 33.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 117.145 -1.407 . . . . 10.0 113.123 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.03 -33.37 9.29 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.627 1.571 . . . . 10.0 114.429 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -55.8 4.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.372 -1.344 . . . . 10.0 107.372 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.32 66.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.159 -0.928 . . . . 10.0 111.795 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.41 6.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 130.122 3.369 . . . . 10.0 113.73 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.16 13.51 34.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.653 1.181 . . . . 10.0 113.153 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.977 2.111 . . . . 10.0 109.819 -163.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.085 1.754 . . . . 10.0 108.787 -179.16 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.292 0 N-CA-C 109.203 -1.559 . . . . 10.0 109.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.66 0.15 Allowed 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 127.081 2.152 . . . . 10.0 110.423 -175.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.2 11.9 0.66 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 112.45 -2.159 . . . . 10.0 112.997 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.41 157.75 43.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.028 1.731 . . . . 10.0 108.009 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.25 132.81 44.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.48 49.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.187 -1.042 . . . . 10.0 108.187 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.6 13.73 52.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.713 1.149 . . . . 10.0 113.423 -166.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.03 0.98 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.858 1.829 . . . . 10.0 107.853 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.4 -26.07 14.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.427 1.491 . . . . 10.0 110.45 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.5 167.14 31.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.25 -0.906 . . . . 10.0 111.702 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.91 115.98 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.802 1.241 . . . . 10.0 109.036 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.41 167.25 20.42 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.927 -1.733 . . . . 10.0 110.534 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.62 40.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.213 1.005 . . . . 10.0 108.835 172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 m -67.32 -9.39 40.61 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.228 0.825 . . . . 10.0 113.228 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -129.35 74.39 81.0 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.14 0.976 . . . . 10.0 108.574 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.53 -179.08 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 125.095 3.864 . . . . 10.0 112.246 -172.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.91 34.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.681 1.193 . . . . 10.0 107.932 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.08 179.08 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.457 2.105 . . . . 10.0 112.601 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.48 168.23 20.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.801 2.04 . . . . 10.0 108.931 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.0 -61.8 1.71 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.808 2.043 . . . . 10.0 110.531 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.03 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.321 2.248 . . . . 10.0 105.34 163.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.9 -164.62 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.576 2.184 . . . . 10.0 110.229 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.67 2.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.323 -2.711 . . . . 10.0 106.323 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.51 133.79 46.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.075 0.95 . . . . 10.0 108.697 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.65 140.76 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.16 35.3 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.5 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.962 -1.866 . . . . 10.0 105.962 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.12 108.16 14.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -172.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.14 143.37 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.305 1.042 . . . . 10.0 108.463 162.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.73 131.14 53.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 158.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.42 176.82 7.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 10.0 110.381 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.82 11.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.0 109.464 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.47 -73.22 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.66 1.184 . . . . 10.0 112.842 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.06 4.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.778 1.18 . . . . 10.0 110.326 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.52 84.76 8.23 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 127.464 2.306 . . . . 10.0 106.111 -163.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.5 168.49 24.2 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.339 2.693 . . . . 10.0 109.239 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.07 -45.7 0.28 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.431 1.892 . . . . 10.0 112.081 -165.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.87 -53.09 12.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.767 2.027 . . . . 10.0 110.518 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.6 t80 -59.05 -49.87 76.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.423 1.489 . . . . 10.0 110.796 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.47 61.63 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -171.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.85 27.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.69 1.596 . . . . 10.0 112.046 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.6 -67.31 0.4 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.174 1.352 . . . . 10.0 112.56 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.0 -9.18 25.67 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 121.986 1.745 . . . . 10.0 114.425 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.2 69.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.812 1.187 . . . . 10.0 108.837 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.22 -28.49 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 113.874 1.065 . . . . 10.0 113.874 -164.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.43 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.746 1.218 . . . . 10.0 109.48 173.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.85 -35.39 78.65 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.273 1.133 . . . . 10.0 112.897 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.24 -51.66 68.47 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.431 0.693 . . . . 10.0 110.304 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.89 -39.22 80.79 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.169 0.509 . . . . 10.0 110.25 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.79 -25.71 64.84 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.096 -1.002 . . . . 10.0 111.415 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.07 39.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.513 1.125 . . . . 10.0 112.923 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.86 151.17 74.5 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 119.485 1.039 . . . . 10.0 110.971 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.07 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.987 3.125 . . . . 10.0 110.49 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.12 -4.19 4.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.011 1.324 . . . . 10.0 113.395 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.62 8.34 43.45 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.743 1.617 . . . . 10.0 110.627 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.52 164.94 30.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 O-C-N 121.189 -0.945 . . . . 10.0 108.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -146.08 137.07 24.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.402 -1.272 . . . . 10.0 108.444 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -117.3 135.64 53.68 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.804 0.335 . . . . 10.0 111.725 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.92 138.67 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.81 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -104.42 118.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.02 138.44 27.01 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.88 152.89 25.32 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.028 2.485 . . . . 10.0 112.4 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 96.96 8.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.271 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.1 76.8 8.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.363 -0.38 . . . . 10.0 111.776 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.22 1.16 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.132 1.53 . . . . 10.0 115.132 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.11 -48.18 3.42 Favored Glycine 0 N--CA 1.467 0.723 0 O-C-N 119.933 -1.729 . . . . 10.0 112.752 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.39 -152.13 1.52 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.389 0.995 . . . . 10.0 110.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.86 -30.75 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.077 0.951 . . . . 10.0 112.081 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.34 -27.52 6.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.049 1.74 . . . . 10.0 113.396 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.86 -36.46 64.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.66 1.118 . . . . 10.0 110.478 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.9 t -73.88 -55.14 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.94 31.91 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.519 3.128 . . . . 10.0 112.137 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.19 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 125.332 1.444 . . . . 10.0 111.196 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.47 -41.86 70.0 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.53 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.32 8.45 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.121 1.156 . . . . 10.0 114.121 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.89 -45.67 92.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.503 0.592 . . . . 10.0 110.335 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.38 -45.33 94.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.786 -1.578 . . . . 10.0 109.251 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.35 -45.63 92.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.592 1.542 . . . . 10.0 110.829 -177.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.6 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.99 1.716 . . . . 10.0 109.483 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.64 -29.03 66.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.919 -0.562 . . . . 10.0 111.789 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.57 -37.24 48.79 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.362 1.065 . . . . 10.0 110.701 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.8 -22.46 56.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.695 -170.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.46 61.83 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.871 0.748 . . . . 10.0 112.986 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.41 130.32 26.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 124.916 1.286 . . . . 10.0 109.277 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.87 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.605 0.762 . . . . 10.0 109.022 -165.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.704 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.26 -5.39 54.26 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.103 2.26 . . . . 10.0 117.103 -170.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 51.96 7.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.313 1.845 . . . . 10.0 112.114 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.93 -47.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.455 -1.26 . . . . 10.0 113.381 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.704 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.93 34.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.576 1.535 . . . . 10.0 113.199 -176.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.41 -44.57 0.61 Allowed 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.832 -1.167 . . . . 10.0 108.84 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.48 44.7 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.605 1.335 . . . . 10.0 114.605 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -71.53 -65.49 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 117.518 -1.23 . . . . 10.0 108.695 166.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.72 74.04 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.407 1.458 . . . . 10.0 112.048 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.49 -40.48 82.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.388 1.475 . . . . 10.0 110.241 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.3 4.65 5.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.818 1.647 . . . . 10.0 112.826 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.29 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.991 -2.225 . . . . 10.0 104.991 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.62 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.713 0.805 . . . . 10.0 112.625 -173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.502 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.26 -21.22 64.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.093 0.86 . . . . 10.0 112.189 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.42 -53.51 3.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.58 1.152 . . . . 10.0 108.831 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.38 88.03 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 10.0 110.656 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.63 15.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.382 1.073 . . . . 10.0 113.325 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.01 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 128.217 2.607 . . . . 10.0 109.57 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.0 mt 54.43 44.71 28.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.815 1.646 . . . . 10.0 112.436 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.6 20.63 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.284 1.434 . . . . 10.0 114.189 -173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 155.39 29.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 127.933 2.493 . . . . 10.0 107.643 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.2 -45.01 10.7 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.576 2.184 . . . . 10.0 109.937 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.36 67.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.208 1.003 . . . . 10.0 111.161 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.15 70.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.981 1.313 . . . . 10.0 110.322 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.89 -48.53 18.03 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.165 0.986 . . . . 10.0 108.909 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.16 84.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.461 0.476 . . . . 10.0 111.349 -172.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.11 -46.89 78.95 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.324 1.45 . . . . 10.0 112.51 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.62 60.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.549 0.74 . . . . 10.0 111.412 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.95 -14.71 59.82 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.36 -0.838 . . . . 10.0 110.418 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.52 -41.73 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.814 0.846 . . . . 10.0 110.098 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.07 10.1 54.52 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.0 -1.445 . . . . 10.0 114.845 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.32 8.79 6.59 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.313 2.556 . . . . 10.0 112.64 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.16 4.15 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.696 -1.362 . . . . 10.0 109.696 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.54 132.88 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.165 -2.161 . . . . 10.0 105.165 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -92.26 133.76 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.561 0.744 . . . . 10.0 110.022 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -64.63 -36.96 85.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.768 -0.634 . . . . 10.0 110.37 174.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.09 -26.79 66.89 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.637 0.653 . . . . 10.0 111.719 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.06 4.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.334 -1.728 . . . . 10.0 106.334 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.776 1.23 . . . . 10.0 112.241 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.51 -33.65 64.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.3 m -62.34 -49.37 75.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.76 -41.33 92.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.555 1.142 . . . . 10.0 110.207 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.1 -48.73 44.18 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.768 1.167 . . . . 10.0 110.83 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.65 38.84 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.714 0.806 . . . . 10.0 111.116 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.461 1.504 . . . . 10.0 111.657 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.18 -40.35 86.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.782 1.233 . . . . 10.0 110.521 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.82 55.38 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.723 0.809 . . . . 10.0 110.489 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.49 -38.78 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.241 1.016 . . . . 10.0 111.324 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.31 63.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.995 0.918 . . . . 10.0 111.016 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.46 19.72 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.851 -0.899 . . . . 10.0 110.851 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.35 -36.21 82.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.751 -0.852 . . . . 10.0 109.53 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -33.63 75.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.751 -1.118 . . . . 10.0 111.542 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.6 -0.87 34.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.581 0.628 . . . . 10.0 112.373 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 54.2 mmtt -95.26 -44.92 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 10.0 110.8 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.34 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.584 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -79.24 -45.75 19.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.692 0.282 . . . . 10.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -16.58 60.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 45.8 mt -75.76 -40.41 55.4 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.293 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.42 77.34 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.1 0.407 . . . . 10.0 112.1 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.0 mtm -70.46 -29.72 66.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.763 0.315 . . . . 10.0 111.556 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.89 78.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.69 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.0 5.02 1.75 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.148 1.779 . . . . 10.0 113.524 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.4 36.8 26.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.885 2.074 . . . . 10.0 112.075 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.17 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.793 2.037 . . . . 10.0 110.319 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.39 -170.96 33.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 126.024 1.773 . . . . 10.0 112.865 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.38 152.99 62.04 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 127.316 2.246 . . . . 10.0 108.341 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.63 152.71 71.76 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.569 -1.013 . . . . 10.0 113.103 -6.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 57.2 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.325 1.45 . . . . 10.0 108.538 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.6 mmm -123.94 158.44 31.99 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.733 1.613 . . . . 10.0 108.225 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.16 136.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.862 -1.533 . . . . 10.0 106.862 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.0 135.2 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.091 -1.448 . . . . 10.0 107.091 168.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 46.99 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 133.151 4.58 . . . . 10.0 117.53 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.67 20.08 60.57 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.778 -1.568 . . . . 10.0 115.552 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.41 1.04 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.954 1.877 . . . . 10.0 114.333 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.72 107.57 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.53 24.55 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.471 1.908 . . . . 10.0 106.79 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.63 169.58 17.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.304 -1.497 . . . . 10.0 107.09 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.91 -178.76 1.29 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.36 -50.08 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 128.482 2.713 . . . . 10.0 107.724 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.54 4.5 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.963 1.744 . . . . 10.0 114.377 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.9 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 118.726 1.263 . . . . 10.0 109.651 168.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.065 1.346 . . . . 10.0 112.247 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.49 -5.68 9.99 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 118.57 -1.128 . . . . 10.0 114.83 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.74 174.25 35.07 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.639 1.719 . . . . 10.0 109.963 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.88 -52.6 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.407 2.072 . . . . 10.0 111.766 -169.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.015 -1.053 . . . . 10.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.41 -27.2 66.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.138 0.575 . . . . 10.0 110.38 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.64 -43.04 32.67 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.097 -1.002 . . . . 10.0 110.822 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.71 -31.87 73.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.965 0.802 . . . . 10.0 111.036 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.48 8.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.537 1.935 . . . . 10.0 108.074 168.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -41.37 93.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.896 -1.526 . . . . 10.0 111.496 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.952 1.705 . . . . 10.0 111.735 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.15 64.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.934 0.494 . . . . 10.0 110.591 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.43 -42.52 96.24 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.584 0.754 . . . . 10.0 111.301 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.18 -37.38 83.61 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.93 -1.106 . . . . 10.0 111.242 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.18 -52.0 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.232 0.924 . . . . 10.0 108.583 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.96 -43.06 63.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.596 1.158 . . . . 10.0 110.016 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.3 tttt -79.7 -0.4 33.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.154 -1.403 . . . . 10.0 113.139 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.08 -33.25 9.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.637 1.575 . . . . 10.0 114.466 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -55.73 4.99 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.763 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.5 6.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 130.244 3.418 . . . . 10.0 113.638 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.12 13.43 35.19 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.717 1.207 . . . . 10.0 113.117 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.33 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.872 2.069 . . . . 10.0 109.845 -163.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.039 1.736 . . . . 10.0 108.768 -179.272 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.296 0 N-CA-C 109.284 -1.526 . . . . 10.0 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.7 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 127.087 2.155 . . . . 10.0 110.406 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.24 11.86 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.07 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.012 1.725 . . . . 10.0 108.081 -175.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.32 132.75 44.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 148.42 49.48 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.7 13.61 52.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.623 1.106 . . . . 10.0 113.42 -167.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -63.04 0.98 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 119.871 1.835 . . . . 10.0 107.769 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.348 1.459 . . . . 10.0 110.521 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.68 167.02 31.57 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.271 -0.893 . . . . 10.0 111.719 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.82 115.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.836 1.254 . . . . 10.0 109.023 -171.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.45 167.32 20.31 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 119.993 -1.692 . . . . 10.0 110.497 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.69 41.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.29 1.036 . . . . 10.0 108.823 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.44 -9.36 41.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.768 0.827 . . . . 10.0 113.116 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.29 74.34 81.06 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.254 1.022 . . . . 10.0 108.647 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.43 -179.11 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 125.121 3.881 . . . . 10.0 112.29 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.92 34.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.769 1.227 . . . . 10.0 107.948 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.14 179.14 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.427 2.085 . . . . 10.0 112.538 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.54 168.18 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.78 2.032 . . . . 10.0 108.938 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -47.0 -61.87 1.67 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.851 2.06 . . . . 10.0 110.44 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.05 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 127.228 2.211 . . . . 10.0 105.301 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.91 -164.56 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.585 2.19 . . . . 10.0 110.304 173.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.07 -112.7 2.46 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.36 -2.696 . . . . 10.0 106.36 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.48 133.71 45.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.07 0.948 . . . . 10.0 108.785 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.64 140.82 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.305 -1.739 . . . . 10.0 106.305 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.31 139.22 35.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.8 t -128.54 130.43 69.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.901 -1.888 . . . . 10.0 105.901 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 HG12 HD13 ' A' ' 63' ' ' LEU . 11.3 t -131.15 108.09 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -172.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.11 143.39 54.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.236 1.014 . . . . 10.0 108.544 162.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.14 53.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 158.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.36 176.87 7.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.391 1.076 . . . . 10.0 110.365 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.05 175.82 11.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.049 1.34 . . . . 10.0 109.555 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.673 1.189 . . . . 10.0 112.882 172.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.98 52.11 4.56 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.78 1.181 . . . . 10.0 110.293 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.492 ' SG ' HG21 ' A' ' 153' ' ' VAL . 35.7 t -113.57 84.83 8.38 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 127.371 2.268 . . . . 10.0 106.147 -163.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.56 168.55 24.08 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.32 2.68 . . . . 10.0 109.253 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.0 -45.68 0.28 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.482 1.913 . . . . 10.0 112.06 -164.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.81 -53.17 12.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.745 2.018 . . . . 10.0 110.556 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HH ' ' HE3' ' A' ' 100' ' ' LYS . 11.7 t80 -58.92 -49.81 76.41 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.349 1.459 . . . . 10.0 110.91 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.52 61.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.63 -16.86 27.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.793 1.637 . . . . 10.0 112.118 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.73 -67.25 0.41 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 120.064 1.302 . . . . 10.0 112.557 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.23 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.066 1.774 . . . . 10.0 114.431 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.85 -43.2 68.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.83 1.195 . . . . 10.0 108.774 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.16 -28.56 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 t -46.35 -60.42 3.68 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.668 1.187 . . . . 10.0 109.492 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.79 -35.42 79.18 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 CA-C-N 120.244 1.123 . . . . 10.0 112.908 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.18 -51.67 68.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.422 0.689 . . . . 10.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -58.92 -39.08 80.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.128 0.489 . . . . 10.0 110.291 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.52 64.61 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.15 -0.969 . . . . 10.0 111.441 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.08 39.81 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.563 1.145 . . . . 10.0 112.834 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.93 151.28 74.72 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 119.52 1.055 . . . . 10.0 110.982 174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.13 169.67 21.59 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.985 3.124 . . . . 10.0 110.537 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.05 -4.19 4.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.969 1.308 . . . . 10.0 113.461 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.72 8.46 43.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.706 1.602 . . . . 10.0 110.6 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.56 165.56 29.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 121.213 -0.929 . . . . 10.0 108.798 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -146.63 135.79 22.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.573 -1.194 . . . . 10.0 108.458 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.87 136.81 52.47 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 t -140.02 139.57 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.022 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -106.33 120.2 41.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.044 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 10.8 mt -118.23 136.45 23.93 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.73 154.64 26.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.502 2.135 . . . . 10.0 112.307 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.78 96.74 7.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.247 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.41 76.77 8.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.757 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.55 20.23 1.15 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.204 1.557 . . . . 10.0 115.204 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.04 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.863 -1.773 . . . . 10.0 112.827 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.54 -152.11 1.58 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.351 0.977 . . . . 10.0 110.759 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.201 1.0 . . . . 10.0 112.002 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.36 -27.44 6.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.123 1.769 . . . . 10.0 113.346 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.96 -36.4 64.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 119.589 1.086 . . . . 10.0 110.498 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.6 t -73.8 -55.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.031 -1.1 . . . . 10.0 108.031 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.532 3.133 . . . . 10.0 112.182 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.12 -42.56 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 125.405 1.479 . . . . 10.0 111.296 173.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.5 -41.86 70.09 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.768 -1.11 . . . . 10.0 112.499 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.5 -44.33 8.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 114.137 1.162 . . . . 10.0 114.137 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.84 -45.77 92.38 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.514 0.597 . . . . 10.0 110.3 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.2 mt -61.39 -45.26 95.1 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 116.744 -1.598 . . . . 10.0 109.209 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -62.37 -45.7 91.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.652 1.569 . . . . 10.0 110.771 -176.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.005 1.722 . . . . 10.0 109.474 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.66 -29.03 66.4 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 118.955 -0.545 . . . . 10.0 111.767 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.22 49.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.325 1.05 . . . . 10.0 110.748 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 31.0 mtp -75.77 -22.49 56.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.644 -0.693 . . . . 10.0 111.632 -170.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.32 14.54 61.87 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.914 0.768 . . . . 10.0 112.985 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.39 130.28 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.012 1.325 . . . . 10.0 109.272 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.56 76.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.955 -0.758 . . . . 10.0 108.955 -165.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.706 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -79.35 -5.33 54.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.092 2.256 . . . . 10.0 117.092 -170.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 44.35 51.99 7.45 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.284 1.833 . . . . 10.0 112.11 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.97 -47.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.448 -1.263 . . . . 10.0 113.364 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.706 ' HD1' ' HE2' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 44.85 34.81 1.29 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.627 1.558 . . . . 10.0 113.159 -176.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.46 0.62 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 120.835 -1.165 . . . . 10.0 108.898 172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.51 45.49 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.542 1.312 . . . . 10.0 114.542 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.42 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 117.67 -1.157 . . . . 10.0 108.756 166.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.48 -46.93 73.5 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.378 1.444 . . . . 10.0 112.033 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.32 -40.65 82.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.473 1.509 . . . . 10.0 110.194 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' ' CE1' ' A' ' 114' ' ' PHE . . . -74.07 4.51 5.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.808 1.643 . . . . 10.0 112.899 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.31 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.3 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.683 0.793 . . . . 10.0 112.615 -173.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HE3' ' HH ' ' A' ' 41' ' ' TYR . 1.1 mtpt -68.33 -21.16 64.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.149 0.886 . . . . 10.0 112.171 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.48 -53.46 3.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.519 1.127 . . . . 10.0 108.781 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.43 88.07 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.541 1.536 . . . . 10.0 110.626 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.39 13.83 15.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.395 1.078 . . . . 10.0 113.267 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.91 -64.24 0.36 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 128.206 2.602 . . . . 10.0 109.591 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.2 mt 54.46 44.63 28.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.734 1.614 . . . . 10.0 112.534 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.63 20.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.228 1.411 . . . . 10.0 114.179 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 155.25 28.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.944 2.498 . . . . 10.0 107.676 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.1 -45.01 10.96 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.525 2.15 . . . . 10.0 109.955 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.22 67.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.193 0.997 . . . . 10.0 111.212 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.13 70.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.02 1.328 . . . . 10.0 110.327 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.89 -48.51 18.07 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.211 1.004 . . . . 10.0 108.93 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.09 84.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.405 0.441 . . . . 10.0 111.367 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.09 -46.94 78.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.307 1.443 . . . . 10.0 112.536 172.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 97' ' ' ALA . 18.7 t80 -74.2 -41.78 60.87 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.597 0.759 . . . . 10.0 111.406 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.86 -14.79 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.35 -0.844 . . . . 10.0 110.39 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.39 -41.79 29.97 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.801 0.84 . . . . 10.0 110.18 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.0 10.12 54.13 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 117.931 -1.483 . . . . 10.0 114.846 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.38 8.84 6.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.367 2.583 . . . . 10.0 112.615 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.25 4.13 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.672 -1.371 . . . . 10.0 109.672 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.49 132.94 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.134 -2.173 . . . . 10.0 105.134 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.41 133.72 35.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.608 0.763 . . . . 10.0 109.915 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.63 -36.96 85.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.8 -0.619 . . . . 10.0 110.406 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.96 -26.86 67.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.748 0.704 . . . . 10.0 111.719 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.69 -57.03 4.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.378 -1.712 . . . . 10.0 106.378 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.87 -59.51 4.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.85 1.26 . . . . 10.0 112.164 -166.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.55 -33.67 64.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.5 m -62.28 -49.43 75.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.327 -0.62 . . . . 10.0 109.327 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.73 -41.33 92.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.645 1.178 . . . . 10.0 110.237 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.694 1.133 . . . . 10.0 110.883 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.682 0.793 . . . . 10.0 111.178 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.392 1.477 . . . . 10.0 111.716 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.1 -40.44 86.92 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.911 1.284 . . . . 10.0 110.523 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.9 54.69 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.754 0.822 . . . . 10.0 110.484 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.48 -38.8 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.158 0.983 . . . . 10.0 111.274 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.28 63.73 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.002 0.921 . . . . 10.0 110.99 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.34 19.88 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.861 -0.896 . . . . 10.0 110.861 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.38 -36.21 82.96 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.712 -0.875 . . . . 10.0 109.583 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.36 77.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.767 -1.111 . . . . 10.0 111.517 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -94.95 -15.05 23.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.607 0.639 . . . . 10.0 112.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.482 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 72.3 mmtt -86.9 -47.25 9.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 10.0 110.845 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.79 -9.4 59.01 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.11 -42.47 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.684 0.278 . . . . 10.0 110.989 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -19.45 57.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 68.8 mt -72.5 -44.18 62.59 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.118 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.75 -46.86 77.76 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 67.3 mtm -69.76 -30.88 68.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 10.0 111.498 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.29 -43.87 80.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.664 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.08 5.05 1.77 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.142 1.777 . . . . 10.0 113.477 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 54.38 36.77 26.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.875 2.07 . . . . 10.0 112.142 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.39 135.04 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.682 -1.229 . . . . 10.0 107.682 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.2 -16.14 4.05 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.766 2.026 . . . . 10.0 110.31 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.91 33.64 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.968 1.747 . . . . 10.0 112.769 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG21 ' SG ' ' A' ' 37' ' ' CYS . 14.7 m -142.51 152.99 61.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 127.216 2.206 . . . . 10.0 108.283 175.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.65 71.41 Favored 'Cis proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.646 -0.981 . . . . 10.0 113.07 -6.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.1 m -145.86 144.3 30.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.331 1.452 . . . . 10.0 108.59 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.94 158.38 32.14 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.792 1.637 . . . . 10.0 108.211 163.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.08 136.41 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.943 -1.502 . . . . 10.0 106.943 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 29.4 t -104.05 135.21 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.054 -1.462 . . . . 10.0 107.054 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.0 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.132 4.573 . . . . 10.0 117.582 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.1 60.58 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.844 -1.531 . . . . 10.0 115.568 -170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.85 -41.26 1.04 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.931 1.866 . . . . 10.0 114.348 -170.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.76 107.61 16.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 -171.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.97 113.4 24.46 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.522 1.929 . . . . 10.0 106.8 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -136.51 169.57 17.48 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 120.408 -1.433 . . . . 10.0 107.141 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.95 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.587 0.355 . . . . 10.0 110.11 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.34 -50.01 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 128.466 2.707 . . . . 10.0 107.764 160.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.56 4.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.881 1.705 . . . . 10.0 114.429 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.28 -51.2 1.3 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.724 1.262 . . . . 10.0 109.667 168.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.66 72.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.102 1.361 . . . . 10.0 112.202 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.64 -5.92 9.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.796 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.31 35.23 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.693 1.747 . . . . 10.0 109.96 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.93 -52.57 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.359 2.039 . . . . 10.0 111.758 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.46 -28.58 69.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.977 -1.077 . . . . 10.0 111.486 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.45 -27.1 66.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.101 0.56 . . . . 10.0 110.392 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.96 32.67 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.959 -1.088 . . . . 10.0 110.904 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.7 -31.88 73.19 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.922 0.783 . . . . 10.0 111.026 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.51 -56.4 8.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.557 1.943 . . . . 10.0 108.075 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.54 -41.36 93.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 116.883 -1.532 . . . . 10.0 111.494 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.73 69.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.985 1.721 . . . . 10.0 111.728 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.05 65.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.975 0.51 . . . . 10.0 110.613 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.57 -42.47 96.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.592 0.757 . . . . 10.0 111.263 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.27 -37.32 83.27 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 120.946 -1.096 . . . . 10.0 111.236 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.3 -51.87 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.28 0.945 . . . . 10.0 108.654 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.08 63.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.573 1.149 . . . . 10.0 110.016 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB1' ' A' ' 189' ' ' ALA . 71.2 tttt -79.71 -0.34 33.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.08 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.33 9.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.671 1.589 . . . . 10.0 114.42 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.74 4.99 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.33 -1.359 . . . . 10.0 107.33 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.37 -20.3 66.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.743 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 130.183 3.393 . . . . 10.0 113.639 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.21 13.45 35.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.667 1.187 . . . . 10.0 113.114 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.87 0.27 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.903 2.081 . . . . 10.0 109.799 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.079 1.751 . . . . 10.0 108.805 -179.276 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . 0.446 ' CAA' ' SAK' ' A' ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.293 0 N-CA-C 109.154 -1.578 . . . . 10.0 109.154 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.71 0.15 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.116 2.166 . . . . 10.0 110.357 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.01 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.081 2.153 . . . . 10.0 113.029 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.46 157.69 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.013 1.725 . . . . 10.0 108.047 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.19 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.7 148.45 49.23 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.63 52.08 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.702 1.144 . . . . 10.0 113.437 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 -63.04 0.98 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.788 1.794 . . . . 10.0 107.817 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.44 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.5 mp0 -98.42 -25.95 14.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.405 1.482 . . . . 10.0 110.506 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.58 167.06 31.38 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.254 -0.904 . . . . 10.0 111.687 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.86 115.91 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.848 1.259 . . . . 10.0 109.054 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.39 20.27 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 119.895 -1.753 . . . . 10.0 110.479 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.56 40.64 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.254 1.022 . . . . 10.0 108.83 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.29 -9.47 41.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.794 0.838 . . . . 10.0 113.19 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 m -129.27 74.4 81.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.163 0.985 . . . . 10.0 108.646 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.58 -179.07 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 125.073 3.849 . . . . 10.0 112.221 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.61 138.88 34.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.698 1.199 . . . . 10.0 107.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -73.01 179.1 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.481 2.121 . . . . 10.0 112.598 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.5 168.27 20.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.804 2.042 . . . . 10.0 108.937 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.809 2.044 . . . . 10.0 110.488 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.83 165.4 21.08 Favored Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 127.315 2.246 . . . . 10.0 105.359 163.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.89 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.55 2.167 . . . . 10.0 110.24 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.58 2.43 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 106.338 -2.705 . . . . 10.0 106.338 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.53 133.71 46.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.116 0.966 . . . . 10.0 108.718 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.25 139.2 35.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.521 -1.288 . . . . 10.0 107.521 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.0 t -128.57 130.39 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.15 108.1 14.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 -172.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.01 143.36 54.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.271 1.028 . . . . 10.0 108.533 162.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.72 131.12 53.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 158.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.37 176.81 7.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.417 1.087 . . . . 10.0 110.398 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.82 11.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.098 1.359 . . . . 10.0 109.511 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.51 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.607 1.163 . . . . 10.0 112.879 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.89 51.99 4.53 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.775 1.178 . . . . 10.0 110.38 -171.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.45 84.8 8.13 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 127.457 2.303 . . . . 10.0 106.098 -163.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.58 23.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.308 2.672 . . . . 10.0 109.253 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.476 1.911 . . . . 10.0 112.083 -165.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.78 -53.14 12.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.704 2.001 . . . . 10.0 110.572 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.91 -49.9 76.05 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.327 1.451 . . . . 10.0 110.884 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -13.47 61.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.713 0.635 . . . . 10.0 112.713 -171.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.74 -16.76 27.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.722 1.609 . . . . 10.0 112.118 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.24 0.41 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.094 1.315 . . . . 10.0 112.593 -172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.04 -9.2 25.7 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.988 1.746 . . . . 10.0 114.403 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.87 -43.15 69.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.797 1.18 . . . . 10.0 108.813 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.27 -28.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 -164.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 t -46.46 -60.35 3.82 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.711 1.205 . . . . 10.0 109.471 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.77 -35.42 79.4 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.272 1.133 . . . . 10.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.9 t90 -57.17 -51.66 68.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.418 0.687 . . . . 10.0 110.367 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.94 -39.13 80.68 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.182 0.515 . . . . 10.0 110.258 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.94 -25.54 64.62 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.117 -0.99 . . . . 10.0 111.418 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.68 10.05 39.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.568 1.147 . . . . 10.0 112.897 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.7 mt -60.97 151.26 75.17 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-N 119.513 1.051 . . . . 10.0 110.922 174.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.13 169.71 21.52 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 124.042 3.161 . . . . 10.0 110.471 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.11 -4.26 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.004 1.322 . . . . 10.0 113.397 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.58 8.35 43.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.744 1.618 . . . . 10.0 110.653 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.48 164.71 31.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 O-C-N 121.161 -0.962 . . . . 10.0 108.834 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -145.98 134.65 22.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.534 -1.212 . . . . 10.0 108.448 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -114.48 135.52 54.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.854 0.359 . . . . 10.0 111.621 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.71 138.91 41.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 10.0 109.685 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -104.91 118.5 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.49 HD12 HG11 ' A' ' 30' ' ' VAL . 15.8 mt -118.75 138.51 26.03 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 112.726 0.639 . . . . 10.0 112.726 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.28 152.86 24.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.933 2.422 . . . . 10.0 112.188 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 97.47 8.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.391 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.88 76.79 8.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.389 -0.369 . . . . 10.0 111.861 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.53 20.16 1.15 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.165 1.542 . . . . 10.0 115.165 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.11 3.42 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 119.939 -1.725 . . . . 10.0 112.793 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.53 -152.08 1.57 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.327 0.965 . . . . 10.0 110.779 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.84 -30.81 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.077 0.951 . . . . 10.0 112.047 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.38 -27.43 6.33 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.079 1.752 . . . . 10.0 113.327 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.95 -36.35 64.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.656 1.116 . . . . 10.0 110.515 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.9 -55.1 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.93 31.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.545 3.138 . . . . 10.0 112.186 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.16 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.33 1.443 . . . . 10.0 111.217 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.57 -41.82 70.3 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.476 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.33 8.46 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 114.181 1.178 . . . . 10.0 114.181 -173.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.85 -45.78 92.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 123.639 0.587 . . . . 10.0 110.241 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -45.24 95.17 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 116.7 -1.619 . . . . 10.0 109.197 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -45.6 92.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.61 1.55 . . . . 10.0 110.778 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -60.59 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.082 1.753 . . . . 10.0 109.415 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.71 -29.0 66.29 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.796 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.16 48.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.365 1.066 . . . . 10.0 110.703 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.9 -22.42 56.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.663 -170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.44 61.9 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.867 0.746 . . . . 10.0 112.97 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.31 130.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 124.929 1.292 . . . . 10.0 109.337 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.55 75.95 1.37 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.47 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.091 2.256 . . . . 10.0 117.091 -170.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 52.0 7.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.329 1.852 . . . . 10.0 112.086 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.93 -47.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 117.452 -1.261 . . . . 10.0 113.403 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.83 1.31 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.57 1.532 . . . . 10.0 113.084 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.4 -44.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.447 0 O-C-N 120.762 -1.211 . . . . 10.0 108.891 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.55 45.41 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.56 1.318 . . . . 10.0 114.56 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.43 -65.64 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 117.601 -1.19 . . . . 10.0 108.671 166.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.53 -46.81 73.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.324 1.42 . . . . 10.0 112.025 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.56 82.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.479 1.511 . . . . 10.0 110.182 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.22 4.57 5.5 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.774 1.63 . . . . 10.0 112.867 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.28 2.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.706 0.803 . . . . 10.0 112.635 -173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.19 64.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.112 0.869 . . . . 10.0 112.171 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.47 3.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.557 1.143 . . . . 10.0 108.79 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.4 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.544 1.538 . . . . 10.0 110.666 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.25 13.74 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.362 1.065 . . . . 10.0 113.34 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.03 -64.27 0.36 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 128.166 2.586 . . . . 10.0 109.57 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.4 mt 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.73 1.612 . . . . 10.0 112.522 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.49 20.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.282 1.433 . . . . 10.0 114.192 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.07 155.41 29.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 127.888 2.475 . . . . 10.0 107.643 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.18 -44.96 10.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.532 2.155 . . . . 10.0 110.012 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.34 67.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.259 1.024 . . . . 10.0 111.19 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.08 70.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.965 1.306 . . . . 10.0 110.344 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.56 17.91 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.16 0.984 . . . . 10.0 108.875 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.19 -37.25 84.57 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 122.761 0.425 . . . . 10.0 111.36 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.86 78.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.279 1.432 . . . . 10.0 112.605 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.69 60.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.609 0.763 . . . . 10.0 111.423 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.376 -0.827 . . . . 10.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.46 -41.73 30.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.788 0.835 . . . . 10.0 110.15 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.08 54.46 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.953 -1.471 . . . . 10.0 114.811 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.33 8.87 6.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.394 2.597 . . . . 10.0 112.604 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.9 49.26 4.12 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.678 -1.369 . . . . 10.0 109.678 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.53 132.89 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.167 -2.16 . . . . 10.0 105.167 169.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.66 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.666 0.786 . . . . 10.0 110.03 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.804 -0.617 . . . . 10.0 110.416 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.14 -26.73 66.81 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.682 0.674 . . . . 10.0 111.706 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.09 4.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.359 -1.719 . . . . 10.0 106.359 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.9 -59.44 4.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.819 1.248 . . . . 10.0 112.169 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.56 -33.7 64.8 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.254 -0.276 . . . . 10.0 110.254 -170.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.25 -49.48 75.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.38 92.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.592 1.157 . . . . 10.0 110.23 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.1 -48.77 44.17 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 119.701 1.137 . . . . 10.0 110.845 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.9 1.02 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.637 0.775 . . . . 10.0 111.181 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.3 8.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.387 1.475 . . . . 10.0 111.69 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.13 -40.4 86.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.262 . . . . 10.0 110.487 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.82 54.94 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.718 0.807 . . . . 10.0 110.505 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.4 mm -69.57 -38.78 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.23 1.012 . . . . 10.0 111.268 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.26 63.78 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.002 0.921 . . . . 10.0 110.963 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.39 19.59 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.837 -0.905 . . . . 10.0 110.837 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.07 82.52 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.762 -0.846 . . . . 10.0 109.611 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.0 76.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.771 -1.109 . . . . 10.0 111.495 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.69 -2.24 35.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.557 0.617 . . . . 10.0 111.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -93.48 -48.32 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.622 0.248 . . . . 10.0 110.953 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.65 58.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.407 . . . . 10.0 111.793 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 66' ' ' LEU . 11.3 tmtt? -79.17 -45.05 20.7 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.818 0.342 . . . . 10.0 110.597 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -18.64 60.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.004 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--O 1.226 -0.163 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.146 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.769 0.319 . . . . 10.0 111.511 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.86 79.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.649 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 4.97 1.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.1 1.76 . . . . 10.0 113.545 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.45 36.8 26.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.888 2.075 . . . . 10.0 112.077 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.7 t -69.37 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.679 -1.23 . . . . 10.0 107.679 172.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.13 4.05 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.757 2.023 . . . . 10.0 110.316 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.32 -170.83 33.52 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.933 1.73 . . . . 10.0 112.777 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.53 153.0 61.54 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 127.286 2.234 . . . . 10.0 108.304 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.58 152.7 71.59 Favored 'Cis proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.6 -1.0 . . . . 10.0 113.087 -6.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.0 m -145.89 144.24 30.07 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.264 1.425 . . . . 10.0 108.537 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.98 158.4 32.15 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.77 1.628 . . . . 10.0 108.174 163.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.05 135.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.04 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 1 C-N-CA 133.17 4.588 . . . . 10.0 117.552 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.19 60.38 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.807 -1.552 . . . . 10.0 115.526 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.88 -41.27 1.04 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.967 1.883 . . . . 10.0 114.349 -170.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.77 107.55 16.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.98 113.45 24.52 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 126.528 1.931 . . . . 10.0 106.738 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.57 169.62 17.41 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.333 -1.479 . . . . 10.0 107.154 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.94 -178.8 1.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.631 0.373 . . . . 10.0 110.191 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.27 -50.16 5.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 128.527 2.731 . . . . 10.0 107.715 160.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.07 16.53 4.45 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.856 1.693 . . . . 10.0 114.435 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.32 -51.11 1.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.735 1.267 . . . . 10.0 109.628 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.56 72.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.076 1.351 . . . . 10.0 112.251 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.57 -5.88 9.89 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.443 -1.199 . . . . 10.0 114.752 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.85 174.32 35.22 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.71 1.755 . . . . 10.0 109.93 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.98 -52.53 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.397 2.065 . . . . 10.0 111.752 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.31 -28.71 69.92 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.965 -1.084 . . . . 10.0 111.526 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.39 -27.24 66.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.144 0.578 . . . . 10.0 110.333 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.65 -42.84 33.36 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.051 -1.031 . . . . 10.0 110.961 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.83 -31.82 73.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.923 0.783 . . . . 10.0 111.014 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.49 -56.4 8.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.59 1.956 . . . . 10.0 108.076 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.32 93.1 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 116.928 -1.51 . . . . 10.0 111.542 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.72 69.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.931 1.696 . . . . 10.0 111.698 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.07 65.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.905 0.482 . . . . 10.0 110.637 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.48 -42.61 96.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.605 0.762 . . . . 10.0 111.272 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.1 mt -67.04 -37.42 84.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.881 -1.137 . . . . 10.0 111.278 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.28 -51.93 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 119.239 0.927 . . . . 10.0 108.574 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.01 -43.08 63.49 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.573 1.149 . . . . 10.0 110.021 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.65 -0.32 33.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.144 -175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.32 9.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.672 1.589 . . . . 10.0 114.461 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -55.75 4.98 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.37 -1.344 . . . . 10.0 107.37 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.28 -20.34 66.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.121 -0.945 . . . . 10.0 111.811 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.73 -35.46 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 130.087 3.355 . . . . 10.0 113.712 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.17 13.48 34.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.701 1.2 . . . . 10.0 113.145 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.82 0.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.92 2.088 . . . . 10.0 109.823 -163.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.058 1.743 . . . . 10.0 108.788 -179.276 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.234 -1.546 . . . . 10.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.23 73.64 0.16 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.046 2.138 . . . . 10.0 110.379 -175.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.25 11.97 0.65 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.429 -2.169 . . . . 10.0 113.011 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -146.41 157.74 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.033 1.733 . . . . 10.0 108.052 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 m -131.25 132.8 44.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.47 49.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.56 51.91 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.632 1.11 . . . . 10.0 113.432 -167.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.09 0.98 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 119.863 1.832 . . . . 10.0 107.727 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.363 1.465 . . . . 10.0 110.488 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.6 167.07 31.36 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.231 -0.918 . . . . 10.0 111.623 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.85 116.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.879 1.272 . . . . 10.0 109.064 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.34 20.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.869 -1.77 . . . . 10.0 110.478 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.56 40.72 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.312 1.045 . . . . 10.0 108.864 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.38 40.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.808 0.843 . . . . 10.0 113.215 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 m -129.3 74.38 81.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.209 1.003 . . . . 10.0 108.62 -176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.62 -179.1 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 125.114 3.876 . . . . 10.0 112.198 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.54 138.87 34.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.732 1.213 . . . . 10.0 107.993 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.09 179.08 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.456 2.104 . . . . 10.0 112.626 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.5 168.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.862 2.065 . . . . 10.0 108.947 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.06 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.778 2.031 . . . . 10.0 110.514 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.77 165.39 21.2 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 10.0 105.388 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.94 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.585 2.19 . . . . 10.0 110.248 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.12 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.343 -2.703 . . . . 10.0 106.343 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.46 133.66 45.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.081 0.952 . . . . 10.0 108.758 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.55 140.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.335 -1.728 . . . . 10.0 106.335 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.3 139.23 35.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.855 -1.905 . . . . 10.0 105.855 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.19 108.13 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 -172.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.07 143.35 54.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.305 1.042 . . . . 10.0 108.515 162.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.69 131.03 53.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 158.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.3 176.77 7.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.438 1.095 . . . . 10.0 110.427 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.05 175.81 11.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.965 1.306 . . . . 10.0 109.479 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.44 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.688 1.195 . . . . 10.0 112.903 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.0 4.53 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.873 1.225 . . . . 10.0 110.379 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.52 84.83 8.3 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 127.427 2.291 . . . . 10.0 106.101 -163.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.56 168.53 24.14 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.365 2.71 . . . . 10.0 109.215 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.03 -45.74 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.538 1.935 . . . . 10.0 112.046 -165.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.82 -53.06 12.81 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.69 1.996 . . . . 10.0 110.618 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.9 76.05 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.368 1.467 . . . . 10.0 110.865 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.44 61.57 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.732 0.642 . . . . 10.0 112.732 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.8 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.709 1.604 . . . . 10.0 112.031 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.83 -67.18 0.41 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 120.124 1.329 . . . . 10.0 112.581 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.94 -9.26 25.84 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 122.141 1.8 . . . . 10.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.21 68.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.795 1.18 . . . . 10.0 108.774 167.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.88 1.067 . . . . 10.0 113.88 -164.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.45 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.799 1.24 . . . . 10.0 109.499 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.88 -35.42 78.17 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.277 1.135 . . . . 10.0 112.928 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.8 t90 -57.11 -51.64 68.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.407 0.683 . . . . 10.0 110.389 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.14 80.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.126 0.489 . . . . 10.0 110.252 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.64 64.67 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.11 -0.993 . . . . 10.0 111.375 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.1 39.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.487 1.115 . . . . 10.0 112.948 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.9 151.23 74.7 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 119.467 1.031 . . . . 10.0 111.002 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.09 169.64 21.67 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.013 3.142 . . . . 10.0 110.505 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 -4.22 4.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.994 1.318 . . . . 10.0 113.452 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.72 8.43 43.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.687 1.595 . . . . 10.0 110.606 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.78 31.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 O-C-N 121.19 -0.944 . . . . 10.0 108.865 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -146.13 134.86 22.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.551 -1.204 . . . . 10.0 108.399 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -114.38 139.9 49.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.869 0.366 . . . . 10.0 111.538 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.45 143.54 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.692 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.368 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 30' ' ' VAL . 16.3 mt -124.21 138.66 31.21 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.66 152.76 22.86 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.069 2.513 . . . . 10.0 112.207 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.67 98.2 9.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.405 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.92 76.75 8.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.13 1.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.11 1.522 . . . . 10.0 115.11 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.14 3.42 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 119.97 -1.706 . . . . 10.0 112.824 168.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.02 1.52 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.335 0.969 . . . . 10.0 110.766 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.96 -30.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.14 0.976 . . . . 10.0 111.976 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.32 -27.54 6.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.103 1.761 . . . . 10.0 113.331 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.86 -36.4 64.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.679 1.127 . . . . 10.0 110.501 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.95 -55.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.923 -1.14 . . . . 10.0 107.923 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.84 31.89 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.495 3.118 . . . . 10.0 112.257 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.14 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 125.314 1.435 . . . . 10.0 111.173 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.44 -41.95 70.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.81 -1.091 . . . . 10.0 112.463 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.45 8.37 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -173.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.77 -45.8 92.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.639 0.587 . . . . 10.0 110.3 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.39 -45.23 95.23 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.738 -1.601 . . . . 10.0 109.226 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.65 92.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.611 1.55 . . . . 10.0 110.874 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.977 1.711 . . . . 10.0 109.48 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.75 -28.95 66.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 118.922 -0.561 . . . . 10.0 111.768 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.19 49.72 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.38 1.072 . . . . 10.0 110.655 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.79 -22.56 56.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.621 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.43 61.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.82 0.724 . . . . 10.0 112.871 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.34 130.26 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.973 1.309 . . . . 10.0 109.313 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.5 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 -165.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.52 54.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.118 2.266 . . . . 10.0 117.118 -170.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.42 52.03 7.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.348 1.859 . . . . 10.0 112.064 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.04 -47.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 117.444 -1.265 . . . . 10.0 113.355 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.95 34.8 1.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.628 1.558 . . . . 10.0 113.079 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.56 0.62 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 120.758 -1.214 . . . . 10.0 108.845 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.49 44.89 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.547 1.314 . . . . 10.0 114.547 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.49 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.549 -1.215 . . . . 10.0 108.661 166.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.57 -46.83 73.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.397 1.453 . . . . 10.0 112.031 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.43 -40.66 83.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.433 1.493 . . . . 10.0 110.135 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.06 4.5 5.43 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.683 1.593 . . . . 10.0 112.888 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.22 -57.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.0 -2.222 . . . . 10.0 105.0 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.56 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.664 0.786 . . . . 10.0 112.716 -173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.31 -21.22 64.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.099 0.863 . . . . 10.0 112.199 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.49 3.9 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.535 1.134 . . . . 10.0 108.81 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 58.42 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.517 1.527 . . . . 10.0 110.695 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.31 13.71 15.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.357 1.063 . . . . 10.0 113.28 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.95 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 128.223 2.609 . . . . 10.0 109.546 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.0 mt 54.52 44.61 28.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.729 1.612 . . . . 10.0 112.542 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.75 14.59 20.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.299 1.44 . . . . 10.0 114.154 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.045 2.538 . . . . 10.0 107.704 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.16 -45.0 10.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.539 2.16 . . . . 10.0 109.973 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.03 -29.34 67.47 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.263 1.025 . . . . 10.0 111.119 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.52 -42.16 70.5 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.022 1.329 . . . . 10.0 110.292 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.5 18.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.169 0.988 . . . . 10.0 108.877 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 123.387 0.43 . . . . 10.0 111.369 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.12 -46.83 79.0 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.262 1.425 . . . . 10.0 112.569 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.3 -41.59 60.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.6 0.76 . . . . 10.0 111.439 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.99 -14.8 59.8 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.357 -0.839 . . . . 10.0 110.384 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 -41.85 30.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.827 0.851 . . . . 10.0 110.114 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.15 53.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.944 -1.475 . . . . 10.0 114.883 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.39 8.85 6.56 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.333 2.567 . . . . 10.0 112.625 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 49.3 4.12 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.67 -1.372 . . . . 10.0 109.67 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.6 132.94 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.144 -2.169 . . . . 10.0 105.144 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.69 35.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.673 0.789 . . . . 10.0 110.009 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.59 -37.01 86.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.788 -0.625 . . . . 10.0 110.352 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.04 -26.75 66.92 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.707 0.685 . . . . 10.0 111.772 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.07 4.01 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.36 -1.719 . . . . 10.0 106.36 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.94 -59.42 4.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.821 1.249 . . . . 10.0 112.154 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.58 -33.73 64.77 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.205 -0.294 . . . . 10.0 110.205 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -62.27 -49.41 75.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.284 -0.636 . . . . 10.0 109.284 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.76 -41.29 92.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.524 1.13 . . . . 10.0 110.216 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.21 -48.71 45.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.686 1.13 . . . . 10.0 110.773 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.63 38.82 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.709 0.804 . . . . 10.0 111.147 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.28 8.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.426 1.49 . . . . 10.0 111.701 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.08 -40.41 87.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.842 1.257 . . . . 10.0 110.54 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.85 55.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.695 0.798 . . . . 10.0 110.495 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.6 mm -69.49 -38.77 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.224 1.009 . . . . 10.0 111.322 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.28 63.8 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 10.0 111.018 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.39 19.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.16 82.79 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.806 -0.82 . . . . 10.0 109.569 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.34 -33.64 75.97 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.749 -1.119 . . . . 10.0 111.527 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.67 -0.89 33.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.592 0.633 . . . . 10.0 112.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.37 -48.41 5.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.701 0.286 . . . . 10.0 110.709 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.86 -5.98 59.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.815 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.5 tmtt? -81.35 -43.81 18.51 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.874 0.369 . . . . 10.0 110.891 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -17.77 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 69.3 mt . . . . . 0 C--O 1.225 -0.186 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.96 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.6 mtm . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.832 0.349 . . . . 10.0 111.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.91 81.12 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.595 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -69.97 5.0 1.74 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.175 1.79 . . . . 10.0 113.539 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 54.37 36.81 26.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.877 2.071 . . . . 10.0 112.146 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 32' ' ' LEU . 90.5 t -69.37 135.13 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.717 -1.216 . . . . 10.0 107.717 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.37 -16.09 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.717 2.007 . . . . 10.0 110.254 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.88 33.61 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.954 1.74 . . . . 10.0 112.821 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 152.99 61.76 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.262 2.225 . . . . 10.0 108.359 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.59 152.65 71.56 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.592 -1.003 . . . . 10.0 113.078 -6.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.7 m -145.86 144.22 30.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 125.294 1.438 . . . . 10.0 108.562 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.93 158.35 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.847 1.659 . . . . 10.0 108.208 163.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.06 136.53 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.955 -1.498 . . . . 10.0 106.955 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.2 t -104.07 135.13 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.1 10.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 133.159 4.584 . . . . 10.0 117.542 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.6 20.19 60.47 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.806 -1.552 . . . . 10.0 115.601 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -131.88 -41.28 1.04 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.916 1.858 . . . . 10.0 114.38 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.81 107.53 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.99 113.39 24.46 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 126.506 1.922 . . . . 10.0 106.808 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.45 169.65 17.34 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 120.393 -1.442 . . . . 10.0 107.172 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.84 1.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.617 0.367 . . . . 10.0 110.123 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.31 -50.09 5.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 128.469 2.708 . . . . 10.0 107.771 160.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.08 16.56 4.44 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.946 1.736 . . . . 10.0 114.368 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.38 -51.16 1.29 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.814 1.307 . . . . 10.0 109.609 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.62 72.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.143 1.377 . . . . 10.0 112.274 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 118.529 -1.151 . . . . 10.0 114.73 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.3 35.22 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.738 1.769 . . . . 10.0 110.015 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.437 2.092 . . . . 10.0 111.72 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.33 -28.65 69.89 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.904 -1.122 . . . . 10.0 111.523 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.15 66.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.058 0.543 . . . . 10.0 110.333 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.67 -43.01 32.65 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.062 -1.024 . . . . 10.0 110.905 -169.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.91 73.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.889 0.768 . . . . 10.0 111.076 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.5 8.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.65 1.98 . . . . 10.0 108.018 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.56 -41.29 93.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 116.959 -1.496 . . . . 10.0 111.538 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 120.946 1.703 . . . . 10.0 111.74 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.49 -47.12 64.89 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.898 0.479 . . . . 10.0 110.635 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.46 -42.55 96.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.616 0.767 . . . . 10.0 111.251 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.45 83.97 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 120.917 -1.114 . . . . 10.0 111.257 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.0 mt -58.15 -51.98 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.217 0.917 . . . . 10.0 108.647 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.05 -43.03 63.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.483 1.113 . . . . 10.0 110.018 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.69 -0.36 33.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.12 -1.419 . . . . 10.0 113.072 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.14 -33.26 9.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.618 1.567 . . . . 10.0 114.458 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -55.69 5.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.413 -1.329 . . . . 10.0 107.413 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.38 66.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.177 -0.919 . . . . 10.0 111.738 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.053 3.341 . . . . 10.0 113.741 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.19 13.51 34.9 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.677 1.191 . . . . 10.0 113.113 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.35 76.84 0.27 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.895 2.078 . . . . 10.0 109.816 -163.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.135 1.774 . . . . 10.0 108.822 -179.291 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.166 -1.573 . . . . 10.0 109.166 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.18 73.72 0.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 127.088 2.155 . . . . 10.0 110.359 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.38 12.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.094 2.158 . . . . 10.0 112.981 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.46 157.72 43.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.029 1.731 . . . . 10.0 108.086 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m -131.2 132.79 44.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.63 148.37 49.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.186 -1.042 . . . . 10.0 108.186 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.68 52.35 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.731 1.158 . . . . 10.0 113.415 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -63.07 0.98 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.825 1.813 . . . . 10.0 107.854 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.9 14.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.369 1.467 . . . . 10.0 110.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.1 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.242 -0.911 . . . . 10.0 111.718 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.95 115.98 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.819 1.248 . . . . 10.0 108.99 -171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -80.43 167.39 20.24 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 119.963 -1.71 . . . . 10.0 110.489 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.24 124.61 40.79 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.309 1.044 . . . . 10.0 108.839 172.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.42 41.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.806 0.842 . . . . 10.0 113.176 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.198 0.999 . . . . 10.0 108.664 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.63 -179.11 2.63 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.987 3.792 . . . . 10.0 112.235 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 138.91 34.1 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.723 1.209 . . . . 10.0 107.948 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.99 179.12 5.67 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.453 2.102 . . . . 10.0 112.643 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.51 168.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.824 2.049 . . . . 10.0 108.946 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 m -47.08 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.855 2.062 . . . . 10.0 110.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.35 21.34 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 127.385 2.274 . . . . 10.0 105.433 163.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.83 -164.73 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.676 2.25 . . . . 10.0 110.248 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.6 2.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.71 45.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.138 0.975 . . . . 10.0 108.706 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.66 140.78 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 169.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.24 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.523 -1.288 . . . . 10.0 107.523 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.59 130.32 68.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.89 -1.892 . . . . 10.0 105.89 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.09 108.12 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.06 143.42 54.26 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.292 1.037 . . . . 10.0 108.516 162.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.84 131.11 53.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 158.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.31 176.81 7.14 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.465 1.106 . . . . 10.0 110.472 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.84 11.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.063 1.345 . . . . 10.0 109.498 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.53 -73.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.63 1.172 . . . . 10.0 112.905 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.99 52.0 4.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.76 1.171 . . . . 10.0 110.376 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.46 84.77 8.12 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 127.452 2.301 . . . . 10.0 106.118 -163.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.51 24.18 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.306 2.671 . . . . 10.0 109.234 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.07 -45.73 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.409 1.883 . . . . 10.0 112.064 -165.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.09 12.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.774 2.029 . . . . 10.0 110.564 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.9 -49.93 75.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.36 1.464 . . . . 10.0 110.888 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.78 -13.52 61.55 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.744 0.646 . . . . 10.0 112.744 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.69 -16.82 27.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.712 1.605 . . . . 10.0 112.038 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 120.122 1.328 . . . . 10.0 112.576 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.03 -9.22 25.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 CA-C-N 122.063 1.773 . . . . 10.0 114.358 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.22 69.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.832 1.196 . . . . 10.0 108.829 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.18 -28.47 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.825 1.046 . . . . 10.0 113.825 -164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -46.48 -60.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.713 1.205 . . . . 10.0 109.448 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.38 79.04 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-N 120.299 1.142 . . . . 10.0 113.004 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.9 t90 -57.17 -51.6 68.65 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.322 0.649 . . . . 10.0 110.421 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.24 80.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.186 0.517 . . . . 10.0 110.211 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.55 64.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.1 -1.0 . . . . 10.0 111.427 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.02 39.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.563 1.145 . . . . 10.0 112.862 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.91 151.26 74.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 119.52 1.054 . . . . 10.0 111.029 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.14 169.68 21.57 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.067 3.178 . . . . 10.0 110.419 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 -4.24 4.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.044 1.338 . . . . 10.0 113.473 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.67 8.38 43.39 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.737 1.615 . . . . 10.0 110.642 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.45 164.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 121.212 -0.93 . . . . 10.0 108.824 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -145.56 135.75 23.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.445 -1.252 . . . . 10.0 108.335 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -115.46 134.57 54.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.904 0.383 . . . . 10.0 111.573 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.64 140.42 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.548 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.0 mtt85 -107.74 123.36 48.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.298 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 63' ' ' LEU . 19.7 mt -124.99 138.76 32.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 112.916 0.71 . . . . 10.0 112.916 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.27 152.95 24.13 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.06 2.507 . . . . 10.0 112.339 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.68 98.47 9.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.369 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.92 76.76 8.61 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.791 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.62 20.28 1.15 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.07 -48.1 3.42 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 119.879 -1.763 . . . . 10.0 112.808 168.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.13 1.55 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.316 0.96 . . . . 10.0 110.74 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.071 0.948 . . . . 10.0 112.089 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.3 -27.52 6.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.098 1.759 . . . . 10.0 113.319 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.9 -36.39 64.74 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 119.693 1.133 . . . . 10.0 110.513 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.88 -55.21 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.93 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.459 3.104 . . . . 10.0 112.193 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.2 -42.46 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 125.346 1.451 . . . . 10.0 111.26 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.65 -41.77 70.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.774 -1.108 . . . . 10.0 112.462 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -44.33 8.52 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.91 -45.69 92.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.639 0.587 . . . . 10.0 110.275 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.34 -45.33 94.84 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 116.784 -1.579 . . . . 10.0 109.211 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -45.57 92.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.609 1.55 . . . . 10.0 110.812 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -60.61 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.988 1.715 . . . . 10.0 109.399 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.64 -28.92 66.31 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 118.966 -0.54 . . . . 10.0 111.825 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.18 49.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.318 1.047 . . . . 10.0 110.699 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.85 -22.42 56.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.671 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.38 14.51 61.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.874 0.749 . . . . 10.0 113.016 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.28 130.28 26.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.95 1.3 . . . . 10.0 109.324 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.58 75.9 1.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.977 -0.749 . . . . 10.0 108.977 -165.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.42 54.27 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.038 2.236 . . . . 10.0 117.038 -170.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.35 51.95 7.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.312 1.845 . . . . 10.0 112.118 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.94 -47.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.417 -1.277 . . . . 10.0 113.398 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.89 34.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.628 1.558 . . . . 10.0 113.095 -176.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.52 0.62 Allowed 'General case' 0 C--O 1.22 -0.468 0 O-C-N 120.814 -1.179 . . . . 10.0 108.901 172.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 -16.54 44.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 10.0 114.569 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.53 -65.51 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 117.478 -1.249 . . . . 10.0 108.676 166.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.58 -46.88 73.81 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 120.42 1.464 . . . . 10.0 112.031 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.451 1.5 . . . . 10.0 110.244 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.14 4.49 5.53 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.776 1.63 . . . . 10.0 112.853 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -115.19 -57.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.6 -61.26 2.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.694 0.798 . . . . 10.0 112.63 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.22 64.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.086 0.857 . . . . 10.0 112.199 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.43 -53.6 3.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.601 1.16 . . . . 10.0 108.795 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.587 1.555 . . . . 10.0 110.659 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.23 13.73 15.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 10.0 113.306 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.96 -64.28 0.36 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 128.239 2.616 . . . . 10.0 109.479 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.55 44.55 28.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.746 1.618 . . . . 10.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.65 20.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.208 1.403 . . . . 10.0 114.184 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 155.33 28.98 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 127.897 2.479 . . . . 10.0 107.679 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.22 -44.89 10.93 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.537 2.158 . . . . 10.0 110.003 -173.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.33 67.49 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.191 0.996 . . . . 10.0 111.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.55 -42.07 70.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.965 1.306 . . . . 10.0 110.361 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.61 17.76 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.2 1.0 . . . . 10.0 108.884 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.2 84.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 123.426 0.453 . . . . 10.0 111.432 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.93 78.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.318 1.447 . . . . 10.0 112.542 172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.16 -41.81 60.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.601 0.761 . . . . 10.0 111.382 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.9 -14.74 59.84 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.401 -0.812 . . . . 10.0 110.421 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.76 30.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.871 0.868 . . . . 10.0 110.143 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.09 54.51 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.926 -1.486 . . . . 10.0 114.836 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.27 8.75 6.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.386 2.593 . . . . 10.0 112.649 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.0 49.26 4.1 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.65 132.84 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.176 -2.157 . . . . 10.0 105.176 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.71 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.679 0.791 . . . . 10.0 110.0 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.68 -36.9 85.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.738 -0.649 . . . . 10.0 110.367 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.8 66.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.744 0.702 . . . . 10.0 111.673 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.59 -57.09 4.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.363 -1.718 . . . . 10.0 106.363 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.9 -59.45 4.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.795 1.238 . . . . 10.0 112.161 -166.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.53 -33.7 64.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 -170.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 m -62.36 -49.31 76.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.75 -41.33 92.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.557 1.143 . . . . 10.0 110.269 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -49.09 -48.78 44.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.673 1.124 . . . . 10.0 110.809 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.88 1.02 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.678 0.791 . . . . 10.0 111.179 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.78 172.32 8.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.474 1.509 . . . . 10.0 111.658 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.42 86.71 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.825 1.25 . . . . 10.0 110.487 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.82 54.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.757 0.823 . . . . 10.0 110.501 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.53 -38.85 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.23 1.012 . . . . 10.0 111.213 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.61 -33.2 63.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.026 0.93 . . . . 10.0 110.987 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.26 -48.39 19.43 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.872 -0.891 . . . . 10.0 110.872 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.03 82.38 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.792 -0.828 . . . . 10.0 109.656 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -34.14 77.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.663 -1.16 . . . . 10.0 111.45 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.01 7.23 41.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.613 0.642 . . . . 10.0 112.045 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -101.09 -48.26 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.645 0.259 . . . . 10.0 110.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.48 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.7 tmtt? -77.16 -44.28 30.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.878 0.371 . . . . 10.0 110.829 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -16.88 57.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.298 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 C--O 1.225 -0.194 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.233 179.686 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 57.7 mtm . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.796 0.331 . . . . 10.0 111.624 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.86 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.688 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.07 5.09 1.75 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.081 1.752 . . . . 10.0 113.53 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 54.34 36.85 26.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.99 2.116 . . . . 10.0 112.082 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.25 -16.2 4.02 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.779 2.032 . . . . 10.0 110.295 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.982 1.753 . . . . 10.0 112.802 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.45 153.06 61.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.192 2.197 . . . . 10.0 108.27 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.7 71.46 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.535 -1.027 . . . . 10.0 113.109 -6.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.5 m -145.91 144.22 30.04 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.287 1.435 . . . . 10.0 108.534 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.86 158.41 31.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.844 1.657 . . . . 10.0 108.221 163.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.936 -1.505 . . . . 10.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.0 135.18 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.065 -1.457 . . . . 10.0 107.065 168.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 1 C-N-CA 133.131 4.572 . . . . 10.0 117.471 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.18 60.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 117.752 -1.582 . . . . 10.0 115.498 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.37 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.975 1.887 . . . . 10.0 114.373 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -112.7 107.61 16.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.4 24.41 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.51 1.924 . . . . 10.0 106.768 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.59 17.44 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 120.316 -1.49 . . . . 10.0 107.087 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.78 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.601 0.36 . . . . 10.0 110.184 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.29 -50.15 5.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 128.615 2.766 . . . . 10.0 107.689 160.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.06 16.48 4.48 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.92 1.724 . . . . 10.0 114.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 m -128.32 -51.14 1.29 Allowed 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.768 1.284 . . . . 10.0 109.654 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.62 72.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.04 1.336 . . . . 10.0 112.252 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.416 -1.213 . . . . 10.0 114.741 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.78 174.27 35.12 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.717 1.758 . . . . 10.0 110.017 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.419 2.079 . . . . 10.0 111.753 -169.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.63 69.86 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.9 -1.125 . . . . 10.0 111.58 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.46 -27.14 66.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.069 0.548 . . . . 10.0 110.368 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.59 -43.05 32.93 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.014 -1.054 . . . . 10.0 110.894 -169.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.71 -31.86 73.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.937 0.79 . . . . 10.0 111.066 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.52 -56.5 8.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.628 1.971 . . . . 10.0 107.984 168.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.43 -41.42 93.53 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 116.905 -1.522 . . . . 10.0 111.503 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.8 -48.66 69.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.965 1.712 . . . . 10.0 111.705 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.51 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.964 0.505 . . . . 10.0 110.617 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.41 -42.68 96.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.585 0.754 . . . . 10.0 111.257 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.03 -37.44 84.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.948 -1.095 . . . . 10.0 111.251 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.32 -51.92 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.99 -43.03 63.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.577 1.151 . . . . 10.0 110.037 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.73 -0.31 33.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.144 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.21 9.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.614 1.566 . . . . 10.0 114.399 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -55.79 4.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.345 -1.354 . . . . 10.0 107.345 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.29 66.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.766 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 130.082 3.353 . . . . 10.0 113.679 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.03 13.33 35.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.759 1.224 . . . . 10.0 113.153 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.4 tttm 56.42 76.78 0.28 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.939 2.096 . . . . 10.0 109.855 -163.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.122 1.769 . . . . 10.0 108.815 -179.251 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 109.135 -1.586 . . . . 10.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.12 73.72 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.144 2.178 . . . . 10.0 110.313 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.428 -2.169 . . . . 10.0 113.023 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.42 157.77 43.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.964 1.706 . . . . 10.0 107.991 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.29 132.76 44.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.671 -1.233 . . . . 10.0 107.671 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.57 148.43 49.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.65 13.69 52.11 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.767 1.175 . . . . 10.0 113.398 -167.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -62.98 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.767 1.783 . . . . 10.0 107.78 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.52 -25.89 14.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.353 1.461 . . . . 10.0 110.46 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.55 167.12 31.16 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.249 -0.907 . . . . 10.0 111.694 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.88 115.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.781 1.232 . . . . 10.0 109.002 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.31 167.32 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.001 -1.687 . . . . 10.0 110.508 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.67 40.98 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.271 1.028 . . . . 10.0 108.853 172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.4 41.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.21 0.819 . . . . 10.0 113.21 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.195 0.998 . . . . 10.0 108.676 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.53 -179.08 2.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 125.047 3.831 . . . . 10.0 112.266 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.87 34.04 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.739 1.215 . . . . 10.0 107.944 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.1 179.04 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.415 2.076 . . . . 10.0 112.58 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.8 m -127.35 168.3 20.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 126.866 2.067 . . . . 10.0 108.949 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.11 -61.8 1.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.812 2.045 . . . . 10.0 110.493 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.85 165.37 21.14 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 127.305 2.242 . . . . 10.0 105.394 163.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.91 -164.61 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.608 2.206 . . . . 10.0 110.201 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.75 2.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.45 133.76 45.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.01 0.924 . . . . 10.0 108.77 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.79 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 169.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.24 139.08 35.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.47 130.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.939 -1.874 . . . . 10.0 105.939 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.13 108.06 14.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.94 143.32 54.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.303 1.041 . . . . 10.0 108.58 162.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.8 131.1 53.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 158.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.34 176.86 7.11 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.376 1.07 . . . . 10.0 110.391 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.06 175.79 11.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.028 1.331 . . . . 10.0 109.525 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.47 -73.14 0.1 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.563 1.145 . . . . 10.0 112.937 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.95 4.53 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 124.858 1.218 . . . . 10.0 110.336 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.49 84.74 8.15 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.532 2.333 . . . . 10.0 106.102 -163.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.54 168.58 24.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.296 2.664 . . . . 10.0 109.217 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.93 -45.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.538 1.935 . . . . 10.0 112.064 -164.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.88 -53.03 13.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.754 2.022 . . . . 10.0 110.569 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.96 -49.94 75.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.472 1.509 . . . . 10.0 110.784 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.43 61.6 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.73 -16.85 27.74 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.727 1.611 . . . . 10.0 112.074 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.81 -67.21 0.41 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.115 1.325 . . . . 10.0 112.559 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.02 -9.17 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 122.076 1.777 . . . . 10.0 114.518 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.16 68.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.766 1.167 . . . . 10.0 108.806 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.17 -28.59 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.348 1.059 . . . . 10.0 113.85 -164.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.36 -60.29 3.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.79 1.236 . . . . 10.0 109.544 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.89 -35.38 78.34 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 CA-C-N 120.243 1.122 . . . . 10.0 112.918 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.28 -51.54 68.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.412 0.685 . . . . 10.0 110.34 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -59.01 -39.17 81.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.128 0.49 . . . . 10.0 110.231 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.81 -25.63 64.77 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.153 -0.967 . . . . 10.0 111.445 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.66 9.99 39.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.625 1.17 . . . . 10.0 112.868 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.405 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.0 mt -60.94 151.17 75.3 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 119.488 1.04 . . . . 10.0 110.994 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.07 169.7 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.982 3.121 . . . . 10.0 110.484 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.1 -4.1 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.024 1.33 . . . . 10.0 113.372 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.8 8.37 43.26 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.765 1.626 . . . . 10.0 110.532 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.44 164.33 32.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 O-C-N 121.164 -0.96 . . . . 10.0 108.863 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.93 140.91 28.59 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.435 -1.257 . . . . 10.0 108.29 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -120.84 134.13 55.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.759 0.314 . . . . 10.0 111.549 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.25 136.94 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.803 -0.635 . . . . 10.0 109.66 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -103.66 119.71 39.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.402 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.26 138.45 28.08 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.859 0.688 . . . . 10.0 112.859 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.5 152.81 23.38 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.027 2.485 . . . . 10.0 112.222 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.07 97.22 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -87.94 76.77 8.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.827 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.15 1.15 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.1 -48.1 3.41 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 119.903 -1.748 . . . . 10.0 112.787 168.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.51 -152.12 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.294 0.949 . . . . 10.0 110.783 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.81 -30.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.074 0.95 . . . . 10.0 112.003 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.4 -27.44 6.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.068 1.747 . . . . 10.0 113.367 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.86 -36.42 64.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.629 1.104 . . . . 10.0 110.485 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.93 -55.21 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.81 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.492 3.117 . . . . 10.0 112.21 170.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.21 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.352 1.453 . . . . 10.0 111.176 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.53 -41.81 70.13 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.789 -1.101 . . . . 10.0 112.535 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.53 -44.33 8.61 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.136 1.161 . . . . 10.0 114.136 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.8 -45.78 92.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.528 0.604 . . . . 10.0 110.304 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.32 -45.35 94.79 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 116.836 -1.554 . . . . 10.0 109.234 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -45.69 92.14 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.552 1.523 . . . . 10.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.978 1.711 . . . . 10.0 109.413 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.7 -28.91 66.24 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 118.881 -0.58 . . . . 10.0 111.806 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.72 -37.15 49.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.347 1.059 . . . . 10.0 110.699 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.5 56.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.653 -0.689 . . . . 10.0 111.634 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.6 61.71 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.974 0.797 . . . . 10.0 113.023 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.35 130.28 26.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.997 1.319 . . . . 10.0 109.315 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.57 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.981 -0.748 . . . . 10.0 108.981 -165.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.4 54.19 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 117.137 2.273 . . . . 10.0 117.137 -170.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.37 51.97 7.49 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.284 1.834 . . . . 10.0 112.113 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.91 -47.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.487 -1.244 . . . . 10.0 113.461 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.77 34.92 1.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.532 1.514 . . . . 10.0 113.067 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.749 -1.219 . . . . 10.0 108.929 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.2 -16.42 44.7 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.576 1.325 . . . . 10.0 114.576 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.52 -65.65 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.552 -1.213 . . . . 10.0 108.625 166.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.57 -46.78 73.77 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.391 1.451 . . . . 10.0 111.997 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.39 -40.62 82.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.459 1.503 . . . . 10.0 110.207 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.1 4.46 5.53 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.736 1.615 . . . . 10.0 112.884 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.23 -57.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.049 -2.204 . . . . 10.0 105.049 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.68 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.704 0.801 . . . . 10.0 112.618 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.26 64.8 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.06 0.845 . . . . 10.0 112.147 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.43 3.91 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.591 1.157 . . . . 10.0 108.802 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.41 87.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.476 1.51 . . . . 10.0 110.698 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.79 15.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.408 1.083 . . . . 10.0 113.372 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.97 -64.2 0.36 Allowed 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 128.226 2.61 . . . . 10.0 109.581 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.9 mt 54.52 44.63 28.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.789 1.635 . . . . 10.0 112.449 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.69 14.64 20.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 10.0 114.148 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.2 155.38 28.98 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 127.907 2.483 . . . . 10.0 107.643 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.27 -44.88 10.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.543 2.162 . . . . 10.0 109.972 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.09 -29.32 67.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.222 1.009 . . . . 10.0 111.124 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.53 -42.1 70.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.945 1.298 . . . . 10.0 110.353 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.93 -48.54 17.87 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.071 0.948 . . . . 10.0 108.901 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.16 -37.2 84.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 123.45 0.469 . . . . 10.0 111.412 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.95 78.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.285 1.434 . . . . 10.0 112.532 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.21 -41.66 61.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.559 0.744 . . . . 10.0 111.443 -177.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.38 -0.825 . . . . 10.0 110.411 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.75 30.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.766 0.826 . . . . 10.0 110.102 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.14 54.36 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.958 -1.468 . . . . 10.0 114.827 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.75 6.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.327 2.563 . . . . 10.0 112.604 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.98 49.24 4.11 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.54 132.93 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.177 -2.157 . . . . 10.0 105.177 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.76 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.642 0.777 . . . . 10.0 109.983 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.64 -37.04 86.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.732 -0.651 . . . . 10.0 110.375 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.92 -26.86 67.06 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.681 0.673 . . . . 10.0 111.732 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.7 -57.05 4.02 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.375 -1.713 . . . . 10.0 106.375 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.8 -59.56 4.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.846 1.258 . . . . 10.0 112.172 -166.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.55 -33.66 64.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -49.38 75.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.8 -41.3 92.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.587 1.155 . . . . 10.0 110.229 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.668 1.122 . . . . 10.0 110.831 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -92.68 38.98 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.674 0.789 . . . . 10.0 111.129 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.92 172.3 8.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.396 1.479 . . . . 10.0 111.569 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.2 -40.4 86.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.814 1.246 . . . . 10.0 110.439 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.5 -49.91 54.32 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.765 0.826 . . . . 10.0 110.445 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.49 -38.84 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.256 1.022 . . . . 10.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 1.7 mtmt -55.52 -33.34 63.68 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.025 0.93 . . . . 10.0 111.017 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.11 -48.47 19.8 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.854 -0.898 . . . . 10.0 110.854 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.42 -36.14 82.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.702 -0.881 . . . . 10.0 109.502 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.693 -1.146 . . . . 10.0 111.478 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 12.7 pt-20 -104.29 10.65 35.48 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.72 0.637 . . . . 10.0 111.853 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.3 tmtt? -102.65 -51.02 3.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.686 0.279 . . . . 10.0 110.495 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.74 -4.81 59.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.844 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.4 tmtt? -77.79 -45.38 24.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.852 0.358 . . . . 10.0 110.848 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.84 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.324 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 36.7 mt . . . . . 0 C--O 1.227 -0.113 0 CA-C-N 116.38 -0.373 . . . . 10.0 110.856 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 63.6 mtm . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 10.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.86 79.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.623 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.05 5.03 1.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.125 1.77 . . . . 10.0 113.493 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.43 36.75 26.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.93 2.092 . . . . 10.0 112.12 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 32' ' ' LEU . 90.4 t -69.35 135.04 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.24 -16.18 4.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.737 2.015 . . . . 10.0 110.277 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.3 -170.86 33.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.928 1.727 . . . . 10.0 112.772 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.54 152.97 61.44 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 127.253 2.221 . . . . 10.0 108.308 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.59 152.68 71.58 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.585 -1.006 . . . . 10.0 113.035 -6.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.87 144.27 30.11 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.272 1.429 . . . . 10.0 108.551 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.95 158.35 32.21 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.906 1.682 . . . . 10.0 108.218 163.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.934 -1.506 . . . . 10.0 106.934 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.0 t -104.06 135.16 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.17 10.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 133.175 4.59 . . . . 10.0 117.505 171.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.23 60.26 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.667 -1.629 . . . . 10.0 115.446 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.89 -41.28 1.04 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.989 1.895 . . . . 10.0 114.315 -170.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -112.78 107.62 16.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.315 -0.995 . . . . 10.0 108.315 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.07 113.42 24.55 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.495 1.918 . . . . 10.0 106.764 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.48 169.59 17.44 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 120.277 -1.514 . . . . 10.0 107.198 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.98 -178.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.62 0.368 . . . . 10.0 110.171 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.35 -50.09 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 128.552 2.741 . . . . 10.0 107.733 160.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 16.52 4.48 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.868 1.699 . . . . 10.0 114.373 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.27 -51.16 1.3 Allowed 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.825 1.313 . . . . 10.0 109.656 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.54 72.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.072 1.349 . . . . 10.0 112.174 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.62 -6.03 9.83 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.535 -1.147 . . . . 10.0 114.802 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.27 35.22 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.667 1.733 . . . . 10.0 109.929 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.92 -52.52 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.355 2.037 . . . . 10.0 111.736 -169.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -28.6 69.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.946 -1.096 . . . . 10.0 111.568 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.16 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.095 0.558 . . . . 10.0 110.351 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.71 -42.86 32.96 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.014 -1.054 . . . . 10.0 110.898 -169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.93 -31.77 73.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.908 0.776 . . . . 10.0 110.985 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.46 8.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.589 1.956 . . . . 10.0 108.103 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.47 -41.33 93.47 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 116.945 -1.502 . . . . 10.0 111.58 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.69 69.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.902 1.683 . . . . 10.0 111.746 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.06 65.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.902 0.481 . . . . 10.0 110.619 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.55 -42.57 96.82 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 10.0 111.217 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.14 -37.38 83.72 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.877 -1.139 . . . . 10.0 111.26 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.23 -51.94 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.284 0.947 . . . . 10.0 108.561 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.02 -43.06 63.53 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.618 1.167 . . . . 10.0 110.052 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.7 -0.27 33.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.173 -1.394 . . . . 10.0 113.188 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.487 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.25 9.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.679 1.591 . . . . 10.0 114.436 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -55.69 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.35 -20.32 66.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.115 -0.948 . . . . 10.0 111.772 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.46 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.108 3.363 . . . . 10.0 113.707 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.06 13.38 35.36 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.732 1.213 . . . . 10.0 113.151 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.92 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.942 2.097 . . . . 10.0 109.78 -163.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.138 1.775 . . . . 10.0 108.82 -179.321 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.194 -1.563 . . . . 10.0 109.194 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.08 73.77 0.15 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 127.131 2.172 . . . . 10.0 110.357 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.37 12.06 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.459 -2.155 . . . . 10.0 112.998 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.47 157.7 43.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.984 1.714 . . . . 10.0 108.041 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.18 132.82 44.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.735 -1.209 . . . . 10.0 107.735 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.38 49.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.62 52.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.67 1.128 . . . . 10.0 113.423 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -63.0 0.98 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.763 1.782 . . . . 10.0 107.77 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.38 -25.97 14.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 10.0 110.501 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -154.59 167.02 31.51 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.27 -0.894 . . . . 10.0 111.624 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.89 115.97 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.797 1.239 . . . . 10.0 108.996 -171.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.36 20.31 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 119.948 -1.72 . . . . 10.0 110.473 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.66 40.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.168 0.987 . . . . 10.0 108.815 172.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 m -67.25 -9.46 40.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.832 0.853 . . . . 10.0 113.219 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 m -129.32 74.37 81.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.195 0.998 . . . . 10.0 108.612 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.49 -179.12 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 125.139 3.892 . . . . 10.0 112.213 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.57 138.96 34.21 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.729 1.211 . . . . 10.0 107.934 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.13 179.17 5.67 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.369 2.046 . . . . 10.0 112.569 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.5 168.3 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.832 2.053 . . . . 10.0 108.947 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.89 1.67 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.834 2.054 . . . . 10.0 110.457 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.74 165.43 21.11 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.283 2.233 . . . . 10.0 105.397 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.99 -164.61 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.571 2.181 . . . . 10.0 110.213 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.68 2.45 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.269 -2.733 . . . . 10.0 106.269 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.47 133.79 45.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.137 0.975 . . . . 10.0 108.723 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.73 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.348 -1.723 . . . . 10.0 106.348 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.15 139.16 35.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.55 130.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.906 -1.887 . . . . 10.0 105.906 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.5 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.2 108.11 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.393 -1.336 . . . . 10.0 107.393 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.04 143.39 54.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.275 1.03 . . . . 10.0 108.583 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 158.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.27 176.85 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.433 1.093 . . . . 10.0 110.459 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.89 11.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.071 1.349 . . . . 10.0 109.502 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HD1' ' CG2' ' A' ' 98' ' ' ILE . 40.2 t80 -61.59 -73.09 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.615 1.166 . . . . 10.0 112.912 172.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.01 4.54 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.828 1.204 . . . . 10.0 110.392 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.9 t -113.57 84.8 8.37 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 127.471 2.308 . . . . 10.0 106.086 -163.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.56 168.6 23.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.279 2.653 . . . . 10.0 109.203 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.03 -45.75 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.46 1.904 . . . . 10.0 112.093 -165.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.79 -53.14 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.672 1.989 . . . . 10.0 110.597 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.88 -49.93 75.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.471 1.508 . . . . 10.0 110.817 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.54 61.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.68 -16.85 27.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.687 1.595 . . . . 10.0 112.071 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.2 0.41 Allowed Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 120.09 1.314 . . . . 10.0 112.621 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.09 -9.11 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 CA-C-N 121.994 1.748 . . . . 10.0 114.45 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.18 68.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.772 1.169 . . . . 10.0 108.827 167.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.23 -28.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.33 1.052 . . . . 10.0 113.816 -164.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 t -46.48 -60.25 3.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.763 1.225 . . . . 10.0 109.483 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.88 -35.35 78.57 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.348 1.16 . . . . 10.0 112.918 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.29 -51.59 68.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.349 0.659 . . . . 10.0 110.372 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.12 80.69 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.168 0.509 . . . . 10.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.6 64.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.094 -1.004 . . . . 10.0 111.39 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.13 39.65 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.535 1.134 . . . . 10.0 112.908 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.97 151.25 75.17 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 119.45 1.023 . . . . 10.0 110.968 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.1 169.69 21.57 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 124.053 3.169 . . . . 10.0 110.458 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.09 -4.16 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.024 1.33 . . . . 10.0 113.457 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.76 8.39 43.29 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.622 1.569 . . . . 10.0 110.587 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.46 164.85 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 O-C-N 121.117 -0.989 . . . . 10.0 108.884 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -145.66 136.18 24.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.477 -1.238 . . . . 10.0 108.413 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -115.4 137.65 51.82 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.778 0.323 . . . . 10.0 111.572 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.98 140.24 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.692 -0.686 . . . . 10.0 109.832 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -106.34 120.87 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.5 HD12 HG11 ' A' ' 30' ' ' VAL . 14.9 mt -121.83 138.76 29.05 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 112.692 0.627 . . . . 10.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.69 152.82 22.81 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.911 2.407 . . . . 10.0 112.287 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.16 98.05 9.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.5 mt -88.21 76.8 8.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.751 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.17 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.161 1.541 . . . . 10.0 115.161 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.09 -48.09 3.41 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 119.897 -1.752 . . . . 10.0 112.801 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.52 -152.06 1.56 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.317 0.961 . . . . 10.0 110.75 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.83 -30.76 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.108 0.963 . . . . 10.0 112.12 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.46 -27.39 6.42 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.064 1.745 . . . . 10.0 113.374 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.9 -36.48 64.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.606 1.094 . . . . 10.0 110.472 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.83 -55.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.495 3.118 . . . . 10.0 112.148 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.15 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 125.407 1.479 . . . . 10.0 111.294 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.59 -41.84 70.37 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 117.757 -1.116 . . . . 10.0 112.457 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.43 -44.32 8.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 114.186 1.18 . . . . 10.0 114.186 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.93 -45.71 92.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.685 0.615 . . . . 10.0 110.272 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.2 95.32 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 116.702 -1.618 . . . . 10.0 109.204 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.7 91.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.628 1.558 . . . . 10.0 110.764 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 126.004 1.722 . . . . 10.0 109.42 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.71 -28.89 66.21 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 118.887 -0.578 . . . . 10.0 111.8 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.78 -37.1 50.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.329 1.052 . . . . 10.0 110.625 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.89 -22.43 56.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.802 -0.618 . . . . 10.0 111.702 -170.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.33 14.55 61.84 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.897 0.761 . . . . 10.0 113.0 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.962 1.305 . . . . 10.0 109.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.36 -5.35 54.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 117.059 2.244 . . . . 10.0 117.059 -170.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.28 52.05 7.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.347 1.859 . . . . 10.0 112.092 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.98 -47.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.425 -1.274 . . . . 10.0 113.328 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.79 1.3 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.586 1.539 . . . . 10.0 113.175 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.33 -44.51 0.62 Allowed 'General case' 0 C--O 1.221 -0.44 0 O-C-N 120.805 -1.185 . . . . 10.0 108.948 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.51 45.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.541 1.311 . . . . 10.0 114.541 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.5 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.6 -1.19 . . . . 10.0 108.637 166.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.6 -46.78 73.88 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.347 1.43 . . . . 10.0 112.006 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.37 -40.51 82.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.468 1.507 . . . . 10.0 110.24 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.24 4.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.766 1.626 . . . . 10.0 112.847 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.4 ' CG2' ' HD1' ' A' ' 35' ' ' TYR . 61.4 mt -115.26 -57.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.033 -2.21 . . . . 10.0 105.033 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.62 -61.37 1.99 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.694 0.798 . . . . 10.0 112.6 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.12 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.073 0.851 . . . . 10.0 112.157 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.5 3.88 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.508 1.123 . . . . 10.0 108.758 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.545 1.538 . . . . 10.0 110.614 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.68 15.67 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.367 1.067 . . . . 10.0 113.322 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.5 tttm 70.07 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 128.17 2.588 . . . . 10.0 109.557 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.47 44.59 28.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.768 1.627 . . . . 10.0 112.475 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.59 20.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.295 1.438 . . . . 10.0 114.177 -173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 155.36 29.0 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 127.959 2.503 . . . . 10.0 107.655 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 -44.96 10.95 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 10.0 110.017 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.0 -29.36 67.54 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.191 0.997 . . . . 10.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.51 -42.15 70.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.983 1.313 . . . . 10.0 110.314 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.58 17.84 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.145 0.978 . . . . 10.0 108.876 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.16 84.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.408 0.443 . . . . 10.0 111.4 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.13 -46.85 79.04 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.328 1.451 . . . . 10.0 112.558 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.57 60.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.537 0.735 . . . . 10.0 111.466 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -77.02 -14.74 59.79 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.414 -0.804 . . . . 10.0 110.365 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.79 30.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.777 0.831 . . . . 10.0 110.115 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.99 10.12 54.07 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 117.981 -1.455 . . . . 10.0 114.847 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.31 8.71 6.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.365 2.583 . . . . 10.0 112.673 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.97 49.23 4.11 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.68 -1.368 . . . . 10.0 109.68 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.53 132.88 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.233 -2.136 . . . . 10.0 105.233 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -92.32 133.64 35.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.63 0.772 . . . . 10.0 110.021 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.59 -36.88 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.811 -0.614 . . . . 10.0 110.445 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.83 66.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.694 0.679 . . . . 10.0 111.687 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.64 -57.02 4.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.88 -59.54 4.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.826 1.25 . . . . 10.0 112.093 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.56 -33.64 64.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 -170.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 m -62.35 -49.38 75.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -65.68 -41.36 92.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.554 1.141 . . . . 10.0 110.212 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.17 -48.8 44.76 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.691 1.132 . . . . 10.0 110.789 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.58 38.97 1.02 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.639 0.776 . . . . 10.0 111.202 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.24 8.6 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 10.0 111.666 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.36 86.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.837 1.255 . . . . 10.0 110.512 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.88 55.05 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.719 0.808 . . . . 10.0 110.477 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.52 -38.79 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.209 1.004 . . . . 10.0 111.262 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.58 -33.23 63.73 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.009 0.923 . . . . 10.0 111.029 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.47 19.33 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.831 -0.908 . . . . 10.0 110.831 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.3 -36.16 82.77 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.703 -0.88 . . . . 10.0 109.616 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -33.87 76.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.661 -1.162 . . . . 10.0 111.488 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.59 -5.46 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.619 0.645 . . . . 10.0 112.127 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.1 mmtt -92.0 -48.74 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.52 0.2 . . . . 10.0 111.01 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.48 -9.02 59.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.818 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' HB2' HD12 ' A' ' 66' ' ' LEU . 12.4 tmtt? -79.36 -45.01 20.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.672 0.273 . . . . 10.0 110.629 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -19.43 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.203 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 51.4 mt . . . . . 0 C--O 1.225 -0.233 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.056 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 59.1 mtm . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.869 0.366 . . . . 10.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.85 80.28 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.929 -0.578 . . . . 10.0 109.666 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.02 5.04 1.75 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.093 1.757 . . . . 10.0 113.5 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.38 36.82 26.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.935 2.094 . . . . 10.0 112.029 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 32' ' ' LEU . 91.4 t -69.31 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.26 -16.16 4.02 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 126.783 2.033 . . . . 10.0 110.267 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.86 33.57 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.979 1.752 . . . . 10.0 112.791 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.57 152.98 61.37 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 127.282 2.233 . . . . 10.0 108.325 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.55 152.66 71.42 Favored 'Cis proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.61 -0.996 . . . . 10.0 113.082 -6.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.282 1.433 . . . . 10.0 108.581 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.92 158.39 32.08 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.779 1.632 . . . . 10.0 108.146 163.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.55 29.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.3 t -104.14 135.19 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.085 -1.45 . . . . 10.0 107.085 168.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.13 10.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.142 4.577 . . . . 10.0 117.517 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.73 20.1 60.42 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 117.753 -1.582 . . . . 10.0 115.531 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.84 -41.35 1.04 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.998 1.899 . . . . 10.0 114.365 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.81 107.58 16.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.277 -1.009 . . . . 10.0 108.277 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 126.511 1.924 . . . . 10.0 106.741 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.54 169.56 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.362 -1.461 . . . . 10.0 107.22 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.96 -178.79 1.28 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.606 0.362 . . . . 10.0 110.14 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.3 mt -46.23 -50.11 4.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 128.528 2.731 . . . . 10.0 107.778 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.1 16.52 4.49 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.927 1.727 . . . . 10.0 114.352 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.29 -51.16 1.3 Allowed 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.851 1.326 . . . . 10.0 109.692 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.5 72.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.068 1.347 . . . . 10.0 112.3 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.53 -5.9 9.92 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-O 118.542 -1.144 . . . . 10.0 114.774 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.81 174.24 35.11 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.672 1.736 . . . . 10.0 109.945 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.86 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.397 2.065 . . . . 10.0 111.73 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.06 -1.025 . . . . 10.0 111.561 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.16 66.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.094 0.558 . . . . 10.0 110.342 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.99 32.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.969 -1.082 . . . . 10.0 110.89 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.4 mt -63.77 -31.86 73.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.876 0.762 . . . . 10.0 110.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.45 -56.44 8.24 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.636 1.974 . . . . 10.0 108.036 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.59 -41.3 92.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 116.922 -1.513 . . . . 10.0 111.555 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.78 69.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 120.984 1.72 . . . . 10.0 111.7 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.47 -47.06 65.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.939 0.496 . . . . 10.0 110.643 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.55 -42.54 96.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.513 0.725 . . . . 10.0 111.228 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.02 -37.49 84.23 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 120.899 -1.126 . . . . 10.0 111.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.27 -51.89 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.234 0.925 . . . . 10.0 108.589 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.0 -43.09 63.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.567 1.147 . . . . 10.0 110.045 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.61 -0.37 33.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.11 -1.424 . . . . 10.0 113.164 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.3 9.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.62 1.568 . . . . 10.0 114.392 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.82 4.93 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.35 66.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 10.0 111.759 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.47 6.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 130.172 3.389 . . . . 10.0 113.689 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.11 13.34 35.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.724 1.21 . . . . 10.0 113.166 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.9 0.27 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.973 2.109 . . . . 10.0 109.806 -163.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.126 1.77 . . . . 10.0 108.834 -179.27 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.232 0 N-CA-C 109.179 -1.568 . . . . 10.0 109.179 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.69 0.15 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 127.152 2.181 . . . . 10.0 110.355 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 112.392 -2.185 . . . . 10.0 113.039 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.43 157.76 43.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.944 1.698 . . . . 10.0 108.057 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 m -131.25 132.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.39 49.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.57 52.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.67 1.129 . . . . 10.0 113.43 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 -63.02 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.86 1.83 . . . . 10.0 107.768 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -25.88 14.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.409 1.483 . . . . 10.0 110.572 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.68 167.0 31.64 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.234 -0.916 . . . . 10.0 111.614 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.82 115.98 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.816 1.246 . . . . 10.0 109.01 -171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.4 167.33 20.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.948 -1.72 . . . . 10.0 110.435 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.2 124.64 40.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.254 1.022 . . . . 10.0 108.883 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.48 41.69 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.816 0.846 . . . . 10.0 113.216 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 m -129.19 74.43 81.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.222 1.009 . . . . 10.0 108.667 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.57 -179.07 2.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 125.111 3.874 . . . . 10.0 112.261 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.91 34.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 124.716 1.207 . . . . 10.0 107.898 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.08 179.11 5.71 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.38 2.054 . . . . 10.0 112.665 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.52 168.26 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.828 2.051 . . . . 10.0 108.902 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -47.1 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.834 2.053 . . . . 10.0 110.45 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.4 21.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 127.37 2.268 . . . . 10.0 105.39 163.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.97 -164.59 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.576 2.184 . . . . 10.0 110.206 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.09 -112.66 2.45 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 106.382 -2.687 . . . . 10.0 106.382 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.15 0.98 . . . . 10.0 108.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.55 140.75 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.323 -1.732 . . . . 10.0 106.323 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -99.19 139.13 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -128.51 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.858 -1.905 . . . . 10.0 105.858 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 11.2 t -131.13 108.03 14.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -172.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.93 143.32 54.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.316 1.046 . . . . 10.0 108.573 162.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 158.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.419 1.088 . . . . 10.0 110.396 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.02 175.84 11.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.969 1.308 . . . . 10.0 109.471 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.51 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.625 1.17 . . . . 10.0 112.884 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.03 4.54 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.823 1.201 . . . . 10.0 110.312 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.58 84.81 8.4 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.412 2.285 . . . . 10.0 106.087 -163.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.47 168.49 24.18 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.4 2.733 . . . . 10.0 109.25 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.06 -45.69 0.28 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.447 1.899 . . . . 10.0 112.051 -165.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.13 12.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.764 2.026 . . . . 10.0 110.572 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.84 -49.98 75.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.389 1.476 . . . . 10.0 110.874 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.8 -13.49 61.57 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.7 -16.91 27.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 10.0 112.045 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.083 1.31 . . . . 10.0 112.554 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.92 -9.32 25.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.063 1.773 . . . . 10.0 114.466 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.1 69.24 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.746 1.157 . . . . 10.0 108.851 167.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.26 -28.58 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.846 1.054 . . . . 10.0 113.846 -164.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.37 -60.31 3.84 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.782 1.233 . . . . 10.0 109.524 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.44 78.62 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 120.266 1.131 . . . . 10.0 112.917 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.19 -51.65 68.46 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.382 0.673 . . . . 10.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.1 80.63 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.154 0.502 . . . . 10.0 110.265 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.97 -25.45 64.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.124 -0.985 . . . . 10.0 111.453 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.74 10.07 39.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.576 1.15 . . . . 10.0 112.887 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.95 151.23 75.1 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.511 1.05 . . . . 10.0 110.977 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.04 169.62 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 124.054 3.17 . . . . 10.0 110.477 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.03 -4.2 4.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.02 1.328 . . . . 10.0 113.434 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.66 8.43 43.36 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.688 1.595 . . . . 10.0 110.63 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.66 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 O-C-N 121.241 -0.912 . . . . 10.0 108.827 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -145.6 136.82 24.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.501 -1.227 . . . . 10.0 108.507 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -114.65 135.88 53.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.96 0.41 . . . . 10.0 111.704 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 1.4 t -139.26 139.81 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.425 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -108.8 121.62 45.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.191 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 18.7 mt -121.76 138.21 28.24 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 112.787 0.662 . . . . 10.0 112.787 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.71 152.85 22.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.0 2.467 . . . . 10.0 112.395 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.37 98.08 9.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.502 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.0 76.74 8.56 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.913 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.54 20.23 1.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.04 -48.12 3.43 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.879 -1.763 . . . . 10.0 112.827 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.48 -152.06 1.54 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.279 0.943 . . . . 10.0 110.791 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.79 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.04 0.936 . . . . 10.0 112.07 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.49 6.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.093 1.757 . . . . 10.0 113.336 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.85 -36.43 64.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.642 1.11 . . . . 10.0 110.573 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.89 -55.17 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.9 31.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.49 3.116 . . . . 10.0 112.192 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 125.383 1.468 . . . . 10.0 111.23 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.55 -41.87 70.29 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 117.721 -1.133 . . . . 10.0 112.45 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.44 8.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 114.129 1.159 . . . . 10.0 114.129 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.87 -45.71 92.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.525 0.602 . . . . 10.0 110.26 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.45 -45.24 95.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 116.71 -1.614 . . . . 10.0 109.257 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.67 92.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.628 1.558 . . . . 10.0 110.835 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.029 1.732 . . . . 10.0 109.448 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.72 -28.94 66.23 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 118.909 -0.567 . . . . 10.0 111.805 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.68 -37.2 49.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.33 1.052 . . . . 10.0 110.677 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.88 -22.44 56.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.63 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.43 14.47 61.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.85 0.738 . . . . 10.0 112.955 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.32 130.23 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.994 1.318 . . . . 10.0 109.261 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.54 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.574 0.75 . . . . 10.0 109.011 -165.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.29 -5.4 54.35 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 117.067 2.247 . . . . 10.0 117.067 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.99 7.49 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.332 1.853 . . . . 10.0 112.072 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.96 -47.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 117.413 -1.28 . . . . 10.0 113.431 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.84 34.85 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.599 1.545 . . . . 10.0 113.183 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.44 -44.43 0.61 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.814 -1.179 . . . . 10.0 108.938 172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.57 45.68 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.484 1.291 . . . . 10.0 114.484 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.47 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 117.588 -1.196 . . . . 10.0 108.654 166.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.63 -46.75 73.96 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.368 1.44 . . . . 10.0 111.98 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.53 -40.54 83.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.458 1.503 . . . . 10.0 110.14 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.12 4.49 5.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 112.883 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.24 -57.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.002 -2.221 . . . . 10.0 105.002 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.57 -61.29 2.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.764 0.825 . . . . 10.0 112.621 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.36 -21.27 64.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.09 0.859 . . . . 10.0 112.136 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.41 -53.48 3.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.571 1.148 . . . . 10.0 108.799 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.556 1.542 . . . . 10.0 110.618 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.29 13.73 15.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.411 1.084 . . . . 10.0 113.328 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.96 -64.29 0.36 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.26 2.624 . . . . 10.0 109.537 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.54 44.73 28.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.768 1.627 . . . . 10.0 112.417 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.73 14.51 21.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.267 1.427 . . . . 10.0 114.137 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.05 155.45 29.21 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 127.983 2.513 . . . . 10.0 107.679 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.27 -44.99 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 10.0 109.936 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.97 -29.41 67.62 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.175 0.99 . . . . 10.0 111.182 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.08 70.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.981 1.313 . . . . 10.0 110.386 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.98 -48.52 17.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.15 0.98 . . . . 10.0 108.895 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 123.396 0.435 . . . . 10.0 111.357 -172.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.12 -46.9 79.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.235 1.414 . . . . 10.0 112.506 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.2 -41.73 60.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.543 0.737 . . . . 10.0 111.388 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.89 -14.75 59.84 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.31 -0.869 . . . . 10.0 110.378 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.78 30.72 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.766 0.827 . . . . 10.0 110.1 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.97 10.14 53.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.93 -1.483 . . . . 10.0 114.85 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.41 8.88 6.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.389 2.595 . . . . 10.0 112.601 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 49.3 4.12 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.638 -1.385 . . . . 10.0 109.638 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.6 132.96 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.39 133.73 35.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.615 0.766 . . . . 10.0 109.993 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.66 -36.96 85.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.729 -0.653 . . . . 10.0 110.375 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.01 -26.81 66.97 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.692 0.678 . . . . 10.0 111.75 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.04 4.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.328 -1.73 . . . . 10.0 106.328 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.9 -59.48 4.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.831 1.252 . . . . 10.0 112.156 -166.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.57 -33.63 64.74 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.296 -0.261 . . . . 10.0 110.296 -170.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 m -62.32 -49.43 75.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.34 92.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.571 1.148 . . . . 10.0 110.264 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.24 -48.71 45.46 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.658 1.117 . . . . 10.0 110.837 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.61 38.92 1.02 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.66 0.784 . . . . 10.0 111.278 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.29 8.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.372 1.469 . . . . 10.0 111.694 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.31 86.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.775 1.23 . . . . 10.0 110.562 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.92 54.54 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.677 0.791 . . . . 10.0 110.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.44 -38.83 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.191 0.997 . . . . 10.0 111.269 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.26 63.72 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.059 0.944 . . . . 10.0 110.974 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.3 -48.38 19.3 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.17 82.8 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.766 -0.844 . . . . 10.0 109.582 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 117.802 -1.094 . . . . 10.0 111.557 178.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.78 3.86 37.28 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.698 0.624 . . . . 10.0 112.09 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -99.06 -45.95 5.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.714 0.292 . . . . 10.0 110.697 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.63 -8.69 55.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.738 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -77.28 -44.31 30.22 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.753 0.311 . . . . 10.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -18.27 58.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.157 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 C--O 1.226 -0.144 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.201 179.661 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 mtm . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.776 0.322 . . . . 10.0 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.91 78.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.615 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -69.98 4.96 1.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.142 1.777 . . . . 10.0 113.518 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.5 36.73 26.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.976 2.11 . . . . 10.0 112.064 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.39 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 172.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.23 -16.08 4.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.672 1.989 . . . . 10.0 110.284 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.34 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.959 1.742 . . . . 10.0 112.744 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.5 153.02 61.67 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.329 2.252 . . . . 10.0 108.336 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.56 152.74 71.52 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.57 -1.012 . . . . 10.0 113.086 -6.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.9 m -145.95 144.22 30.0 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.281 1.432 . . . . 10.0 108.562 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.86 158.42 31.91 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.832 1.653 . . . . 10.0 108.294 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.975 -1.491 . . . . 10.0 106.975 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.5 t -103.97 135.2 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 168.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 t30 47.02 10.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 1 C-N-CA 133.145 4.578 . . . . 10.0 117.546 171.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.66 20.13 60.48 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.839 -1.534 . . . . 10.0 115.605 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.81 -41.31 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.897 1.849 . . . . 10.0 114.353 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -112.87 107.59 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.46 24.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 126.54 1.936 . . . . 10.0 106.713 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.58 169.61 17.42 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.297 -1.502 . . . . 10.0 107.162 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.81 1.28 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.643 0.377 . . . . 10.0 110.175 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.25 -50.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 128.557 2.743 . . . . 10.0 107.687 160.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.04 16.53 4.43 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.952 1.739 . . . . 10.0 114.354 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.772 1.286 . . . . 10.0 109.689 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.47 -34.49 72.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.098 1.359 . . . . 10.0 112.283 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.5 -5.9 9.95 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-O 118.554 -1.137 . . . . 10.0 114.852 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.28 35.23 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.614 1.707 . . . . 10.0 109.913 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.54 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.378 2.052 . . . . 10.0 111.816 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.39 -28.63 69.92 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.006 -1.059 . . . . 10.0 111.488 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.47 -27.15 66.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.104 0.562 . . . . 10.0 110.344 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.7 -42.84 33.05 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.971 -1.081 . . . . 10.0 110.928 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.8 -31.91 73.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.926 0.784 . . . . 10.0 110.975 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.45 8.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.637 1.975 . . . . 10.0 108.079 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.6 -41.3 92.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 116.898 -1.525 . . . . 10.0 111.53 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.74 69.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.987 1.721 . . . . 10.0 111.693 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.04 65.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 10.0 110.592 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.45 -42.63 96.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.604 0.762 . . . . 10.0 111.254 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.12 -37.43 83.86 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.958 -1.089 . . . . 10.0 111.219 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.7 mt -58.23 -51.93 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.265 0.939 . . . . 10.0 108.604 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.97 -43.08 63.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.579 1.151 . . . . 10.0 110.07 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.64 -0.37 33.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.183 -1.389 . . . . 10.0 113.157 -175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.521 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.05 -33.33 9.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.656 1.582 . . . . 10.0 114.442 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -55.72 5.02 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.445 -1.317 . . . . 10.0 107.445 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.34 -20.32 66.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 10.0 111.756 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.36 6.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.08 3.352 . . . . 10.0 113.694 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 13.39 35.29 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.729 1.212 . . . . 10.0 113.111 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.31 76.93 0.27 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.886 2.075 . . . . 10.0 109.827 -163.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.13 1.772 . . . . 10.0 108.878 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 109.175 -1.57 . . . . 10.0 109.175 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.22 73.71 0.15 Allowed 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 127.046 2.138 . . . . 10.0 110.324 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.467 -2.151 . . . . 10.0 113.053 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.47 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.995 1.718 . . . . 10.0 108.063 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.18 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.44 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.66 52.29 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.67 1.129 . . . . 10.0 113.405 -167.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.11 0.97 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.794 1.797 . . . . 10.0 107.745 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.37 -25.94 14.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.383 1.473 . . . . 10.0 110.528 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.08 31.3 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.345 -0.847 . . . . 10.0 111.694 -171.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.87 115.85 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.874 1.27 . . . . 10.0 109.07 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.33 167.37 20.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 119.924 -1.735 . . . . 10.0 110.5 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.64 40.88 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.261 1.024 . . . . 10.0 108.9 172.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.29 -9.55 41.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.816 0.846 . . . . 10.0 113.22 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.1 m -129.23 74.39 81.07 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.255 1.022 . . . . 10.0 108.692 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.53 -179.0 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 125.084 3.856 . . . . 10.0 112.231 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.69 138.91 34.13 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.685 1.194 . . . . 10.0 107.905 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.05 179.12 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.474 2.116 . . . . 10.0 112.593 176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.57 168.24 21.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.845 2.058 . . . . 10.0 108.902 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -46.99 -61.88 1.67 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.817 2.047 . . . . 10.0 110.489 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.37 21.27 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 127.319 2.248 . . . . 10.0 105.378 163.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.91 -164.64 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.524 2.149 . . . . 10.0 110.237 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.16 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.355 -2.698 . . . . 10.0 106.355 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.49 133.76 46.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.03 0.932 . . . . 10.0 108.744 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.78 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.312 -1.736 . . . . 10.0 106.312 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.16 139.14 35.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.3 t -128.5 130.35 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.11 108.13 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.42 54.36 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.219 1.008 . . . . 10.0 108.524 162.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.86 131.1 53.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 158.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.28 176.78 7.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.515 1.126 . . . . 10.0 110.414 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.0 175.83 11.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.008 1.323 . . . . 10.0 109.469 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.48 -73.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 10.0 112.905 172.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.08 4.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.824 1.202 . . . . 10.0 110.322 -171.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.55 84.73 8.26 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 127.472 2.309 . . . . 10.0 106.115 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.5 168.6 23.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.281 2.654 . . . . 10.0 109.252 171.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.446 1.898 . . . . 10.0 112.068 -165.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.73 -53.22 12.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.736 2.015 . . . . 10.0 110.542 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.89 -49.88 76.13 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.349 1.46 . . . . 10.0 110.877 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.88 -13.4 61.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.683 0.623 . . . . 10.0 112.683 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.83 -16.73 27.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.659 1.584 . . . . 10.0 112.029 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.72 -67.26 0.41 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.081 1.309 . . . . 10.0 112.569 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.08 -9.13 25.49 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 122.031 1.761 . . . . 10.0 114.411 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.29 68.97 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 10.0 108.781 167.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.46 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.906 1.076 . . . . 10.0 113.906 -164.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.37 -60.39 3.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 10.0 109.505 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.18 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.255 1.127 . . . . 10.0 112.996 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.6 t90 -57.18 -51.64 68.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.407 0.683 . . . . 10.0 110.367 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.2 80.74 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.171 0.51 . . . . 10.0 110.279 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.53 64.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.211 -0.931 . . . . 10.0 111.393 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.7 10.13 39.62 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.613 1.165 . . . . 10.0 112.905 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.409 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.99 151.25 75.4 Favored Pre-proline 0 C--O 1.237 0.416 0 CA-C-N 119.483 1.038 . . . . 10.0 110.953 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.13 169.75 21.44 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.003 3.135 . . . . 10.0 110.509 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -4.14 4.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.973 1.309 . . . . 10.0 113.394 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.41 43.33 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.671 1.588 . . . . 10.0 110.61 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.49 164.97 30.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 121.141 -0.974 . . . . 10.0 108.809 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -145.81 137.25 24.94 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.497 -1.229 . . . . 10.0 108.402 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -115.45 137.07 52.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.913 0.387 . . . . 10.0 111.553 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.08 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.468 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -109.17 126.75 53.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.255 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -127.07 139.19 34.42 Favored Pre-proline 0 N--CA 1.462 0.172 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.23 153.16 21.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.974 2.449 . . . . 10.0 112.241 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.87 99.02 10.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.296 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -88.18 76.9 8.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.757 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.69 20.26 1.17 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.122 1.527 . . . . 10.0 115.122 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.1 3.43 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 119.886 -1.759 . . . . 10.0 112.852 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.08 1.53 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.292 0.949 . . . . 10.0 110.78 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.83 -30.78 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.088 0.955 . . . . 10.0 112.057 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.43 -27.44 6.45 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.124 1.77 . . . . 10.0 113.337 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.87 -36.37 64.81 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.661 1.119 . . . . 10.0 110.588 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.88 -55.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.533 3.133 . . . . 10.0 112.171 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.13 -42.5 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 125.336 1.446 . . . . 10.0 111.239 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.59 -41.9 70.43 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.778 -1.106 . . . . 10.0 112.471 -175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.38 -44.34 8.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 114.183 1.179 . . . . 10.0 114.183 -173.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.9 -45.77 92.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.49 0.586 . . . . 10.0 110.201 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -45.31 94.95 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 116.761 -1.59 . . . . 10.0 109.205 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.7 92.0 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.601 1.546 . . . . 10.0 110.789 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -60.59 3.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.015 1.726 . . . . 10.0 109.35 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.7 -28.92 66.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 118.963 -0.542 . . . . 10.0 111.767 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.63 -37.22 49.24 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.401 1.081 . . . . 10.0 110.71 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.86 -22.46 56.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.606 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.34 14.54 61.84 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.906 0.765 . . . . 10.0 113.0 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.37 130.28 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.932 1.293 . . . . 10.0 109.326 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -123.54 75.96 1.37 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -165.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.27 -5.37 54.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.11 2.263 . . . . 10.0 117.11 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.32 52.02 7.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.343 1.857 . . . . 10.0 112.071 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 117.484 -1.246 . . . . 10.0 113.368 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.83 34.91 1.3 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.565 1.529 . . . . 10.0 113.14 -176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.42 -44.5 0.61 Allowed 'General case' 0 C--O 1.219 -0.505 0 O-C-N 120.822 -1.174 . . . . 10.0 108.899 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.44 44.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.45 -65.62 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 117.654 -1.165 . . . . 10.0 108.673 166.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.61 -46.81 73.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.255 1.389 . . . . 10.0 111.98 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.56 82.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.406 1.482 . . . . 10.0 110.186 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.11 4.5 5.47 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.76 1.624 . . . . 10.0 112.896 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.21 -57.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.071 -2.196 . . . . 10.0 105.071 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.65 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.706 0.802 . . . . 10.0 112.615 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.34 -21.1 64.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.115 0.87 . . . . 10.0 112.217 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.52 -53.48 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.591 1.157 . . . . 10.0 108.772 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.44 87.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.571 1.548 . . . . 10.0 110.671 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.18 13.75 15.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.399 1.08 . . . . 10.0 113.389 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.94 -64.25 0.36 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.207 2.603 . . . . 10.0 109.567 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.7 mt 54.61 44.53 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.764 1.626 . . . . 10.0 112.504 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.56 20.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.269 1.428 . . . . 10.0 114.208 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.33 28.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 127.921 2.488 . . . . 10.0 107.682 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.11 -45.04 10.87 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.575 2.183 . . . . 10.0 109.968 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.3 67.39 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.232 1.013 . . . . 10.0 111.175 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.56 -42.08 70.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.941 1.297 . . . . 10.0 110.336 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.55 17.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.208 1.003 . . . . 10.0 108.886 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.2 84.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 122.76 0.424 . . . . 10.0 111.418 -172.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.93 78.75 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.279 1.432 . . . . 10.0 112.569 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.65 61.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.535 0.734 . . . . 10.0 111.448 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.371 -0.83 . . . . 10.0 110.366 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.79 30.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.893 0.877 . . . . 10.0 110.095 172.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.09 54.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.917 -1.49 . . . . 10.0 114.773 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.84 6.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 121.358 2.579 . . . . 10.0 112.652 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.25 4.12 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.629 -1.388 . . . . 10.0 109.629 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.57 132.95 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 105.161 -2.163 . . . . 10.0 105.161 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.65 35.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.611 0.764 . . . . 10.0 110.005 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.53 -37.03 86.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.791 -0.623 . . . . 10.0 110.366 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.06 -26.8 66.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.733 0.697 . . . . 10.0 111.717 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.03 4.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.95 -59.45 4.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.829 1.252 . . . . 10.0 112.192 -166.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.56 -33.69 64.79 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.226 -0.287 . . . . 10.0 110.226 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 m -62.2 -49.49 75.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.75 -41.27 92.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.518 1.127 . . . . 10.0 110.255 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.15 -48.71 44.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.723 1.147 . . . . 10.0 110.84 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.66 38.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.697 0.799 . . . . 10.0 111.191 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.31 8.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.413 1.485 . . . . 10.0 111.624 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.19 -40.36 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.852 1.261 . . . . 10.0 110.473 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.84 55.59 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.682 0.793 . . . . 10.0 110.46 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.5 -38.84 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.244 1.018 . . . . 10.0 111.261 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.23 63.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 10.0 111.001 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.41 19.48 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.2 82.93 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.732 -0.863 . . . . 10.0 109.553 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.421 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.32 -34.15 77.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.74 -1.124 . . . . 10.0 111.432 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.12 1.76 39.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.749 0.704 . . . . 10.0 111.922 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.5 -52.91 3.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.587 0.232 . . . . 10.0 110.533 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.31 -5.88 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.137 0.421 . . . . 10.0 112.137 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 66' ' ' LEU . 4.0 tmmt? -79.1 -45.92 19.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.938 0.399 . . . . 10.0 110.821 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -19.59 59.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.164 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 54.6 mt . . . . . 0 C--O 1.227 -0.084 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.605 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.74 0.305 . . . . 10.0 111.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.87 82.97 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.631 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 5.04 1.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.158 1.783 . . . . 10.0 113.558 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.41 36.74 26.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.916 2.086 . . . . 10.0 112.077 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.442 HG21 HD22 ' A' ' 32' ' ' LEU . 90.6 t -69.3 135.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.729 -1.211 . . . . 10.0 107.729 172.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.2 -16.08 4.06 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.637 1.975 . . . . 10.0 110.261 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -170.89 33.64 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.036 1.779 . . . . 10.0 112.853 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.49 153.02 61.71 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.271 2.228 . . . . 10.0 108.299 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.57 152.65 71.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.561 -1.016 . . . . 10.0 113.152 -6.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.6 m -145.81 144.3 30.19 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.317 1.447 . . . . 10.0 108.583 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.96 158.39 32.15 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.837 1.655 . . . . 10.0 108.19 163.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.5 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.6 t -104.08 135.16 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 107.117 -1.438 . . . . 10.0 107.117 168.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.09 10.97 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 133.19 4.596 . . . . 10.0 117.463 171.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.11 60.57 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.77 -1.572 . . . . 10.0 115.57 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.89 -41.31 1.04 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.976 1.888 . . . . 10.0 114.325 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.77 107.58 16.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.01 113.37 24.46 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 126.549 1.94 . . . . 10.0 106.765 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.62 17.39 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 120.344 -1.473 . . . . 10.0 107.159 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.92 -178.82 1.3 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.603 0.361 . . . . 10.0 110.171 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.28 -50.06 5.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 128.483 2.713 . . . . 10.0 107.811 160.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.53 4.5 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.849 1.69 . . . . 10.0 114.365 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.25 -51.25 1.3 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.759 1.28 . . . . 10.0 109.697 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.6 72.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.1 1.36 . . . . 10.0 112.238 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.51 -5.87 9.94 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.489 -1.173 . . . . 10.0 114.844 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.79 174.31 35.17 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.699 1.749 . . . . 10.0 110.012 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.86 -52.57 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.391 2.061 . . . . 10.0 111.81 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.37 -28.66 69.92 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.907 -1.121 . . . . 10.0 111.478 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.16 66.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.044 0.538 . . . . 10.0 110.406 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.63 -42.94 33.08 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.079 -1.013 . . . . 10.0 110.938 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.96 73.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.941 0.791 . . . . 10.0 111.01 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.47 8.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.604 1.962 . . . . 10.0 108.057 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.61 -41.27 92.94 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 116.888 -1.53 . . . . 10.0 111.508 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.81 69.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 121.017 1.735 . . . . 10.0 111.663 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.46 -47.01 65.33 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.844 0.458 . . . . 10.0 110.661 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.5 -42.64 96.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.581 0.752 . . . . 10.0 111.245 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.07 -37.39 83.94 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.922 -1.111 . . . . 10.0 111.247 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.26 -51.92 65.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 119.265 0.939 . . . . 10.0 108.553 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.03 -43.1 63.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.622 1.169 . . . . 10.0 109.972 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.69 -0.29 33.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.15 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.38 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.647 1.579 . . . . 10.0 114.425 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -55.77 4.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.833 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.71 -35.54 6.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.174 3.389 . . . . 10.0 113.65 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.08 13.42 35.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.682 1.193 . . . . 10.0 113.105 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.34 76.87 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.93 2.092 . . . . 10.0 109.837 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.113 1.765 . . . . 10.0 108.797 -179.227 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.254 0 N-CA-C 109.17 -1.572 . . . . 10.0 109.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.15 73.76 0.15 Allowed 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 127.166 2.186 . . . . 10.0 110.312 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.96 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 112.4 -2.182 . . . . 10.0 113.047 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.44 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.09 1.756 . . . . 10.0 108.037 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.21 132.85 44.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.676 -1.231 . . . . 10.0 107.676 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.41 49.34 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.79 52.37 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.734 1.159 . . . . 10.0 113.375 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 -63.05 0.97 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 119.857 1.828 . . . . 10.0 107.69 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.46 -25.93 14.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.406 1.482 . . . . 10.0 110.517 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.53 167.12 31.15 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.275 -0.891 . . . . 10.0 111.789 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.0 115.98 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.775 1.23 . . . . 10.0 108.968 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.41 20.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.908 -1.745 . . . . 10.0 110.457 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.29 124.64 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.238 1.015 . . . . 10.0 108.822 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.28 -9.5 41.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.86 0.864 . . . . 10.0 113.197 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 m -129.32 74.52 80.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 10.0 108.633 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.63 -179.09 2.62 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 125.095 3.863 . . . . 10.0 112.217 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.82 33.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.716 1.206 . . . . 10.0 107.928 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.97 179.13 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.406 2.071 . . . . 10.0 112.616 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.48 168.2 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 126.926 2.09 . . . . 10.0 108.906 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.76 1.73 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.785 2.034 . . . . 10.0 110.503 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.86 165.32 21.32 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.37 2.268 . . . . 10.0 105.435 163.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.8 -164.72 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.631 2.221 . . . . 10.0 110.249 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.18 -112.72 2.46 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.277 -2.729 . . . . 10.0 106.277 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.37 133.66 45.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.142 0.977 . . . . 10.0 108.739 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.62 140.84 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.355 -1.72 . . . . 10.0 106.355 169.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.27 139.14 35.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.53 130.42 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.828 -1.916 . . . . 10.0 105.828 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 63' ' ' LEU . 11.2 t -131.16 108.07 14.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.335 . . . . 10.0 107.394 -172.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.99 143.37 54.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.292 1.037 . . . . 10.0 108.568 162.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.77 131.05 53.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.898 -0.779 . . . . 10.0 108.898 158.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.475 1.11 . . . . 10.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.79 11.78 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.111 1.364 . . . . 10.0 109.533 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.46 -73.15 0.1 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.694 1.198 . . . . 10.0 112.891 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.96 52.02 4.54 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.813 1.197 . . . . 10.0 110.307 -171.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.57 84.83 8.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.437 2.295 . . . . 10.0 106.03 -163.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.55 168.51 24.2 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.33 2.687 . . . . 10.0 109.246 171.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.1 -45.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.457 1.903 . . . . 10.0 112.091 -165.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.76 -53.14 12.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 10.0 110.577 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.86 -50.05 75.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.332 1.453 . . . . 10.0 110.824 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.7 -13.55 61.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.71 -16.92 27.64 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.764 1.625 . . . . 10.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.59 -67.3 0.4 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 120.11 1.323 . . . . 10.0 112.587 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.21 25.72 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-N 122.052 1.768 . . . . 10.0 114.469 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.9 -43.12 68.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.734 1.152 . . . . 10.0 108.765 167.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 tt -105.27 -28.48 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -164.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.7 t -46.44 -60.33 3.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.817 1.247 . . . . 10.0 109.475 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.2 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.277 1.135 . . . . 10.0 113.002 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.25 -51.61 68.66 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.356 0.663 . . . . 10.0 110.366 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.99 -39.12 80.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.091 0.472 . . . . 10.0 110.223 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.84 -25.64 64.75 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.178 -0.951 . . . . 10.0 111.431 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.01 39.77 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.607 1.163 . . . . 10.0 112.923 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.99 151.25 75.38 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 119.493 1.042 . . . . 10.0 110.938 174.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.1 169.74 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.967 3.111 . . . . 10.0 110.541 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -4.2 4.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.018 1.327 . . . . 10.0 113.428 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.39 43.34 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.705 1.602 . . . . 10.0 110.533 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.53 164.87 30.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 121.245 -0.909 . . . . 10.0 108.796 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.53 135.0 21.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.568 -1.196 . . . . 10.0 108.431 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -113.82 138.98 49.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.855 0.359 . . . . 10.0 111.733 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.23 142.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.484 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -109.09 122.34 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.186 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.7 mt -121.59 138.29 28.18 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.76 153.14 22.76 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.937 2.425 . . . . 10.0 112.211 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.69 97.78 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.433 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.12 76.78 8.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.798 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.64 20.31 1.15 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.176 1.547 . . . . 10.0 115.176 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.02 -48.13 3.43 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.937 -1.727 . . . . 10.0 112.88 168.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 -152.14 1.53 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.342 0.973 . . . . 10.0 110.737 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.82 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.154 0.982 . . . . 10.0 112.029 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.48 6.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.093 1.757 . . . . 10.0 113.347 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.88 -36.47 64.8 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.631 1.105 . . . . 10.0 110.464 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.79 -55.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -65.83 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.56 3.144 . . . . 10.0 112.237 170.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.22 -42.47 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 125.409 1.48 . . . . 10.0 111.226 173.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.62 -41.8 70.43 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.744 -1.122 . . . . 10.0 112.461 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.56 -44.26 8.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.119 1.155 . . . . 10.0 114.119 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -61.87 -45.8 92.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.568 0.622 . . . . 10.0 110.252 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.24 95.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 116.74 -1.6 . . . . 10.0 109.16 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.69 91.99 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.637 1.562 . . . . 10.0 110.775 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -60.6 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.017 1.727 . . . . 10.0 109.38 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.59 -29.02 66.47 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.962 -0.542 . . . . 10.0 111.855 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.64 -37.28 49.58 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.325 1.05 . . . . 10.0 110.669 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.6 mtp -75.74 -22.49 56.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.72 -0.657 . . . . 10.0 111.709 -170.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.44 61.85 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.844 0.735 . . . . 10.0 112.995 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.3 130.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.957 1.303 . . . . 10.0 109.314 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.59 75.95 1.38 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.572 0.749 . . . . 10.0 108.982 -165.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -5.36 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.077 2.251 . . . . 10.0 117.077 -170.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.39 51.91 7.54 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.352 1.861 . . . . 10.0 112.127 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.92 -47.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.42 -1.276 . . . . 10.0 113.419 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.78 34.84 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.589 1.541 . . . . 10.0 113.131 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.454 0 O-C-N 120.813 -1.179 . . . . 10.0 108.974 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.53 45.52 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -71.47 -65.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 117.556 -1.211 . . . . 10.0 108.698 166.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.75 74.06 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.389 1.45 . . . . 10.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.41 -40.6 82.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.478 1.511 . . . . 10.0 110.156 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.18 4.58 5.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.719 1.608 . . . . 10.0 112.871 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.08 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.56 -61.35 2.0 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.678 0.791 . . . . 10.0 112.671 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.2 64.8 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.045 0.839 . . . . 10.0 112.152 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.63 3.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.614 1.166 . . . . 10.0 108.772 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.55 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.543 1.537 . . . . 10.0 110.647 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.61 15.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.421 1.088 . . . . 10.0 113.331 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.0 -64.19 0.36 Allowed 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 128.266 2.626 . . . . 10.0 109.513 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.8 mt 54.52 44.58 28.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.764 1.625 . . . . 10.0 112.498 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.65 14.56 20.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.324 1.45 . . . . 10.0 114.224 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.42 29.11 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 127.984 2.514 . . . . 10.0 107.629 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.2 -44.92 10.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.551 2.167 . . . . 10.0 110.038 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.35 67.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.229 1.012 . . . . 10.0 111.133 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.48 -42.14 70.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.027 1.331 . . . . 10.0 110.333 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.86 -48.57 18.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.155 0.982 . . . . 10.0 108.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.24 84.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 123.402 0.439 . . . . 10.0 111.292 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.03 -46.9 78.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.378 1.471 . . . . 10.0 112.565 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.2 -41.69 61.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.556 0.742 . . . . 10.0 111.489 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.0 -14.72 59.8 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.367 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.76 30.65 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.86 0.864 . . . . 10.0 110.135 172.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.06 54.19 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 117.969 -1.462 . . . . 10.0 114.906 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.74 6.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.355 2.577 . . . . 10.0 112.674 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.95 49.35 4.08 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.67 132.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.138 -2.171 . . . . 10.0 105.138 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.26 133.7 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.63 0.772 . . . . 10.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.57 -37.0 86.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.375 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.76 66.87 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.721 0.691 . . . . 10.0 111.721 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.65 -57.1 4.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.796 1.238 . . . . 10.0 112.201 -166.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.57 -33.64 64.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.4 m -62.29 -49.5 75.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.28 92.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.522 1.129 . . . . 10.0 110.232 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.28 -48.72 45.79 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.726 1.148 . . . . 10.0 110.721 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.57 38.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.712 0.805 . . . . 10.0 111.195 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.84 172.32 8.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.361 1.464 . . . . 10.0 111.59 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.17 -40.45 86.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.824 1.25 . . . . 10.0 110.444 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.86 54.68 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.745 0.818 . . . . 10.0 110.495 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.47 -38.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.287 1.035 . . . . 10.0 111.321 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.32 63.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.07 0.948 . . . . 10.0 111.003 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.37 19.6 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.12 82.65 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.817 -0.814 . . . . 10.0 109.608 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -33.98 76.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.729 -1.129 . . . . 10.0 111.46 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.41 1.58 38.53 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.627 0.649 . . . . 10.0 112.136 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 11.7 mmtt -96.89 -47.14 5.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 10.0 110.91 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.13 -6.04 58.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -79.44 -44.96 20.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.923 0.392 . . . . 10.0 110.751 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -74.53 -21.21 59.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 37.8 mt . . . . . 0 C--O 1.225 -0.208 0 CA-C-N 116.207 -0.452 . . . . 10.0 111.1 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.1 mtm . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.763 0.316 . . . . 10.0 111.582 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.93 78.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.612 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.0 5.05 1.73 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 113.49 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.3 36.78 26.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.897 2.079 . . . . 10.0 112.127 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 32' ' ' LEU . 89.9 t -69.36 135.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.33 -16.04 4.01 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.701 2.0 . . . . 10.0 110.255 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.48 -170.92 33.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.892 1.71 . . . . 10.0 112.72 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.45 153.01 61.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.242 2.217 . . . . 10.0 108.309 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.53 152.67 71.37 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.599 -1.0 . . . . 10.0 113.07 -6.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.1 m -145.86 144.26 30.12 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.351 1.46 . . . . 10.0 108.634 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.94 158.39 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.823 1.649 . . . . 10.0 108.204 163.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.14 136.48 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.7 t -104.06 135.06 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.123 -1.436 . . . . 10.0 107.123 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.08 10.96 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.148 4.579 . . . . 10.0 117.561 171.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.57 20.28 60.34 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.803 -1.554 . . . . 10.0 115.52 -170.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.9 -41.4 1.03 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.962 1.881 . . . . 10.0 114.346 -170.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.69 107.58 16.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.553 1.941 . . . . 10.0 106.765 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.59 169.54 17.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.141 -1.429 . . . . 10.0 107.141 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.8 1.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.585 0.354 . . . . 10.0 110.193 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.26 -50.1 5.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 128.569 2.748 . . . . 10.0 107.717 160.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.13 16.57 4.48 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.834 1.683 . . . . 10.0 114.4 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -128.28 -51.21 1.3 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.793 1.297 . . . . 10.0 109.692 168.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.59 72.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.037 1.335 . . . . 10.0 112.298 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.54 -5.98 9.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 118.496 -1.169 . . . . 10.0 114.754 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.36 35.26 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 119.75 1.775 . . . . 10.0 110.046 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 -52.62 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.354 2.036 . . . . 10.0 111.724 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.27 -28.7 69.9 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.999 -1.063 . . . . 10.0 111.539 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.12 66.81 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.07 0.548 . . . . 10.0 110.409 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.69 -42.9 32.92 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.014 -1.054 . . . . 10.0 110.939 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.76 -31.83 73.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.91 0.777 . . . . 10.0 111.04 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.56 -56.4 8.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.502 1.921 . . . . 10.0 108.053 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.33 93.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 116.917 -1.516 . . . . 10.0 111.509 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.65 69.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.996 1.725 . . . . 10.0 111.729 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.58 -47.04 64.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.863 0.465 . . . . 10.0 110.58 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.45 -42.63 96.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.608 0.763 . . . . 10.0 111.256 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.08 -37.38 83.89 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 120.94 -1.1 . . . . 10.0 111.266 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.31 -51.89 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.261 0.937 . . . . 10.0 108.582 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.06 63.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.543 1.137 . . . . 10.0 110.064 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.63 -0.46 33.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 117.145 -1.407 . . . . 10.0 113.123 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.418 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.03 -33.37 9.29 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.627 1.571 . . . . 10.0 114.429 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -55.8 4.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.372 -1.344 . . . . 10.0 107.372 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.32 66.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.159 -0.928 . . . . 10.0 111.795 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.41 6.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 130.122 3.369 . . . . 10.0 113.73 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.16 13.51 34.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.653 1.181 . . . . 10.0 113.153 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.977 2.111 . . . . 10.0 109.819 -163.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.085 1.754 . . . . 10.0 108.787 -179.16 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.292 0 N-CA-C 109.203 -1.559 . . . . 10.0 109.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.66 0.15 Allowed 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 127.081 2.152 . . . . 10.0 110.423 -175.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.2 11.9 0.66 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 112.45 -2.159 . . . . 10.0 112.997 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.41 157.75 43.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.028 1.731 . . . . 10.0 108.009 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.25 132.81 44.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.48 49.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.187 -1.042 . . . . 10.0 108.187 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.6 13.73 52.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.713 1.149 . . . . 10.0 113.423 -166.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.03 0.98 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.858 1.829 . . . . 10.0 107.853 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -26.07 14.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.427 1.491 . . . . 10.0 110.45 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.5 167.14 31.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.25 -0.906 . . . . 10.0 111.702 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.91 115.98 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.802 1.241 . . . . 10.0 109.036 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.41 167.25 20.42 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.927 -1.733 . . . . 10.0 110.534 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.62 40.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.213 1.005 . . . . 10.0 108.835 172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 m -67.32 -9.39 40.61 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.228 0.825 . . . . 10.0 113.228 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -129.35 74.39 81.0 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.14 0.976 . . . . 10.0 108.574 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.53 -179.08 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 125.095 3.864 . . . . 10.0 112.246 -172.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.91 34.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.681 1.193 . . . . 10.0 107.932 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.08 179.08 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.457 2.105 . . . . 10.0 112.601 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.48 168.23 20.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.801 2.04 . . . . 10.0 108.931 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.0 -61.8 1.71 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.808 2.043 . . . . 10.0 110.531 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.03 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.321 2.248 . . . . 10.0 105.34 163.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.9 -164.62 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.576 2.184 . . . . 10.0 110.229 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.67 2.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.323 -2.711 . . . . 10.0 106.323 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.51 133.79 46.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.075 0.95 . . . . 10.0 108.697 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.76 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.16 35.3 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.5 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.962 -1.866 . . . . 10.0 105.962 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.12 108.16 14.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -172.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.14 143.37 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.305 1.042 . . . . 10.0 108.463 162.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.73 131.14 53.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 158.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.42 176.82 7.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 10.0 110.381 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.82 11.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.0 109.464 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.47 -73.22 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.66 1.184 . . . . 10.0 112.842 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.06 4.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.778 1.18 . . . . 10.0 110.326 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.52 84.76 8.23 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 127.464 2.306 . . . . 10.0 106.111 -163.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.5 168.49 24.2 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.339 2.693 . . . . 10.0 109.239 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.07 -45.7 0.28 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.431 1.892 . . . . 10.0 112.081 -165.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.87 -53.09 12.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.767 2.027 . . . . 10.0 110.518 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.05 -49.87 76.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.423 1.489 . . . . 10.0 110.796 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.47 61.63 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -171.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.85 27.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.69 1.596 . . . . 10.0 112.046 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.6 -67.31 0.4 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.174 1.352 . . . . 10.0 112.56 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.0 -9.18 25.67 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 121.986 1.745 . . . . 10.0 114.425 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.2 69.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.812 1.187 . . . . 10.0 108.837 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.22 -28.49 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 113.874 1.065 . . . . 10.0 113.874 -164.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.43 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.746 1.218 . . . . 10.0 109.48 173.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.85 -35.39 78.65 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.273 1.133 . . . . 10.0 112.897 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.24 -51.66 68.47 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.431 0.693 . . . . 10.0 110.304 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.89 -39.22 80.79 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.169 0.509 . . . . 10.0 110.25 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.79 -25.71 64.84 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.096 -1.002 . . . . 10.0 111.415 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.07 39.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.513 1.125 . . . . 10.0 112.923 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.86 151.17 74.5 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 119.485 1.039 . . . . 10.0 110.971 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.07 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.987 3.125 . . . . 10.0 110.49 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.12 -4.19 4.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.011 1.324 . . . . 10.0 113.395 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.62 8.34 43.45 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.743 1.617 . . . . 10.0 110.627 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.52 164.94 30.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 O-C-N 121.189 -0.945 . . . . 10.0 108.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -146.08 137.07 24.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.402 -1.272 . . . . 10.0 108.444 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -117.3 135.64 53.68 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.804 0.335 . . . . 10.0 111.725 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.92 138.67 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.81 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -104.42 118.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.02 138.44 27.01 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.88 152.89 25.32 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.028 2.485 . . . . 10.0 112.4 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 96.96 8.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.271 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.1 76.8 8.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.363 -0.38 . . . . 10.0 111.776 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.22 1.16 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.132 1.53 . . . . 10.0 115.132 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.11 -48.18 3.42 Favored Glycine 0 N--CA 1.467 0.723 0 O-C-N 119.933 -1.729 . . . . 10.0 112.752 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.39 -152.13 1.52 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.389 0.995 . . . . 10.0 110.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.86 -30.75 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.077 0.951 . . . . 10.0 112.081 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.34 -27.52 6.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.049 1.74 . . . . 10.0 113.396 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.86 -36.46 64.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.66 1.118 . . . . 10.0 110.478 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.88 -55.14 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.94 31.91 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.519 3.128 . . . . 10.0 112.137 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 125.332 1.444 . . . . 10.0 111.196 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.47 -41.86 70.0 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.53 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.32 8.45 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.121 1.156 . . . . 10.0 114.121 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.89 -45.67 92.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.503 0.592 . . . . 10.0 110.335 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.38 -45.33 94.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.786 -1.578 . . . . 10.0 109.251 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.63 92.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.592 1.542 . . . . 10.0 110.829 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.6 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.99 1.716 . . . . 10.0 109.483 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.64 -29.03 66.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.919 -0.562 . . . . 10.0 111.789 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.57 -37.24 48.79 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.362 1.065 . . . . 10.0 110.701 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.8 -22.46 56.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.695 -170.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.46 61.83 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.871 0.748 . . . . 10.0 112.986 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.41 130.32 26.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 124.916 1.286 . . . . 10.0 109.277 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.87 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.605 0.762 . . . . 10.0 109.022 -165.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -5.39 54.26 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.103 2.26 . . . . 10.0 117.103 -170.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 51.96 7.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.313 1.845 . . . . 10.0 112.114 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.93 -47.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.455 -1.26 . . . . 10.0 113.381 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.93 34.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.576 1.535 . . . . 10.0 113.199 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.41 -44.57 0.61 Allowed 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.832 -1.167 . . . . 10.0 108.84 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.48 44.7 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.605 1.335 . . . . 10.0 114.605 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -71.53 -65.49 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 117.518 -1.23 . . . . 10.0 108.695 166.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.72 74.04 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.407 1.458 . . . . 10.0 112.048 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.49 -40.48 82.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.388 1.475 . . . . 10.0 110.241 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.3 4.65 5.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.818 1.647 . . . . 10.0 112.826 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.29 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.991 -2.225 . . . . 10.0 104.991 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.62 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.713 0.805 . . . . 10.0 112.625 -173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.26 -21.22 64.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.093 0.86 . . . . 10.0 112.189 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.42 -53.51 3.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.58 1.152 . . . . 10.0 108.831 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.38 88.03 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 10.0 110.656 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.63 15.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.382 1.073 . . . . 10.0 113.325 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.01 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 128.217 2.607 . . . . 10.0 109.57 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 41.0 mt 54.43 44.71 28.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.815 1.646 . . . . 10.0 112.436 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.6 20.63 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.284 1.434 . . . . 10.0 114.189 -173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 155.39 29.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 127.933 2.493 . . . . 10.0 107.643 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.2 -45.01 10.7 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.576 2.184 . . . . 10.0 109.937 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.36 67.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.208 1.003 . . . . 10.0 111.161 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.15 70.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.981 1.313 . . . . 10.0 110.322 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.53 18.03 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.165 0.986 . . . . 10.0 108.909 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.25 -37.16 84.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.461 0.476 . . . . 10.0 111.349 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.11 -46.89 78.95 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.324 1.45 . . . . 10.0 112.51 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.62 60.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.549 0.74 . . . . 10.0 111.412 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.95 -14.71 59.82 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.36 -0.838 . . . . 10.0 110.418 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.52 -41.73 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.814 0.846 . . . . 10.0 110.098 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.07 10.1 54.52 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.0 -1.445 . . . . 10.0 114.845 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.32 8.79 6.59 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.313 2.556 . . . . 10.0 112.64 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.16 4.15 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.696 -1.362 . . . . 10.0 109.696 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.54 132.88 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.165 -2.161 . . . . 10.0 105.165 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -92.26 133.76 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.561 0.744 . . . . 10.0 110.022 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.63 -36.96 85.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.768 -0.634 . . . . 10.0 110.37 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.09 -26.79 66.89 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.637 0.653 . . . . 10.0 111.719 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.06 4.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.334 -1.728 . . . . 10.0 106.334 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.776 1.23 . . . . 10.0 112.241 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.51 -33.65 64.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.3 m -62.34 -49.37 75.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.76 -41.33 92.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.555 1.142 . . . . 10.0 110.207 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.1 -48.73 44.18 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.768 1.167 . . . . 10.0 110.83 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.65 38.84 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.714 0.806 . . . . 10.0 111.116 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.461 1.504 . . . . 10.0 111.657 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.18 -40.35 86.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.782 1.233 . . . . 10.0 110.521 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.82 55.38 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.723 0.809 . . . . 10.0 110.489 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.49 -38.78 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.241 1.016 . . . . 10.0 111.324 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.31 63.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.995 0.918 . . . . 10.0 111.016 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.46 19.72 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.851 -0.899 . . . . 10.0 110.851 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.35 -36.21 82.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.751 -0.852 . . . . 10.0 109.53 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -33.63 75.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.751 -1.118 . . . . 10.0 111.542 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.6 -0.87 34.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.581 0.628 . . . . 10.0 112.373 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 54.2 mmtt -95.26 -44.92 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 10.0 110.8 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.34 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.584 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -79.24 -45.75 19.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.692 0.282 . . . . 10.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -16.58 60.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 45.8 mt . . . . . 0 C--O 1.227 -0.093 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.293 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.763 0.315 . . . . 10.0 111.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.89 78.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.69 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.0 5.02 1.75 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.148 1.779 . . . . 10.0 113.524 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.4 36.8 26.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.885 2.074 . . . . 10.0 112.075 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 172.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.17 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.793 2.037 . . . . 10.0 110.319 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.39 -170.96 33.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 126.024 1.773 . . . . 10.0 112.865 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.38 152.99 62.04 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 127.316 2.246 . . . . 10.0 108.341 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.63 152.71 71.76 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.569 -1.013 . . . . 10.0 113.103 -6.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 57.2 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.325 1.45 . . . . 10.0 108.538 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.6 mmm -123.94 158.44 31.99 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.733 1.613 . . . . 10.0 108.225 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.16 136.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.862 -1.533 . . . . 10.0 106.862 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.0 135.2 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.091 -1.448 . . . . 10.0 107.091 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 46.99 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 133.151 4.58 . . . . 10.0 117.53 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.67 20.08 60.57 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.778 -1.568 . . . . 10.0 115.552 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.41 1.04 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.954 1.877 . . . . 10.0 114.333 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.72 107.57 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.53 24.55 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.471 1.908 . . . . 10.0 106.79 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.63 169.58 17.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.304 -1.497 . . . . 10.0 107.09 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.91 -178.76 1.29 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.36 -50.08 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 128.482 2.713 . . . . 10.0 107.724 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.54 4.5 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.963 1.744 . . . . 10.0 114.377 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.9 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 118.726 1.263 . . . . 10.0 109.651 168.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.065 1.346 . . . . 10.0 112.247 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.49 -5.68 9.99 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 118.57 -1.128 . . . . 10.0 114.83 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.74 174.25 35.07 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.639 1.719 . . . . 10.0 109.963 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.88 -52.6 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.407 2.072 . . . . 10.0 111.766 -169.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.015 -1.053 . . . . 10.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.41 -27.2 66.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.138 0.575 . . . . 10.0 110.38 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.64 -43.04 32.67 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.097 -1.002 . . . . 10.0 110.822 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.71 -31.87 73.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.965 0.802 . . . . 10.0 111.036 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.48 8.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.537 1.935 . . . . 10.0 108.074 168.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.5 -41.37 93.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.896 -1.526 . . . . 10.0 111.496 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.952 1.705 . . . . 10.0 111.735 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.15 64.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.934 0.494 . . . . 10.0 110.591 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.43 -42.52 96.24 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.584 0.754 . . . . 10.0 111.301 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.18 -37.38 83.61 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.93 -1.106 . . . . 10.0 111.242 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.18 -52.0 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.232 0.924 . . . . 10.0 108.583 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.96 -43.06 63.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.596 1.158 . . . . 10.0 110.016 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.7 -0.4 33.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.154 -1.403 . . . . 10.0 113.139 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.477 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.08 -33.25 9.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.637 1.575 . . . . 10.0 114.466 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -55.73 4.99 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.763 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.5 6.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 130.244 3.418 . . . . 10.0 113.638 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.12 13.43 35.19 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.717 1.207 . . . . 10.0 113.117 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.33 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.872 2.069 . . . . 10.0 109.845 -163.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.039 1.736 . . . . 10.0 108.768 -179.272 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.296 0 N-CA-C 109.284 -1.526 . . . . 10.0 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.7 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 127.087 2.155 . . . . 10.0 110.406 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.24 11.86 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.07 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.012 1.725 . . . . 10.0 108.081 -175.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.32 132.75 44.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 148.42 49.48 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.7 13.61 52.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.623 1.106 . . . . 10.0 113.42 -167.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -63.04 0.98 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 119.871 1.835 . . . . 10.0 107.769 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.348 1.459 . . . . 10.0 110.521 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.68 167.02 31.57 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.271 -0.893 . . . . 10.0 111.719 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.82 115.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.836 1.254 . . . . 10.0 109.023 -171.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.45 167.32 20.31 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 119.993 -1.692 . . . . 10.0 110.497 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.69 41.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.29 1.036 . . . . 10.0 108.823 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.44 -9.36 41.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.768 0.827 . . . . 10.0 113.116 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.29 74.34 81.06 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.254 1.022 . . . . 10.0 108.647 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.43 -179.11 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 125.121 3.881 . . . . 10.0 112.29 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.92 34.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.769 1.227 . . . . 10.0 107.948 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.14 179.14 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.427 2.085 . . . . 10.0 112.538 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.54 168.18 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.78 2.032 . . . . 10.0 108.938 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -47.0 -61.87 1.67 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.851 2.06 . . . . 10.0 110.44 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.05 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 127.228 2.211 . . . . 10.0 105.301 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.91 -164.56 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.585 2.19 . . . . 10.0 110.304 173.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.07 -112.7 2.46 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.36 -2.696 . . . . 10.0 106.36 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.48 133.71 45.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.07 0.948 . . . . 10.0 108.785 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.64 140.82 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.305 -1.739 . . . . 10.0 106.305 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.31 139.22 35.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.8 t -128.54 130.43 69.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.901 -1.888 . . . . 10.0 105.901 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.15 108.09 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -172.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.11 143.39 54.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.236 1.014 . . . . 10.0 108.544 162.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.14 53.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 158.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.36 176.87 7.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.391 1.076 . . . . 10.0 110.365 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.05 175.82 11.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.049 1.34 . . . . 10.0 109.555 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.673 1.189 . . . . 10.0 112.882 172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.98 52.11 4.56 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.78 1.181 . . . . 10.0 110.293 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.57 84.83 8.38 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 127.371 2.268 . . . . 10.0 106.147 -163.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.56 168.55 24.08 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.32 2.68 . . . . 10.0 109.253 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.0 -45.68 0.28 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.482 1.913 . . . . 10.0 112.06 -164.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.81 -53.17 12.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.745 2.018 . . . . 10.0 110.556 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.81 76.41 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.349 1.459 . . . . 10.0 110.91 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.52 61.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.63 -16.86 27.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.793 1.637 . . . . 10.0 112.118 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.73 -67.25 0.41 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 120.064 1.302 . . . . 10.0 112.557 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.23 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.066 1.774 . . . . 10.0 114.431 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.85 -43.2 68.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.83 1.195 . . . . 10.0 108.774 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.16 -28.56 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 t -46.35 -60.42 3.68 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.668 1.187 . . . . 10.0 109.492 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.79 -35.42 79.18 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 CA-C-N 120.244 1.123 . . . . 10.0 112.908 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.18 -51.67 68.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.422 0.689 . . . . 10.0 110.362 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -58.92 -39.08 80.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.128 0.489 . . . . 10.0 110.291 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.52 64.61 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.15 -0.969 . . . . 10.0 111.441 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.08 39.81 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.563 1.145 . . . . 10.0 112.834 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.93 151.28 74.72 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 119.52 1.055 . . . . 10.0 110.982 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.13 169.67 21.59 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.985 3.124 . . . . 10.0 110.537 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.05 -4.19 4.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.969 1.308 . . . . 10.0 113.461 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.72 8.46 43.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.706 1.602 . . . . 10.0 110.6 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.56 165.56 29.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 121.213 -0.929 . . . . 10.0 108.798 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -146.63 135.79 22.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.573 -1.194 . . . . 10.0 108.458 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.87 136.81 52.47 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 t -140.02 139.57 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.022 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -106.33 120.2 41.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.044 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG11 ' A' ' 30' ' ' VAL . 10.8 mt -118.23 136.45 23.93 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.73 154.64 26.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.502 2.135 . . . . 10.0 112.307 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.78 96.74 7.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.247 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.41 76.77 8.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.757 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.55 20.23 1.15 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.204 1.557 . . . . 10.0 115.204 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.04 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.863 -1.773 . . . . 10.0 112.827 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.54 -152.11 1.58 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.351 0.977 . . . . 10.0 110.759 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.201 1.0 . . . . 10.0 112.002 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.36 -27.44 6.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.123 1.769 . . . . 10.0 113.346 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.96 -36.4 64.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 119.589 1.086 . . . . 10.0 110.498 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.8 -55.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.031 -1.1 . . . . 10.0 108.031 174.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.532 3.133 . . . . 10.0 112.182 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.12 -42.56 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 125.405 1.479 . . . . 10.0 111.296 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.5 -41.86 70.09 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.768 -1.11 . . . . 10.0 112.499 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.5 -44.33 8.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 114.137 1.162 . . . . 10.0 114.137 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.84 -45.77 92.38 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.514 0.597 . . . . 10.0 110.3 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.2 mt -61.39 -45.26 95.1 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 116.744 -1.598 . . . . 10.0 109.209 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -45.7 91.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.652 1.569 . . . . 10.0 110.771 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.005 1.722 . . . . 10.0 109.474 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.66 -29.03 66.4 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 118.955 -0.545 . . . . 10.0 111.767 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.22 49.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.325 1.05 . . . . 10.0 110.748 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 31.0 mtp -75.77 -22.49 56.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.644 -0.693 . . . . 10.0 111.632 -170.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.32 14.54 61.87 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.914 0.768 . . . . 10.0 112.985 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.39 130.28 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.012 1.325 . . . . 10.0 109.272 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.56 76.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.955 -0.758 . . . . 10.0 108.955 -165.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.35 -5.33 54.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.092 2.256 . . . . 10.0 117.092 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 44.35 51.99 7.45 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.284 1.833 . . . . 10.0 112.11 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.97 -47.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.448 -1.263 . . . . 10.0 113.364 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.85 34.81 1.29 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.627 1.558 . . . . 10.0 113.159 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.46 0.62 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 120.835 -1.165 . . . . 10.0 108.898 172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.51 45.49 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.542 1.312 . . . . 10.0 114.542 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.42 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 117.67 -1.157 . . . . 10.0 108.756 166.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.48 -46.93 73.5 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.378 1.444 . . . . 10.0 112.033 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.32 -40.65 82.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.473 1.509 . . . . 10.0 110.194 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.07 4.51 5.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.808 1.643 . . . . 10.0 112.899 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.31 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.3 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.683 0.793 . . . . 10.0 112.615 -173.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.33 -21.16 64.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.149 0.886 . . . . 10.0 112.171 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.48 -53.46 3.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.519 1.127 . . . . 10.0 108.781 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.43 88.07 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.541 1.536 . . . . 10.0 110.626 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.39 13.83 15.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.395 1.078 . . . . 10.0 113.267 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.91 -64.24 0.36 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 128.206 2.602 . . . . 10.0 109.591 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.46 44.63 28.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.734 1.614 . . . . 10.0 112.534 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.63 20.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.228 1.411 . . . . 10.0 114.179 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 155.25 28.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.944 2.498 . . . . 10.0 107.676 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.1 -45.01 10.96 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.525 2.15 . . . . 10.0 109.955 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.22 67.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.193 0.997 . . . . 10.0 111.212 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.13 70.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.02 1.328 . . . . 10.0 110.327 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.51 18.07 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.211 1.004 . . . . 10.0 108.93 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.09 84.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.405 0.441 . . . . 10.0 111.367 -172.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.09 -46.94 78.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.307 1.443 . . . . 10.0 112.536 172.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.7 t80 -74.2 -41.78 60.87 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.597 0.759 . . . . 10.0 111.406 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.86 -14.79 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.35 -0.844 . . . . 10.0 110.39 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.39 -41.79 29.97 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.801 0.84 . . . . 10.0 110.18 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.0 10.12 54.13 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 117.931 -1.483 . . . . 10.0 114.846 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.38 8.84 6.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.367 2.583 . . . . 10.0 112.615 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.25 4.13 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.672 -1.371 . . . . 10.0 109.672 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.49 132.94 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.134 -2.173 . . . . 10.0 105.134 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.41 133.72 35.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.608 0.763 . . . . 10.0 109.915 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.96 85.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.8 -0.619 . . . . 10.0 110.406 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.96 -26.86 67.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.748 0.704 . . . . 10.0 111.719 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.69 -57.03 4.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.378 -1.712 . . . . 10.0 106.378 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.87 -59.51 4.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.85 1.26 . . . . 10.0 112.164 -166.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.55 -33.67 64.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.5 m -62.28 -49.43 75.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.327 -0.62 . . . . 10.0 109.327 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.73 -41.33 92.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.645 1.178 . . . . 10.0 110.237 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.694 1.133 . . . . 10.0 110.883 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.682 0.793 . . . . 10.0 111.178 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.392 1.477 . . . . 10.0 111.716 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.1 -40.44 86.92 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.911 1.284 . . . . 10.0 110.523 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.9 54.69 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.754 0.822 . . . . 10.0 110.484 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.48 -38.8 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.158 0.983 . . . . 10.0 111.274 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.28 63.73 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.002 0.921 . . . . 10.0 110.99 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.34 19.88 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.861 -0.896 . . . . 10.0 110.861 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.38 -36.21 82.96 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.712 -0.875 . . . . 10.0 109.583 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.36 77.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.767 -1.111 . . . . 10.0 111.517 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -94.95 -15.05 23.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.607 0.639 . . . . 10.0 112.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 72.3 mmtt -86.9 -47.25 9.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 10.0 110.845 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.79 -9.4 59.01 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.11 -42.47 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.684 0.278 . . . . 10.0 110.989 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -19.45 57.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 68.8 mt . . . . . 0 C--O 1.227 -0.094 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.118 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.852 0.358 . . . . 10.0 111.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.29 -43.87 80.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.664 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.08 5.05 1.77 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.142 1.777 . . . . 10.0 113.477 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 54.38 36.77 26.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.875 2.07 . . . . 10.0 112.142 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.1 t -69.39 135.04 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.682 -1.229 . . . . 10.0 107.682 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.2 -16.14 4.05 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.766 2.026 . . . . 10.0 110.31 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.91 33.64 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.968 1.747 . . . . 10.0 112.769 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.51 152.99 61.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 127.216 2.206 . . . . 10.0 108.283 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.65 71.41 Favored 'Cis proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.646 -0.981 . . . . 10.0 113.07 -6.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.1 m -145.86 144.3 30.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.331 1.452 . . . . 10.0 108.59 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.94 158.38 32.14 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.792 1.637 . . . . 10.0 108.211 163.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.08 136.41 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.943 -1.502 . . . . 10.0 106.943 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.4 t -104.05 135.21 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.054 -1.462 . . . . 10.0 107.054 168.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.0 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.132 4.573 . . . . 10.0 117.582 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.1 60.58 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.844 -1.531 . . . . 10.0 115.568 -170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.85 -41.26 1.04 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.931 1.866 . . . . 10.0 114.348 -170.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.76 107.61 16.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 -171.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.97 113.4 24.46 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.522 1.929 . . . . 10.0 106.8 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.51 169.57 17.48 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 120.408 -1.433 . . . . 10.0 107.141 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.95 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.587 0.355 . . . . 10.0 110.11 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.34 -50.01 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 128.466 2.707 . . . . 10.0 107.764 160.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.56 4.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.881 1.705 . . . . 10.0 114.429 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.28 -51.2 1.3 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.724 1.262 . . . . 10.0 109.667 168.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.66 72.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.102 1.361 . . . . 10.0 112.202 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.64 -5.92 9.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.796 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.31 35.23 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.693 1.747 . . . . 10.0 109.96 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.93 -52.57 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.359 2.039 . . . . 10.0 111.758 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.46 -28.58 69.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.977 -1.077 . . . . 10.0 111.486 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.45 -27.1 66.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.101 0.56 . . . . 10.0 110.392 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.96 32.67 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.959 -1.088 . . . . 10.0 110.904 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.7 -31.88 73.19 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.922 0.783 . . . . 10.0 111.026 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.51 -56.4 8.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.557 1.943 . . . . 10.0 108.075 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.54 -41.36 93.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 116.883 -1.532 . . . . 10.0 111.494 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.75 -48.73 69.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.985 1.721 . . . . 10.0 111.728 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.05 65.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.975 0.51 . . . . 10.0 110.613 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.57 -42.47 96.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.592 0.757 . . . . 10.0 111.263 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.27 -37.32 83.27 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 120.946 -1.096 . . . . 10.0 111.236 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.3 -51.87 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.28 0.945 . . . . 10.0 108.654 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.08 63.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.573 1.149 . . . . 10.0 110.016 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.71 -0.34 33.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.08 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.33 9.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.671 1.589 . . . . 10.0 114.42 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.74 4.99 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.33 -1.359 . . . . 10.0 107.33 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.37 -20.3 66.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.743 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 130.183 3.393 . . . . 10.0 113.639 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.21 13.45 35.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.667 1.187 . . . . 10.0 113.114 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.87 0.27 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.903 2.081 . . . . 10.0 109.799 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.079 1.751 . . . . 10.0 108.805 -179.276 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.293 0 N-CA-C 109.154 -1.578 . . . . 10.0 109.154 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.71 0.15 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.116 2.166 . . . . 10.0 110.357 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.01 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.081 2.153 . . . . 10.0 113.029 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.46 157.69 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.013 1.725 . . . . 10.0 108.047 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.19 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.7 148.45 49.23 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.63 52.08 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.702 1.144 . . . . 10.0 113.437 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 -63.04 0.98 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.788 1.794 . . . . 10.0 107.817 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.44 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.5 mp0 -98.42 -25.95 14.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.405 1.482 . . . . 10.0 110.506 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.58 167.06 31.38 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.254 -0.904 . . . . 10.0 111.687 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.86 115.91 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.848 1.259 . . . . 10.0 109.054 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.39 20.27 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 119.895 -1.753 . . . . 10.0 110.479 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.56 40.64 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.254 1.022 . . . . 10.0 108.83 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.29 -9.47 41.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.794 0.838 . . . . 10.0 113.19 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 m -129.27 74.4 81.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.163 0.985 . . . . 10.0 108.646 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.58 -179.07 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 125.073 3.849 . . . . 10.0 112.221 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.61 138.88 34.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.698 1.199 . . . . 10.0 107.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -73.01 179.1 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.481 2.121 . . . . 10.0 112.598 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.5 168.27 20.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.804 2.042 . . . . 10.0 108.937 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.809 2.044 . . . . 10.0 110.488 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.83 165.4 21.08 Favored Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 127.315 2.246 . . . . 10.0 105.359 163.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.89 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.55 2.167 . . . . 10.0 110.24 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.58 2.43 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 106.338 -2.705 . . . . 10.0 106.338 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.53 133.71 46.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.116 0.966 . . . . 10.0 108.718 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.25 139.2 35.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.521 -1.288 . . . . 10.0 107.521 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.0 t -128.57 130.39 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.15 108.1 14.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 -172.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.01 143.36 54.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.271 1.028 . . . . 10.0 108.533 162.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.72 131.12 53.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 158.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.37 176.81 7.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.417 1.087 . . . . 10.0 110.398 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.82 11.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.098 1.359 . . . . 10.0 109.511 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.51 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.607 1.163 . . . . 10.0 112.879 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.89 51.99 4.53 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.775 1.178 . . . . 10.0 110.38 -171.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.45 84.8 8.13 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 127.457 2.303 . . . . 10.0 106.098 -163.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.58 23.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.308 2.672 . . . . 10.0 109.253 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.476 1.911 . . . . 10.0 112.083 -165.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.78 -53.14 12.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.704 2.001 . . . . 10.0 110.572 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.91 -49.9 76.05 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.327 1.451 . . . . 10.0 110.884 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -13.47 61.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.713 0.635 . . . . 10.0 112.713 -171.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.74 -16.76 27.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.722 1.609 . . . . 10.0 112.118 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.24 0.41 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.094 1.315 . . . . 10.0 112.593 -172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.04 -9.2 25.7 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.988 1.746 . . . . 10.0 114.403 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.87 -43.15 69.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.797 1.18 . . . . 10.0 108.813 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.27 -28.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 -164.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 t -46.46 -60.35 3.82 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.711 1.205 . . . . 10.0 109.471 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.77 -35.42 79.4 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.272 1.133 . . . . 10.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.9 t90 -57.17 -51.66 68.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.418 0.687 . . . . 10.0 110.367 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.94 -39.13 80.68 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.182 0.515 . . . . 10.0 110.258 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.94 -25.54 64.62 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.117 -0.99 . . . . 10.0 111.418 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.68 10.05 39.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.568 1.147 . . . . 10.0 112.897 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.7 mt -60.97 151.26 75.17 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-N 119.513 1.051 . . . . 10.0 110.922 174.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.13 169.71 21.52 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 124.042 3.161 . . . . 10.0 110.471 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.11 -4.26 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.004 1.322 . . . . 10.0 113.397 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.58 8.35 43.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.744 1.618 . . . . 10.0 110.653 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.48 164.71 31.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 O-C-N 121.161 -0.962 . . . . 10.0 108.834 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -145.98 134.65 22.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.534 -1.212 . . . . 10.0 108.448 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -114.48 135.52 54.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.854 0.359 . . . . 10.0 111.621 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.71 138.91 41.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 10.0 109.685 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -104.91 118.5 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.49 HD12 HG11 ' A' ' 30' ' ' VAL . 15.8 mt -118.75 138.51 26.03 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 112.726 0.639 . . . . 10.0 112.726 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.28 152.86 24.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.933 2.422 . . . . 10.0 112.188 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 97.47 8.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.391 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.88 76.79 8.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.389 -0.369 . . . . 10.0 111.861 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.53 20.16 1.15 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.165 1.542 . . . . 10.0 115.165 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.11 3.42 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 119.939 -1.725 . . . . 10.0 112.793 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.53 -152.08 1.57 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.327 0.965 . . . . 10.0 110.779 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.84 -30.81 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.077 0.951 . . . . 10.0 112.047 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.38 -27.43 6.33 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.079 1.752 . . . . 10.0 113.327 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.95 -36.35 64.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.656 1.116 . . . . 10.0 110.515 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.9 -55.1 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.93 31.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.545 3.138 . . . . 10.0 112.186 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.16 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.33 1.443 . . . . 10.0 111.217 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.57 -41.82 70.3 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.476 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.33 8.46 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 114.181 1.178 . . . . 10.0 114.181 -173.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.85 -45.78 92.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 123.639 0.587 . . . . 10.0 110.241 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -45.24 95.17 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 116.7 -1.619 . . . . 10.0 109.197 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -45.6 92.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.61 1.55 . . . . 10.0 110.778 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -60.59 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.082 1.753 . . . . 10.0 109.415 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.71 -29.0 66.29 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.796 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.16 48.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.365 1.066 . . . . 10.0 110.703 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.9 -22.42 56.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.663 -170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.44 61.9 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.867 0.746 . . . . 10.0 112.97 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.31 130.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 124.929 1.292 . . . . 10.0 109.337 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.55 75.95 1.37 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.47 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.091 2.256 . . . . 10.0 117.091 -170.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 52.0 7.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.329 1.852 . . . . 10.0 112.086 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.93 -47.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 117.452 -1.261 . . . . 10.0 113.403 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.83 1.31 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.57 1.532 . . . . 10.0 113.084 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.4 -44.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.447 0 O-C-N 120.762 -1.211 . . . . 10.0 108.891 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.55 45.41 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.56 1.318 . . . . 10.0 114.56 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.43 -65.64 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 117.601 -1.19 . . . . 10.0 108.671 166.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.53 -46.81 73.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.324 1.42 . . . . 10.0 112.025 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.56 82.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.479 1.511 . . . . 10.0 110.182 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.22 4.57 5.5 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.774 1.63 . . . . 10.0 112.867 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.28 2.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.706 0.803 . . . . 10.0 112.635 -173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.19 64.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.112 0.869 . . . . 10.0 112.171 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.47 3.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.557 1.143 . . . . 10.0 108.79 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.4 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.544 1.538 . . . . 10.0 110.666 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.25 13.74 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.362 1.065 . . . . 10.0 113.34 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.03 -64.27 0.36 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 128.166 2.586 . . . . 10.0 109.57 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.4 mt 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.73 1.612 . . . . 10.0 112.522 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.49 20.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.282 1.433 . . . . 10.0 114.192 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.07 155.41 29.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 127.888 2.475 . . . . 10.0 107.643 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.18 -44.96 10.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.532 2.155 . . . . 10.0 110.012 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.34 67.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.259 1.024 . . . . 10.0 111.19 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.08 70.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.965 1.306 . . . . 10.0 110.344 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.56 17.91 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.16 0.984 . . . . 10.0 108.875 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.19 -37.25 84.57 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 122.761 0.425 . . . . 10.0 111.36 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.86 78.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.279 1.432 . . . . 10.0 112.605 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.69 60.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.609 0.763 . . . . 10.0 111.423 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.376 -0.827 . . . . 10.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.46 -41.73 30.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.788 0.835 . . . . 10.0 110.15 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.08 54.46 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.953 -1.471 . . . . 10.0 114.811 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.33 8.87 6.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.394 2.597 . . . . 10.0 112.604 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.9 49.26 4.12 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.678 -1.369 . . . . 10.0 109.678 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.53 132.89 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.167 -2.16 . . . . 10.0 105.167 169.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.66 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.666 0.786 . . . . 10.0 110.03 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.804 -0.617 . . . . 10.0 110.416 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.14 -26.73 66.81 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.682 0.674 . . . . 10.0 111.706 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.09 4.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.359 -1.719 . . . . 10.0 106.359 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.9 -59.44 4.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.819 1.248 . . . . 10.0 112.169 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.56 -33.7 64.8 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.254 -0.276 . . . . 10.0 110.254 -170.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.25 -49.48 75.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.38 92.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.592 1.157 . . . . 10.0 110.23 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.1 -48.77 44.17 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 119.701 1.137 . . . . 10.0 110.845 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.9 1.02 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.637 0.775 . . . . 10.0 111.181 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.3 8.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.387 1.475 . . . . 10.0 111.69 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.13 -40.4 86.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.262 . . . . 10.0 110.487 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.82 54.94 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.718 0.807 . . . . 10.0 110.505 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.4 mm -69.57 -38.78 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.23 1.012 . . . . 10.0 111.268 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.26 63.78 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.002 0.921 . . . . 10.0 110.963 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.39 19.59 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.837 -0.905 . . . . 10.0 110.837 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.07 82.52 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.762 -0.846 . . . . 10.0 109.611 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.0 76.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.771 -1.109 . . . . 10.0 111.495 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.69 -2.24 35.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.557 0.617 . . . . 10.0 111.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -93.48 -48.32 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.622 0.248 . . . . 10.0 110.953 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.65 58.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.407 . . . . 10.0 111.793 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 66' ' ' LEU . 11.3 tmtt? -79.17 -45.05 20.7 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.818 0.342 . . . . 10.0 110.597 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -18.64 60.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.004 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.72 -40.23 63.72 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.146 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.19 79.06 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.055 0.391 . . . . 10.0 112.055 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.44 -30.03 66.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.366 -0.379 . . . . 10.0 111.511 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.86 79.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.649 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 4.97 1.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.1 1.76 . . . . 10.0 113.545 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.45 36.8 26.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.888 2.075 . . . . 10.0 112.077 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.7 t -69.37 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.679 -1.23 . . . . 10.0 107.679 172.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.13 4.05 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.757 2.023 . . . . 10.0 110.316 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.32 -170.83 33.52 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.933 1.73 . . . . 10.0 112.777 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.53 153.0 61.54 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 127.286 2.234 . . . . 10.0 108.304 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.58 152.7 71.59 Favored 'Cis proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.6 -1.0 . . . . 10.0 113.087 -6.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.0 m -145.89 144.24 30.07 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.264 1.425 . . . . 10.0 108.537 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.98 158.4 32.15 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.77 1.628 . . . . 10.0 108.174 163.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.05 135.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.04 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 1 C-N-CA 133.17 4.588 . . . . 10.0 117.552 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.19 60.38 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.807 -1.552 . . . . 10.0 115.526 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.88 -41.27 1.04 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.967 1.883 . . . . 10.0 114.349 -170.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.77 107.55 16.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.98 113.45 24.52 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 126.528 1.931 . . . . 10.0 106.738 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.57 169.62 17.41 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.333 -1.479 . . . . 10.0 107.154 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.94 -178.8 1.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.631 0.373 . . . . 10.0 110.191 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.27 -50.16 5.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 128.527 2.731 . . . . 10.0 107.715 160.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.07 16.53 4.45 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.856 1.693 . . . . 10.0 114.435 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.32 -51.11 1.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.735 1.267 . . . . 10.0 109.628 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.56 72.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.076 1.351 . . . . 10.0 112.251 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.57 -5.88 9.89 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.443 -1.199 . . . . 10.0 114.752 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.85 174.32 35.22 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.71 1.755 . . . . 10.0 109.93 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.98 -52.53 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.397 2.065 . . . . 10.0 111.752 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.31 -28.71 69.92 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.965 -1.084 . . . . 10.0 111.526 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.39 -27.24 66.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.144 0.578 . . . . 10.0 110.333 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.65 -42.84 33.36 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.051 -1.031 . . . . 10.0 110.961 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.83 -31.82 73.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.923 0.783 . . . . 10.0 111.014 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.49 -56.4 8.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.59 1.956 . . . . 10.0 108.076 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.32 93.1 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 116.928 -1.51 . . . . 10.0 111.542 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.72 69.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.931 1.696 . . . . 10.0 111.698 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.07 65.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.905 0.482 . . . . 10.0 110.637 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.48 -42.61 96.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.605 0.762 . . . . 10.0 111.272 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.1 mt -67.04 -37.42 84.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.881 -1.137 . . . . 10.0 111.278 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.28 -51.93 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 119.239 0.927 . . . . 10.0 108.574 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.01 -43.08 63.49 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.573 1.149 . . . . 10.0 110.021 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.65 -0.32 33.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.144 -175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.32 9.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.672 1.589 . . . . 10.0 114.461 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -55.75 4.98 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.37 -1.344 . . . . 10.0 107.37 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.28 -20.34 66.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.121 -0.945 . . . . 10.0 111.811 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.73 -35.46 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 130.087 3.355 . . . . 10.0 113.712 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.17 13.48 34.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.701 1.2 . . . . 10.0 113.145 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.82 0.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.92 2.088 . . . . 10.0 109.823 -163.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.058 1.743 . . . . 10.0 108.788 -179.276 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.234 -1.546 . . . . 10.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.23 73.64 0.16 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.046 2.138 . . . . 10.0 110.379 -175.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.25 11.97 0.65 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.429 -2.169 . . . . 10.0 113.011 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -146.41 157.74 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.033 1.733 . . . . 10.0 108.052 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 m -131.25 132.8 44.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.47 49.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.56 51.91 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.632 1.11 . . . . 10.0 113.432 -167.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.09 0.98 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 119.863 1.832 . . . . 10.0 107.727 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.363 1.465 . . . . 10.0 110.488 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.6 167.07 31.36 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.231 -0.918 . . . . 10.0 111.623 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.85 116.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.879 1.272 . . . . 10.0 109.064 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.34 20.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.869 -1.77 . . . . 10.0 110.478 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.56 40.72 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.312 1.045 . . . . 10.0 108.864 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.38 40.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.808 0.843 . . . . 10.0 113.215 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 m -129.3 74.38 81.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.209 1.003 . . . . 10.0 108.62 -176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.62 -179.1 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 125.114 3.876 . . . . 10.0 112.198 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.54 138.87 34.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.732 1.213 . . . . 10.0 107.993 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.09 179.08 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.456 2.104 . . . . 10.0 112.626 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.5 168.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.862 2.065 . . . . 10.0 108.947 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.06 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.778 2.031 . . . . 10.0 110.514 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.77 165.39 21.2 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 10.0 105.388 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.94 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.585 2.19 . . . . 10.0 110.248 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.12 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.343 -2.703 . . . . 10.0 106.343 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.46 133.66 45.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.081 0.952 . . . . 10.0 108.758 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.55 140.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.335 -1.728 . . . . 10.0 106.335 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.3 139.23 35.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.855 -1.905 . . . . 10.0 105.855 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.19 108.13 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 -172.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.07 143.35 54.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.305 1.042 . . . . 10.0 108.515 162.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.69 131.03 53.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 158.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.3 176.77 7.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.438 1.095 . . . . 10.0 110.427 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.05 175.81 11.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.965 1.306 . . . . 10.0 109.479 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.44 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.688 1.195 . . . . 10.0 112.903 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.0 4.53 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.873 1.225 . . . . 10.0 110.379 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.52 84.83 8.3 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 127.427 2.291 . . . . 10.0 106.101 -163.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.56 168.53 24.14 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.365 2.71 . . . . 10.0 109.215 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.03 -45.74 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.538 1.935 . . . . 10.0 112.046 -165.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.82 -53.06 12.81 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.69 1.996 . . . . 10.0 110.618 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.9 76.05 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.368 1.467 . . . . 10.0 110.865 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.44 61.57 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.732 0.642 . . . . 10.0 112.732 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.8 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.709 1.604 . . . . 10.0 112.031 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.83 -67.18 0.41 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 120.124 1.329 . . . . 10.0 112.581 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.94 -9.26 25.84 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 122.141 1.8 . . . . 10.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.21 68.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.795 1.18 . . . . 10.0 108.774 167.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.88 1.067 . . . . 10.0 113.88 -164.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.45 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.799 1.24 . . . . 10.0 109.499 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.88 -35.42 78.17 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.277 1.135 . . . . 10.0 112.928 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.8 t90 -57.11 -51.64 68.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.407 0.683 . . . . 10.0 110.389 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.14 80.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.126 0.489 . . . . 10.0 110.252 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.64 64.67 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.11 -0.993 . . . . 10.0 111.375 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.1 39.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.487 1.115 . . . . 10.0 112.948 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.9 151.23 74.7 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 119.467 1.031 . . . . 10.0 111.002 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.09 169.64 21.67 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.013 3.142 . . . . 10.0 110.505 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 -4.22 4.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.994 1.318 . . . . 10.0 113.452 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.72 8.43 43.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.687 1.595 . . . . 10.0 110.606 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.78 31.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 O-C-N 121.19 -0.944 . . . . 10.0 108.865 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -146.13 134.86 22.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.551 -1.204 . . . . 10.0 108.399 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -114.38 139.9 49.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.869 0.366 . . . . 10.0 111.538 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.45 143.54 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.692 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.368 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 30' ' ' VAL . 16.3 mt -124.21 138.66 31.21 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.66 152.76 22.86 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.069 2.513 . . . . 10.0 112.207 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.67 98.2 9.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.405 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.92 76.75 8.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.13 1.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.11 1.522 . . . . 10.0 115.11 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.14 3.42 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 119.97 -1.706 . . . . 10.0 112.824 168.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.02 1.52 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.335 0.969 . . . . 10.0 110.766 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.96 -30.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.14 0.976 . . . . 10.0 111.976 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.32 -27.54 6.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.103 1.761 . . . . 10.0 113.331 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.86 -36.4 64.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.679 1.127 . . . . 10.0 110.501 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.95 -55.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.923 -1.14 . . . . 10.0 107.923 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.84 31.89 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.495 3.118 . . . . 10.0 112.257 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.14 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 125.314 1.435 . . . . 10.0 111.173 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.44 -41.95 70.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.81 -1.091 . . . . 10.0 112.463 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.45 8.37 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -173.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.77 -45.8 92.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.639 0.587 . . . . 10.0 110.3 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.39 -45.23 95.23 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.738 -1.601 . . . . 10.0 109.226 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.65 92.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.611 1.55 . . . . 10.0 110.874 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.977 1.711 . . . . 10.0 109.48 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.75 -28.95 66.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 118.922 -0.561 . . . . 10.0 111.768 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.19 49.72 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.38 1.072 . . . . 10.0 110.655 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.79 -22.56 56.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.621 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.43 61.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.82 0.724 . . . . 10.0 112.871 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.34 130.26 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.973 1.309 . . . . 10.0 109.313 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.5 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 -165.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.52 54.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.118 2.266 . . . . 10.0 117.118 -170.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.42 52.03 7.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.348 1.859 . . . . 10.0 112.064 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.04 -47.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 117.444 -1.265 . . . . 10.0 113.355 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.95 34.8 1.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.628 1.558 . . . . 10.0 113.079 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.56 0.62 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 120.758 -1.214 . . . . 10.0 108.845 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.49 44.89 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.547 1.314 . . . . 10.0 114.547 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.49 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.549 -1.215 . . . . 10.0 108.661 166.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.57 -46.83 73.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.397 1.453 . . . . 10.0 112.031 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.43 -40.66 83.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.433 1.493 . . . . 10.0 110.135 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.06 4.5 5.43 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.683 1.593 . . . . 10.0 112.888 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.22 -57.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.0 -2.222 . . . . 10.0 105.0 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.56 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.664 0.786 . . . . 10.0 112.716 -173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.31 -21.22 64.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.099 0.863 . . . . 10.0 112.199 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.49 3.9 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.535 1.134 . . . . 10.0 108.81 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 58.42 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.517 1.527 . . . . 10.0 110.695 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.31 13.71 15.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.357 1.063 . . . . 10.0 113.28 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.95 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 128.223 2.609 . . . . 10.0 109.546 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.0 mt 54.52 44.61 28.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.729 1.612 . . . . 10.0 112.542 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.75 14.59 20.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.299 1.44 . . . . 10.0 114.154 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.045 2.538 . . . . 10.0 107.704 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.16 -45.0 10.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.539 2.16 . . . . 10.0 109.973 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.03 -29.34 67.47 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.263 1.025 . . . . 10.0 111.119 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.52 -42.16 70.5 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.022 1.329 . . . . 10.0 110.292 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.5 18.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.169 0.988 . . . . 10.0 108.877 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 123.387 0.43 . . . . 10.0 111.369 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.12 -46.83 79.0 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.262 1.425 . . . . 10.0 112.569 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.3 -41.59 60.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.6 0.76 . . . . 10.0 111.439 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.99 -14.8 59.8 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.357 -0.839 . . . . 10.0 110.384 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 -41.85 30.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.827 0.851 . . . . 10.0 110.114 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.15 53.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.944 -1.475 . . . . 10.0 114.883 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.39 8.85 6.56 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.333 2.567 . . . . 10.0 112.625 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 49.3 4.12 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.67 -1.372 . . . . 10.0 109.67 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.6 132.94 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.144 -2.169 . . . . 10.0 105.144 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.69 35.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.673 0.789 . . . . 10.0 110.009 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.59 -37.01 86.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.788 -0.625 . . . . 10.0 110.352 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.04 -26.75 66.92 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.707 0.685 . . . . 10.0 111.772 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.07 4.01 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.36 -1.719 . . . . 10.0 106.36 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.94 -59.42 4.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.821 1.249 . . . . 10.0 112.154 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.58 -33.73 64.77 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.205 -0.294 . . . . 10.0 110.205 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -62.27 -49.41 75.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.284 -0.636 . . . . 10.0 109.284 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.76 -41.29 92.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.524 1.13 . . . . 10.0 110.216 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.21 -48.71 45.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.686 1.13 . . . . 10.0 110.773 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.63 38.82 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.709 0.804 . . . . 10.0 111.147 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.28 8.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.426 1.49 . . . . 10.0 111.701 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.08 -40.41 87.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.842 1.257 . . . . 10.0 110.54 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.85 55.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.695 0.798 . . . . 10.0 110.495 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.6 mm -69.49 -38.77 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.224 1.009 . . . . 10.0 111.322 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.28 63.8 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 10.0 111.018 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.39 19.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.16 82.79 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.806 -0.82 . . . . 10.0 109.569 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.34 -33.64 75.97 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.749 -1.119 . . . . 10.0 111.527 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.67 -0.89 33.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.592 0.633 . . . . 10.0 112.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.37 -48.41 5.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.701 0.286 . . . . 10.0 110.709 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.86 -5.98 59.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.815 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.5 tmtt? -81.35 -43.81 18.51 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.874 0.369 . . . . 10.0 110.891 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -17.77 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 69.3 mt -75.89 -38.55 57.71 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.96 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.26 80.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.6 mtm -71.2 -29.2 64.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.91 81.12 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.595 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -69.97 5.0 1.74 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.175 1.79 . . . . 10.0 113.539 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 54.37 36.81 26.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.877 2.071 . . . . 10.0 112.146 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 32' ' ' LEU . 90.5 t -69.37 135.13 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.717 -1.216 . . . . 10.0 107.717 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.37 -16.09 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.717 2.007 . . . . 10.0 110.254 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.88 33.61 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.954 1.74 . . . . 10.0 112.821 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 152.99 61.76 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.262 2.225 . . . . 10.0 108.359 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.59 152.65 71.56 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.592 -1.003 . . . . 10.0 113.078 -6.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.7 m -145.86 144.22 30.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 125.294 1.438 . . . . 10.0 108.562 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.93 158.35 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.847 1.659 . . . . 10.0 108.208 163.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.06 136.53 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.955 -1.498 . . . . 10.0 106.955 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.2 t -104.07 135.13 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.1 10.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 133.159 4.584 . . . . 10.0 117.542 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.6 20.19 60.47 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.806 -1.552 . . . . 10.0 115.601 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -131.88 -41.28 1.04 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.916 1.858 . . . . 10.0 114.38 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.81 107.53 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.99 113.39 24.46 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 126.506 1.922 . . . . 10.0 106.808 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.45 169.65 17.34 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 120.393 -1.442 . . . . 10.0 107.172 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.84 1.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.617 0.367 . . . . 10.0 110.123 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.31 -50.09 5.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 128.469 2.708 . . . . 10.0 107.771 160.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.08 16.56 4.44 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.946 1.736 . . . . 10.0 114.368 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.38 -51.16 1.29 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.814 1.307 . . . . 10.0 109.609 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.62 72.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.143 1.377 . . . . 10.0 112.274 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 118.529 -1.151 . . . . 10.0 114.73 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.3 35.22 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.738 1.769 . . . . 10.0 110.015 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.437 2.092 . . . . 10.0 111.72 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.33 -28.65 69.89 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.904 -1.122 . . . . 10.0 111.523 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.15 66.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.058 0.543 . . . . 10.0 110.333 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.67 -43.01 32.65 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.062 -1.024 . . . . 10.0 110.905 -169.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.91 73.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.889 0.768 . . . . 10.0 111.076 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.5 8.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.65 1.98 . . . . 10.0 108.018 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.56 -41.29 93.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 116.959 -1.496 . . . . 10.0 111.538 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 120.946 1.703 . . . . 10.0 111.74 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.49 -47.12 64.89 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.898 0.479 . . . . 10.0 110.635 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.46 -42.55 96.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.616 0.767 . . . . 10.0 111.251 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.45 83.97 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 120.917 -1.114 . . . . 10.0 111.257 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.0 mt -58.15 -51.98 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.217 0.917 . . . . 10.0 108.647 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.05 -43.03 63.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.483 1.113 . . . . 10.0 110.018 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.69 -0.36 33.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.12 -1.419 . . . . 10.0 113.072 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.14 -33.26 9.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.618 1.567 . . . . 10.0 114.458 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -55.69 5.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.413 -1.329 . . . . 10.0 107.413 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.38 66.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.177 -0.919 . . . . 10.0 111.738 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.053 3.341 . . . . 10.0 113.741 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.19 13.51 34.9 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.677 1.191 . . . . 10.0 113.113 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.35 76.84 0.27 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.895 2.078 . . . . 10.0 109.816 -163.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.135 1.774 . . . . 10.0 108.822 -179.291 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.166 -1.573 . . . . 10.0 109.166 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.18 73.72 0.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 127.088 2.155 . . . . 10.0 110.359 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.38 12.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.094 2.158 . . . . 10.0 112.981 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.46 157.72 43.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.029 1.731 . . . . 10.0 108.086 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m -131.2 132.79 44.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.63 148.37 49.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.186 -1.042 . . . . 10.0 108.186 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.68 52.35 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.731 1.158 . . . . 10.0 113.415 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -63.07 0.98 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.825 1.813 . . . . 10.0 107.854 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.9 14.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.369 1.467 . . . . 10.0 110.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.1 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.242 -0.911 . . . . 10.0 111.718 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.95 115.98 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.819 1.248 . . . . 10.0 108.99 -171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -80.43 167.39 20.24 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 119.963 -1.71 . . . . 10.0 110.489 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.24 124.61 40.79 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.309 1.044 . . . . 10.0 108.839 172.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.42 41.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.806 0.842 . . . . 10.0 113.176 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.198 0.999 . . . . 10.0 108.664 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.63 -179.11 2.63 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.987 3.792 . . . . 10.0 112.235 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 138.91 34.1 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.723 1.209 . . . . 10.0 107.948 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.99 179.12 5.67 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.453 2.102 . . . . 10.0 112.643 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.51 168.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.824 2.049 . . . . 10.0 108.946 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 m -47.08 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.855 2.062 . . . . 10.0 110.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.35 21.34 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 127.385 2.274 . . . . 10.0 105.433 163.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.83 -164.73 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.676 2.25 . . . . 10.0 110.248 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.6 2.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.71 45.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.138 0.975 . . . . 10.0 108.706 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.66 140.78 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 169.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.24 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.523 -1.288 . . . . 10.0 107.523 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.59 130.32 68.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.89 -1.892 . . . . 10.0 105.89 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.09 108.12 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.06 143.42 54.26 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.292 1.037 . . . . 10.0 108.516 162.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.84 131.11 53.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 158.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.31 176.81 7.14 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.465 1.106 . . . . 10.0 110.472 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.84 11.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.063 1.345 . . . . 10.0 109.498 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.53 -73.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.63 1.172 . . . . 10.0 112.905 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.99 52.0 4.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.76 1.171 . . . . 10.0 110.376 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.46 84.77 8.12 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 127.452 2.301 . . . . 10.0 106.118 -163.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.51 24.18 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.306 2.671 . . . . 10.0 109.234 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.07 -45.73 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.409 1.883 . . . . 10.0 112.064 -165.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.09 12.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.774 2.029 . . . . 10.0 110.564 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.9 -49.93 75.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.36 1.464 . . . . 10.0 110.888 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.78 -13.52 61.55 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.744 0.646 . . . . 10.0 112.744 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.69 -16.82 27.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.712 1.605 . . . . 10.0 112.038 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 120.122 1.328 . . . . 10.0 112.576 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.03 -9.22 25.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 CA-C-N 122.063 1.773 . . . . 10.0 114.358 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.22 69.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.832 1.196 . . . . 10.0 108.829 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.18 -28.47 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.825 1.046 . . . . 10.0 113.825 -164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -46.48 -60.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.713 1.205 . . . . 10.0 109.448 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.38 79.04 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-N 120.299 1.142 . . . . 10.0 113.004 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.9 t90 -57.17 -51.6 68.65 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.322 0.649 . . . . 10.0 110.421 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.24 80.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.186 0.517 . . . . 10.0 110.211 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.55 64.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.1 -1.0 . . . . 10.0 111.427 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.02 39.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.563 1.145 . . . . 10.0 112.862 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.91 151.26 74.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 119.52 1.054 . . . . 10.0 111.029 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.14 169.68 21.57 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.067 3.178 . . . . 10.0 110.419 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 -4.24 4.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.044 1.338 . . . . 10.0 113.473 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.67 8.38 43.39 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.737 1.615 . . . . 10.0 110.642 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.45 164.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 121.212 -0.93 . . . . 10.0 108.824 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -145.56 135.75 23.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.445 -1.252 . . . . 10.0 108.335 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -115.46 134.57 54.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.904 0.383 . . . . 10.0 111.573 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.64 140.42 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.548 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.0 mtt85 -107.74 123.36 48.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.298 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 63' ' ' LEU . 19.7 mt -124.99 138.76 32.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 112.916 0.71 . . . . 10.0 112.916 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.27 152.95 24.13 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.06 2.507 . . . . 10.0 112.339 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.68 98.47 9.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.369 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.92 76.76 8.61 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.791 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.62 20.28 1.15 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.07 -48.1 3.42 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 119.879 -1.763 . . . . 10.0 112.808 168.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.13 1.55 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.316 0.96 . . . . 10.0 110.74 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.071 0.948 . . . . 10.0 112.089 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.3 -27.52 6.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.098 1.759 . . . . 10.0 113.319 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.9 -36.39 64.74 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 119.693 1.133 . . . . 10.0 110.513 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.88 -55.21 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.93 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.459 3.104 . . . . 10.0 112.193 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.2 -42.46 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 125.346 1.451 . . . . 10.0 111.26 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.65 -41.77 70.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.774 -1.108 . . . . 10.0 112.462 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -44.33 8.52 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.91 -45.69 92.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.639 0.587 . . . . 10.0 110.275 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.34 -45.33 94.84 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 116.784 -1.579 . . . . 10.0 109.211 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -45.57 92.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.609 1.55 . . . . 10.0 110.812 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -60.61 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.988 1.715 . . . . 10.0 109.399 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.64 -28.92 66.31 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 118.966 -0.54 . . . . 10.0 111.825 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.18 49.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.318 1.047 . . . . 10.0 110.699 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.85 -22.42 56.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.671 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.38 14.51 61.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.874 0.749 . . . . 10.0 113.016 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.28 130.28 26.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.95 1.3 . . . . 10.0 109.324 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.58 75.9 1.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.977 -0.749 . . . . 10.0 108.977 -165.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.42 54.27 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.038 2.236 . . . . 10.0 117.038 -170.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.35 51.95 7.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.312 1.845 . . . . 10.0 112.118 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.94 -47.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.417 -1.277 . . . . 10.0 113.398 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.89 34.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.628 1.558 . . . . 10.0 113.095 -176.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.52 0.62 Allowed 'General case' 0 C--O 1.22 -0.468 0 O-C-N 120.814 -1.179 . . . . 10.0 108.901 172.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 -16.54 44.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 10.0 114.569 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.53 -65.51 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 117.478 -1.249 . . . . 10.0 108.676 166.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.58 -46.88 73.81 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 120.42 1.464 . . . . 10.0 112.031 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.451 1.5 . . . . 10.0 110.244 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.14 4.49 5.53 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.776 1.63 . . . . 10.0 112.853 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -115.19 -57.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.6 -61.26 2.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.694 0.798 . . . . 10.0 112.63 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.22 64.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.086 0.857 . . . . 10.0 112.199 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.43 -53.6 3.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.601 1.16 . . . . 10.0 108.795 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.587 1.555 . . . . 10.0 110.659 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.23 13.73 15.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 10.0 113.306 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.96 -64.28 0.36 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 128.239 2.616 . . . . 10.0 109.479 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.55 44.55 28.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.746 1.618 . . . . 10.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.65 20.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.208 1.403 . . . . 10.0 114.184 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 155.33 28.98 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 127.897 2.479 . . . . 10.0 107.679 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.22 -44.89 10.93 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.537 2.158 . . . . 10.0 110.003 -173.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.33 67.49 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.191 0.996 . . . . 10.0 111.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.55 -42.07 70.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.965 1.306 . . . . 10.0 110.361 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.61 17.76 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.2 1.0 . . . . 10.0 108.884 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.2 84.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 123.426 0.453 . . . . 10.0 111.432 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.93 78.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.318 1.447 . . . . 10.0 112.542 172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.16 -41.81 60.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.601 0.761 . . . . 10.0 111.382 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.9 -14.74 59.84 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.401 -0.812 . . . . 10.0 110.421 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.76 30.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.871 0.868 . . . . 10.0 110.143 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.09 54.51 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.926 -1.486 . . . . 10.0 114.836 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.27 8.75 6.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.386 2.593 . . . . 10.0 112.649 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.0 49.26 4.1 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.65 132.84 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.176 -2.157 . . . . 10.0 105.176 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.71 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.679 0.791 . . . . 10.0 110.0 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.68 -36.9 85.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.738 -0.649 . . . . 10.0 110.367 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.8 66.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.744 0.702 . . . . 10.0 111.673 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.59 -57.09 4.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.363 -1.718 . . . . 10.0 106.363 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.9 -59.45 4.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.795 1.238 . . . . 10.0 112.161 -166.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.53 -33.7 64.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 -170.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 m -62.36 -49.31 76.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.75 -41.33 92.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.557 1.143 . . . . 10.0 110.269 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -49.09 -48.78 44.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.673 1.124 . . . . 10.0 110.809 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.88 1.02 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.678 0.791 . . . . 10.0 111.179 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.78 172.32 8.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.474 1.509 . . . . 10.0 111.658 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.42 86.71 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.825 1.25 . . . . 10.0 110.487 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.82 54.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.757 0.823 . . . . 10.0 110.501 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.53 -38.85 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.23 1.012 . . . . 10.0 111.213 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.61 -33.2 63.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.026 0.93 . . . . 10.0 110.987 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.26 -48.39 19.43 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.872 -0.891 . . . . 10.0 110.872 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.03 82.38 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.792 -0.828 . . . . 10.0 109.656 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -34.14 77.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.663 -1.16 . . . . 10.0 111.45 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.01 7.23 41.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.613 0.642 . . . . 10.0 112.045 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -101.09 -48.26 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.645 0.259 . . . . 10.0 110.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.48 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.7 tmtt? -77.16 -44.28 30.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.878 0.371 . . . . 10.0 110.829 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -16.88 57.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.298 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.4 mt -74.97 -37.63 61.87 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.233 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.34 82.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.974 0.361 . . . . 10.0 111.974 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 57.7 mtm -71.59 -28.89 64.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.86 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.688 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.07 5.09 1.75 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.081 1.752 . . . . 10.0 113.53 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 54.34 36.85 26.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.99 2.116 . . . . 10.0 112.082 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.25 -16.2 4.02 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.779 2.032 . . . . 10.0 110.295 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.982 1.753 . . . . 10.0 112.802 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.45 153.06 61.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.192 2.197 . . . . 10.0 108.27 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.7 71.46 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.535 -1.027 . . . . 10.0 113.109 -6.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.5 m -145.91 144.22 30.04 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.287 1.435 . . . . 10.0 108.534 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.86 158.41 31.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.844 1.657 . . . . 10.0 108.221 163.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.936 -1.505 . . . . 10.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.0 135.18 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.065 -1.457 . . . . 10.0 107.065 168.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 1 C-N-CA 133.131 4.572 . . . . 10.0 117.471 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.18 60.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 117.752 -1.582 . . . . 10.0 115.498 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.37 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.975 1.887 . . . . 10.0 114.373 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -112.7 107.61 16.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.4 24.41 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.51 1.924 . . . . 10.0 106.768 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.59 17.44 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 120.316 -1.49 . . . . 10.0 107.087 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.78 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.601 0.36 . . . . 10.0 110.184 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.29 -50.15 5.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 128.615 2.766 . . . . 10.0 107.689 160.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.06 16.48 4.48 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.92 1.724 . . . . 10.0 114.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 m -128.32 -51.14 1.29 Allowed 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.768 1.284 . . . . 10.0 109.654 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.62 72.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.04 1.336 . . . . 10.0 112.252 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.416 -1.213 . . . . 10.0 114.741 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.78 174.27 35.12 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.717 1.758 . . . . 10.0 110.017 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.419 2.079 . . . . 10.0 111.753 -169.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.63 69.86 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.9 -1.125 . . . . 10.0 111.58 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.46 -27.14 66.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.069 0.548 . . . . 10.0 110.368 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.59 -43.05 32.93 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.014 -1.054 . . . . 10.0 110.894 -169.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.71 -31.86 73.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.937 0.79 . . . . 10.0 111.066 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.52 -56.5 8.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.628 1.971 . . . . 10.0 107.984 168.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.43 -41.42 93.53 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 116.905 -1.522 . . . . 10.0 111.503 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.8 -48.66 69.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.965 1.712 . . . . 10.0 111.705 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.51 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.964 0.505 . . . . 10.0 110.617 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.41 -42.68 96.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.585 0.754 . . . . 10.0 111.257 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.03 -37.44 84.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.948 -1.095 . . . . 10.0 111.251 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.32 -51.92 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.99 -43.03 63.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.577 1.151 . . . . 10.0 110.037 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.73 -0.31 33.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.144 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.21 9.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.614 1.566 . . . . 10.0 114.399 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -55.79 4.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.345 -1.354 . . . . 10.0 107.345 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.29 66.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.766 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 130.082 3.353 . . . . 10.0 113.679 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.03 13.33 35.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.759 1.224 . . . . 10.0 113.153 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.4 tttm 56.42 76.78 0.28 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.939 2.096 . . . . 10.0 109.855 -163.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.122 1.769 . . . . 10.0 108.815 -179.251 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 109.135 -1.586 . . . . 10.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.12 73.72 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.144 2.178 . . . . 10.0 110.313 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.428 -2.169 . . . . 10.0 113.023 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.42 157.77 43.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.964 1.706 . . . . 10.0 107.991 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.29 132.76 44.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.671 -1.233 . . . . 10.0 107.671 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.57 148.43 49.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.65 13.69 52.11 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.767 1.175 . . . . 10.0 113.398 -167.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -62.98 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.767 1.783 . . . . 10.0 107.78 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.52 -25.89 14.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.353 1.461 . . . . 10.0 110.46 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.55 167.12 31.16 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.249 -0.907 . . . . 10.0 111.694 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.88 115.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.781 1.232 . . . . 10.0 109.002 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.31 167.32 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.001 -1.687 . . . . 10.0 110.508 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.67 40.98 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.271 1.028 . . . . 10.0 108.853 172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.4 41.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.21 0.819 . . . . 10.0 113.21 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.195 0.998 . . . . 10.0 108.676 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.53 -179.08 2.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 125.047 3.831 . . . . 10.0 112.266 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.87 34.04 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.739 1.215 . . . . 10.0 107.944 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.1 179.04 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.415 2.076 . . . . 10.0 112.58 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.8 m -127.35 168.3 20.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 126.866 2.067 . . . . 10.0 108.949 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.11 -61.8 1.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.812 2.045 . . . . 10.0 110.493 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.85 165.37 21.14 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 127.305 2.242 . . . . 10.0 105.394 163.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.91 -164.61 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.608 2.206 . . . . 10.0 110.201 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.75 2.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.45 133.76 45.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.01 0.924 . . . . 10.0 108.77 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.79 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 169.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.24 139.08 35.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.47 130.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.939 -1.874 . . . . 10.0 105.939 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.13 108.06 14.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.94 143.32 54.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.303 1.041 . . . . 10.0 108.58 162.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.8 131.1 53.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 158.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.34 176.86 7.11 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.376 1.07 . . . . 10.0 110.391 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.06 175.79 11.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.028 1.331 . . . . 10.0 109.525 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.47 -73.14 0.1 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.563 1.145 . . . . 10.0 112.937 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.95 4.53 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 124.858 1.218 . . . . 10.0 110.336 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.49 84.74 8.15 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.532 2.333 . . . . 10.0 106.102 -163.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.54 168.58 24.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.296 2.664 . . . . 10.0 109.217 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.93 -45.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.538 1.935 . . . . 10.0 112.064 -164.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.88 -53.03 13.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.754 2.022 . . . . 10.0 110.569 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.96 -49.94 75.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.472 1.509 . . . . 10.0 110.784 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.43 61.6 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.73 -16.85 27.74 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.727 1.611 . . . . 10.0 112.074 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.81 -67.21 0.41 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.115 1.325 . . . . 10.0 112.559 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.02 -9.17 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 122.076 1.777 . . . . 10.0 114.518 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.16 68.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.766 1.167 . . . . 10.0 108.806 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.17 -28.59 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.348 1.059 . . . . 10.0 113.85 -164.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.36 -60.29 3.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.79 1.236 . . . . 10.0 109.544 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.89 -35.38 78.34 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 CA-C-N 120.243 1.122 . . . . 10.0 112.918 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.28 -51.54 68.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.412 0.685 . . . . 10.0 110.34 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -59.01 -39.17 81.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.128 0.49 . . . . 10.0 110.231 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.81 -25.63 64.77 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.153 -0.967 . . . . 10.0 111.445 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.66 9.99 39.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.625 1.17 . . . . 10.0 112.868 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.405 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.0 mt -60.94 151.17 75.3 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 119.488 1.04 . . . . 10.0 110.994 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.07 169.7 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.982 3.121 . . . . 10.0 110.484 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.1 -4.1 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.024 1.33 . . . . 10.0 113.372 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.8 8.37 43.26 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.765 1.626 . . . . 10.0 110.532 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.44 164.33 32.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 O-C-N 121.164 -0.96 . . . . 10.0 108.863 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.93 140.91 28.59 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.435 -1.257 . . . . 10.0 108.29 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -120.84 134.13 55.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.759 0.314 . . . . 10.0 111.549 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.25 136.94 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.803 -0.635 . . . . 10.0 109.66 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -103.66 119.71 39.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.402 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD21 ' CAA' ' A' ' 201' ' ' 1YO . 22.9 mt -121.26 138.45 28.08 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.859 0.688 . . . . 10.0 112.859 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.5 152.81 23.38 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.027 2.485 . . . . 10.0 112.222 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.07 97.22 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -87.94 76.77 8.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.827 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.15 1.15 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.1 -48.1 3.41 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 119.903 -1.748 . . . . 10.0 112.787 168.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.51 -152.12 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.294 0.949 . . . . 10.0 110.783 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.81 -30.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.074 0.95 . . . . 10.0 112.003 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.4 -27.44 6.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.068 1.747 . . . . 10.0 113.367 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.86 -36.42 64.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.629 1.104 . . . . 10.0 110.485 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.93 -55.21 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.81 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.492 3.117 . . . . 10.0 112.21 170.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.21 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.352 1.453 . . . . 10.0 111.176 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.53 -41.81 70.13 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.789 -1.101 . . . . 10.0 112.535 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.53 -44.33 8.61 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.136 1.161 . . . . 10.0 114.136 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.8 -45.78 92.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.528 0.604 . . . . 10.0 110.304 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.32 -45.35 94.79 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 116.836 -1.554 . . . . 10.0 109.234 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -45.69 92.14 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.552 1.523 . . . . 10.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.978 1.711 . . . . 10.0 109.413 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.7 -28.91 66.24 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 118.881 -0.58 . . . . 10.0 111.806 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.72 -37.15 49.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.347 1.059 . . . . 10.0 110.699 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.5 56.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.653 -0.689 . . . . 10.0 111.634 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.6 61.71 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.974 0.797 . . . . 10.0 113.023 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.35 130.28 26.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.997 1.319 . . . . 10.0 109.315 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.57 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.981 -0.748 . . . . 10.0 108.981 -165.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.4 54.19 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 117.137 2.273 . . . . 10.0 117.137 -170.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.37 51.97 7.49 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.284 1.834 . . . . 10.0 112.113 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.91 -47.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.487 -1.244 . . . . 10.0 113.461 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.77 34.92 1.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.532 1.514 . . . . 10.0 113.067 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.749 -1.219 . . . . 10.0 108.929 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.2 -16.42 44.7 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.576 1.325 . . . . 10.0 114.576 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.52 -65.65 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.552 -1.213 . . . . 10.0 108.625 166.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.57 -46.78 73.77 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.391 1.451 . . . . 10.0 111.997 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.39 -40.62 82.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.459 1.503 . . . . 10.0 110.207 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.1 4.46 5.53 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.736 1.615 . . . . 10.0 112.884 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.23 -57.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.049 -2.204 . . . . 10.0 105.049 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.68 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.704 0.801 . . . . 10.0 112.618 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.26 64.8 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.06 0.845 . . . . 10.0 112.147 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.43 3.91 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.591 1.157 . . . . 10.0 108.802 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.41 87.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.476 1.51 . . . . 10.0 110.698 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.79 15.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.408 1.083 . . . . 10.0 113.372 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.97 -64.2 0.36 Allowed 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 128.226 2.61 . . . . 10.0 109.581 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.9 mt 54.52 44.63 28.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.789 1.635 . . . . 10.0 112.449 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.69 14.64 20.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 10.0 114.148 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.2 155.38 28.98 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 127.907 2.483 . . . . 10.0 107.643 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.27 -44.88 10.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.543 2.162 . . . . 10.0 109.972 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.09 -29.32 67.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.222 1.009 . . . . 10.0 111.124 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.53 -42.1 70.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.945 1.298 . . . . 10.0 110.353 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.93 -48.54 17.87 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.071 0.948 . . . . 10.0 108.901 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.16 -37.2 84.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 123.45 0.469 . . . . 10.0 111.412 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.95 78.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.285 1.434 . . . . 10.0 112.532 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.21 -41.66 61.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.559 0.744 . . . . 10.0 111.443 -177.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.38 -0.825 . . . . 10.0 110.411 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.75 30.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.766 0.826 . . . . 10.0 110.102 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.14 54.36 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.958 -1.468 . . . . 10.0 114.827 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.75 6.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.327 2.563 . . . . 10.0 112.604 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.98 49.24 4.11 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.54 132.93 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.177 -2.157 . . . . 10.0 105.177 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.76 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.642 0.777 . . . . 10.0 109.983 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.64 -37.04 86.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.732 -0.651 . . . . 10.0 110.375 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.92 -26.86 67.06 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.681 0.673 . . . . 10.0 111.732 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.7 -57.05 4.02 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.375 -1.713 . . . . 10.0 106.375 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.8 -59.56 4.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.846 1.258 . . . . 10.0 112.172 -166.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.55 -33.66 64.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -49.38 75.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.8 -41.3 92.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.587 1.155 . . . . 10.0 110.229 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.668 1.122 . . . . 10.0 110.831 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -92.68 38.98 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.674 0.789 . . . . 10.0 111.129 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.92 172.3 8.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.396 1.479 . . . . 10.0 111.569 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.2 -40.4 86.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.814 1.246 . . . . 10.0 110.439 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.5 -49.91 54.32 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.765 0.826 . . . . 10.0 110.445 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.49 -38.84 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.256 1.022 . . . . 10.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 1.7 mtmt -55.52 -33.34 63.68 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.025 0.93 . . . . 10.0 111.017 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.11 -48.47 19.8 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.854 -0.898 . . . . 10.0 110.854 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.42 -36.14 82.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.702 -0.881 . . . . 10.0 109.502 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.693 -1.146 . . . . 10.0 111.478 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 12.7 pt-20 -104.29 10.65 35.48 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.72 0.637 . . . . 10.0 111.853 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.3 tmtt? -102.65 -51.02 3.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.686 0.279 . . . . 10.0 110.495 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.74 -4.81 59.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.844 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.4 tmtt? -77.79 -45.38 24.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.852 0.358 . . . . 10.0 110.848 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.84 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.324 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 36.7 mt -75.14 -38.57 60.97 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.38 -0.373 . . . . 10.0 110.856 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.69 83.75 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.083 0.401 . . . . 10.0 112.083 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 63.6 mtm -69.35 -30.1 68.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 10.0 111.436 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.86 79.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.623 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.05 5.03 1.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.125 1.77 . . . . 10.0 113.493 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.43 36.75 26.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.93 2.092 . . . . 10.0 112.12 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 32' ' ' LEU . 90.4 t -69.35 135.04 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.24 -16.18 4.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.737 2.015 . . . . 10.0 110.277 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.3 -170.86 33.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.928 1.727 . . . . 10.0 112.772 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.54 152.97 61.44 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 127.253 2.221 . . . . 10.0 108.308 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.59 152.68 71.58 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.585 -1.006 . . . . 10.0 113.035 -6.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.87 144.27 30.11 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.272 1.429 . . . . 10.0 108.551 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.95 158.35 32.21 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.906 1.682 . . . . 10.0 108.218 163.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.934 -1.506 . . . . 10.0 106.934 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.0 t -104.06 135.16 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.17 10.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 133.175 4.59 . . . . 10.0 117.505 171.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.23 60.26 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.667 -1.629 . . . . 10.0 115.446 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.89 -41.28 1.04 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.989 1.895 . . . . 10.0 114.315 -170.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -112.78 107.62 16.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.315 -0.995 . . . . 10.0 108.315 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.07 113.42 24.55 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.495 1.918 . . . . 10.0 106.764 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.48 169.59 17.44 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 120.277 -1.514 . . . . 10.0 107.198 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.98 -178.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.62 0.368 . . . . 10.0 110.171 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.35 -50.09 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 128.552 2.741 . . . . 10.0 107.733 160.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 16.52 4.48 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.868 1.699 . . . . 10.0 114.373 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.27 -51.16 1.3 Allowed 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.825 1.313 . . . . 10.0 109.656 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.54 72.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.072 1.349 . . . . 10.0 112.174 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.62 -6.03 9.83 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.535 -1.147 . . . . 10.0 114.802 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.27 35.22 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.667 1.733 . . . . 10.0 109.929 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.92 -52.52 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.355 2.037 . . . . 10.0 111.736 -169.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -28.6 69.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.946 -1.096 . . . . 10.0 111.568 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.16 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.095 0.558 . . . . 10.0 110.351 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.71 -42.86 32.96 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.014 -1.054 . . . . 10.0 110.898 -169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.93 -31.77 73.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.908 0.776 . . . . 10.0 110.985 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.46 8.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.589 1.956 . . . . 10.0 108.103 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.47 -41.33 93.47 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 116.945 -1.502 . . . . 10.0 111.58 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.69 69.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.902 1.683 . . . . 10.0 111.746 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.06 65.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.902 0.481 . . . . 10.0 110.619 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.55 -42.57 96.82 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 10.0 111.217 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.14 -37.38 83.72 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.877 -1.139 . . . . 10.0 111.26 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.23 -51.94 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.284 0.947 . . . . 10.0 108.561 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.02 -43.06 63.53 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.618 1.167 . . . . 10.0 110.052 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.7 -0.27 33.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.173 -1.394 . . . . 10.0 113.188 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.487 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.25 9.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.679 1.591 . . . . 10.0 114.436 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -55.69 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.35 -20.32 66.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.115 -0.948 . . . . 10.0 111.772 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.46 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.108 3.363 . . . . 10.0 113.707 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.06 13.38 35.36 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.732 1.213 . . . . 10.0 113.151 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.92 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.942 2.097 . . . . 10.0 109.78 -163.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.138 1.775 . . . . 10.0 108.82 -179.321 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . 0.422 ' CAA' HD21 ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.194 -1.563 . . . . 10.0 109.194 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.08 73.77 0.15 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 127.131 2.172 . . . . 10.0 110.357 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.37 12.06 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.459 -2.155 . . . . 10.0 112.998 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.47 157.7 43.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.984 1.714 . . . . 10.0 108.041 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.18 132.82 44.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.735 -1.209 . . . . 10.0 107.735 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.38 49.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.62 52.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.67 1.128 . . . . 10.0 113.423 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -63.0 0.98 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.763 1.782 . . . . 10.0 107.77 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.38 -25.97 14.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 10.0 110.501 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -154.59 167.02 31.51 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.27 -0.894 . . . . 10.0 111.624 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.89 115.97 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.797 1.239 . . . . 10.0 108.996 -171.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.36 20.31 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 119.948 -1.72 . . . . 10.0 110.473 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.66 40.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.168 0.987 . . . . 10.0 108.815 172.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 m -67.25 -9.46 40.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.832 0.853 . . . . 10.0 113.219 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 m -129.32 74.37 81.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.195 0.998 . . . . 10.0 108.612 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.49 -179.12 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 125.139 3.892 . . . . 10.0 112.213 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.57 138.96 34.21 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.729 1.211 . . . . 10.0 107.934 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.13 179.17 5.67 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.369 2.046 . . . . 10.0 112.569 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.5 168.3 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.832 2.053 . . . . 10.0 108.947 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.89 1.67 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.834 2.054 . . . . 10.0 110.457 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.74 165.43 21.11 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.283 2.233 . . . . 10.0 105.397 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.99 -164.61 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.571 2.181 . . . . 10.0 110.213 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.68 2.45 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.269 -2.733 . . . . 10.0 106.269 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.47 133.79 45.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.137 0.975 . . . . 10.0 108.723 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.73 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.348 -1.723 . . . . 10.0 106.348 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.15 139.16 35.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.55 130.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.906 -1.887 . . . . 10.0 105.906 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.5 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.2 108.11 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.393 -1.336 . . . . 10.0 107.393 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.04 143.39 54.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.275 1.03 . . . . 10.0 108.583 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 158.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.27 176.85 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.433 1.093 . . . . 10.0 110.459 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.89 11.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.071 1.349 . . . . 10.0 109.502 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HD1' ' CG2' ' A' ' 98' ' ' ILE . 40.2 t80 -61.59 -73.09 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.615 1.166 . . . . 10.0 112.912 172.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.01 4.54 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.828 1.204 . . . . 10.0 110.392 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.9 t -113.57 84.8 8.37 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 127.471 2.308 . . . . 10.0 106.086 -163.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.56 168.6 23.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.279 2.653 . . . . 10.0 109.203 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.03 -45.75 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.46 1.904 . . . . 10.0 112.093 -165.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.79 -53.14 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.672 1.989 . . . . 10.0 110.597 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.88 -49.93 75.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.471 1.508 . . . . 10.0 110.817 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.54 61.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.68 -16.85 27.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.687 1.595 . . . . 10.0 112.071 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.2 0.41 Allowed Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 120.09 1.314 . . . . 10.0 112.621 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.09 -9.11 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 CA-C-N 121.994 1.748 . . . . 10.0 114.45 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.18 68.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.772 1.169 . . . . 10.0 108.827 167.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.23 -28.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.33 1.052 . . . . 10.0 113.816 -164.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 t -46.48 -60.25 3.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.763 1.225 . . . . 10.0 109.483 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.88 -35.35 78.57 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.348 1.16 . . . . 10.0 112.918 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.29 -51.59 68.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.349 0.659 . . . . 10.0 110.372 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.12 80.69 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.168 0.509 . . . . 10.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.6 64.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.094 -1.004 . . . . 10.0 111.39 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.13 39.65 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.535 1.134 . . . . 10.0 112.908 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.97 151.25 75.17 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 119.45 1.023 . . . . 10.0 110.968 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.1 169.69 21.57 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 124.053 3.169 . . . . 10.0 110.458 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.09 -4.16 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.024 1.33 . . . . 10.0 113.457 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.76 8.39 43.29 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.622 1.569 . . . . 10.0 110.587 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.46 164.85 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 O-C-N 121.117 -0.989 . . . . 10.0 108.884 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -145.66 136.18 24.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.477 -1.238 . . . . 10.0 108.413 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -115.4 137.65 51.82 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.778 0.323 . . . . 10.0 111.572 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.98 140.24 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.692 -0.686 . . . . 10.0 109.832 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -106.34 120.87 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.5 HD12 HG11 ' A' ' 30' ' ' VAL . 14.9 mt -121.83 138.76 29.05 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 112.692 0.627 . . . . 10.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.69 152.82 22.81 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.911 2.407 . . . . 10.0 112.287 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.16 98.05 9.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.5 mt -88.21 76.8 8.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.751 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.17 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.161 1.541 . . . . 10.0 115.161 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.09 -48.09 3.41 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 119.897 -1.752 . . . . 10.0 112.801 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.52 -152.06 1.56 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.317 0.961 . . . . 10.0 110.75 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.83 -30.76 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.108 0.963 . . . . 10.0 112.12 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.46 -27.39 6.42 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.064 1.745 . . . . 10.0 113.374 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.9 -36.48 64.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.606 1.094 . . . . 10.0 110.472 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.83 -55.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.495 3.118 . . . . 10.0 112.148 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.15 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 125.407 1.479 . . . . 10.0 111.294 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.59 -41.84 70.37 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 117.757 -1.116 . . . . 10.0 112.457 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.43 -44.32 8.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 114.186 1.18 . . . . 10.0 114.186 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.93 -45.71 92.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.685 0.615 . . . . 10.0 110.272 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.2 95.32 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 116.702 -1.618 . . . . 10.0 109.204 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.7 91.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.628 1.558 . . . . 10.0 110.764 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 126.004 1.722 . . . . 10.0 109.42 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.71 -28.89 66.21 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 118.887 -0.578 . . . . 10.0 111.8 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.78 -37.1 50.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.329 1.052 . . . . 10.0 110.625 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.89 -22.43 56.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.802 -0.618 . . . . 10.0 111.702 -170.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.33 14.55 61.84 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.897 0.761 . . . . 10.0 113.0 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.962 1.305 . . . . 10.0 109.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.36 -5.35 54.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 117.059 2.244 . . . . 10.0 117.059 -170.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.28 52.05 7.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.347 1.859 . . . . 10.0 112.092 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.98 -47.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.425 -1.274 . . . . 10.0 113.328 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.79 1.3 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.586 1.539 . . . . 10.0 113.175 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.33 -44.51 0.62 Allowed 'General case' 0 C--O 1.221 -0.44 0 O-C-N 120.805 -1.185 . . . . 10.0 108.948 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.51 45.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.541 1.311 . . . . 10.0 114.541 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.5 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.6 -1.19 . . . . 10.0 108.637 166.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.6 -46.78 73.88 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.347 1.43 . . . . 10.0 112.006 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.37 -40.51 82.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.468 1.507 . . . . 10.0 110.24 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.24 4.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.766 1.626 . . . . 10.0 112.847 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.4 ' CG2' ' HD1' ' A' ' 35' ' ' TYR . 61.4 mt -115.26 -57.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.033 -2.21 . . . . 10.0 105.033 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.62 -61.37 1.99 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.694 0.798 . . . . 10.0 112.6 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.12 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.073 0.851 . . . . 10.0 112.157 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.5 3.88 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.508 1.123 . . . . 10.0 108.758 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.545 1.538 . . . . 10.0 110.614 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.68 15.67 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.367 1.067 . . . . 10.0 113.322 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.5 tttm 70.07 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 128.17 2.588 . . . . 10.0 109.557 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.47 44.59 28.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.768 1.627 . . . . 10.0 112.475 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.59 20.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.295 1.438 . . . . 10.0 114.177 -173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 155.36 29.0 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 127.959 2.503 . . . . 10.0 107.655 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 -44.96 10.95 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 10.0 110.017 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.0 -29.36 67.54 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.191 0.997 . . . . 10.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.51 -42.15 70.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.983 1.313 . . . . 10.0 110.314 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.58 17.84 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.145 0.978 . . . . 10.0 108.876 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.16 84.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.408 0.443 . . . . 10.0 111.4 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.13 -46.85 79.04 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.328 1.451 . . . . 10.0 112.558 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.57 60.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.537 0.735 . . . . 10.0 111.466 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -77.02 -14.74 59.79 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.414 -0.804 . . . . 10.0 110.365 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.79 30.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.777 0.831 . . . . 10.0 110.115 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.99 10.12 54.07 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 117.981 -1.455 . . . . 10.0 114.847 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.31 8.71 6.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.365 2.583 . . . . 10.0 112.673 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.97 49.23 4.11 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.68 -1.368 . . . . 10.0 109.68 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.53 132.88 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.233 -2.136 . . . . 10.0 105.233 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -92.32 133.64 35.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.63 0.772 . . . . 10.0 110.021 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.59 -36.88 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.811 -0.614 . . . . 10.0 110.445 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.83 66.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.694 0.679 . . . . 10.0 111.687 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.64 -57.02 4.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.88 -59.54 4.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.826 1.25 . . . . 10.0 112.093 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.56 -33.64 64.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 -170.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 m -62.35 -49.38 75.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -65.68 -41.36 92.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.554 1.141 . . . . 10.0 110.212 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.17 -48.8 44.76 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.691 1.132 . . . . 10.0 110.789 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.58 38.97 1.02 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.639 0.776 . . . . 10.0 111.202 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.24 8.6 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 10.0 111.666 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.36 86.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.837 1.255 . . . . 10.0 110.512 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.88 55.05 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.719 0.808 . . . . 10.0 110.477 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.52 -38.79 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.209 1.004 . . . . 10.0 111.262 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.58 -33.23 63.73 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.009 0.923 . . . . 10.0 111.029 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.47 19.33 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.831 -0.908 . . . . 10.0 110.831 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.3 -36.16 82.77 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.703 -0.88 . . . . 10.0 109.616 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -33.87 76.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.661 -1.162 . . . . 10.0 111.488 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.59 -5.46 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.619 0.645 . . . . 10.0 112.127 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.1 mmtt -92.0 -48.74 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.52 0.2 . . . . 10.0 111.01 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.48 -9.02 59.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.818 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' HB2' HD12 ' A' ' 66' ' ' LEU . 12.4 tmtt? -79.36 -45.01 20.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.672 0.273 . . . . 10.0 110.629 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -19.43 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.203 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 51.4 mt -74.02 -40.57 62.79 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.12 78.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.949 0.352 . . . . 10.0 111.949 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.08 -29.99 65.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 10.0 111.482 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.85 80.28 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.929 -0.578 . . . . 10.0 109.666 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.02 5.04 1.75 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.093 1.757 . . . . 10.0 113.5 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.38 36.82 26.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.935 2.094 . . . . 10.0 112.029 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 32' ' ' LEU . 91.4 t -69.31 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.26 -16.16 4.02 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 126.783 2.033 . . . . 10.0 110.267 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.86 33.57 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.979 1.752 . . . . 10.0 112.791 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.57 152.98 61.37 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 127.282 2.233 . . . . 10.0 108.325 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.55 152.66 71.42 Favored 'Cis proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.61 -0.996 . . . . 10.0 113.082 -6.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.282 1.433 . . . . 10.0 108.581 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.92 158.39 32.08 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.779 1.632 . . . . 10.0 108.146 163.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.55 29.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.3 t -104.14 135.19 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.085 -1.45 . . . . 10.0 107.085 168.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.13 10.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.142 4.577 . . . . 10.0 117.517 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.73 20.1 60.42 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 117.753 -1.582 . . . . 10.0 115.531 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.84 -41.35 1.04 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.998 1.899 . . . . 10.0 114.365 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.81 107.58 16.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.277 -1.009 . . . . 10.0 108.277 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 126.511 1.924 . . . . 10.0 106.741 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.54 169.56 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.362 -1.461 . . . . 10.0 107.22 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.96 -178.79 1.28 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.606 0.362 . . . . 10.0 110.14 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.3 mt -46.23 -50.11 4.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 128.528 2.731 . . . . 10.0 107.778 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.1 16.52 4.49 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.927 1.727 . . . . 10.0 114.352 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.29 -51.16 1.3 Allowed 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.851 1.326 . . . . 10.0 109.692 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.5 72.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.068 1.347 . . . . 10.0 112.3 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.53 -5.9 9.92 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-O 118.542 -1.144 . . . . 10.0 114.774 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.81 174.24 35.11 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.672 1.736 . . . . 10.0 109.945 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.86 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.397 2.065 . . . . 10.0 111.73 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.06 -1.025 . . . . 10.0 111.561 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.16 66.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.094 0.558 . . . . 10.0 110.342 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.99 32.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.969 -1.082 . . . . 10.0 110.89 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.4 mt -63.77 -31.86 73.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.876 0.762 . . . . 10.0 110.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.45 -56.44 8.24 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.636 1.974 . . . . 10.0 108.036 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.59 -41.3 92.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 116.922 -1.513 . . . . 10.0 111.555 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.78 69.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 120.984 1.72 . . . . 10.0 111.7 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.47 -47.06 65.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.939 0.496 . . . . 10.0 110.643 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.55 -42.54 96.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.513 0.725 . . . . 10.0 111.228 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.02 -37.49 84.23 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 120.899 -1.126 . . . . 10.0 111.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.27 -51.89 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.234 0.925 . . . . 10.0 108.589 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.0 -43.09 63.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.567 1.147 . . . . 10.0 110.045 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.61 -0.37 33.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.11 -1.424 . . . . 10.0 113.164 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.3 9.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.62 1.568 . . . . 10.0 114.392 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.82 4.93 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.35 66.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 10.0 111.759 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.47 6.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 130.172 3.389 . . . . 10.0 113.689 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.11 13.34 35.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.724 1.21 . . . . 10.0 113.166 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.9 0.27 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.973 2.109 . . . . 10.0 109.806 -163.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.126 1.77 . . . . 10.0 108.834 -179.27 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.232 0 N-CA-C 109.179 -1.568 . . . . 10.0 109.179 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.69 0.15 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 127.152 2.181 . . . . 10.0 110.355 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 112.392 -2.185 . . . . 10.0 113.039 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.43 157.76 43.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.944 1.698 . . . . 10.0 108.057 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 m -131.25 132.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.39 49.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.57 52.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.67 1.129 . . . . 10.0 113.43 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 -63.02 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.86 1.83 . . . . 10.0 107.768 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -25.88 14.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.409 1.483 . . . . 10.0 110.572 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.68 167.0 31.64 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.234 -0.916 . . . . 10.0 111.614 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.82 115.98 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.816 1.246 . . . . 10.0 109.01 -171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.4 167.33 20.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.948 -1.72 . . . . 10.0 110.435 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.2 124.64 40.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.254 1.022 . . . . 10.0 108.883 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.48 41.69 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.816 0.846 . . . . 10.0 113.216 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 m -129.19 74.43 81.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.222 1.009 . . . . 10.0 108.667 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.57 -179.07 2.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 125.111 3.874 . . . . 10.0 112.261 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.91 34.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 124.716 1.207 . . . . 10.0 107.898 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.08 179.11 5.71 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.38 2.054 . . . . 10.0 112.665 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.52 168.26 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.828 2.051 . . . . 10.0 108.902 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -47.1 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.834 2.053 . . . . 10.0 110.45 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.4 21.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 127.37 2.268 . . . . 10.0 105.39 163.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.97 -164.59 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.576 2.184 . . . . 10.0 110.206 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.09 -112.66 2.45 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 106.382 -2.687 . . . . 10.0 106.382 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.15 0.98 . . . . 10.0 108.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.55 140.75 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.323 -1.732 . . . . 10.0 106.323 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -99.19 139.13 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -128.51 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.858 -1.905 . . . . 10.0 105.858 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 11.2 t -131.13 108.03 14.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -172.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.93 143.32 54.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.316 1.046 . . . . 10.0 108.573 162.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 158.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.419 1.088 . . . . 10.0 110.396 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.02 175.84 11.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.969 1.308 . . . . 10.0 109.471 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.51 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.625 1.17 . . . . 10.0 112.884 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.03 4.54 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.823 1.201 . . . . 10.0 110.312 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.58 84.81 8.4 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.412 2.285 . . . . 10.0 106.087 -163.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.47 168.49 24.18 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.4 2.733 . . . . 10.0 109.25 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.06 -45.69 0.28 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.447 1.899 . . . . 10.0 112.051 -165.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.13 12.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.764 2.026 . . . . 10.0 110.572 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.84 -49.98 75.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.389 1.476 . . . . 10.0 110.874 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.8 -13.49 61.57 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.7 -16.91 27.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 10.0 112.045 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.083 1.31 . . . . 10.0 112.554 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.92 -9.32 25.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.063 1.773 . . . . 10.0 114.466 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.1 69.24 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.746 1.157 . . . . 10.0 108.851 167.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.26 -28.58 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.846 1.054 . . . . 10.0 113.846 -164.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.37 -60.31 3.84 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.782 1.233 . . . . 10.0 109.524 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.44 78.62 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 120.266 1.131 . . . . 10.0 112.917 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.19 -51.65 68.46 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.382 0.673 . . . . 10.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.1 80.63 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.154 0.502 . . . . 10.0 110.265 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.97 -25.45 64.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.124 -0.985 . . . . 10.0 111.453 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.74 10.07 39.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.576 1.15 . . . . 10.0 112.887 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.95 151.23 75.1 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.511 1.05 . . . . 10.0 110.977 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.04 169.62 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 124.054 3.17 . . . . 10.0 110.477 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.03 -4.2 4.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.02 1.328 . . . . 10.0 113.434 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.66 8.43 43.36 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.688 1.595 . . . . 10.0 110.63 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.66 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 O-C-N 121.241 -0.912 . . . . 10.0 108.827 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -145.6 136.82 24.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.501 -1.227 . . . . 10.0 108.507 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -114.65 135.88 53.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.96 0.41 . . . . 10.0 111.704 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 1.4 t -139.26 139.81 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.425 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -108.8 121.62 45.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.191 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 18.7 mt -121.76 138.21 28.24 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 112.787 0.662 . . . . 10.0 112.787 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.71 152.85 22.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.0 2.467 . . . . 10.0 112.395 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.37 98.08 9.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.502 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.0 76.74 8.56 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.913 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.54 20.23 1.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.04 -48.12 3.43 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.879 -1.763 . . . . 10.0 112.827 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.48 -152.06 1.54 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.279 0.943 . . . . 10.0 110.791 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.79 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.04 0.936 . . . . 10.0 112.07 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.49 6.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.093 1.757 . . . . 10.0 113.336 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.85 -36.43 64.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.642 1.11 . . . . 10.0 110.573 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.89 -55.17 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.9 31.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.49 3.116 . . . . 10.0 112.192 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 125.383 1.468 . . . . 10.0 111.23 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.55 -41.87 70.29 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 117.721 -1.133 . . . . 10.0 112.45 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.44 8.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 114.129 1.159 . . . . 10.0 114.129 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.87 -45.71 92.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.525 0.602 . . . . 10.0 110.26 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.45 -45.24 95.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 116.71 -1.614 . . . . 10.0 109.257 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.67 92.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.628 1.558 . . . . 10.0 110.835 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.029 1.732 . . . . 10.0 109.448 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.72 -28.94 66.23 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 118.909 -0.567 . . . . 10.0 111.805 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.68 -37.2 49.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.33 1.052 . . . . 10.0 110.677 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.88 -22.44 56.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.63 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.43 14.47 61.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.85 0.738 . . . . 10.0 112.955 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.32 130.23 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.994 1.318 . . . . 10.0 109.261 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.54 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.574 0.75 . . . . 10.0 109.011 -165.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.29 -5.4 54.35 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 117.067 2.247 . . . . 10.0 117.067 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.99 7.49 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.332 1.853 . . . . 10.0 112.072 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.96 -47.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 117.413 -1.28 . . . . 10.0 113.431 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.84 34.85 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.599 1.545 . . . . 10.0 113.183 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.44 -44.43 0.61 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.814 -1.179 . . . . 10.0 108.938 172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.57 45.68 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.484 1.291 . . . . 10.0 114.484 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.47 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 117.588 -1.196 . . . . 10.0 108.654 166.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.63 -46.75 73.96 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.368 1.44 . . . . 10.0 111.98 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.53 -40.54 83.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.458 1.503 . . . . 10.0 110.14 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.12 4.49 5.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 112.883 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.24 -57.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.002 -2.221 . . . . 10.0 105.002 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.57 -61.29 2.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.764 0.825 . . . . 10.0 112.621 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.36 -21.27 64.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.09 0.859 . . . . 10.0 112.136 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.41 -53.48 3.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.571 1.148 . . . . 10.0 108.799 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.556 1.542 . . . . 10.0 110.618 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.29 13.73 15.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.411 1.084 . . . . 10.0 113.328 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.96 -64.29 0.36 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.26 2.624 . . . . 10.0 109.537 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.54 44.73 28.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.768 1.627 . . . . 10.0 112.417 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.73 14.51 21.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.267 1.427 . . . . 10.0 114.137 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.05 155.45 29.21 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 127.983 2.513 . . . . 10.0 107.679 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.27 -44.99 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 10.0 109.936 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.97 -29.41 67.62 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.175 0.99 . . . . 10.0 111.182 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.08 70.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.981 1.313 . . . . 10.0 110.386 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.98 -48.52 17.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.15 0.98 . . . . 10.0 108.895 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 123.396 0.435 . . . . 10.0 111.357 -172.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.12 -46.9 79.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.235 1.414 . . . . 10.0 112.506 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.2 -41.73 60.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.543 0.737 . . . . 10.0 111.388 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.89 -14.75 59.84 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.31 -0.869 . . . . 10.0 110.378 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.78 30.72 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.766 0.827 . . . . 10.0 110.1 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.97 10.14 53.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.93 -1.483 . . . . 10.0 114.85 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.41 8.88 6.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.389 2.595 . . . . 10.0 112.601 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 49.3 4.12 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.638 -1.385 . . . . 10.0 109.638 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.6 132.96 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.39 133.73 35.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.615 0.766 . . . . 10.0 109.993 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.66 -36.96 85.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.729 -0.653 . . . . 10.0 110.375 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.01 -26.81 66.97 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.692 0.678 . . . . 10.0 111.75 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.04 4.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.328 -1.73 . . . . 10.0 106.328 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.9 -59.48 4.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.831 1.252 . . . . 10.0 112.156 -166.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.57 -33.63 64.74 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.296 -0.261 . . . . 10.0 110.296 -170.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 m -62.32 -49.43 75.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.34 92.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.571 1.148 . . . . 10.0 110.264 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.24 -48.71 45.46 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.658 1.117 . . . . 10.0 110.837 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.61 38.92 1.02 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.66 0.784 . . . . 10.0 111.278 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.29 8.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.372 1.469 . . . . 10.0 111.694 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.31 86.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.775 1.23 . . . . 10.0 110.562 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.92 54.54 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.677 0.791 . . . . 10.0 110.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.44 -38.83 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.191 0.997 . . . . 10.0 111.269 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.26 63.72 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.059 0.944 . . . . 10.0 110.974 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.3 -48.38 19.3 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.17 82.8 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.766 -0.844 . . . . 10.0 109.582 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 117.802 -1.094 . . . . 10.0 111.557 178.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.78 3.86 37.28 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.698 0.624 . . . . 10.0 112.09 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -99.06 -45.95 5.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.714 0.292 . . . . 10.0 110.697 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.63 -8.69 55.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.738 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -77.28 -44.31 30.22 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.753 0.311 . . . . 10.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -18.27 58.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.157 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.9 mt -74.08 -36.88 64.33 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.201 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.01 -46.53 82.24 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 mtm -71.86 -28.86 63.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.91 78.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.615 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -69.98 4.96 1.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.142 1.777 . . . . 10.0 113.518 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.5 36.73 26.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.976 2.11 . . . . 10.0 112.064 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.39 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 172.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.23 -16.08 4.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.672 1.989 . . . . 10.0 110.284 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.34 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.959 1.742 . . . . 10.0 112.744 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.5 153.02 61.67 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.329 2.252 . . . . 10.0 108.336 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.56 152.74 71.52 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.57 -1.012 . . . . 10.0 113.086 -6.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.9 m -145.95 144.22 30.0 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.281 1.432 . . . . 10.0 108.562 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.86 158.42 31.91 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.832 1.653 . . . . 10.0 108.294 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.975 -1.491 . . . . 10.0 106.975 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.5 t -103.97 135.2 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 168.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 t30 47.02 10.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 1 C-N-CA 133.145 4.578 . . . . 10.0 117.546 171.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.66 20.13 60.48 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.839 -1.534 . . . . 10.0 115.605 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.81 -41.31 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.897 1.849 . . . . 10.0 114.353 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -112.87 107.59 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.46 24.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 126.54 1.936 . . . . 10.0 106.713 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.58 169.61 17.42 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.297 -1.502 . . . . 10.0 107.162 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.81 1.28 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.643 0.377 . . . . 10.0 110.175 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.25 -50.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 128.557 2.743 . . . . 10.0 107.687 160.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.04 16.53 4.43 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.952 1.739 . . . . 10.0 114.354 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.772 1.286 . . . . 10.0 109.689 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.47 -34.49 72.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.098 1.359 . . . . 10.0 112.283 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.5 -5.9 9.95 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-O 118.554 -1.137 . . . . 10.0 114.852 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.28 35.23 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.614 1.707 . . . . 10.0 109.913 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.54 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.378 2.052 . . . . 10.0 111.816 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.39 -28.63 69.92 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.006 -1.059 . . . . 10.0 111.488 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.47 -27.15 66.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.104 0.562 . . . . 10.0 110.344 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.7 -42.84 33.05 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.971 -1.081 . . . . 10.0 110.928 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.8 -31.91 73.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.926 0.784 . . . . 10.0 110.975 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.45 8.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.637 1.975 . . . . 10.0 108.079 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.6 -41.3 92.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 116.898 -1.525 . . . . 10.0 111.53 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.74 69.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.987 1.721 . . . . 10.0 111.693 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.04 65.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 10.0 110.592 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.45 -42.63 96.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.604 0.762 . . . . 10.0 111.254 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.12 -37.43 83.86 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.958 -1.089 . . . . 10.0 111.219 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.7 mt -58.23 -51.93 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.265 0.939 . . . . 10.0 108.604 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.97 -43.08 63.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.579 1.151 . . . . 10.0 110.07 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.64 -0.37 33.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.183 -1.389 . . . . 10.0 113.157 -175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.521 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.05 -33.33 9.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.656 1.582 . . . . 10.0 114.442 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -55.72 5.02 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.445 -1.317 . . . . 10.0 107.445 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.34 -20.32 66.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 10.0 111.756 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.36 6.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.08 3.352 . . . . 10.0 113.694 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 13.39 35.29 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.729 1.212 . . . . 10.0 113.111 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.31 76.93 0.27 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.886 2.075 . . . . 10.0 109.827 -163.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.13 1.772 . . . . 10.0 108.878 -179.272 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 109.175 -1.57 . . . . 10.0 109.175 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.22 73.71 0.15 Allowed 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 127.046 2.138 . . . . 10.0 110.324 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.467 -2.151 . . . . 10.0 113.053 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.47 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.995 1.718 . . . . 10.0 108.063 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.18 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.44 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.66 52.29 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.67 1.129 . . . . 10.0 113.405 -167.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.11 0.97 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.794 1.797 . . . . 10.0 107.745 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.37 -25.94 14.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.383 1.473 . . . . 10.0 110.528 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.08 31.3 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.345 -0.847 . . . . 10.0 111.694 -171.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.87 115.85 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.874 1.27 . . . . 10.0 109.07 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.33 167.37 20.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 119.924 -1.735 . . . . 10.0 110.5 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.64 40.88 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.261 1.024 . . . . 10.0 108.9 172.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.29 -9.55 41.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.816 0.846 . . . . 10.0 113.22 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.1 m -129.23 74.39 81.07 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.255 1.022 . . . . 10.0 108.692 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.53 -179.0 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 125.084 3.856 . . . . 10.0 112.231 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.69 138.91 34.13 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.685 1.194 . . . . 10.0 107.905 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.05 179.12 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.474 2.116 . . . . 10.0 112.593 176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.57 168.24 21.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.845 2.058 . . . . 10.0 108.902 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -46.99 -61.88 1.67 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.817 2.047 . . . . 10.0 110.489 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.37 21.27 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 127.319 2.248 . . . . 10.0 105.378 163.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.91 -164.64 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.524 2.149 . . . . 10.0 110.237 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.16 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.355 -2.698 . . . . 10.0 106.355 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.49 133.76 46.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.03 0.932 . . . . 10.0 108.744 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.78 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.312 -1.736 . . . . 10.0 106.312 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.16 139.14 35.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.3 t -128.5 130.35 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.11 108.13 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.42 54.36 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.219 1.008 . . . . 10.0 108.524 162.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.86 131.1 53.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 158.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.28 176.78 7.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.515 1.126 . . . . 10.0 110.414 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.0 175.83 11.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.008 1.323 . . . . 10.0 109.469 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.48 -73.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 10.0 112.905 172.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.08 4.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.824 1.202 . . . . 10.0 110.322 -171.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.55 84.73 8.26 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 127.472 2.309 . . . . 10.0 106.115 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.5 168.6 23.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.281 2.654 . . . . 10.0 109.252 171.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.446 1.898 . . . . 10.0 112.068 -165.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.73 -53.22 12.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.736 2.015 . . . . 10.0 110.542 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.89 -49.88 76.13 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.349 1.46 . . . . 10.0 110.877 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.88 -13.4 61.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.683 0.623 . . . . 10.0 112.683 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.83 -16.73 27.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.659 1.584 . . . . 10.0 112.029 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.72 -67.26 0.41 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.081 1.309 . . . . 10.0 112.569 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.08 -9.13 25.49 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 122.031 1.761 . . . . 10.0 114.411 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.29 68.97 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 10.0 108.781 167.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.46 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.906 1.076 . . . . 10.0 113.906 -164.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.37 -60.39 3.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 10.0 109.505 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.18 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.255 1.127 . . . . 10.0 112.996 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.6 t90 -57.18 -51.64 68.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.407 0.683 . . . . 10.0 110.367 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.2 80.74 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.171 0.51 . . . . 10.0 110.279 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.53 64.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.211 -0.931 . . . . 10.0 111.393 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.7 10.13 39.62 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.613 1.165 . . . . 10.0 112.905 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.409 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.99 151.25 75.4 Favored Pre-proline 0 C--O 1.237 0.416 0 CA-C-N 119.483 1.038 . . . . 10.0 110.953 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.13 169.75 21.44 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.003 3.135 . . . . 10.0 110.509 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -4.14 4.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.973 1.309 . . . . 10.0 113.394 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.41 43.33 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.671 1.588 . . . . 10.0 110.61 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.49 164.97 30.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 121.141 -0.974 . . . . 10.0 108.809 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -145.81 137.25 24.94 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.497 -1.229 . . . . 10.0 108.402 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -115.45 137.07 52.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.913 0.387 . . . . 10.0 111.553 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.08 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.468 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -109.17 126.75 53.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.255 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -127.07 139.19 34.42 Favored Pre-proline 0 N--CA 1.462 0.172 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.23 153.16 21.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.974 2.449 . . . . 10.0 112.241 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.87 99.02 10.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.296 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -88.18 76.9 8.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.757 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.69 20.26 1.17 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.122 1.527 . . . . 10.0 115.122 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.1 3.43 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 119.886 -1.759 . . . . 10.0 112.852 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.08 1.53 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.292 0.949 . . . . 10.0 110.78 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.83 -30.78 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.088 0.955 . . . . 10.0 112.057 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.43 -27.44 6.45 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.124 1.77 . . . . 10.0 113.337 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.87 -36.37 64.81 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.661 1.119 . . . . 10.0 110.588 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.88 -55.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.533 3.133 . . . . 10.0 112.171 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.13 -42.5 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 125.336 1.446 . . . . 10.0 111.239 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.59 -41.9 70.43 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.778 -1.106 . . . . 10.0 112.471 -175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.38 -44.34 8.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 114.183 1.179 . . . . 10.0 114.183 -173.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.9 -45.77 92.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.49 0.586 . . . . 10.0 110.201 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -45.31 94.95 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 116.761 -1.59 . . . . 10.0 109.205 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.7 92.0 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.601 1.546 . . . . 10.0 110.789 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -60.59 3.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.015 1.726 . . . . 10.0 109.35 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.7 -28.92 66.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 118.963 -0.542 . . . . 10.0 111.767 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.63 -37.22 49.24 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.401 1.081 . . . . 10.0 110.71 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.86 -22.46 56.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.606 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.34 14.54 61.84 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.906 0.765 . . . . 10.0 113.0 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.37 130.28 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.932 1.293 . . . . 10.0 109.326 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -123.54 75.96 1.37 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -165.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.27 -5.37 54.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.11 2.263 . . . . 10.0 117.11 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.32 52.02 7.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.343 1.857 . . . . 10.0 112.071 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 117.484 -1.246 . . . . 10.0 113.368 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.83 34.91 1.3 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.565 1.529 . . . . 10.0 113.14 -176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.42 -44.5 0.61 Allowed 'General case' 0 C--O 1.219 -0.505 0 O-C-N 120.822 -1.174 . . . . 10.0 108.899 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.44 44.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.45 -65.62 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 117.654 -1.165 . . . . 10.0 108.673 166.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.61 -46.81 73.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.255 1.389 . . . . 10.0 111.98 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.56 82.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.406 1.482 . . . . 10.0 110.186 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.11 4.5 5.47 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.76 1.624 . . . . 10.0 112.896 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.21 -57.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.071 -2.196 . . . . 10.0 105.071 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.65 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.706 0.802 . . . . 10.0 112.615 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.34 -21.1 64.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.115 0.87 . . . . 10.0 112.217 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.52 -53.48 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.591 1.157 . . . . 10.0 108.772 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.44 87.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.571 1.548 . . . . 10.0 110.671 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.18 13.75 15.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.399 1.08 . . . . 10.0 113.389 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.94 -64.25 0.36 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.207 2.603 . . . . 10.0 109.567 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.7 mt 54.61 44.53 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.764 1.626 . . . . 10.0 112.504 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.56 20.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.269 1.428 . . . . 10.0 114.208 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.33 28.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 127.921 2.488 . . . . 10.0 107.682 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.11 -45.04 10.87 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.575 2.183 . . . . 10.0 109.968 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.3 67.39 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.232 1.013 . . . . 10.0 111.175 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.56 -42.08 70.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.941 1.297 . . . . 10.0 110.336 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.55 17.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.208 1.003 . . . . 10.0 108.886 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.2 84.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 122.76 0.424 . . . . 10.0 111.418 -172.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.93 78.75 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.279 1.432 . . . . 10.0 112.569 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.65 61.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.535 0.734 . . . . 10.0 111.448 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.371 -0.83 . . . . 10.0 110.366 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.79 30.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.893 0.877 . . . . 10.0 110.095 172.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.09 54.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.917 -1.49 . . . . 10.0 114.773 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.84 6.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 121.358 2.579 . . . . 10.0 112.652 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.25 4.12 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.629 -1.388 . . . . 10.0 109.629 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.57 132.95 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 105.161 -2.163 . . . . 10.0 105.161 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.65 35.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.611 0.764 . . . . 10.0 110.005 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.53 -37.03 86.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.791 -0.623 . . . . 10.0 110.366 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.06 -26.8 66.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.733 0.697 . . . . 10.0 111.717 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.03 4.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.95 -59.45 4.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.829 1.252 . . . . 10.0 112.192 -166.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.56 -33.69 64.79 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.226 -0.287 . . . . 10.0 110.226 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 m -62.2 -49.49 75.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.75 -41.27 92.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.518 1.127 . . . . 10.0 110.255 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.15 -48.71 44.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.723 1.147 . . . . 10.0 110.84 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.66 38.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.697 0.799 . . . . 10.0 111.191 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.31 8.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.413 1.485 . . . . 10.0 111.624 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.19 -40.36 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.852 1.261 . . . . 10.0 110.473 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.84 55.59 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.682 0.793 . . . . 10.0 110.46 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.5 -38.84 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.244 1.018 . . . . 10.0 111.261 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.23 63.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 10.0 111.001 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.41 19.48 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.2 82.93 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.732 -0.863 . . . . 10.0 109.553 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.421 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.32 -34.15 77.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.74 -1.124 . . . . 10.0 111.432 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.12 1.76 39.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.749 0.704 . . . . 10.0 111.922 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.5 -52.91 3.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.587 0.232 . . . . 10.0 110.533 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.31 -5.88 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.137 0.421 . . . . 10.0 112.137 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 66' ' ' LEU . 4.0 tmmt? -79.1 -45.92 19.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.938 0.399 . . . . 10.0 110.821 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -19.59 59.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.164 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 54.6 mt -71.87 -37.82 70.14 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.605 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.47 80.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.015 0.376 . . . . 10.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.39 -29.37 64.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.74 0.305 . . . . 10.0 111.464 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.87 82.97 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.631 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 5.04 1.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.158 1.783 . . . . 10.0 113.558 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.41 36.74 26.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.916 2.086 . . . . 10.0 112.077 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.442 HG21 HD22 ' A' ' 32' ' ' LEU . 90.6 t -69.3 135.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.729 -1.211 . . . . 10.0 107.729 172.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.2 -16.08 4.06 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.637 1.975 . . . . 10.0 110.261 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -170.89 33.64 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.036 1.779 . . . . 10.0 112.853 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.49 153.02 61.71 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.271 2.228 . . . . 10.0 108.299 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.57 152.65 71.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.561 -1.016 . . . . 10.0 113.152 -6.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.6 m -145.81 144.3 30.19 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.317 1.447 . . . . 10.0 108.583 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.96 158.39 32.15 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.837 1.655 . . . . 10.0 108.19 163.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.5 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.6 t -104.08 135.16 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 107.117 -1.438 . . . . 10.0 107.117 168.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.09 10.97 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 133.19 4.596 . . . . 10.0 117.463 171.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.11 60.57 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.77 -1.572 . . . . 10.0 115.57 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.89 -41.31 1.04 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.976 1.888 . . . . 10.0 114.325 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.77 107.58 16.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.01 113.37 24.46 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 126.549 1.94 . . . . 10.0 106.765 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.62 17.39 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 120.344 -1.473 . . . . 10.0 107.159 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.92 -178.82 1.3 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.603 0.361 . . . . 10.0 110.171 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.28 -50.06 5.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 128.483 2.713 . . . . 10.0 107.811 160.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.53 4.5 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.849 1.69 . . . . 10.0 114.365 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.25 -51.25 1.3 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.759 1.28 . . . . 10.0 109.697 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.6 72.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.1 1.36 . . . . 10.0 112.238 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.51 -5.87 9.94 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.489 -1.173 . . . . 10.0 114.844 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.79 174.31 35.17 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.699 1.749 . . . . 10.0 110.012 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.86 -52.57 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.391 2.061 . . . . 10.0 111.81 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.37 -28.66 69.92 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.907 -1.121 . . . . 10.0 111.478 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.16 66.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.044 0.538 . . . . 10.0 110.406 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.63 -42.94 33.08 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.079 -1.013 . . . . 10.0 110.938 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.96 73.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.941 0.791 . . . . 10.0 111.01 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.47 8.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.604 1.962 . . . . 10.0 108.057 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.61 -41.27 92.94 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 116.888 -1.53 . . . . 10.0 111.508 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.81 69.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 121.017 1.735 . . . . 10.0 111.663 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.46 -47.01 65.33 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.844 0.458 . . . . 10.0 110.661 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.5 -42.64 96.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.581 0.752 . . . . 10.0 111.245 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.07 -37.39 83.94 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.922 -1.111 . . . . 10.0 111.247 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.26 -51.92 65.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 119.265 0.939 . . . . 10.0 108.553 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.03 -43.1 63.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.622 1.169 . . . . 10.0 109.972 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.69 -0.29 33.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.15 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.38 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.647 1.579 . . . . 10.0 114.425 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -55.77 4.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.833 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.71 -35.54 6.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.174 3.389 . . . . 10.0 113.65 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.08 13.42 35.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.682 1.193 . . . . 10.0 113.105 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.34 76.87 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.93 2.092 . . . . 10.0 109.837 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.113 1.765 . . . . 10.0 108.797 -179.227 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . 0.452 ' CAA' ' SAK' ' A' ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.254 0 N-CA-C 109.17 -1.572 . . . . 10.0 109.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.15 73.76 0.15 Allowed 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 127.166 2.186 . . . . 10.0 110.312 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.96 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 112.4 -2.182 . . . . 10.0 113.047 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.44 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.09 1.756 . . . . 10.0 108.037 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.21 132.85 44.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.676 -1.231 . . . . 10.0 107.676 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.41 49.34 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.79 52.37 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.734 1.159 . . . . 10.0 113.375 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 -63.05 0.97 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 119.857 1.828 . . . . 10.0 107.69 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.46 -25.93 14.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.406 1.482 . . . . 10.0 110.517 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.53 167.12 31.15 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.275 -0.891 . . . . 10.0 111.789 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.0 115.98 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.775 1.23 . . . . 10.0 108.968 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.41 20.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.908 -1.745 . . . . 10.0 110.457 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.29 124.64 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.238 1.015 . . . . 10.0 108.822 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.28 -9.5 41.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.86 0.864 . . . . 10.0 113.197 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 m -129.32 74.52 80.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 10.0 108.633 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.63 -179.09 2.62 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 125.095 3.863 . . . . 10.0 112.217 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.82 33.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.716 1.206 . . . . 10.0 107.928 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.97 179.13 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.406 2.071 . . . . 10.0 112.616 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.48 168.2 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 126.926 2.09 . . . . 10.0 108.906 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.76 1.73 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.785 2.034 . . . . 10.0 110.503 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.86 165.32 21.32 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.37 2.268 . . . . 10.0 105.435 163.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.8 -164.72 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.631 2.221 . . . . 10.0 110.249 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.18 -112.72 2.46 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.277 -2.729 . . . . 10.0 106.277 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.37 133.66 45.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.142 0.977 . . . . 10.0 108.739 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.62 140.84 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.355 -1.72 . . . . 10.0 106.355 169.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.27 139.14 35.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.53 130.42 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.828 -1.916 . . . . 10.0 105.828 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 63' ' ' LEU . 11.2 t -131.16 108.07 14.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.335 . . . . 10.0 107.394 -172.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.99 143.37 54.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.292 1.037 . . . . 10.0 108.568 162.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.77 131.05 53.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.898 -0.779 . . . . 10.0 108.898 158.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.475 1.11 . . . . 10.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.79 11.78 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.111 1.364 . . . . 10.0 109.533 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.46 -73.15 0.1 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.694 1.198 . . . . 10.0 112.891 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.96 52.02 4.54 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.813 1.197 . . . . 10.0 110.307 -171.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.57 84.83 8.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.437 2.295 . . . . 10.0 106.03 -163.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.55 168.51 24.2 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.33 2.687 . . . . 10.0 109.246 171.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.1 -45.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.457 1.903 . . . . 10.0 112.091 -165.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.76 -53.14 12.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 10.0 110.577 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.86 -50.05 75.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.332 1.453 . . . . 10.0 110.824 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.7 -13.55 61.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.71 -16.92 27.64 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.764 1.625 . . . . 10.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.59 -67.3 0.4 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 120.11 1.323 . . . . 10.0 112.587 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.21 25.72 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-N 122.052 1.768 . . . . 10.0 114.469 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.9 -43.12 68.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.734 1.152 . . . . 10.0 108.765 167.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 tt -105.27 -28.48 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -164.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.7 t -46.44 -60.33 3.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.817 1.247 . . . . 10.0 109.475 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.2 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.277 1.135 . . . . 10.0 113.002 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.25 -51.61 68.66 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.356 0.663 . . . . 10.0 110.366 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.99 -39.12 80.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.091 0.472 . . . . 10.0 110.223 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.84 -25.64 64.75 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.178 -0.951 . . . . 10.0 111.431 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.01 39.77 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.607 1.163 . . . . 10.0 112.923 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.99 151.25 75.38 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 119.493 1.042 . . . . 10.0 110.938 174.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.1 169.74 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.967 3.111 . . . . 10.0 110.541 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -4.2 4.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.018 1.327 . . . . 10.0 113.428 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.39 43.34 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.705 1.602 . . . . 10.0 110.533 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.53 164.87 30.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 121.245 -0.909 . . . . 10.0 108.796 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.53 135.0 21.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.568 -1.196 . . . . 10.0 108.431 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -113.82 138.98 49.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.855 0.359 . . . . 10.0 111.733 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.23 142.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.484 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -109.09 122.34 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.186 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.7 mt -121.59 138.29 28.18 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.76 153.14 22.76 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.937 2.425 . . . . 10.0 112.211 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.69 97.78 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.433 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.12 76.78 8.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.798 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.64 20.31 1.15 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.176 1.547 . . . . 10.0 115.176 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.02 -48.13 3.43 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.937 -1.727 . . . . 10.0 112.88 168.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 -152.14 1.53 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.342 0.973 . . . . 10.0 110.737 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.82 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.154 0.982 . . . . 10.0 112.029 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.48 6.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.093 1.757 . . . . 10.0 113.347 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.88 -36.47 64.8 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.631 1.105 . . . . 10.0 110.464 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.79 -55.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -65.83 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.56 3.144 . . . . 10.0 112.237 170.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.22 -42.47 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 125.409 1.48 . . . . 10.0 111.226 173.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.62 -41.8 70.43 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.744 -1.122 . . . . 10.0 112.461 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.56 -44.26 8.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.119 1.155 . . . . 10.0 114.119 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -61.87 -45.8 92.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.568 0.622 . . . . 10.0 110.252 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.24 95.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 116.74 -1.6 . . . . 10.0 109.16 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.69 91.99 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.637 1.562 . . . . 10.0 110.775 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -60.6 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.017 1.727 . . . . 10.0 109.38 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.59 -29.02 66.47 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.962 -0.542 . . . . 10.0 111.855 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.64 -37.28 49.58 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.325 1.05 . . . . 10.0 110.669 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.6 mtp -75.74 -22.49 56.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.72 -0.657 . . . . 10.0 111.709 -170.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.44 61.85 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.844 0.735 . . . . 10.0 112.995 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.3 130.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.957 1.303 . . . . 10.0 109.314 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.59 75.95 1.38 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.572 0.749 . . . . 10.0 108.982 -165.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -5.36 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.077 2.251 . . . . 10.0 117.077 -170.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.39 51.91 7.54 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.352 1.861 . . . . 10.0 112.127 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.92 -47.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.42 -1.276 . . . . 10.0 113.419 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.78 34.84 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.589 1.541 . . . . 10.0 113.131 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.454 0 O-C-N 120.813 -1.179 . . . . 10.0 108.974 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.53 45.52 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -71.47 -65.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 117.556 -1.211 . . . . 10.0 108.698 166.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.75 74.06 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.389 1.45 . . . . 10.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.41 -40.6 82.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.478 1.511 . . . . 10.0 110.156 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.18 4.58 5.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.719 1.608 . . . . 10.0 112.871 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.08 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.56 -61.35 2.0 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.678 0.791 . . . . 10.0 112.671 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.2 64.8 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.045 0.839 . . . . 10.0 112.152 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.63 3.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.614 1.166 . . . . 10.0 108.772 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.55 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.543 1.537 . . . . 10.0 110.647 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.61 15.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.421 1.088 . . . . 10.0 113.331 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.0 -64.19 0.36 Allowed 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 128.266 2.626 . . . . 10.0 109.513 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.8 mt 54.52 44.58 28.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.764 1.625 . . . . 10.0 112.498 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.65 14.56 20.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.324 1.45 . . . . 10.0 114.224 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.42 29.11 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 127.984 2.514 . . . . 10.0 107.629 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.2 -44.92 10.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.551 2.167 . . . . 10.0 110.038 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.35 67.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.229 1.012 . . . . 10.0 111.133 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.48 -42.14 70.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.027 1.331 . . . . 10.0 110.333 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.86 -48.57 18.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.155 0.982 . . . . 10.0 108.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.24 84.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 123.402 0.439 . . . . 10.0 111.292 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.03 -46.9 78.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.378 1.471 . . . . 10.0 112.565 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.2 -41.69 61.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.556 0.742 . . . . 10.0 111.489 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.0 -14.72 59.8 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.367 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.76 30.65 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.86 0.864 . . . . 10.0 110.135 172.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.06 54.19 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 117.969 -1.462 . . . . 10.0 114.906 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.74 6.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.355 2.577 . . . . 10.0 112.674 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.95 49.35 4.08 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.67 132.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.138 -2.171 . . . . 10.0 105.138 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.26 133.7 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.63 0.772 . . . . 10.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.57 -37.0 86.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.375 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.76 66.87 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.721 0.691 . . . . 10.0 111.721 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.65 -57.1 4.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.796 1.238 . . . . 10.0 112.201 -166.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.57 -33.64 64.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.4 m -62.29 -49.5 75.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.28 92.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.522 1.129 . . . . 10.0 110.232 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.28 -48.72 45.79 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.726 1.148 . . . . 10.0 110.721 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.57 38.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.712 0.805 . . . . 10.0 111.195 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.84 172.32 8.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.361 1.464 . . . . 10.0 111.59 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.17 -40.45 86.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.824 1.25 . . . . 10.0 110.444 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.86 54.68 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.745 0.818 . . . . 10.0 110.495 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.47 -38.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.287 1.035 . . . . 10.0 111.321 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.32 63.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.07 0.948 . . . . 10.0 111.003 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.37 19.6 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.12 82.65 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.817 -0.814 . . . . 10.0 109.608 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -33.98 76.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.729 -1.129 . . . . 10.0 111.46 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.41 1.58 38.53 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.627 0.649 . . . . 10.0 112.136 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 11.7 mmtt -96.89 -47.14 5.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 10.0 110.91 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.13 -6.04 58.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -79.44 -44.96 20.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.923 0.392 . . . . 10.0 110.751 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -74.53 -21.21 59.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 37.8 mt -71.93 -37.89 69.95 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.207 -0.452 . . . . 10.0 111.1 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.33 78.0 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.001 0.371 . . . . 10.0 112.001 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.1 mtm -72.79 -28.64 62.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.582 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.93 78.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.612 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.0 5.05 1.73 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 113.49 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.3 36.78 26.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.897 2.079 . . . . 10.0 112.127 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 32' ' ' LEU . 89.9 t -69.36 135.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.33 -16.04 4.01 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.701 2.0 . . . . 10.0 110.255 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.48 -170.92 33.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.892 1.71 . . . . 10.0 112.72 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.45 153.01 61.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.242 2.217 . . . . 10.0 108.309 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.53 152.67 71.37 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.599 -1.0 . . . . 10.0 113.07 -6.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.1 m -145.86 144.26 30.12 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.351 1.46 . . . . 10.0 108.634 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.94 158.39 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.823 1.649 . . . . 10.0 108.204 163.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.14 136.48 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.7 t -104.06 135.06 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.123 -1.436 . . . . 10.0 107.123 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.08 10.96 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.148 4.579 . . . . 10.0 117.561 171.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.57 20.28 60.34 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.803 -1.554 . . . . 10.0 115.52 -170.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.9 -41.4 1.03 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.962 1.881 . . . . 10.0 114.346 -170.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.69 107.58 16.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.553 1.941 . . . . 10.0 106.765 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.59 169.54 17.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.141 -1.429 . . . . 10.0 107.141 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.8 1.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.585 0.354 . . . . 10.0 110.193 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.26 -50.1 5.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 128.569 2.748 . . . . 10.0 107.717 160.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.13 16.57 4.48 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.834 1.683 . . . . 10.0 114.4 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -128.28 -51.21 1.3 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.793 1.297 . . . . 10.0 109.692 168.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.59 72.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.037 1.335 . . . . 10.0 112.298 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.54 -5.98 9.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 118.496 -1.169 . . . . 10.0 114.754 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.36 35.26 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 119.75 1.775 . . . . 10.0 110.046 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 -52.62 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.354 2.036 . . . . 10.0 111.724 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.27 -28.7 69.9 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.999 -1.063 . . . . 10.0 111.539 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.12 66.81 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.07 0.548 . . . . 10.0 110.409 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.69 -42.9 32.92 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.014 -1.054 . . . . 10.0 110.939 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.76 -31.83 73.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.91 0.777 . . . . 10.0 111.04 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.56 -56.4 8.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.502 1.921 . . . . 10.0 108.053 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.33 93.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 116.917 -1.516 . . . . 10.0 111.509 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.65 69.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.996 1.725 . . . . 10.0 111.729 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.58 -47.04 64.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.863 0.465 . . . . 10.0 110.58 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.45 -42.63 96.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.608 0.763 . . . . 10.0 111.256 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.08 -37.38 83.89 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 120.94 -1.1 . . . . 10.0 111.266 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.31 -51.89 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.261 0.937 . . . . 10.0 108.582 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.06 63.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.543 1.137 . . . . 10.0 110.064 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.63 -0.46 33.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 117.145 -1.407 . . . . 10.0 113.123 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.418 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.03 -33.37 9.29 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.627 1.571 . . . . 10.0 114.429 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -55.8 4.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.372 -1.344 . . . . 10.0 107.372 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.32 66.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.159 -0.928 . . . . 10.0 111.795 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.41 6.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 130.122 3.369 . . . . 10.0 113.73 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.16 13.51 34.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.653 1.181 . . . . 10.0 113.153 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.977 2.111 . . . . 10.0 109.819 -163.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.085 1.754 . . . . 10.0 108.787 -179.16 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.292 0 N-CA-C 109.203 -1.559 . . . . 10.0 109.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.66 0.15 Allowed 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 127.081 2.152 . . . . 10.0 110.423 -175.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.2 11.9 0.66 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 112.45 -2.159 . . . . 10.0 112.997 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.41 157.75 43.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.028 1.731 . . . . 10.0 108.009 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.25 132.81 44.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.48 49.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.187 -1.042 . . . . 10.0 108.187 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.6 13.73 52.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.713 1.149 . . . . 10.0 113.423 -166.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.03 0.98 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.858 1.829 . . . . 10.0 107.853 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -26.07 14.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.427 1.491 . . . . 10.0 110.45 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.5 167.14 31.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.25 -0.906 . . . . 10.0 111.702 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.91 115.98 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.802 1.241 . . . . 10.0 109.036 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.41 167.25 20.42 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.927 -1.733 . . . . 10.0 110.534 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.62 40.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.213 1.005 . . . . 10.0 108.835 172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 m -67.32 -9.39 40.61 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.228 0.825 . . . . 10.0 113.228 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -129.35 74.39 81.0 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.14 0.976 . . . . 10.0 108.574 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.53 -179.08 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 125.095 3.864 . . . . 10.0 112.246 -172.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.91 34.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.681 1.193 . . . . 10.0 107.932 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.08 179.08 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.457 2.105 . . . . 10.0 112.601 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.48 168.23 20.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.801 2.04 . . . . 10.0 108.931 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.0 -61.8 1.71 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.808 2.043 . . . . 10.0 110.531 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.03 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.321 2.248 . . . . 10.0 105.34 163.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.9 -164.62 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.576 2.184 . . . . 10.0 110.229 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.67 2.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.323 -2.711 . . . . 10.0 106.323 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.51 133.79 46.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.075 0.95 . . . . 10.0 108.697 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.76 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.16 35.3 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.5 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.962 -1.866 . . . . 10.0 105.962 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.12 108.16 14.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -172.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.14 143.37 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.305 1.042 . . . . 10.0 108.463 162.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.73 131.14 53.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 158.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.42 176.82 7.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 10.0 110.381 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.82 11.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.0 109.464 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.47 -73.22 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.66 1.184 . . . . 10.0 112.842 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.06 4.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.778 1.18 . . . . 10.0 110.326 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.52 84.76 8.23 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 127.464 2.306 . . . . 10.0 106.111 -163.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.5 168.49 24.2 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.339 2.693 . . . . 10.0 109.239 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.07 -45.7 0.28 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.431 1.892 . . . . 10.0 112.081 -165.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.87 -53.09 12.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.767 2.027 . . . . 10.0 110.518 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.05 -49.87 76.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.423 1.489 . . . . 10.0 110.796 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.47 61.63 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -171.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.85 27.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.69 1.596 . . . . 10.0 112.046 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.6 -67.31 0.4 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.174 1.352 . . . . 10.0 112.56 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.0 -9.18 25.67 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 121.986 1.745 . . . . 10.0 114.425 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.2 69.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.812 1.187 . . . . 10.0 108.837 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.22 -28.49 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 113.874 1.065 . . . . 10.0 113.874 -164.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.43 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.746 1.218 . . . . 10.0 109.48 173.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.85 -35.39 78.65 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.273 1.133 . . . . 10.0 112.897 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.24 -51.66 68.47 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.431 0.693 . . . . 10.0 110.304 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.89 -39.22 80.79 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.169 0.509 . . . . 10.0 110.25 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.79 -25.71 64.84 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.096 -1.002 . . . . 10.0 111.415 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.07 39.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.513 1.125 . . . . 10.0 112.923 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.86 151.17 74.5 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 119.485 1.039 . . . . 10.0 110.971 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.07 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.987 3.125 . . . . 10.0 110.49 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.12 -4.19 4.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.011 1.324 . . . . 10.0 113.395 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.62 8.34 43.45 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.743 1.617 . . . . 10.0 110.627 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.52 164.94 30.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 O-C-N 121.189 -0.945 . . . . 10.0 108.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -146.08 137.07 24.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.402 -1.272 . . . . 10.0 108.444 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -117.3 135.64 53.68 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.804 0.335 . . . . 10.0 111.725 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.92 138.67 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.81 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -104.42 118.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.02 138.44 27.01 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.88 152.89 25.32 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.028 2.485 . . . . 10.0 112.4 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 96.96 8.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.271 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.1 76.8 8.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.363 -0.38 . . . . 10.0 111.776 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.22 1.16 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.132 1.53 . . . . 10.0 115.132 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.11 -48.18 3.42 Favored Glycine 0 N--CA 1.467 0.723 0 O-C-N 119.933 -1.729 . . . . 10.0 112.752 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.39 -152.13 1.52 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.389 0.995 . . . . 10.0 110.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.86 -30.75 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.077 0.951 . . . . 10.0 112.081 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.34 -27.52 6.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.049 1.74 . . . . 10.0 113.396 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.86 -36.46 64.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.66 1.118 . . . . 10.0 110.478 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.88 -55.14 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.94 31.91 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.519 3.128 . . . . 10.0 112.137 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 125.332 1.444 . . . . 10.0 111.196 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.47 -41.86 70.0 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.53 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.32 8.45 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.121 1.156 . . . . 10.0 114.121 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.89 -45.67 92.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.503 0.592 . . . . 10.0 110.335 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.38 -45.33 94.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.786 -1.578 . . . . 10.0 109.251 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.63 92.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.592 1.542 . . . . 10.0 110.829 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.6 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.99 1.716 . . . . 10.0 109.483 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.64 -29.03 66.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.919 -0.562 . . . . 10.0 111.789 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.57 -37.24 48.79 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.362 1.065 . . . . 10.0 110.701 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.8 -22.46 56.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.695 -170.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.46 61.83 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.871 0.748 . . . . 10.0 112.986 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.41 130.32 26.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 124.916 1.286 . . . . 10.0 109.277 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.87 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.605 0.762 . . . . 10.0 109.022 -165.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -5.39 54.26 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.103 2.26 . . . . 10.0 117.103 -170.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 51.96 7.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.313 1.845 . . . . 10.0 112.114 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.93 -47.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.455 -1.26 . . . . 10.0 113.381 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.93 34.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.576 1.535 . . . . 10.0 113.199 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.41 -44.57 0.61 Allowed 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.832 -1.167 . . . . 10.0 108.84 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.48 44.7 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.605 1.335 . . . . 10.0 114.605 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -71.53 -65.49 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 117.518 -1.23 . . . . 10.0 108.695 166.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.72 74.04 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.407 1.458 . . . . 10.0 112.048 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.49 -40.48 82.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.388 1.475 . . . . 10.0 110.241 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.3 4.65 5.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.818 1.647 . . . . 10.0 112.826 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.29 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.991 -2.225 . . . . 10.0 104.991 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.62 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.713 0.805 . . . . 10.0 112.625 -173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.26 -21.22 64.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.093 0.86 . . . . 10.0 112.189 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.42 -53.51 3.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.58 1.152 . . . . 10.0 108.831 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.38 88.03 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 10.0 110.656 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.63 15.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.382 1.073 . . . . 10.0 113.325 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.01 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 128.217 2.607 . . . . 10.0 109.57 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 41.0 mt 54.43 44.71 28.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.815 1.646 . . . . 10.0 112.436 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.6 20.63 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.284 1.434 . . . . 10.0 114.189 -173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 155.39 29.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 127.933 2.493 . . . . 10.0 107.643 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.2 -45.01 10.7 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.576 2.184 . . . . 10.0 109.937 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.36 67.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.208 1.003 . . . . 10.0 111.161 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.15 70.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.981 1.313 . . . . 10.0 110.322 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.53 18.03 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.165 0.986 . . . . 10.0 108.909 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.25 -37.16 84.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.461 0.476 . . . . 10.0 111.349 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.11 -46.89 78.95 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.324 1.45 . . . . 10.0 112.51 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.62 60.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.549 0.74 . . . . 10.0 111.412 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.95 -14.71 59.82 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.36 -0.838 . . . . 10.0 110.418 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.52 -41.73 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.814 0.846 . . . . 10.0 110.098 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.07 10.1 54.52 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.0 -1.445 . . . . 10.0 114.845 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.32 8.79 6.59 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.313 2.556 . . . . 10.0 112.64 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.16 4.15 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.696 -1.362 . . . . 10.0 109.696 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.54 132.88 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.165 -2.161 . . . . 10.0 105.165 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -92.26 133.76 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.561 0.744 . . . . 10.0 110.022 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.63 -36.96 85.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.768 -0.634 . . . . 10.0 110.37 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.09 -26.79 66.89 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.637 0.653 . . . . 10.0 111.719 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.06 4.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.334 -1.728 . . . . 10.0 106.334 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.776 1.23 . . . . 10.0 112.241 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.51 -33.65 64.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.3 m -62.34 -49.37 75.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.76 -41.33 92.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.555 1.142 . . . . 10.0 110.207 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.1 -48.73 44.18 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.768 1.167 . . . . 10.0 110.83 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.65 38.84 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.714 0.806 . . . . 10.0 111.116 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.461 1.504 . . . . 10.0 111.657 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.18 -40.35 86.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.782 1.233 . . . . 10.0 110.521 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.82 55.38 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.723 0.809 . . . . 10.0 110.489 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.49 -38.78 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.241 1.016 . . . . 10.0 111.324 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.31 63.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.995 0.918 . . . . 10.0 111.016 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.46 19.72 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.851 -0.899 . . . . 10.0 110.851 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.35 -36.21 82.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.751 -0.852 . . . . 10.0 109.53 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -33.63 75.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.751 -1.118 . . . . 10.0 111.542 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.6 -0.87 34.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.581 0.628 . . . . 10.0 112.373 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 54.2 mmtt -95.26 -44.92 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 10.0 110.8 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.34 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.584 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -79.24 -45.75 19.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.692 0.282 . . . . 10.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -16.58 60.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 45.8 mt -75.76 -40.41 55.4 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.293 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.42 77.34 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.1 0.407 . . . . 10.0 112.1 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.0 mtm -70.46 -29.72 66.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.763 0.315 . . . . 10.0 111.556 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.89 78.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.69 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.0 5.02 1.75 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.148 1.779 . . . . 10.0 113.524 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.4 36.8 26.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.885 2.074 . . . . 10.0 112.075 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 172.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.17 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.793 2.037 . . . . 10.0 110.319 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.39 -170.96 33.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 126.024 1.773 . . . . 10.0 112.865 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.38 152.99 62.04 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 127.316 2.246 . . . . 10.0 108.341 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.63 152.71 71.76 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.569 -1.013 . . . . 10.0 113.103 -6.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 57.2 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.325 1.45 . . . . 10.0 108.538 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.6 mmm -123.94 158.44 31.99 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.733 1.613 . . . . 10.0 108.225 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.16 136.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.862 -1.533 . . . . 10.0 106.862 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.0 135.2 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.091 -1.448 . . . . 10.0 107.091 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 46.99 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 133.151 4.58 . . . . 10.0 117.53 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.67 20.08 60.57 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.778 -1.568 . . . . 10.0 115.552 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.41 1.04 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.954 1.877 . . . . 10.0 114.333 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.72 107.57 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.53 24.55 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.471 1.908 . . . . 10.0 106.79 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.63 169.58 17.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.304 -1.497 . . . . 10.0 107.09 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.91 -178.76 1.29 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.36 -50.08 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 128.482 2.713 . . . . 10.0 107.724 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.54 4.5 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.963 1.744 . . . . 10.0 114.377 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.9 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 118.726 1.263 . . . . 10.0 109.651 168.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.065 1.346 . . . . 10.0 112.247 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.49 -5.68 9.99 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 118.57 -1.128 . . . . 10.0 114.83 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.74 174.25 35.07 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.639 1.719 . . . . 10.0 109.963 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.88 -52.6 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.407 2.072 . . . . 10.0 111.766 -169.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.015 -1.053 . . . . 10.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.41 -27.2 66.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.138 0.575 . . . . 10.0 110.38 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.64 -43.04 32.67 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.097 -1.002 . . . . 10.0 110.822 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.71 -31.87 73.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.965 0.802 . . . . 10.0 111.036 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.48 8.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.537 1.935 . . . . 10.0 108.074 168.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.5 -41.37 93.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.896 -1.526 . . . . 10.0 111.496 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.952 1.705 . . . . 10.0 111.735 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.15 64.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.934 0.494 . . . . 10.0 110.591 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.43 -42.52 96.24 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.584 0.754 . . . . 10.0 111.301 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.18 -37.38 83.61 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.93 -1.106 . . . . 10.0 111.242 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.18 -52.0 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.232 0.924 . . . . 10.0 108.583 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.96 -43.06 63.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.596 1.158 . . . . 10.0 110.016 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.7 -0.4 33.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.154 -1.403 . . . . 10.0 113.139 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.477 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.08 -33.25 9.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.637 1.575 . . . . 10.0 114.466 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -55.73 4.99 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.763 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.5 6.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 130.244 3.418 . . . . 10.0 113.638 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.12 13.43 35.19 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.717 1.207 . . . . 10.0 113.117 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.33 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.872 2.069 . . . . 10.0 109.845 -163.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.039 1.736 . . . . 10.0 108.768 -179.272 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.296 0 N-CA-C 109.284 -1.526 . . . . 10.0 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.7 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 127.087 2.155 . . . . 10.0 110.406 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.24 11.86 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.07 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.012 1.725 . . . . 10.0 108.081 -175.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.32 132.75 44.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 148.42 49.48 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.7 13.61 52.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.623 1.106 . . . . 10.0 113.42 -167.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -63.04 0.98 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 119.871 1.835 . . . . 10.0 107.769 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.348 1.459 . . . . 10.0 110.521 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.68 167.02 31.57 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.271 -0.893 . . . . 10.0 111.719 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.82 115.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.836 1.254 . . . . 10.0 109.023 -171.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.45 167.32 20.31 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 119.993 -1.692 . . . . 10.0 110.497 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.69 41.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.29 1.036 . . . . 10.0 108.823 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.44 -9.36 41.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.768 0.827 . . . . 10.0 113.116 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.29 74.34 81.06 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.254 1.022 . . . . 10.0 108.647 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.43 -179.11 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 125.121 3.881 . . . . 10.0 112.29 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.92 34.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.769 1.227 . . . . 10.0 107.948 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.14 179.14 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.427 2.085 . . . . 10.0 112.538 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.54 168.18 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.78 2.032 . . . . 10.0 108.938 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -47.0 -61.87 1.67 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.851 2.06 . . . . 10.0 110.44 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.05 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 127.228 2.211 . . . . 10.0 105.301 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.91 -164.56 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.585 2.19 . . . . 10.0 110.304 173.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.07 -112.7 2.46 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.36 -2.696 . . . . 10.0 106.36 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.48 133.71 45.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.07 0.948 . . . . 10.0 108.785 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.64 140.82 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.305 -1.739 . . . . 10.0 106.305 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.31 139.22 35.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.8 t -128.54 130.43 69.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.901 -1.888 . . . . 10.0 105.901 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.15 108.09 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -172.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.11 143.39 54.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.236 1.014 . . . . 10.0 108.544 162.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.14 53.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 158.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.36 176.87 7.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.391 1.076 . . . . 10.0 110.365 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.05 175.82 11.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.049 1.34 . . . . 10.0 109.555 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.673 1.189 . . . . 10.0 112.882 172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.98 52.11 4.56 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.78 1.181 . . . . 10.0 110.293 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.57 84.83 8.38 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 127.371 2.268 . . . . 10.0 106.147 -163.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.56 168.55 24.08 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.32 2.68 . . . . 10.0 109.253 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.0 -45.68 0.28 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.482 1.913 . . . . 10.0 112.06 -164.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.81 -53.17 12.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.745 2.018 . . . . 10.0 110.556 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.81 76.41 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.349 1.459 . . . . 10.0 110.91 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.52 61.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.63 -16.86 27.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.793 1.637 . . . . 10.0 112.118 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.73 -67.25 0.41 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 120.064 1.302 . . . . 10.0 112.557 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.23 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.066 1.774 . . . . 10.0 114.431 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.85 -43.2 68.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.83 1.195 . . . . 10.0 108.774 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.16 -28.56 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 t -46.35 -60.42 3.68 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.668 1.187 . . . . 10.0 109.492 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.79 -35.42 79.18 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 CA-C-N 120.244 1.123 . . . . 10.0 112.908 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.18 -51.67 68.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.422 0.689 . . . . 10.0 110.362 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -58.92 -39.08 80.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.128 0.489 . . . . 10.0 110.291 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.52 64.61 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.15 -0.969 . . . . 10.0 111.441 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.08 39.81 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.563 1.145 . . . . 10.0 112.834 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.93 151.28 74.72 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 119.52 1.055 . . . . 10.0 110.982 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.13 169.67 21.59 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.985 3.124 . . . . 10.0 110.537 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.05 -4.19 4.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.969 1.308 . . . . 10.0 113.461 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.72 8.46 43.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.706 1.602 . . . . 10.0 110.6 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.56 165.56 29.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 121.213 -0.929 . . . . 10.0 108.798 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -146.63 135.79 22.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.573 -1.194 . . . . 10.0 108.458 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.87 136.81 52.47 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 t -140.02 139.57 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.022 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -106.33 120.2 41.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.044 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG11 ' A' ' 30' ' ' VAL . 10.8 mt -118.23 136.45 23.93 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.73 154.64 26.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.502 2.135 . . . . 10.0 112.307 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.78 96.74 7.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.247 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.41 76.77 8.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.757 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.55 20.23 1.15 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.204 1.557 . . . . 10.0 115.204 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.04 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.863 -1.773 . . . . 10.0 112.827 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.54 -152.11 1.58 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.351 0.977 . . . . 10.0 110.759 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.201 1.0 . . . . 10.0 112.002 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.36 -27.44 6.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.123 1.769 . . . . 10.0 113.346 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.96 -36.4 64.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 119.589 1.086 . . . . 10.0 110.498 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.8 -55.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.031 -1.1 . . . . 10.0 108.031 174.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.532 3.133 . . . . 10.0 112.182 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.12 -42.56 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 125.405 1.479 . . . . 10.0 111.296 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.5 -41.86 70.09 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.768 -1.11 . . . . 10.0 112.499 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.5 -44.33 8.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 114.137 1.162 . . . . 10.0 114.137 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.84 -45.77 92.38 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.514 0.597 . . . . 10.0 110.3 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.2 mt -61.39 -45.26 95.1 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 116.744 -1.598 . . . . 10.0 109.209 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -45.7 91.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.652 1.569 . . . . 10.0 110.771 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.005 1.722 . . . . 10.0 109.474 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.66 -29.03 66.4 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 118.955 -0.545 . . . . 10.0 111.767 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.22 49.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.325 1.05 . . . . 10.0 110.748 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 31.0 mtp -75.77 -22.49 56.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.644 -0.693 . . . . 10.0 111.632 -170.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.32 14.54 61.87 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.914 0.768 . . . . 10.0 112.985 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.39 130.28 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.012 1.325 . . . . 10.0 109.272 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.56 76.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.955 -0.758 . . . . 10.0 108.955 -165.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.35 -5.33 54.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.092 2.256 . . . . 10.0 117.092 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 44.35 51.99 7.45 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.284 1.833 . . . . 10.0 112.11 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.97 -47.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.448 -1.263 . . . . 10.0 113.364 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.85 34.81 1.29 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.627 1.558 . . . . 10.0 113.159 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.46 0.62 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 120.835 -1.165 . . . . 10.0 108.898 172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.51 45.49 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.542 1.312 . . . . 10.0 114.542 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.42 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 117.67 -1.157 . . . . 10.0 108.756 166.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.48 -46.93 73.5 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.378 1.444 . . . . 10.0 112.033 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.32 -40.65 82.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.473 1.509 . . . . 10.0 110.194 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.07 4.51 5.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.808 1.643 . . . . 10.0 112.899 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.31 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.3 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.683 0.793 . . . . 10.0 112.615 -173.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.33 -21.16 64.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.149 0.886 . . . . 10.0 112.171 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.48 -53.46 3.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.519 1.127 . . . . 10.0 108.781 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.43 88.07 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.541 1.536 . . . . 10.0 110.626 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.39 13.83 15.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.395 1.078 . . . . 10.0 113.267 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.91 -64.24 0.36 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 128.206 2.602 . . . . 10.0 109.591 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.46 44.63 28.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.734 1.614 . . . . 10.0 112.534 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.63 20.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.228 1.411 . . . . 10.0 114.179 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 155.25 28.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.944 2.498 . . . . 10.0 107.676 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.1 -45.01 10.96 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.525 2.15 . . . . 10.0 109.955 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.22 67.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.193 0.997 . . . . 10.0 111.212 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.13 70.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.02 1.328 . . . . 10.0 110.327 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.51 18.07 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.211 1.004 . . . . 10.0 108.93 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.09 84.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.405 0.441 . . . . 10.0 111.367 -172.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.09 -46.94 78.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.307 1.443 . . . . 10.0 112.536 172.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.7 t80 -74.2 -41.78 60.87 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.597 0.759 . . . . 10.0 111.406 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.86 -14.79 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.35 -0.844 . . . . 10.0 110.39 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.39 -41.79 29.97 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.801 0.84 . . . . 10.0 110.18 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.0 10.12 54.13 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 117.931 -1.483 . . . . 10.0 114.846 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.38 8.84 6.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.367 2.583 . . . . 10.0 112.615 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.25 4.13 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.672 -1.371 . . . . 10.0 109.672 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.49 132.94 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.134 -2.173 . . . . 10.0 105.134 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.41 133.72 35.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.608 0.763 . . . . 10.0 109.915 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.96 85.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.8 -0.619 . . . . 10.0 110.406 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.96 -26.86 67.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.748 0.704 . . . . 10.0 111.719 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.69 -57.03 4.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.378 -1.712 . . . . 10.0 106.378 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.87 -59.51 4.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.85 1.26 . . . . 10.0 112.164 -166.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.55 -33.67 64.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.5 m -62.28 -49.43 75.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.327 -0.62 . . . . 10.0 109.327 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.73 -41.33 92.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.645 1.178 . . . . 10.0 110.237 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.694 1.133 . . . . 10.0 110.883 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.682 0.793 . . . . 10.0 111.178 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.392 1.477 . . . . 10.0 111.716 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.1 -40.44 86.92 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.911 1.284 . . . . 10.0 110.523 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.9 54.69 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.754 0.822 . . . . 10.0 110.484 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.48 -38.8 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.158 0.983 . . . . 10.0 111.274 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.28 63.73 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.002 0.921 . . . . 10.0 110.99 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.34 19.88 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.861 -0.896 . . . . 10.0 110.861 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.38 -36.21 82.96 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.712 -0.875 . . . . 10.0 109.583 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.36 77.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.767 -1.111 . . . . 10.0 111.517 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -94.95 -15.05 23.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.607 0.639 . . . . 10.0 112.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 72.3 mmtt -86.9 -47.25 9.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 10.0 110.845 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.79 -9.4 59.01 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.11 -42.47 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.684 0.278 . . . . 10.0 110.989 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -19.45 57.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 68.8 mt -72.5 -44.18 62.59 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.118 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.75 -46.86 77.76 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 67.3 mtm -69.76 -30.88 68.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 10.0 111.498 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.29 -43.87 80.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.664 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.08 5.05 1.77 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.142 1.777 . . . . 10.0 113.477 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 54.38 36.77 26.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.875 2.07 . . . . 10.0 112.142 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.1 t -69.39 135.04 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.682 -1.229 . . . . 10.0 107.682 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.2 -16.14 4.05 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.766 2.026 . . . . 10.0 110.31 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.91 33.64 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.968 1.747 . . . . 10.0 112.769 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.51 152.99 61.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 127.216 2.206 . . . . 10.0 108.283 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.65 71.41 Favored 'Cis proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.646 -0.981 . . . . 10.0 113.07 -6.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.1 m -145.86 144.3 30.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.331 1.452 . . . . 10.0 108.59 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.94 158.38 32.14 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.792 1.637 . . . . 10.0 108.211 163.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.08 136.41 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.943 -1.502 . . . . 10.0 106.943 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.4 t -104.05 135.21 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.054 -1.462 . . . . 10.0 107.054 168.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.0 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.132 4.573 . . . . 10.0 117.582 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.1 60.58 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.844 -1.531 . . . . 10.0 115.568 -170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.85 -41.26 1.04 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.931 1.866 . . . . 10.0 114.348 -170.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.76 107.61 16.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 -171.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.97 113.4 24.46 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.522 1.929 . . . . 10.0 106.8 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.51 169.57 17.48 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 120.408 -1.433 . . . . 10.0 107.141 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.95 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.587 0.355 . . . . 10.0 110.11 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.34 -50.01 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 128.466 2.707 . . . . 10.0 107.764 160.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.56 4.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.881 1.705 . . . . 10.0 114.429 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.28 -51.2 1.3 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.724 1.262 . . . . 10.0 109.667 168.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.66 72.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.102 1.361 . . . . 10.0 112.202 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.64 -5.92 9.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.796 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.31 35.23 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.693 1.747 . . . . 10.0 109.96 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.93 -52.57 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.359 2.039 . . . . 10.0 111.758 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.46 -28.58 69.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.977 -1.077 . . . . 10.0 111.486 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.45 -27.1 66.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.101 0.56 . . . . 10.0 110.392 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.96 32.67 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.959 -1.088 . . . . 10.0 110.904 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.7 -31.88 73.19 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.922 0.783 . . . . 10.0 111.026 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.51 -56.4 8.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.557 1.943 . . . . 10.0 108.075 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.54 -41.36 93.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 116.883 -1.532 . . . . 10.0 111.494 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.75 -48.73 69.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.985 1.721 . . . . 10.0 111.728 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.05 65.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.975 0.51 . . . . 10.0 110.613 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.57 -42.47 96.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.592 0.757 . . . . 10.0 111.263 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.27 -37.32 83.27 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 120.946 -1.096 . . . . 10.0 111.236 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.3 -51.87 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.28 0.945 . . . . 10.0 108.654 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.08 63.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.573 1.149 . . . . 10.0 110.016 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.71 -0.34 33.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.08 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.33 9.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.671 1.589 . . . . 10.0 114.42 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.74 4.99 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.33 -1.359 . . . . 10.0 107.33 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.37 -20.3 66.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.743 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 130.183 3.393 . . . . 10.0 113.639 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.21 13.45 35.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.667 1.187 . . . . 10.0 113.114 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.87 0.27 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.903 2.081 . . . . 10.0 109.799 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.079 1.751 . . . . 10.0 108.805 -179.276 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . 0.446 ' CAA' ' SAK' ' A' ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.293 0 N-CA-C 109.154 -1.578 . . . . 10.0 109.154 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.71 0.15 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.116 2.166 . . . . 10.0 110.357 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.01 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.081 2.153 . . . . 10.0 113.029 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.46 157.69 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.013 1.725 . . . . 10.0 108.047 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.19 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.7 148.45 49.23 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.63 52.08 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.702 1.144 . . . . 10.0 113.437 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 -63.04 0.98 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.788 1.794 . . . . 10.0 107.817 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.44 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.5 mp0 -98.42 -25.95 14.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.405 1.482 . . . . 10.0 110.506 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.58 167.06 31.38 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.254 -0.904 . . . . 10.0 111.687 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.86 115.91 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.848 1.259 . . . . 10.0 109.054 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.39 20.27 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 119.895 -1.753 . . . . 10.0 110.479 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.56 40.64 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.254 1.022 . . . . 10.0 108.83 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.29 -9.47 41.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.794 0.838 . . . . 10.0 113.19 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 m -129.27 74.4 81.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.163 0.985 . . . . 10.0 108.646 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.58 -179.07 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 125.073 3.849 . . . . 10.0 112.221 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.61 138.88 34.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.698 1.199 . . . . 10.0 107.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -73.01 179.1 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.481 2.121 . . . . 10.0 112.598 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.5 168.27 20.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.804 2.042 . . . . 10.0 108.937 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.809 2.044 . . . . 10.0 110.488 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.83 165.4 21.08 Favored Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 127.315 2.246 . . . . 10.0 105.359 163.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.89 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.55 2.167 . . . . 10.0 110.24 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.58 2.43 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 106.338 -2.705 . . . . 10.0 106.338 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.53 133.71 46.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.116 0.966 . . . . 10.0 108.718 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.25 139.2 35.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.521 -1.288 . . . . 10.0 107.521 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.0 t -128.57 130.39 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.15 108.1 14.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 -172.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.01 143.36 54.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.271 1.028 . . . . 10.0 108.533 162.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.72 131.12 53.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 158.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.37 176.81 7.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.417 1.087 . . . . 10.0 110.398 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.82 11.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.098 1.359 . . . . 10.0 109.511 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.51 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.607 1.163 . . . . 10.0 112.879 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.89 51.99 4.53 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.775 1.178 . . . . 10.0 110.38 -171.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.45 84.8 8.13 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 127.457 2.303 . . . . 10.0 106.098 -163.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.58 23.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.308 2.672 . . . . 10.0 109.253 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.476 1.911 . . . . 10.0 112.083 -165.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.78 -53.14 12.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.704 2.001 . . . . 10.0 110.572 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.91 -49.9 76.05 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.327 1.451 . . . . 10.0 110.884 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -13.47 61.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.713 0.635 . . . . 10.0 112.713 -171.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.74 -16.76 27.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.722 1.609 . . . . 10.0 112.118 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.24 0.41 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.094 1.315 . . . . 10.0 112.593 -172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.04 -9.2 25.7 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.988 1.746 . . . . 10.0 114.403 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.87 -43.15 69.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.797 1.18 . . . . 10.0 108.813 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.27 -28.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 -164.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 t -46.46 -60.35 3.82 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.711 1.205 . . . . 10.0 109.471 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.77 -35.42 79.4 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.272 1.133 . . . . 10.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.9 t90 -57.17 -51.66 68.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.418 0.687 . . . . 10.0 110.367 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.94 -39.13 80.68 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.182 0.515 . . . . 10.0 110.258 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.94 -25.54 64.62 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.117 -0.99 . . . . 10.0 111.418 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.68 10.05 39.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.568 1.147 . . . . 10.0 112.897 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.7 mt -60.97 151.26 75.17 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-N 119.513 1.051 . . . . 10.0 110.922 174.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.13 169.71 21.52 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 124.042 3.161 . . . . 10.0 110.471 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.11 -4.26 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.004 1.322 . . . . 10.0 113.397 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.58 8.35 43.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.744 1.618 . . . . 10.0 110.653 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.48 164.71 31.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 O-C-N 121.161 -0.962 . . . . 10.0 108.834 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -145.98 134.65 22.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.534 -1.212 . . . . 10.0 108.448 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -114.48 135.52 54.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.854 0.359 . . . . 10.0 111.621 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.71 138.91 41.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 10.0 109.685 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -104.91 118.5 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.49 HD12 HG11 ' A' ' 30' ' ' VAL . 15.8 mt -118.75 138.51 26.03 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 112.726 0.639 . . . . 10.0 112.726 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.28 152.86 24.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.933 2.422 . . . . 10.0 112.188 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 97.47 8.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.391 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.88 76.79 8.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.389 -0.369 . . . . 10.0 111.861 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.53 20.16 1.15 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.165 1.542 . . . . 10.0 115.165 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.11 3.42 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 119.939 -1.725 . . . . 10.0 112.793 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.53 -152.08 1.57 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.327 0.965 . . . . 10.0 110.779 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.84 -30.81 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.077 0.951 . . . . 10.0 112.047 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.38 -27.43 6.33 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.079 1.752 . . . . 10.0 113.327 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.95 -36.35 64.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.656 1.116 . . . . 10.0 110.515 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.9 -55.1 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.93 31.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.545 3.138 . . . . 10.0 112.186 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.16 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.33 1.443 . . . . 10.0 111.217 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.57 -41.82 70.3 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.476 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.33 8.46 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 114.181 1.178 . . . . 10.0 114.181 -173.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.85 -45.78 92.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 123.639 0.587 . . . . 10.0 110.241 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -45.24 95.17 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 116.7 -1.619 . . . . 10.0 109.197 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -45.6 92.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.61 1.55 . . . . 10.0 110.778 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -60.59 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.082 1.753 . . . . 10.0 109.415 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.71 -29.0 66.29 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.796 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.16 48.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.365 1.066 . . . . 10.0 110.703 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.9 -22.42 56.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.663 -170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.44 61.9 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.867 0.746 . . . . 10.0 112.97 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.31 130.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 124.929 1.292 . . . . 10.0 109.337 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.55 75.95 1.37 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.47 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.091 2.256 . . . . 10.0 117.091 -170.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 52.0 7.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.329 1.852 . . . . 10.0 112.086 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.93 -47.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 117.452 -1.261 . . . . 10.0 113.403 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.83 1.31 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.57 1.532 . . . . 10.0 113.084 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.4 -44.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.447 0 O-C-N 120.762 -1.211 . . . . 10.0 108.891 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.55 45.41 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.56 1.318 . . . . 10.0 114.56 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.43 -65.64 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 117.601 -1.19 . . . . 10.0 108.671 166.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.53 -46.81 73.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.324 1.42 . . . . 10.0 112.025 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.56 82.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.479 1.511 . . . . 10.0 110.182 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.22 4.57 5.5 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.774 1.63 . . . . 10.0 112.867 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.28 2.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.706 0.803 . . . . 10.0 112.635 -173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.19 64.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.112 0.869 . . . . 10.0 112.171 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.47 3.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.557 1.143 . . . . 10.0 108.79 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.4 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.544 1.538 . . . . 10.0 110.666 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.25 13.74 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.362 1.065 . . . . 10.0 113.34 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.03 -64.27 0.36 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 128.166 2.586 . . . . 10.0 109.57 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.4 mt 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.73 1.612 . . . . 10.0 112.522 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.49 20.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.282 1.433 . . . . 10.0 114.192 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.07 155.41 29.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 127.888 2.475 . . . . 10.0 107.643 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.18 -44.96 10.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.532 2.155 . . . . 10.0 110.012 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.34 67.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.259 1.024 . . . . 10.0 111.19 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.08 70.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.965 1.306 . . . . 10.0 110.344 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.56 17.91 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.16 0.984 . . . . 10.0 108.875 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.19 -37.25 84.57 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 122.761 0.425 . . . . 10.0 111.36 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.86 78.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.279 1.432 . . . . 10.0 112.605 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.69 60.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.609 0.763 . . . . 10.0 111.423 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.376 -0.827 . . . . 10.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.46 -41.73 30.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.788 0.835 . . . . 10.0 110.15 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.08 54.46 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.953 -1.471 . . . . 10.0 114.811 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.33 8.87 6.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.394 2.597 . . . . 10.0 112.604 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.9 49.26 4.12 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.678 -1.369 . . . . 10.0 109.678 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.53 132.89 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.167 -2.16 . . . . 10.0 105.167 169.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.66 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.666 0.786 . . . . 10.0 110.03 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.804 -0.617 . . . . 10.0 110.416 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.14 -26.73 66.81 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.682 0.674 . . . . 10.0 111.706 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.09 4.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.359 -1.719 . . . . 10.0 106.359 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.9 -59.44 4.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.819 1.248 . . . . 10.0 112.169 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.56 -33.7 64.8 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.254 -0.276 . . . . 10.0 110.254 -170.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.25 -49.48 75.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.38 92.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.592 1.157 . . . . 10.0 110.23 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.1 -48.77 44.17 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 119.701 1.137 . . . . 10.0 110.845 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.9 1.02 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.637 0.775 . . . . 10.0 111.181 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.3 8.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.387 1.475 . . . . 10.0 111.69 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.13 -40.4 86.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.262 . . . . 10.0 110.487 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.82 54.94 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.718 0.807 . . . . 10.0 110.505 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.4 mm -69.57 -38.78 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.23 1.012 . . . . 10.0 111.268 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.26 63.78 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.002 0.921 . . . . 10.0 110.963 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.39 19.59 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.837 -0.905 . . . . 10.0 110.837 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.07 82.52 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.762 -0.846 . . . . 10.0 109.611 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.0 76.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.771 -1.109 . . . . 10.0 111.495 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.69 -2.24 35.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.557 0.617 . . . . 10.0 111.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -93.48 -48.32 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.622 0.248 . . . . 10.0 110.953 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.65 58.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.407 . . . . 10.0 111.793 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 66' ' ' LEU . 11.3 tmtt? -79.17 -45.05 20.7 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.818 0.342 . . . . 10.0 110.597 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -18.64 60.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.004 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--O 1.226 -0.163 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.146 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.769 0.319 . . . . 10.0 111.511 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.86 79.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.649 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 4.97 1.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.1 1.76 . . . . 10.0 113.545 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.45 36.8 26.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.888 2.075 . . . . 10.0 112.077 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.7 t -69.37 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.679 -1.23 . . . . 10.0 107.679 172.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.13 4.05 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.757 2.023 . . . . 10.0 110.316 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.32 -170.83 33.52 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.933 1.73 . . . . 10.0 112.777 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.53 153.0 61.54 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 127.286 2.234 . . . . 10.0 108.304 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.58 152.7 71.59 Favored 'Cis proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.6 -1.0 . . . . 10.0 113.087 -6.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.0 m -145.89 144.24 30.07 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.264 1.425 . . . . 10.0 108.537 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.98 158.4 32.15 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.77 1.628 . . . . 10.0 108.174 163.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.05 135.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.04 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 1 C-N-CA 133.17 4.588 . . . . 10.0 117.552 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.19 60.38 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.807 -1.552 . . . . 10.0 115.526 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.88 -41.27 1.04 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.967 1.883 . . . . 10.0 114.349 -170.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.77 107.55 16.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.98 113.45 24.52 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 126.528 1.931 . . . . 10.0 106.738 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.57 169.62 17.41 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.333 -1.479 . . . . 10.0 107.154 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.94 -178.8 1.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.631 0.373 . . . . 10.0 110.191 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.27 -50.16 5.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 128.527 2.731 . . . . 10.0 107.715 160.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.07 16.53 4.45 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.856 1.693 . . . . 10.0 114.435 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.32 -51.11 1.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.735 1.267 . . . . 10.0 109.628 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.56 72.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.076 1.351 . . . . 10.0 112.251 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.57 -5.88 9.89 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.443 -1.199 . . . . 10.0 114.752 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.85 174.32 35.22 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.71 1.755 . . . . 10.0 109.93 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.98 -52.53 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.397 2.065 . . . . 10.0 111.752 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.31 -28.71 69.92 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.965 -1.084 . . . . 10.0 111.526 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.39 -27.24 66.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.144 0.578 . . . . 10.0 110.333 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.65 -42.84 33.36 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.051 -1.031 . . . . 10.0 110.961 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.83 -31.82 73.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.923 0.783 . . . . 10.0 111.014 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.49 -56.4 8.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.59 1.956 . . . . 10.0 108.076 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.32 93.1 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 116.928 -1.51 . . . . 10.0 111.542 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.72 69.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.931 1.696 . . . . 10.0 111.698 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.07 65.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.905 0.482 . . . . 10.0 110.637 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.48 -42.61 96.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.605 0.762 . . . . 10.0 111.272 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.1 mt -67.04 -37.42 84.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.881 -1.137 . . . . 10.0 111.278 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.28 -51.93 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 119.239 0.927 . . . . 10.0 108.574 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.01 -43.08 63.49 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.573 1.149 . . . . 10.0 110.021 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.65 -0.32 33.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.144 -175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.32 9.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.672 1.589 . . . . 10.0 114.461 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -55.75 4.98 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.37 -1.344 . . . . 10.0 107.37 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.28 -20.34 66.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.121 -0.945 . . . . 10.0 111.811 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.73 -35.46 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 130.087 3.355 . . . . 10.0 113.712 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.17 13.48 34.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.701 1.2 . . . . 10.0 113.145 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.82 0.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.92 2.088 . . . . 10.0 109.823 -163.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.058 1.743 . . . . 10.0 108.788 -179.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.234 -1.546 . . . . 10.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.23 73.64 0.16 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.046 2.138 . . . . 10.0 110.379 -175.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.25 11.97 0.65 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.429 -2.169 . . . . 10.0 113.011 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -146.41 157.74 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.033 1.733 . . . . 10.0 108.052 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 m -131.25 132.8 44.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.47 49.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.56 51.91 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.632 1.11 . . . . 10.0 113.432 -167.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.09 0.98 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 119.863 1.832 . . . . 10.0 107.727 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.363 1.465 . . . . 10.0 110.488 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.6 167.07 31.36 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.231 -0.918 . . . . 10.0 111.623 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.85 116.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.879 1.272 . . . . 10.0 109.064 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.34 20.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.869 -1.77 . . . . 10.0 110.478 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.56 40.72 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.312 1.045 . . . . 10.0 108.864 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.38 40.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.808 0.843 . . . . 10.0 113.215 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 m -129.3 74.38 81.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.209 1.003 . . . . 10.0 108.62 -176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.62 -179.1 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 125.114 3.876 . . . . 10.0 112.198 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.54 138.87 34.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.732 1.213 . . . . 10.0 107.993 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.09 179.08 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.456 2.104 . . . . 10.0 112.626 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.5 168.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.862 2.065 . . . . 10.0 108.947 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.06 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.778 2.031 . . . . 10.0 110.514 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.77 165.39 21.2 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 10.0 105.388 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.94 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.585 2.19 . . . . 10.0 110.248 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.12 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.343 -2.703 . . . . 10.0 106.343 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.46 133.66 45.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.081 0.952 . . . . 10.0 108.758 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.55 140.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.335 -1.728 . . . . 10.0 106.335 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.3 139.23 35.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.855 -1.905 . . . . 10.0 105.855 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.19 108.13 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 -172.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.07 143.35 54.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.305 1.042 . . . . 10.0 108.515 162.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.69 131.03 53.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 158.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.3 176.77 7.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.438 1.095 . . . . 10.0 110.427 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.05 175.81 11.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.965 1.306 . . . . 10.0 109.479 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.44 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.688 1.195 . . . . 10.0 112.903 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.0 4.53 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.873 1.225 . . . . 10.0 110.379 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.52 84.83 8.3 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 127.427 2.291 . . . . 10.0 106.101 -163.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.56 168.53 24.14 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.365 2.71 . . . . 10.0 109.215 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.03 -45.74 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.538 1.935 . . . . 10.0 112.046 -165.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.82 -53.06 12.81 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.69 1.996 . . . . 10.0 110.618 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.9 76.05 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.368 1.467 . . . . 10.0 110.865 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.44 61.57 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.732 0.642 . . . . 10.0 112.732 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.8 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.709 1.604 . . . . 10.0 112.031 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.83 -67.18 0.41 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 120.124 1.329 . . . . 10.0 112.581 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.94 -9.26 25.84 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 122.141 1.8 . . . . 10.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.21 68.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.795 1.18 . . . . 10.0 108.774 167.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.88 1.067 . . . . 10.0 113.88 -164.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.45 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.799 1.24 . . . . 10.0 109.499 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.88 -35.42 78.17 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.277 1.135 . . . . 10.0 112.928 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.8 t90 -57.11 -51.64 68.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.407 0.683 . . . . 10.0 110.389 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.14 80.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.126 0.489 . . . . 10.0 110.252 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.64 64.67 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.11 -0.993 . . . . 10.0 111.375 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.1 39.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.487 1.115 . . . . 10.0 112.948 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.9 151.23 74.7 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 119.467 1.031 . . . . 10.0 111.002 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.09 169.64 21.67 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.013 3.142 . . . . 10.0 110.505 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 -4.22 4.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.994 1.318 . . . . 10.0 113.452 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.72 8.43 43.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.687 1.595 . . . . 10.0 110.606 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.78 31.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 O-C-N 121.19 -0.944 . . . . 10.0 108.865 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -146.13 134.86 22.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.551 -1.204 . . . . 10.0 108.399 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -114.38 139.9 49.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.869 0.366 . . . . 10.0 111.538 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.45 143.54 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.692 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.368 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 30' ' ' VAL . 16.3 mt -124.21 138.66 31.21 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.66 152.76 22.86 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.069 2.513 . . . . 10.0 112.207 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.67 98.2 9.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.405 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.92 76.75 8.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.13 1.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.11 1.522 . . . . 10.0 115.11 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.14 3.42 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 119.97 -1.706 . . . . 10.0 112.824 168.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.02 1.52 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.335 0.969 . . . . 10.0 110.766 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.96 -30.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.14 0.976 . . . . 10.0 111.976 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.32 -27.54 6.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.103 1.761 . . . . 10.0 113.331 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.86 -36.4 64.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.679 1.127 . . . . 10.0 110.501 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.95 -55.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.923 -1.14 . . . . 10.0 107.923 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.84 31.89 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.495 3.118 . . . . 10.0 112.257 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.14 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 125.314 1.435 . . . . 10.0 111.173 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.44 -41.95 70.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.81 -1.091 . . . . 10.0 112.463 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.45 8.37 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -173.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.77 -45.8 92.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.639 0.587 . . . . 10.0 110.3 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.39 -45.23 95.23 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.738 -1.601 . . . . 10.0 109.226 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.65 92.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.611 1.55 . . . . 10.0 110.874 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.977 1.711 . . . . 10.0 109.48 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.75 -28.95 66.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 118.922 -0.561 . . . . 10.0 111.768 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.19 49.72 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.38 1.072 . . . . 10.0 110.655 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.79 -22.56 56.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.621 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.43 61.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.82 0.724 . . . . 10.0 112.871 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.34 130.26 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.973 1.309 . . . . 10.0 109.313 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.5 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 -165.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.52 54.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.118 2.266 . . . . 10.0 117.118 -170.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.42 52.03 7.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.348 1.859 . . . . 10.0 112.064 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.04 -47.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 117.444 -1.265 . . . . 10.0 113.355 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.95 34.8 1.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.628 1.558 . . . . 10.0 113.079 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.56 0.62 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 120.758 -1.214 . . . . 10.0 108.845 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.49 44.89 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.547 1.314 . . . . 10.0 114.547 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.49 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.549 -1.215 . . . . 10.0 108.661 166.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.57 -46.83 73.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.397 1.453 . . . . 10.0 112.031 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.43 -40.66 83.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.433 1.493 . . . . 10.0 110.135 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.06 4.5 5.43 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.683 1.593 . . . . 10.0 112.888 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.22 -57.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.0 -2.222 . . . . 10.0 105.0 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.56 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.664 0.786 . . . . 10.0 112.716 -173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.31 -21.22 64.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.099 0.863 . . . . 10.0 112.199 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.49 3.9 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.535 1.134 . . . . 10.0 108.81 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 58.42 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.517 1.527 . . . . 10.0 110.695 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.31 13.71 15.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.357 1.063 . . . . 10.0 113.28 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.95 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 128.223 2.609 . . . . 10.0 109.546 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.0 mt 54.52 44.61 28.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.729 1.612 . . . . 10.0 112.542 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.75 14.59 20.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.299 1.44 . . . . 10.0 114.154 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.045 2.538 . . . . 10.0 107.704 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.16 -45.0 10.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.539 2.16 . . . . 10.0 109.973 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.03 -29.34 67.47 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.263 1.025 . . . . 10.0 111.119 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.52 -42.16 70.5 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.022 1.329 . . . . 10.0 110.292 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.5 18.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.169 0.988 . . . . 10.0 108.877 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 123.387 0.43 . . . . 10.0 111.369 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.12 -46.83 79.0 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.262 1.425 . . . . 10.0 112.569 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.3 -41.59 60.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.6 0.76 . . . . 10.0 111.439 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.99 -14.8 59.8 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.357 -0.839 . . . . 10.0 110.384 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 -41.85 30.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.827 0.851 . . . . 10.0 110.114 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.15 53.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.944 -1.475 . . . . 10.0 114.883 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.39 8.85 6.56 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.333 2.567 . . . . 10.0 112.625 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 49.3 4.12 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.67 -1.372 . . . . 10.0 109.67 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.6 132.94 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.144 -2.169 . . . . 10.0 105.144 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.69 35.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.673 0.789 . . . . 10.0 110.009 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.59 -37.01 86.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.788 -0.625 . . . . 10.0 110.352 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.04 -26.75 66.92 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.707 0.685 . . . . 10.0 111.772 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.07 4.01 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.36 -1.719 . . . . 10.0 106.36 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.94 -59.42 4.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.821 1.249 . . . . 10.0 112.154 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.58 -33.73 64.77 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.205 -0.294 . . . . 10.0 110.205 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -62.27 -49.41 75.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.284 -0.636 . . . . 10.0 109.284 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.76 -41.29 92.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.524 1.13 . . . . 10.0 110.216 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.21 -48.71 45.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.686 1.13 . . . . 10.0 110.773 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.63 38.82 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.709 0.804 . . . . 10.0 111.147 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.28 8.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.426 1.49 . . . . 10.0 111.701 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.08 -40.41 87.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.842 1.257 . . . . 10.0 110.54 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.85 55.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.695 0.798 . . . . 10.0 110.495 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.6 mm -69.49 -38.77 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.224 1.009 . . . . 10.0 111.322 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.28 63.8 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 10.0 111.018 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.39 19.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.16 82.79 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.806 -0.82 . . . . 10.0 109.569 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.34 -33.64 75.97 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.749 -1.119 . . . . 10.0 111.527 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.67 -0.89 33.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.592 0.633 . . . . 10.0 112.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.37 -48.41 5.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.701 0.286 . . . . 10.0 110.709 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.86 -5.98 59.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.815 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.5 tmtt? -81.35 -43.81 18.51 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.874 0.369 . . . . 10.0 110.891 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -17.77 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 69.3 mt . . . . . 0 C--O 1.225 -0.186 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.96 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.6 mtm . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.832 0.349 . . . . 10.0 111.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.91 81.12 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.595 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -69.97 5.0 1.74 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.175 1.79 . . . . 10.0 113.539 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 54.37 36.81 26.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.877 2.071 . . . . 10.0 112.146 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 32' ' ' LEU . 90.5 t -69.37 135.13 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.717 -1.216 . . . . 10.0 107.717 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.37 -16.09 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.717 2.007 . . . . 10.0 110.254 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.88 33.61 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.954 1.74 . . . . 10.0 112.821 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 152.99 61.76 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.262 2.225 . . . . 10.0 108.359 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.59 152.65 71.56 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.592 -1.003 . . . . 10.0 113.078 -6.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.7 m -145.86 144.22 30.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 125.294 1.438 . . . . 10.0 108.562 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.93 158.35 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.847 1.659 . . . . 10.0 108.208 163.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.06 136.53 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.955 -1.498 . . . . 10.0 106.955 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.2 t -104.07 135.13 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.1 10.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 133.159 4.584 . . . . 10.0 117.542 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.6 20.19 60.47 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.806 -1.552 . . . . 10.0 115.601 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -131.88 -41.28 1.04 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.916 1.858 . . . . 10.0 114.38 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.81 107.53 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.99 113.39 24.46 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 126.506 1.922 . . . . 10.0 106.808 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.45 169.65 17.34 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 120.393 -1.442 . . . . 10.0 107.172 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.84 1.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.617 0.367 . . . . 10.0 110.123 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.31 -50.09 5.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 128.469 2.708 . . . . 10.0 107.771 160.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.08 16.56 4.44 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.946 1.736 . . . . 10.0 114.368 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.38 -51.16 1.29 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.814 1.307 . . . . 10.0 109.609 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.62 72.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.143 1.377 . . . . 10.0 112.274 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 118.529 -1.151 . . . . 10.0 114.73 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.3 35.22 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.738 1.769 . . . . 10.0 110.015 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.437 2.092 . . . . 10.0 111.72 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.33 -28.65 69.89 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.904 -1.122 . . . . 10.0 111.523 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.15 66.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.058 0.543 . . . . 10.0 110.333 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.67 -43.01 32.65 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.062 -1.024 . . . . 10.0 110.905 -169.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.91 73.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.889 0.768 . . . . 10.0 111.076 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.5 8.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.65 1.98 . . . . 10.0 108.018 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.56 -41.29 93.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 116.959 -1.496 . . . . 10.0 111.538 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 120.946 1.703 . . . . 10.0 111.74 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.49 -47.12 64.89 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.898 0.479 . . . . 10.0 110.635 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.46 -42.55 96.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.616 0.767 . . . . 10.0 111.251 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.45 83.97 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 120.917 -1.114 . . . . 10.0 111.257 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.0 mt -58.15 -51.98 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.217 0.917 . . . . 10.0 108.647 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.05 -43.03 63.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.483 1.113 . . . . 10.0 110.018 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.69 -0.36 33.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.12 -1.419 . . . . 10.0 113.072 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.14 -33.26 9.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.618 1.567 . . . . 10.0 114.458 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -55.69 5.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.413 -1.329 . . . . 10.0 107.413 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.38 66.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.177 -0.919 . . . . 10.0 111.738 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.053 3.341 . . . . 10.0 113.741 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.19 13.51 34.9 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.677 1.191 . . . . 10.0 113.113 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.35 76.84 0.27 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.895 2.078 . . . . 10.0 109.816 -163.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.135 1.774 . . . . 10.0 108.822 -179.291 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.166 -1.573 . . . . 10.0 109.166 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.18 73.72 0.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 127.088 2.155 . . . . 10.0 110.359 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.38 12.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.094 2.158 . . . . 10.0 112.981 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.46 157.72 43.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.029 1.731 . . . . 10.0 108.086 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m -131.2 132.79 44.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.63 148.37 49.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.186 -1.042 . . . . 10.0 108.186 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.68 52.35 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.731 1.158 . . . . 10.0 113.415 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -63.07 0.98 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.825 1.813 . . . . 10.0 107.854 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.9 14.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.369 1.467 . . . . 10.0 110.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.1 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.242 -0.911 . . . . 10.0 111.718 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.95 115.98 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.819 1.248 . . . . 10.0 108.99 -171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -80.43 167.39 20.24 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 119.963 -1.71 . . . . 10.0 110.489 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.24 124.61 40.79 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.309 1.044 . . . . 10.0 108.839 172.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.42 41.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.806 0.842 . . . . 10.0 113.176 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.198 0.999 . . . . 10.0 108.664 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.63 -179.11 2.63 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.987 3.792 . . . . 10.0 112.235 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 138.91 34.1 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.723 1.209 . . . . 10.0 107.948 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.99 179.12 5.67 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.453 2.102 . . . . 10.0 112.643 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.51 168.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.824 2.049 . . . . 10.0 108.946 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 m -47.08 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.855 2.062 . . . . 10.0 110.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.35 21.34 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 127.385 2.274 . . . . 10.0 105.433 163.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.83 -164.73 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.676 2.25 . . . . 10.0 110.248 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.6 2.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.71 45.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.138 0.975 . . . . 10.0 108.706 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.66 140.78 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 169.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.24 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.523 -1.288 . . . . 10.0 107.523 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.59 130.32 68.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.89 -1.892 . . . . 10.0 105.89 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.09 108.12 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.06 143.42 54.26 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.292 1.037 . . . . 10.0 108.516 162.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.84 131.11 53.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 158.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.31 176.81 7.14 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.465 1.106 . . . . 10.0 110.472 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.84 11.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.063 1.345 . . . . 10.0 109.498 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.53 -73.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.63 1.172 . . . . 10.0 112.905 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.99 52.0 4.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.76 1.171 . . . . 10.0 110.376 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.46 84.77 8.12 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 127.452 2.301 . . . . 10.0 106.118 -163.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.51 24.18 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.306 2.671 . . . . 10.0 109.234 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.07 -45.73 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.409 1.883 . . . . 10.0 112.064 -165.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.09 12.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.774 2.029 . . . . 10.0 110.564 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.9 -49.93 75.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.36 1.464 . . . . 10.0 110.888 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.78 -13.52 61.55 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.744 0.646 . . . . 10.0 112.744 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.69 -16.82 27.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.712 1.605 . . . . 10.0 112.038 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 120.122 1.328 . . . . 10.0 112.576 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.03 -9.22 25.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 CA-C-N 122.063 1.773 . . . . 10.0 114.358 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.22 69.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.832 1.196 . . . . 10.0 108.829 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.18 -28.47 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.825 1.046 . . . . 10.0 113.825 -164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -46.48 -60.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.713 1.205 . . . . 10.0 109.448 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.38 79.04 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-N 120.299 1.142 . . . . 10.0 113.004 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.9 t90 -57.17 -51.6 68.65 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.322 0.649 . . . . 10.0 110.421 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.24 80.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.186 0.517 . . . . 10.0 110.211 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.55 64.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.1 -1.0 . . . . 10.0 111.427 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.02 39.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.563 1.145 . . . . 10.0 112.862 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.91 151.26 74.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 119.52 1.054 . . . . 10.0 111.029 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.14 169.68 21.57 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.067 3.178 . . . . 10.0 110.419 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 -4.24 4.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.044 1.338 . . . . 10.0 113.473 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.67 8.38 43.39 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.737 1.615 . . . . 10.0 110.642 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.45 164.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 121.212 -0.93 . . . . 10.0 108.824 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -145.56 135.75 23.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.445 -1.252 . . . . 10.0 108.335 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -115.46 134.57 54.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.904 0.383 . . . . 10.0 111.573 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.64 140.42 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.548 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.0 mtt85 -107.74 123.36 48.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.298 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 63' ' ' LEU . 19.7 mt -124.99 138.76 32.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 112.916 0.71 . . . . 10.0 112.916 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.27 152.95 24.13 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.06 2.507 . . . . 10.0 112.339 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.68 98.47 9.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.369 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.92 76.76 8.61 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.791 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.62 20.28 1.15 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.07 -48.1 3.42 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 119.879 -1.763 . . . . 10.0 112.808 168.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.13 1.55 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.316 0.96 . . . . 10.0 110.74 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.071 0.948 . . . . 10.0 112.089 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.3 -27.52 6.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.098 1.759 . . . . 10.0 113.319 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.9 -36.39 64.74 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 119.693 1.133 . . . . 10.0 110.513 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.88 -55.21 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.93 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.459 3.104 . . . . 10.0 112.193 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.2 -42.46 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 125.346 1.451 . . . . 10.0 111.26 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.65 -41.77 70.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.774 -1.108 . . . . 10.0 112.462 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -44.33 8.52 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.91 -45.69 92.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.639 0.587 . . . . 10.0 110.275 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.34 -45.33 94.84 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 116.784 -1.579 . . . . 10.0 109.211 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -45.57 92.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.609 1.55 . . . . 10.0 110.812 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -60.61 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.988 1.715 . . . . 10.0 109.399 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.64 -28.92 66.31 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 118.966 -0.54 . . . . 10.0 111.825 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.18 49.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.318 1.047 . . . . 10.0 110.699 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.85 -22.42 56.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.671 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.38 14.51 61.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.874 0.749 . . . . 10.0 113.016 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.28 130.28 26.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.95 1.3 . . . . 10.0 109.324 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.58 75.9 1.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.977 -0.749 . . . . 10.0 108.977 -165.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.42 54.27 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.038 2.236 . . . . 10.0 117.038 -170.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.35 51.95 7.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.312 1.845 . . . . 10.0 112.118 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.94 -47.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.417 -1.277 . . . . 10.0 113.398 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.89 34.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.628 1.558 . . . . 10.0 113.095 -176.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.52 0.62 Allowed 'General case' 0 C--O 1.22 -0.468 0 O-C-N 120.814 -1.179 . . . . 10.0 108.901 172.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 -16.54 44.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 10.0 114.569 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.53 -65.51 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 117.478 -1.249 . . . . 10.0 108.676 166.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.58 -46.88 73.81 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 120.42 1.464 . . . . 10.0 112.031 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.451 1.5 . . . . 10.0 110.244 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.14 4.49 5.53 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.776 1.63 . . . . 10.0 112.853 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -115.19 -57.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.6 -61.26 2.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.694 0.798 . . . . 10.0 112.63 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.22 64.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.086 0.857 . . . . 10.0 112.199 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.43 -53.6 3.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.601 1.16 . . . . 10.0 108.795 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.587 1.555 . . . . 10.0 110.659 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.23 13.73 15.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 10.0 113.306 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.96 -64.28 0.36 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 128.239 2.616 . . . . 10.0 109.479 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.55 44.55 28.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.746 1.618 . . . . 10.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.65 20.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.208 1.403 . . . . 10.0 114.184 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 155.33 28.98 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 127.897 2.479 . . . . 10.0 107.679 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.22 -44.89 10.93 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.537 2.158 . . . . 10.0 110.003 -173.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.33 67.49 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.191 0.996 . . . . 10.0 111.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.55 -42.07 70.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.965 1.306 . . . . 10.0 110.361 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.61 17.76 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.2 1.0 . . . . 10.0 108.884 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.2 84.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 123.426 0.453 . . . . 10.0 111.432 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.93 78.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.318 1.447 . . . . 10.0 112.542 172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.16 -41.81 60.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.601 0.761 . . . . 10.0 111.382 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.9 -14.74 59.84 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.401 -0.812 . . . . 10.0 110.421 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.76 30.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.871 0.868 . . . . 10.0 110.143 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.09 54.51 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.926 -1.486 . . . . 10.0 114.836 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.27 8.75 6.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.386 2.593 . . . . 10.0 112.649 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.0 49.26 4.1 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.65 132.84 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.176 -2.157 . . . . 10.0 105.176 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.71 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.679 0.791 . . . . 10.0 110.0 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.68 -36.9 85.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.738 -0.649 . . . . 10.0 110.367 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.8 66.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.744 0.702 . . . . 10.0 111.673 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.59 -57.09 4.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.363 -1.718 . . . . 10.0 106.363 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.9 -59.45 4.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.795 1.238 . . . . 10.0 112.161 -166.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.53 -33.7 64.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 -170.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 m -62.36 -49.31 76.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.75 -41.33 92.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.557 1.143 . . . . 10.0 110.269 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -49.09 -48.78 44.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.673 1.124 . . . . 10.0 110.809 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.88 1.02 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.678 0.791 . . . . 10.0 111.179 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.78 172.32 8.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.474 1.509 . . . . 10.0 111.658 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.42 86.71 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.825 1.25 . . . . 10.0 110.487 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.82 54.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.757 0.823 . . . . 10.0 110.501 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.53 -38.85 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.23 1.012 . . . . 10.0 111.213 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.61 -33.2 63.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.026 0.93 . . . . 10.0 110.987 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.26 -48.39 19.43 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.872 -0.891 . . . . 10.0 110.872 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.03 82.38 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.792 -0.828 . . . . 10.0 109.656 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -34.14 77.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.663 -1.16 . . . . 10.0 111.45 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.01 7.23 41.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.613 0.642 . . . . 10.0 112.045 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -101.09 -48.26 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.645 0.259 . . . . 10.0 110.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.48 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.7 tmtt? -77.16 -44.28 30.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.878 0.371 . . . . 10.0 110.829 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -16.88 57.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.298 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 C--O 1.225 -0.194 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.233 179.686 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 57.7 mtm . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.796 0.331 . . . . 10.0 111.624 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.86 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.688 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.07 5.09 1.75 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.081 1.752 . . . . 10.0 113.53 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 54.34 36.85 26.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.99 2.116 . . . . 10.0 112.082 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.25 -16.2 4.02 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.779 2.032 . . . . 10.0 110.295 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.982 1.753 . . . . 10.0 112.802 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.45 153.06 61.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.192 2.197 . . . . 10.0 108.27 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.7 71.46 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.535 -1.027 . . . . 10.0 113.109 -6.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.5 m -145.91 144.22 30.04 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.287 1.435 . . . . 10.0 108.534 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.86 158.41 31.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.844 1.657 . . . . 10.0 108.221 163.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.936 -1.505 . . . . 10.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.0 135.18 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.065 -1.457 . . . . 10.0 107.065 168.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 1 C-N-CA 133.131 4.572 . . . . 10.0 117.471 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.18 60.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 117.752 -1.582 . . . . 10.0 115.498 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.37 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.975 1.887 . . . . 10.0 114.373 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -112.7 107.61 16.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.4 24.41 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.51 1.924 . . . . 10.0 106.768 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.59 17.44 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 120.316 -1.49 . . . . 10.0 107.087 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.78 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.601 0.36 . . . . 10.0 110.184 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.29 -50.15 5.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 128.615 2.766 . . . . 10.0 107.689 160.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.06 16.48 4.48 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.92 1.724 . . . . 10.0 114.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 m -128.32 -51.14 1.29 Allowed 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.768 1.284 . . . . 10.0 109.654 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.62 72.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.04 1.336 . . . . 10.0 112.252 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.416 -1.213 . . . . 10.0 114.741 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.78 174.27 35.12 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.717 1.758 . . . . 10.0 110.017 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.419 2.079 . . . . 10.0 111.753 -169.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.63 69.86 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.9 -1.125 . . . . 10.0 111.58 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.46 -27.14 66.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.069 0.548 . . . . 10.0 110.368 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.59 -43.05 32.93 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.014 -1.054 . . . . 10.0 110.894 -169.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.71 -31.86 73.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.937 0.79 . . . . 10.0 111.066 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.52 -56.5 8.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.628 1.971 . . . . 10.0 107.984 168.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.43 -41.42 93.53 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 116.905 -1.522 . . . . 10.0 111.503 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.8 -48.66 69.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.965 1.712 . . . . 10.0 111.705 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.51 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.964 0.505 . . . . 10.0 110.617 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.41 -42.68 96.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.585 0.754 . . . . 10.0 111.257 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.03 -37.44 84.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.948 -1.095 . . . . 10.0 111.251 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.32 -51.92 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.99 -43.03 63.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.577 1.151 . . . . 10.0 110.037 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.73 -0.31 33.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.144 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.21 9.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.614 1.566 . . . . 10.0 114.399 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -55.79 4.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.345 -1.354 . . . . 10.0 107.345 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.29 66.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.766 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 130.082 3.353 . . . . 10.0 113.679 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.03 13.33 35.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.759 1.224 . . . . 10.0 113.153 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.4 tttm 56.42 76.78 0.28 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.939 2.096 . . . . 10.0 109.855 -163.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.122 1.769 . . . . 10.0 108.815 -179.251 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 109.135 -1.586 . . . . 10.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.12 73.72 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.144 2.178 . . . . 10.0 110.313 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.428 -2.169 . . . . 10.0 113.023 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.42 157.77 43.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.964 1.706 . . . . 10.0 107.991 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.29 132.76 44.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.671 -1.233 . . . . 10.0 107.671 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.57 148.43 49.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.65 13.69 52.11 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.767 1.175 . . . . 10.0 113.398 -167.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -62.98 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.767 1.783 . . . . 10.0 107.78 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.52 -25.89 14.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.353 1.461 . . . . 10.0 110.46 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.55 167.12 31.16 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.249 -0.907 . . . . 10.0 111.694 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.88 115.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.781 1.232 . . . . 10.0 109.002 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.31 167.32 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.001 -1.687 . . . . 10.0 110.508 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.67 40.98 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.271 1.028 . . . . 10.0 108.853 172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.4 41.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.21 0.819 . . . . 10.0 113.21 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.195 0.998 . . . . 10.0 108.676 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.53 -179.08 2.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 125.047 3.831 . . . . 10.0 112.266 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.87 34.04 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.739 1.215 . . . . 10.0 107.944 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.1 179.04 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.415 2.076 . . . . 10.0 112.58 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.8 m -127.35 168.3 20.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 126.866 2.067 . . . . 10.0 108.949 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.11 -61.8 1.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.812 2.045 . . . . 10.0 110.493 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.85 165.37 21.14 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 127.305 2.242 . . . . 10.0 105.394 163.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.91 -164.61 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.608 2.206 . . . . 10.0 110.201 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.75 2.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.45 133.76 45.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.01 0.924 . . . . 10.0 108.77 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.79 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 169.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.24 139.08 35.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.47 130.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.939 -1.874 . . . . 10.0 105.939 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.13 108.06 14.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.94 143.32 54.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.303 1.041 . . . . 10.0 108.58 162.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.8 131.1 53.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 158.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.34 176.86 7.11 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.376 1.07 . . . . 10.0 110.391 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.06 175.79 11.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.028 1.331 . . . . 10.0 109.525 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.47 -73.14 0.1 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.563 1.145 . . . . 10.0 112.937 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.95 4.53 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 124.858 1.218 . . . . 10.0 110.336 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.49 84.74 8.15 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.532 2.333 . . . . 10.0 106.102 -163.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.54 168.58 24.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.296 2.664 . . . . 10.0 109.217 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.93 -45.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.538 1.935 . . . . 10.0 112.064 -164.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.88 -53.03 13.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.754 2.022 . . . . 10.0 110.569 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.96 -49.94 75.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.472 1.509 . . . . 10.0 110.784 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.43 61.6 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.73 -16.85 27.74 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.727 1.611 . . . . 10.0 112.074 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.81 -67.21 0.41 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.115 1.325 . . . . 10.0 112.559 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.02 -9.17 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 122.076 1.777 . . . . 10.0 114.518 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.16 68.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.766 1.167 . . . . 10.0 108.806 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.17 -28.59 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.348 1.059 . . . . 10.0 113.85 -164.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.36 -60.29 3.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.79 1.236 . . . . 10.0 109.544 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.89 -35.38 78.34 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 CA-C-N 120.243 1.122 . . . . 10.0 112.918 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.28 -51.54 68.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.412 0.685 . . . . 10.0 110.34 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -59.01 -39.17 81.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.128 0.49 . . . . 10.0 110.231 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.81 -25.63 64.77 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.153 -0.967 . . . . 10.0 111.445 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.66 9.99 39.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.625 1.17 . . . . 10.0 112.868 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.405 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.0 mt -60.94 151.17 75.3 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 119.488 1.04 . . . . 10.0 110.994 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.07 169.7 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.982 3.121 . . . . 10.0 110.484 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.1 -4.1 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.024 1.33 . . . . 10.0 113.372 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.8 8.37 43.26 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.765 1.626 . . . . 10.0 110.532 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.44 164.33 32.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 O-C-N 121.164 -0.96 . . . . 10.0 108.863 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.93 140.91 28.59 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.435 -1.257 . . . . 10.0 108.29 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -120.84 134.13 55.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.759 0.314 . . . . 10.0 111.549 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.25 136.94 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.803 -0.635 . . . . 10.0 109.66 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -103.66 119.71 39.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.402 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.26 138.45 28.08 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.859 0.688 . . . . 10.0 112.859 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.5 152.81 23.38 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.027 2.485 . . . . 10.0 112.222 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.07 97.22 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -87.94 76.77 8.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.827 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.15 1.15 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.1 -48.1 3.41 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 119.903 -1.748 . . . . 10.0 112.787 168.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.51 -152.12 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.294 0.949 . . . . 10.0 110.783 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.81 -30.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.074 0.95 . . . . 10.0 112.003 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.4 -27.44 6.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.068 1.747 . . . . 10.0 113.367 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.86 -36.42 64.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.629 1.104 . . . . 10.0 110.485 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.93 -55.21 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.81 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.492 3.117 . . . . 10.0 112.21 170.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.21 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.352 1.453 . . . . 10.0 111.176 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.53 -41.81 70.13 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.789 -1.101 . . . . 10.0 112.535 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.53 -44.33 8.61 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.136 1.161 . . . . 10.0 114.136 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.8 -45.78 92.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.528 0.604 . . . . 10.0 110.304 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.32 -45.35 94.79 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 116.836 -1.554 . . . . 10.0 109.234 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -45.69 92.14 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.552 1.523 . . . . 10.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.978 1.711 . . . . 10.0 109.413 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.7 -28.91 66.24 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 118.881 -0.58 . . . . 10.0 111.806 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.72 -37.15 49.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.347 1.059 . . . . 10.0 110.699 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.5 56.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.653 -0.689 . . . . 10.0 111.634 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.6 61.71 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.974 0.797 . . . . 10.0 113.023 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.35 130.28 26.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.997 1.319 . . . . 10.0 109.315 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.57 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.981 -0.748 . . . . 10.0 108.981 -165.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.4 54.19 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 117.137 2.273 . . . . 10.0 117.137 -170.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.37 51.97 7.49 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.284 1.834 . . . . 10.0 112.113 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.91 -47.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.487 -1.244 . . . . 10.0 113.461 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.77 34.92 1.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.532 1.514 . . . . 10.0 113.067 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.749 -1.219 . . . . 10.0 108.929 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.2 -16.42 44.7 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.576 1.325 . . . . 10.0 114.576 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.52 -65.65 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.552 -1.213 . . . . 10.0 108.625 166.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.57 -46.78 73.77 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.391 1.451 . . . . 10.0 111.997 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.39 -40.62 82.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.459 1.503 . . . . 10.0 110.207 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.1 4.46 5.53 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.736 1.615 . . . . 10.0 112.884 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.23 -57.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.049 -2.204 . . . . 10.0 105.049 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.68 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.704 0.801 . . . . 10.0 112.618 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.26 64.8 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.06 0.845 . . . . 10.0 112.147 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.43 3.91 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.591 1.157 . . . . 10.0 108.802 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.41 87.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.476 1.51 . . . . 10.0 110.698 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.79 15.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.408 1.083 . . . . 10.0 113.372 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.97 -64.2 0.36 Allowed 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 128.226 2.61 . . . . 10.0 109.581 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.9 mt 54.52 44.63 28.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.789 1.635 . . . . 10.0 112.449 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.69 14.64 20.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 10.0 114.148 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.2 155.38 28.98 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 127.907 2.483 . . . . 10.0 107.643 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.27 -44.88 10.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.543 2.162 . . . . 10.0 109.972 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.09 -29.32 67.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.222 1.009 . . . . 10.0 111.124 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.53 -42.1 70.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.945 1.298 . . . . 10.0 110.353 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.93 -48.54 17.87 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.071 0.948 . . . . 10.0 108.901 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.16 -37.2 84.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 123.45 0.469 . . . . 10.0 111.412 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.95 78.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.285 1.434 . . . . 10.0 112.532 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.21 -41.66 61.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.559 0.744 . . . . 10.0 111.443 -177.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.38 -0.825 . . . . 10.0 110.411 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.75 30.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.766 0.826 . . . . 10.0 110.102 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.14 54.36 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.958 -1.468 . . . . 10.0 114.827 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.75 6.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.327 2.563 . . . . 10.0 112.604 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.98 49.24 4.11 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.54 132.93 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.177 -2.157 . . . . 10.0 105.177 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.76 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.642 0.777 . . . . 10.0 109.983 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.64 -37.04 86.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.732 -0.651 . . . . 10.0 110.375 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.92 -26.86 67.06 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.681 0.673 . . . . 10.0 111.732 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.7 -57.05 4.02 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.375 -1.713 . . . . 10.0 106.375 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.8 -59.56 4.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.846 1.258 . . . . 10.0 112.172 -166.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.55 -33.66 64.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -49.38 75.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.8 -41.3 92.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.587 1.155 . . . . 10.0 110.229 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.668 1.122 . . . . 10.0 110.831 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -92.68 38.98 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.674 0.789 . . . . 10.0 111.129 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.92 172.3 8.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.396 1.479 . . . . 10.0 111.569 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.2 -40.4 86.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.814 1.246 . . . . 10.0 110.439 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.5 -49.91 54.32 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.765 0.826 . . . . 10.0 110.445 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.49 -38.84 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.256 1.022 . . . . 10.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 1.7 mtmt -55.52 -33.34 63.68 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.025 0.93 . . . . 10.0 111.017 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.11 -48.47 19.8 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.854 -0.898 . . . . 10.0 110.854 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.42 -36.14 82.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.702 -0.881 . . . . 10.0 109.502 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.693 -1.146 . . . . 10.0 111.478 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 12.7 pt-20 -104.29 10.65 35.48 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.72 0.637 . . . . 10.0 111.853 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.3 tmtt? -102.65 -51.02 3.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.686 0.279 . . . . 10.0 110.495 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.74 -4.81 59.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.844 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.4 tmtt? -77.79 -45.38 24.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.852 0.358 . . . . 10.0 110.848 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.84 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.324 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 36.7 mt . . . . . 0 C--O 1.227 -0.113 0 CA-C-N 116.38 -0.373 . . . . 10.0 110.856 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 63.6 mtm . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 10.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.86 79.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.623 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.05 5.03 1.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.125 1.77 . . . . 10.0 113.493 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.43 36.75 26.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.93 2.092 . . . . 10.0 112.12 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 32' ' ' LEU . 90.4 t -69.35 135.04 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.24 -16.18 4.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.737 2.015 . . . . 10.0 110.277 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.3 -170.86 33.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.928 1.727 . . . . 10.0 112.772 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.54 152.97 61.44 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 127.253 2.221 . . . . 10.0 108.308 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.59 152.68 71.58 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.585 -1.006 . . . . 10.0 113.035 -6.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.87 144.27 30.11 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.272 1.429 . . . . 10.0 108.551 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.95 158.35 32.21 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.906 1.682 . . . . 10.0 108.218 163.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.934 -1.506 . . . . 10.0 106.934 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.0 t -104.06 135.16 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.17 10.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 133.175 4.59 . . . . 10.0 117.505 171.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.23 60.26 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.667 -1.629 . . . . 10.0 115.446 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.89 -41.28 1.04 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.989 1.895 . . . . 10.0 114.315 -170.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -112.78 107.62 16.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.315 -0.995 . . . . 10.0 108.315 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.07 113.42 24.55 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.495 1.918 . . . . 10.0 106.764 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.48 169.59 17.44 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 120.277 -1.514 . . . . 10.0 107.198 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.98 -178.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.62 0.368 . . . . 10.0 110.171 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.35 -50.09 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 128.552 2.741 . . . . 10.0 107.733 160.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 16.52 4.48 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.868 1.699 . . . . 10.0 114.373 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.27 -51.16 1.3 Allowed 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.825 1.313 . . . . 10.0 109.656 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.54 72.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.072 1.349 . . . . 10.0 112.174 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.62 -6.03 9.83 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.535 -1.147 . . . . 10.0 114.802 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.27 35.22 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.667 1.733 . . . . 10.0 109.929 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.92 -52.52 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.355 2.037 . . . . 10.0 111.736 -169.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -28.6 69.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.946 -1.096 . . . . 10.0 111.568 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.16 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.095 0.558 . . . . 10.0 110.351 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.71 -42.86 32.96 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.014 -1.054 . . . . 10.0 110.898 -169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.93 -31.77 73.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.908 0.776 . . . . 10.0 110.985 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.46 8.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.589 1.956 . . . . 10.0 108.103 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.47 -41.33 93.47 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 116.945 -1.502 . . . . 10.0 111.58 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.69 69.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.902 1.683 . . . . 10.0 111.746 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.06 65.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.902 0.481 . . . . 10.0 110.619 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.55 -42.57 96.82 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 10.0 111.217 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.14 -37.38 83.72 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.877 -1.139 . . . . 10.0 111.26 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.23 -51.94 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.284 0.947 . . . . 10.0 108.561 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.02 -43.06 63.53 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.618 1.167 . . . . 10.0 110.052 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.7 -0.27 33.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.173 -1.394 . . . . 10.0 113.188 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.487 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.25 9.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.679 1.591 . . . . 10.0 114.436 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -55.69 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.35 -20.32 66.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.115 -0.948 . . . . 10.0 111.772 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.46 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.108 3.363 . . . . 10.0 113.707 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.06 13.38 35.36 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.732 1.213 . . . . 10.0 113.151 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.92 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.942 2.097 . . . . 10.0 109.78 -163.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.138 1.775 . . . . 10.0 108.82 -179.321 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.194 -1.563 . . . . 10.0 109.194 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.08 73.77 0.15 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 127.131 2.172 . . . . 10.0 110.357 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.37 12.06 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.459 -2.155 . . . . 10.0 112.998 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.47 157.7 43.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.984 1.714 . . . . 10.0 108.041 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.18 132.82 44.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.735 -1.209 . . . . 10.0 107.735 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.38 49.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.62 52.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.67 1.128 . . . . 10.0 113.423 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -63.0 0.98 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.763 1.782 . . . . 10.0 107.77 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.38 -25.97 14.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 10.0 110.501 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -154.59 167.02 31.51 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.27 -0.894 . . . . 10.0 111.624 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.89 115.97 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.797 1.239 . . . . 10.0 108.996 -171.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.36 20.31 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 119.948 -1.72 . . . . 10.0 110.473 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.66 40.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.168 0.987 . . . . 10.0 108.815 172.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 m -67.25 -9.46 40.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.832 0.853 . . . . 10.0 113.219 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 m -129.32 74.37 81.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.195 0.998 . . . . 10.0 108.612 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.49 -179.12 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 125.139 3.892 . . . . 10.0 112.213 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.57 138.96 34.21 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.729 1.211 . . . . 10.0 107.934 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.13 179.17 5.67 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.369 2.046 . . . . 10.0 112.569 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.5 168.3 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.832 2.053 . . . . 10.0 108.947 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.89 1.67 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.834 2.054 . . . . 10.0 110.457 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.74 165.43 21.11 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.283 2.233 . . . . 10.0 105.397 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.99 -164.61 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.571 2.181 . . . . 10.0 110.213 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.68 2.45 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.269 -2.733 . . . . 10.0 106.269 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.47 133.79 45.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.137 0.975 . . . . 10.0 108.723 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.73 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.348 -1.723 . . . . 10.0 106.348 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.15 139.16 35.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.55 130.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.906 -1.887 . . . . 10.0 105.906 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.5 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.2 108.11 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.393 -1.336 . . . . 10.0 107.393 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.04 143.39 54.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.275 1.03 . . . . 10.0 108.583 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 158.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.27 176.85 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.433 1.093 . . . . 10.0 110.459 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.89 11.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.071 1.349 . . . . 10.0 109.502 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HD1' ' CG2' ' A' ' 98' ' ' ILE . 40.2 t80 -61.59 -73.09 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.615 1.166 . . . . 10.0 112.912 172.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.01 4.54 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.828 1.204 . . . . 10.0 110.392 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.9 t -113.57 84.8 8.37 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 127.471 2.308 . . . . 10.0 106.086 -163.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.56 168.6 23.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.279 2.653 . . . . 10.0 109.203 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.03 -45.75 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.46 1.904 . . . . 10.0 112.093 -165.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.79 -53.14 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.672 1.989 . . . . 10.0 110.597 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.88 -49.93 75.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.471 1.508 . . . . 10.0 110.817 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.54 61.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.68 -16.85 27.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.687 1.595 . . . . 10.0 112.071 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.2 0.41 Allowed Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 120.09 1.314 . . . . 10.0 112.621 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.09 -9.11 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 CA-C-N 121.994 1.748 . . . . 10.0 114.45 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.18 68.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.772 1.169 . . . . 10.0 108.827 167.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.23 -28.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.33 1.052 . . . . 10.0 113.816 -164.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 t -46.48 -60.25 3.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.763 1.225 . . . . 10.0 109.483 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.88 -35.35 78.57 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.348 1.16 . . . . 10.0 112.918 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.29 -51.59 68.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.349 0.659 . . . . 10.0 110.372 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.12 80.69 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.168 0.509 . . . . 10.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.6 64.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.094 -1.004 . . . . 10.0 111.39 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.13 39.65 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.535 1.134 . . . . 10.0 112.908 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.97 151.25 75.17 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 119.45 1.023 . . . . 10.0 110.968 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.1 169.69 21.57 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 124.053 3.169 . . . . 10.0 110.458 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.09 -4.16 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.024 1.33 . . . . 10.0 113.457 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.76 8.39 43.29 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.622 1.569 . . . . 10.0 110.587 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.46 164.85 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 O-C-N 121.117 -0.989 . . . . 10.0 108.884 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -145.66 136.18 24.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.477 -1.238 . . . . 10.0 108.413 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -115.4 137.65 51.82 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.778 0.323 . . . . 10.0 111.572 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.98 140.24 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.692 -0.686 . . . . 10.0 109.832 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -106.34 120.87 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.5 HD12 HG11 ' A' ' 30' ' ' VAL . 14.9 mt -121.83 138.76 29.05 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 112.692 0.627 . . . . 10.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.69 152.82 22.81 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.911 2.407 . . . . 10.0 112.287 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.16 98.05 9.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.5 mt -88.21 76.8 8.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.751 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.17 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.161 1.541 . . . . 10.0 115.161 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.09 -48.09 3.41 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 119.897 -1.752 . . . . 10.0 112.801 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.52 -152.06 1.56 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.317 0.961 . . . . 10.0 110.75 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.83 -30.76 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.108 0.963 . . . . 10.0 112.12 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.46 -27.39 6.42 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.064 1.745 . . . . 10.0 113.374 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.9 -36.48 64.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.606 1.094 . . . . 10.0 110.472 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.83 -55.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.495 3.118 . . . . 10.0 112.148 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.15 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 125.407 1.479 . . . . 10.0 111.294 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.59 -41.84 70.37 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 117.757 -1.116 . . . . 10.0 112.457 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.43 -44.32 8.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 114.186 1.18 . . . . 10.0 114.186 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.93 -45.71 92.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.685 0.615 . . . . 10.0 110.272 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.2 95.32 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 116.702 -1.618 . . . . 10.0 109.204 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.7 91.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.628 1.558 . . . . 10.0 110.764 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 126.004 1.722 . . . . 10.0 109.42 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.71 -28.89 66.21 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 118.887 -0.578 . . . . 10.0 111.8 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.78 -37.1 50.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.329 1.052 . . . . 10.0 110.625 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.89 -22.43 56.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.802 -0.618 . . . . 10.0 111.702 -170.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.33 14.55 61.84 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.897 0.761 . . . . 10.0 113.0 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.962 1.305 . . . . 10.0 109.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.36 -5.35 54.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 117.059 2.244 . . . . 10.0 117.059 -170.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.28 52.05 7.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.347 1.859 . . . . 10.0 112.092 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.98 -47.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.425 -1.274 . . . . 10.0 113.328 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.79 1.3 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.586 1.539 . . . . 10.0 113.175 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.33 -44.51 0.62 Allowed 'General case' 0 C--O 1.221 -0.44 0 O-C-N 120.805 -1.185 . . . . 10.0 108.948 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.51 45.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.541 1.311 . . . . 10.0 114.541 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.5 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.6 -1.19 . . . . 10.0 108.637 166.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.6 -46.78 73.88 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.347 1.43 . . . . 10.0 112.006 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.37 -40.51 82.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.468 1.507 . . . . 10.0 110.24 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.24 4.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.766 1.626 . . . . 10.0 112.847 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.4 ' CG2' ' HD1' ' A' ' 35' ' ' TYR . 61.4 mt -115.26 -57.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.033 -2.21 . . . . 10.0 105.033 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.62 -61.37 1.99 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.694 0.798 . . . . 10.0 112.6 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.12 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.073 0.851 . . . . 10.0 112.157 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.5 3.88 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.508 1.123 . . . . 10.0 108.758 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.545 1.538 . . . . 10.0 110.614 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.68 15.67 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.367 1.067 . . . . 10.0 113.322 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.5 tttm 70.07 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 128.17 2.588 . . . . 10.0 109.557 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.47 44.59 28.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.768 1.627 . . . . 10.0 112.475 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.59 20.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.295 1.438 . . . . 10.0 114.177 -173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 155.36 29.0 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 127.959 2.503 . . . . 10.0 107.655 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 -44.96 10.95 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 10.0 110.017 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.0 -29.36 67.54 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.191 0.997 . . . . 10.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.51 -42.15 70.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.983 1.313 . . . . 10.0 110.314 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.58 17.84 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.145 0.978 . . . . 10.0 108.876 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.16 84.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.408 0.443 . . . . 10.0 111.4 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.13 -46.85 79.04 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.328 1.451 . . . . 10.0 112.558 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.57 60.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.537 0.735 . . . . 10.0 111.466 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -77.02 -14.74 59.79 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.414 -0.804 . . . . 10.0 110.365 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.79 30.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.777 0.831 . . . . 10.0 110.115 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.99 10.12 54.07 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 117.981 -1.455 . . . . 10.0 114.847 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.31 8.71 6.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.365 2.583 . . . . 10.0 112.673 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.97 49.23 4.11 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.68 -1.368 . . . . 10.0 109.68 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.53 132.88 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.233 -2.136 . . . . 10.0 105.233 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -92.32 133.64 35.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.63 0.772 . . . . 10.0 110.021 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.59 -36.88 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.811 -0.614 . . . . 10.0 110.445 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.83 66.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.694 0.679 . . . . 10.0 111.687 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.64 -57.02 4.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.88 -59.54 4.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.826 1.25 . . . . 10.0 112.093 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.56 -33.64 64.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 -170.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 m -62.35 -49.38 75.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -65.68 -41.36 92.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.554 1.141 . . . . 10.0 110.212 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.17 -48.8 44.76 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.691 1.132 . . . . 10.0 110.789 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.58 38.97 1.02 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.639 0.776 . . . . 10.0 111.202 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.24 8.6 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 10.0 111.666 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.36 86.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.837 1.255 . . . . 10.0 110.512 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.88 55.05 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.719 0.808 . . . . 10.0 110.477 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.52 -38.79 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.209 1.004 . . . . 10.0 111.262 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.58 -33.23 63.73 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.009 0.923 . . . . 10.0 111.029 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.47 19.33 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.831 -0.908 . . . . 10.0 110.831 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.3 -36.16 82.77 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.703 -0.88 . . . . 10.0 109.616 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -33.87 76.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.661 -1.162 . . . . 10.0 111.488 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.59 -5.46 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.619 0.645 . . . . 10.0 112.127 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.1 mmtt -92.0 -48.74 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.52 0.2 . . . . 10.0 111.01 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.48 -9.02 59.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.818 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' HB2' HD12 ' A' ' 66' ' ' LEU . 12.4 tmtt? -79.36 -45.01 20.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.672 0.273 . . . . 10.0 110.629 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -19.43 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.203 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 51.4 mt . . . . . 0 C--O 1.225 -0.233 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.056 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 59.1 mtm . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.869 0.366 . . . . 10.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.85 80.28 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.929 -0.578 . . . . 10.0 109.666 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.02 5.04 1.75 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.093 1.757 . . . . 10.0 113.5 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.38 36.82 26.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.935 2.094 . . . . 10.0 112.029 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 32' ' ' LEU . 91.4 t -69.31 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.26 -16.16 4.02 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 126.783 2.033 . . . . 10.0 110.267 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.86 33.57 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.979 1.752 . . . . 10.0 112.791 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.57 152.98 61.37 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 127.282 2.233 . . . . 10.0 108.325 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.55 152.66 71.42 Favored 'Cis proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.61 -0.996 . . . . 10.0 113.082 -6.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.282 1.433 . . . . 10.0 108.581 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.92 158.39 32.08 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.779 1.632 . . . . 10.0 108.146 163.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.55 29.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.3 t -104.14 135.19 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.085 -1.45 . . . . 10.0 107.085 168.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.13 10.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.142 4.577 . . . . 10.0 117.517 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.73 20.1 60.42 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 117.753 -1.582 . . . . 10.0 115.531 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.84 -41.35 1.04 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.998 1.899 . . . . 10.0 114.365 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.81 107.58 16.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.277 -1.009 . . . . 10.0 108.277 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 126.511 1.924 . . . . 10.0 106.741 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.54 169.56 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.362 -1.461 . . . . 10.0 107.22 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.96 -178.79 1.28 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.606 0.362 . . . . 10.0 110.14 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.3 mt -46.23 -50.11 4.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 128.528 2.731 . . . . 10.0 107.778 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.1 16.52 4.49 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.927 1.727 . . . . 10.0 114.352 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.29 -51.16 1.3 Allowed 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.851 1.326 . . . . 10.0 109.692 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.5 72.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.068 1.347 . . . . 10.0 112.3 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.53 -5.9 9.92 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-O 118.542 -1.144 . . . . 10.0 114.774 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.81 174.24 35.11 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.672 1.736 . . . . 10.0 109.945 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.86 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.397 2.065 . . . . 10.0 111.73 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.06 -1.025 . . . . 10.0 111.561 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.16 66.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.094 0.558 . . . . 10.0 110.342 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.99 32.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.969 -1.082 . . . . 10.0 110.89 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.4 mt -63.77 -31.86 73.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.876 0.762 . . . . 10.0 110.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.45 -56.44 8.24 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.636 1.974 . . . . 10.0 108.036 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.59 -41.3 92.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 116.922 -1.513 . . . . 10.0 111.555 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.78 69.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 120.984 1.72 . . . . 10.0 111.7 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.47 -47.06 65.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.939 0.496 . . . . 10.0 110.643 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.55 -42.54 96.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.513 0.725 . . . . 10.0 111.228 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.02 -37.49 84.23 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 120.899 -1.126 . . . . 10.0 111.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.27 -51.89 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.234 0.925 . . . . 10.0 108.589 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.0 -43.09 63.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.567 1.147 . . . . 10.0 110.045 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.61 -0.37 33.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.11 -1.424 . . . . 10.0 113.164 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.3 9.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.62 1.568 . . . . 10.0 114.392 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.82 4.93 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.35 66.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 10.0 111.759 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.47 6.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 130.172 3.389 . . . . 10.0 113.689 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.11 13.34 35.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.724 1.21 . . . . 10.0 113.166 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.9 0.27 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.973 2.109 . . . . 10.0 109.806 -163.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.126 1.77 . . . . 10.0 108.834 -179.27 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.232 0 N-CA-C 109.179 -1.568 . . . . 10.0 109.179 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.69 0.15 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 127.152 2.181 . . . . 10.0 110.355 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 112.392 -2.185 . . . . 10.0 113.039 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.43 157.76 43.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.944 1.698 . . . . 10.0 108.057 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 m -131.25 132.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.39 49.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.57 52.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.67 1.129 . . . . 10.0 113.43 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 -63.02 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.86 1.83 . . . . 10.0 107.768 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -25.88 14.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.409 1.483 . . . . 10.0 110.572 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.68 167.0 31.64 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.234 -0.916 . . . . 10.0 111.614 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.82 115.98 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.816 1.246 . . . . 10.0 109.01 -171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.4 167.33 20.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.948 -1.72 . . . . 10.0 110.435 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.2 124.64 40.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.254 1.022 . . . . 10.0 108.883 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.48 41.69 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.816 0.846 . . . . 10.0 113.216 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 m -129.19 74.43 81.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.222 1.009 . . . . 10.0 108.667 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.57 -179.07 2.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 125.111 3.874 . . . . 10.0 112.261 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.91 34.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 124.716 1.207 . . . . 10.0 107.898 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.08 179.11 5.71 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.38 2.054 . . . . 10.0 112.665 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.52 168.26 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.828 2.051 . . . . 10.0 108.902 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -47.1 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.834 2.053 . . . . 10.0 110.45 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.4 21.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 127.37 2.268 . . . . 10.0 105.39 163.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.97 -164.59 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.576 2.184 . . . . 10.0 110.206 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.09 -112.66 2.45 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 106.382 -2.687 . . . . 10.0 106.382 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.15 0.98 . . . . 10.0 108.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.55 140.75 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.323 -1.732 . . . . 10.0 106.323 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -99.19 139.13 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -128.51 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.858 -1.905 . . . . 10.0 105.858 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 11.2 t -131.13 108.03 14.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -172.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.93 143.32 54.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.316 1.046 . . . . 10.0 108.573 162.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 158.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.419 1.088 . . . . 10.0 110.396 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.02 175.84 11.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.969 1.308 . . . . 10.0 109.471 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.51 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.625 1.17 . . . . 10.0 112.884 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.03 4.54 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.823 1.201 . . . . 10.0 110.312 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.58 84.81 8.4 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.412 2.285 . . . . 10.0 106.087 -163.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.47 168.49 24.18 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.4 2.733 . . . . 10.0 109.25 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.06 -45.69 0.28 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.447 1.899 . . . . 10.0 112.051 -165.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.13 12.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.764 2.026 . . . . 10.0 110.572 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.84 -49.98 75.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.389 1.476 . . . . 10.0 110.874 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.8 -13.49 61.57 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.7 -16.91 27.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 10.0 112.045 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.083 1.31 . . . . 10.0 112.554 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.92 -9.32 25.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.063 1.773 . . . . 10.0 114.466 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.1 69.24 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.746 1.157 . . . . 10.0 108.851 167.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.26 -28.58 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.846 1.054 . . . . 10.0 113.846 -164.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.37 -60.31 3.84 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.782 1.233 . . . . 10.0 109.524 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.44 78.62 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 120.266 1.131 . . . . 10.0 112.917 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.19 -51.65 68.46 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.382 0.673 . . . . 10.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.1 80.63 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.154 0.502 . . . . 10.0 110.265 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.97 -25.45 64.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.124 -0.985 . . . . 10.0 111.453 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.74 10.07 39.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.576 1.15 . . . . 10.0 112.887 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.95 151.23 75.1 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.511 1.05 . . . . 10.0 110.977 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.04 169.62 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 124.054 3.17 . . . . 10.0 110.477 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.03 -4.2 4.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.02 1.328 . . . . 10.0 113.434 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.66 8.43 43.36 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.688 1.595 . . . . 10.0 110.63 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.66 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 O-C-N 121.241 -0.912 . . . . 10.0 108.827 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -145.6 136.82 24.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.501 -1.227 . . . . 10.0 108.507 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -114.65 135.88 53.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.96 0.41 . . . . 10.0 111.704 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 1.4 t -139.26 139.81 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.425 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -108.8 121.62 45.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.191 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 18.7 mt -121.76 138.21 28.24 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 112.787 0.662 . . . . 10.0 112.787 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.71 152.85 22.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.0 2.467 . . . . 10.0 112.395 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.37 98.08 9.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.502 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.0 76.74 8.56 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.913 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.54 20.23 1.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.04 -48.12 3.43 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.879 -1.763 . . . . 10.0 112.827 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.48 -152.06 1.54 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.279 0.943 . . . . 10.0 110.791 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.79 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.04 0.936 . . . . 10.0 112.07 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.49 6.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.093 1.757 . . . . 10.0 113.336 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.85 -36.43 64.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.642 1.11 . . . . 10.0 110.573 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.89 -55.17 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.9 31.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.49 3.116 . . . . 10.0 112.192 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 125.383 1.468 . . . . 10.0 111.23 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.55 -41.87 70.29 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 117.721 -1.133 . . . . 10.0 112.45 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.44 8.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 114.129 1.159 . . . . 10.0 114.129 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.87 -45.71 92.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.525 0.602 . . . . 10.0 110.26 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.45 -45.24 95.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 116.71 -1.614 . . . . 10.0 109.257 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.67 92.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.628 1.558 . . . . 10.0 110.835 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.029 1.732 . . . . 10.0 109.448 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.72 -28.94 66.23 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 118.909 -0.567 . . . . 10.0 111.805 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.68 -37.2 49.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.33 1.052 . . . . 10.0 110.677 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.88 -22.44 56.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.63 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.43 14.47 61.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.85 0.738 . . . . 10.0 112.955 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.32 130.23 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.994 1.318 . . . . 10.0 109.261 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.54 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.574 0.75 . . . . 10.0 109.011 -165.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.29 -5.4 54.35 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 117.067 2.247 . . . . 10.0 117.067 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.99 7.49 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.332 1.853 . . . . 10.0 112.072 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.96 -47.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 117.413 -1.28 . . . . 10.0 113.431 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.84 34.85 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.599 1.545 . . . . 10.0 113.183 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.44 -44.43 0.61 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.814 -1.179 . . . . 10.0 108.938 172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.57 45.68 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.484 1.291 . . . . 10.0 114.484 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.47 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 117.588 -1.196 . . . . 10.0 108.654 166.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.63 -46.75 73.96 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.368 1.44 . . . . 10.0 111.98 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.53 -40.54 83.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.458 1.503 . . . . 10.0 110.14 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.12 4.49 5.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 112.883 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.24 -57.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.002 -2.221 . . . . 10.0 105.002 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.57 -61.29 2.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.764 0.825 . . . . 10.0 112.621 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.36 -21.27 64.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.09 0.859 . . . . 10.0 112.136 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.41 -53.48 3.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.571 1.148 . . . . 10.0 108.799 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.556 1.542 . . . . 10.0 110.618 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.29 13.73 15.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.411 1.084 . . . . 10.0 113.328 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.96 -64.29 0.36 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.26 2.624 . . . . 10.0 109.537 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.54 44.73 28.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.768 1.627 . . . . 10.0 112.417 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.73 14.51 21.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.267 1.427 . . . . 10.0 114.137 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.05 155.45 29.21 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 127.983 2.513 . . . . 10.0 107.679 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.27 -44.99 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 10.0 109.936 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.97 -29.41 67.62 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.175 0.99 . . . . 10.0 111.182 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.08 70.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.981 1.313 . . . . 10.0 110.386 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.98 -48.52 17.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.15 0.98 . . . . 10.0 108.895 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 123.396 0.435 . . . . 10.0 111.357 -172.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.12 -46.9 79.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.235 1.414 . . . . 10.0 112.506 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.2 -41.73 60.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.543 0.737 . . . . 10.0 111.388 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.89 -14.75 59.84 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.31 -0.869 . . . . 10.0 110.378 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.78 30.72 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.766 0.827 . . . . 10.0 110.1 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.97 10.14 53.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.93 -1.483 . . . . 10.0 114.85 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.41 8.88 6.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.389 2.595 . . . . 10.0 112.601 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 49.3 4.12 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.638 -1.385 . . . . 10.0 109.638 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.6 132.96 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.39 133.73 35.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.615 0.766 . . . . 10.0 109.993 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.66 -36.96 85.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.729 -0.653 . . . . 10.0 110.375 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.01 -26.81 66.97 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.692 0.678 . . . . 10.0 111.75 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.04 4.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.328 -1.73 . . . . 10.0 106.328 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.9 -59.48 4.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.831 1.252 . . . . 10.0 112.156 -166.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.57 -33.63 64.74 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.296 -0.261 . . . . 10.0 110.296 -170.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 m -62.32 -49.43 75.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.34 92.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.571 1.148 . . . . 10.0 110.264 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.24 -48.71 45.46 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.658 1.117 . . . . 10.0 110.837 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.61 38.92 1.02 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.66 0.784 . . . . 10.0 111.278 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.29 8.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.372 1.469 . . . . 10.0 111.694 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.31 86.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.775 1.23 . . . . 10.0 110.562 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.92 54.54 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.677 0.791 . . . . 10.0 110.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.44 -38.83 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.191 0.997 . . . . 10.0 111.269 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.26 63.72 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.059 0.944 . . . . 10.0 110.974 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.3 -48.38 19.3 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.17 82.8 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.766 -0.844 . . . . 10.0 109.582 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 117.802 -1.094 . . . . 10.0 111.557 178.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.78 3.86 37.28 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.698 0.624 . . . . 10.0 112.09 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -99.06 -45.95 5.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.714 0.292 . . . . 10.0 110.697 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.63 -8.69 55.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.738 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -77.28 -44.31 30.22 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.753 0.311 . . . . 10.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -18.27 58.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.157 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 C--O 1.226 -0.144 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.201 179.661 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 mtm . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.776 0.322 . . . . 10.0 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.91 78.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.615 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -69.98 4.96 1.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.142 1.777 . . . . 10.0 113.518 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.5 36.73 26.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.976 2.11 . . . . 10.0 112.064 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.39 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 172.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.23 -16.08 4.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.672 1.989 . . . . 10.0 110.284 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.34 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.959 1.742 . . . . 10.0 112.744 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.5 153.02 61.67 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.329 2.252 . . . . 10.0 108.336 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.56 152.74 71.52 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.57 -1.012 . . . . 10.0 113.086 -6.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.9 m -145.95 144.22 30.0 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.281 1.432 . . . . 10.0 108.562 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.86 158.42 31.91 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.832 1.653 . . . . 10.0 108.294 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.975 -1.491 . . . . 10.0 106.975 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.5 t -103.97 135.2 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 168.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 t30 47.02 10.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 1 C-N-CA 133.145 4.578 . . . . 10.0 117.546 171.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.66 20.13 60.48 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.839 -1.534 . . . . 10.0 115.605 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.81 -41.31 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.897 1.849 . . . . 10.0 114.353 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -112.87 107.59 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.46 24.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 126.54 1.936 . . . . 10.0 106.713 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.58 169.61 17.42 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.297 -1.502 . . . . 10.0 107.162 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.81 1.28 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.643 0.377 . . . . 10.0 110.175 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.25 -50.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 128.557 2.743 . . . . 10.0 107.687 160.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.04 16.53 4.43 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.952 1.739 . . . . 10.0 114.354 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.772 1.286 . . . . 10.0 109.689 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.47 -34.49 72.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.098 1.359 . . . . 10.0 112.283 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.5 -5.9 9.95 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-O 118.554 -1.137 . . . . 10.0 114.852 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.28 35.23 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.614 1.707 . . . . 10.0 109.913 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.54 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.378 2.052 . . . . 10.0 111.816 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.39 -28.63 69.92 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.006 -1.059 . . . . 10.0 111.488 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.47 -27.15 66.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.104 0.562 . . . . 10.0 110.344 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.7 -42.84 33.05 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.971 -1.081 . . . . 10.0 110.928 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.8 -31.91 73.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.926 0.784 . . . . 10.0 110.975 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.45 8.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.637 1.975 . . . . 10.0 108.079 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.6 -41.3 92.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 116.898 -1.525 . . . . 10.0 111.53 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.74 69.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.987 1.721 . . . . 10.0 111.693 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.04 65.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 10.0 110.592 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.45 -42.63 96.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.604 0.762 . . . . 10.0 111.254 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.12 -37.43 83.86 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.958 -1.089 . . . . 10.0 111.219 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.7 mt -58.23 -51.93 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.265 0.939 . . . . 10.0 108.604 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.97 -43.08 63.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.579 1.151 . . . . 10.0 110.07 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.64 -0.37 33.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.183 -1.389 . . . . 10.0 113.157 -175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.521 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.05 -33.33 9.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.656 1.582 . . . . 10.0 114.442 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -55.72 5.02 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.445 -1.317 . . . . 10.0 107.445 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.34 -20.32 66.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 10.0 111.756 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.36 6.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.08 3.352 . . . . 10.0 113.694 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 13.39 35.29 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.729 1.212 . . . . 10.0 113.111 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.31 76.93 0.27 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.886 2.075 . . . . 10.0 109.827 -163.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.13 1.772 . . . . 10.0 108.878 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 109.175 -1.57 . . . . 10.0 109.175 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.22 73.71 0.15 Allowed 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 127.046 2.138 . . . . 10.0 110.324 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.467 -2.151 . . . . 10.0 113.053 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.47 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.995 1.718 . . . . 10.0 108.063 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.18 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.44 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.66 52.29 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.67 1.129 . . . . 10.0 113.405 -167.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.11 0.97 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.794 1.797 . . . . 10.0 107.745 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.37 -25.94 14.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.383 1.473 . . . . 10.0 110.528 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.08 31.3 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.345 -0.847 . . . . 10.0 111.694 -171.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.87 115.85 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.874 1.27 . . . . 10.0 109.07 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.33 167.37 20.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 119.924 -1.735 . . . . 10.0 110.5 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.64 40.88 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.261 1.024 . . . . 10.0 108.9 172.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.29 -9.55 41.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.816 0.846 . . . . 10.0 113.22 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.1 m -129.23 74.39 81.07 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.255 1.022 . . . . 10.0 108.692 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.53 -179.0 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 125.084 3.856 . . . . 10.0 112.231 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.69 138.91 34.13 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.685 1.194 . . . . 10.0 107.905 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.05 179.12 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.474 2.116 . . . . 10.0 112.593 176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.57 168.24 21.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.845 2.058 . . . . 10.0 108.902 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -46.99 -61.88 1.67 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.817 2.047 . . . . 10.0 110.489 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.37 21.27 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 127.319 2.248 . . . . 10.0 105.378 163.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.91 -164.64 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.524 2.149 . . . . 10.0 110.237 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.16 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.355 -2.698 . . . . 10.0 106.355 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.49 133.76 46.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.03 0.932 . . . . 10.0 108.744 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.78 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.312 -1.736 . . . . 10.0 106.312 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.16 139.14 35.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.3 t -128.5 130.35 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.11 108.13 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.42 54.36 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.219 1.008 . . . . 10.0 108.524 162.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.86 131.1 53.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 158.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.28 176.78 7.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.515 1.126 . . . . 10.0 110.414 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.0 175.83 11.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.008 1.323 . . . . 10.0 109.469 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.48 -73.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 10.0 112.905 172.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.08 4.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.824 1.202 . . . . 10.0 110.322 -171.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.55 84.73 8.26 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 127.472 2.309 . . . . 10.0 106.115 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.5 168.6 23.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.281 2.654 . . . . 10.0 109.252 171.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.446 1.898 . . . . 10.0 112.068 -165.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.73 -53.22 12.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.736 2.015 . . . . 10.0 110.542 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.89 -49.88 76.13 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.349 1.46 . . . . 10.0 110.877 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.88 -13.4 61.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.683 0.623 . . . . 10.0 112.683 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.83 -16.73 27.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.659 1.584 . . . . 10.0 112.029 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.72 -67.26 0.41 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.081 1.309 . . . . 10.0 112.569 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.08 -9.13 25.49 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 122.031 1.761 . . . . 10.0 114.411 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.29 68.97 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 10.0 108.781 167.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.46 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.906 1.076 . . . . 10.0 113.906 -164.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.37 -60.39 3.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 10.0 109.505 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.18 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.255 1.127 . . . . 10.0 112.996 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.6 t90 -57.18 -51.64 68.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.407 0.683 . . . . 10.0 110.367 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.2 80.74 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.171 0.51 . . . . 10.0 110.279 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.53 64.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.211 -0.931 . . . . 10.0 111.393 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.7 10.13 39.62 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.613 1.165 . . . . 10.0 112.905 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.409 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.99 151.25 75.4 Favored Pre-proline 0 C--O 1.237 0.416 0 CA-C-N 119.483 1.038 . . . . 10.0 110.953 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.13 169.75 21.44 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.003 3.135 . . . . 10.0 110.509 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -4.14 4.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.973 1.309 . . . . 10.0 113.394 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.41 43.33 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.671 1.588 . . . . 10.0 110.61 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.49 164.97 30.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 121.141 -0.974 . . . . 10.0 108.809 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -145.81 137.25 24.94 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.497 -1.229 . . . . 10.0 108.402 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -115.45 137.07 52.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.913 0.387 . . . . 10.0 111.553 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.08 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.468 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -109.17 126.75 53.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.255 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -127.07 139.19 34.42 Favored Pre-proline 0 N--CA 1.462 0.172 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.23 153.16 21.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.974 2.449 . . . . 10.0 112.241 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.87 99.02 10.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.296 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -88.18 76.9 8.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.757 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.69 20.26 1.17 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.122 1.527 . . . . 10.0 115.122 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.1 3.43 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 119.886 -1.759 . . . . 10.0 112.852 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.08 1.53 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.292 0.949 . . . . 10.0 110.78 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.83 -30.78 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.088 0.955 . . . . 10.0 112.057 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.43 -27.44 6.45 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.124 1.77 . . . . 10.0 113.337 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.87 -36.37 64.81 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.661 1.119 . . . . 10.0 110.588 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.88 -55.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.533 3.133 . . . . 10.0 112.171 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.13 -42.5 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 125.336 1.446 . . . . 10.0 111.239 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.59 -41.9 70.43 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.778 -1.106 . . . . 10.0 112.471 -175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.38 -44.34 8.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 114.183 1.179 . . . . 10.0 114.183 -173.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.9 -45.77 92.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.49 0.586 . . . . 10.0 110.201 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -45.31 94.95 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 116.761 -1.59 . . . . 10.0 109.205 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.7 92.0 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.601 1.546 . . . . 10.0 110.789 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -60.59 3.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.015 1.726 . . . . 10.0 109.35 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.7 -28.92 66.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 118.963 -0.542 . . . . 10.0 111.767 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.63 -37.22 49.24 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.401 1.081 . . . . 10.0 110.71 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.86 -22.46 56.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.606 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.34 14.54 61.84 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.906 0.765 . . . . 10.0 113.0 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.37 130.28 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.932 1.293 . . . . 10.0 109.326 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -123.54 75.96 1.37 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -165.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.27 -5.37 54.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.11 2.263 . . . . 10.0 117.11 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.32 52.02 7.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.343 1.857 . . . . 10.0 112.071 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 117.484 -1.246 . . . . 10.0 113.368 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.83 34.91 1.3 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.565 1.529 . . . . 10.0 113.14 -176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.42 -44.5 0.61 Allowed 'General case' 0 C--O 1.219 -0.505 0 O-C-N 120.822 -1.174 . . . . 10.0 108.899 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.44 44.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.45 -65.62 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 117.654 -1.165 . . . . 10.0 108.673 166.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.61 -46.81 73.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.255 1.389 . . . . 10.0 111.98 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.56 82.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.406 1.482 . . . . 10.0 110.186 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.11 4.5 5.47 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.76 1.624 . . . . 10.0 112.896 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.21 -57.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.071 -2.196 . . . . 10.0 105.071 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.65 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.706 0.802 . . . . 10.0 112.615 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.34 -21.1 64.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.115 0.87 . . . . 10.0 112.217 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.52 -53.48 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.591 1.157 . . . . 10.0 108.772 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.44 87.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.571 1.548 . . . . 10.0 110.671 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.18 13.75 15.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.399 1.08 . . . . 10.0 113.389 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.94 -64.25 0.36 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.207 2.603 . . . . 10.0 109.567 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.7 mt 54.61 44.53 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.764 1.626 . . . . 10.0 112.504 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.56 20.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.269 1.428 . . . . 10.0 114.208 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.33 28.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 127.921 2.488 . . . . 10.0 107.682 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.11 -45.04 10.87 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.575 2.183 . . . . 10.0 109.968 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.3 67.39 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.232 1.013 . . . . 10.0 111.175 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.56 -42.08 70.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.941 1.297 . . . . 10.0 110.336 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.55 17.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.208 1.003 . . . . 10.0 108.886 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.2 84.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 122.76 0.424 . . . . 10.0 111.418 -172.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.93 78.75 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.279 1.432 . . . . 10.0 112.569 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.65 61.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.535 0.734 . . . . 10.0 111.448 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.371 -0.83 . . . . 10.0 110.366 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.79 30.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.893 0.877 . . . . 10.0 110.095 172.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.09 54.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.917 -1.49 . . . . 10.0 114.773 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.84 6.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 121.358 2.579 . . . . 10.0 112.652 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.25 4.12 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.629 -1.388 . . . . 10.0 109.629 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.57 132.95 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 105.161 -2.163 . . . . 10.0 105.161 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.65 35.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.611 0.764 . . . . 10.0 110.005 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.53 -37.03 86.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.791 -0.623 . . . . 10.0 110.366 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.06 -26.8 66.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.733 0.697 . . . . 10.0 111.717 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.03 4.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.95 -59.45 4.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.829 1.252 . . . . 10.0 112.192 -166.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.56 -33.69 64.79 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.226 -0.287 . . . . 10.0 110.226 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 m -62.2 -49.49 75.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.75 -41.27 92.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.518 1.127 . . . . 10.0 110.255 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.15 -48.71 44.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.723 1.147 . . . . 10.0 110.84 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.66 38.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.697 0.799 . . . . 10.0 111.191 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.31 8.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.413 1.485 . . . . 10.0 111.624 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.19 -40.36 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.852 1.261 . . . . 10.0 110.473 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.84 55.59 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.682 0.793 . . . . 10.0 110.46 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.5 -38.84 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.244 1.018 . . . . 10.0 111.261 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.23 63.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 10.0 111.001 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.41 19.48 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.2 82.93 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.732 -0.863 . . . . 10.0 109.553 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.421 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.32 -34.15 77.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.74 -1.124 . . . . 10.0 111.432 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.12 1.76 39.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.749 0.704 . . . . 10.0 111.922 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.5 -52.91 3.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.587 0.232 . . . . 10.0 110.533 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.31 -5.88 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.137 0.421 . . . . 10.0 112.137 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 66' ' ' LEU . 4.0 tmmt? -79.1 -45.92 19.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.938 0.399 . . . . 10.0 110.821 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -19.59 59.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.164 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 54.6 mt . . . . . 0 C--O 1.227 -0.084 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.605 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.74 0.305 . . . . 10.0 111.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.87 82.97 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.631 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 5.04 1.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.158 1.783 . . . . 10.0 113.558 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.41 36.74 26.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.916 2.086 . . . . 10.0 112.077 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.442 HG21 HD22 ' A' ' 32' ' ' LEU . 90.6 t -69.3 135.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.729 -1.211 . . . . 10.0 107.729 172.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.2 -16.08 4.06 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.637 1.975 . . . . 10.0 110.261 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -170.89 33.64 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.036 1.779 . . . . 10.0 112.853 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.49 153.02 61.71 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.271 2.228 . . . . 10.0 108.299 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.57 152.65 71.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.561 -1.016 . . . . 10.0 113.152 -6.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.6 m -145.81 144.3 30.19 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.317 1.447 . . . . 10.0 108.583 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.96 158.39 32.15 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.837 1.655 . . . . 10.0 108.19 163.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.5 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.6 t -104.08 135.16 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 107.117 -1.438 . . . . 10.0 107.117 168.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.09 10.97 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 133.19 4.596 . . . . 10.0 117.463 171.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.11 60.57 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.77 -1.572 . . . . 10.0 115.57 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.89 -41.31 1.04 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.976 1.888 . . . . 10.0 114.325 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.77 107.58 16.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.01 113.37 24.46 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 126.549 1.94 . . . . 10.0 106.765 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.62 17.39 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 120.344 -1.473 . . . . 10.0 107.159 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.92 -178.82 1.3 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.603 0.361 . . . . 10.0 110.171 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.28 -50.06 5.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 128.483 2.713 . . . . 10.0 107.811 160.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.53 4.5 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.849 1.69 . . . . 10.0 114.365 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.25 -51.25 1.3 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.759 1.28 . . . . 10.0 109.697 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.6 72.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.1 1.36 . . . . 10.0 112.238 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.51 -5.87 9.94 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.489 -1.173 . . . . 10.0 114.844 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.79 174.31 35.17 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.699 1.749 . . . . 10.0 110.012 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.86 -52.57 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.391 2.061 . . . . 10.0 111.81 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.37 -28.66 69.92 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.907 -1.121 . . . . 10.0 111.478 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.16 66.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.044 0.538 . . . . 10.0 110.406 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.63 -42.94 33.08 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.079 -1.013 . . . . 10.0 110.938 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.96 73.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.941 0.791 . . . . 10.0 111.01 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.47 8.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.604 1.962 . . . . 10.0 108.057 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.61 -41.27 92.94 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 116.888 -1.53 . . . . 10.0 111.508 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.81 69.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 121.017 1.735 . . . . 10.0 111.663 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.46 -47.01 65.33 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.844 0.458 . . . . 10.0 110.661 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.5 -42.64 96.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.581 0.752 . . . . 10.0 111.245 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.07 -37.39 83.94 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.922 -1.111 . . . . 10.0 111.247 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.26 -51.92 65.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 119.265 0.939 . . . . 10.0 108.553 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.03 -43.1 63.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.622 1.169 . . . . 10.0 109.972 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.69 -0.29 33.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.15 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.38 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.647 1.579 . . . . 10.0 114.425 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -55.77 4.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.833 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.71 -35.54 6.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.174 3.389 . . . . 10.0 113.65 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.08 13.42 35.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.682 1.193 . . . . 10.0 113.105 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.34 76.87 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.93 2.092 . . . . 10.0 109.837 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.113 1.765 . . . . 10.0 108.797 -179.227 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.254 0 N-CA-C 109.17 -1.572 . . . . 10.0 109.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.15 73.76 0.15 Allowed 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 127.166 2.186 . . . . 10.0 110.312 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.96 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 112.4 -2.182 . . . . 10.0 113.047 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.44 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.09 1.756 . . . . 10.0 108.037 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.21 132.85 44.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.676 -1.231 . . . . 10.0 107.676 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.41 49.34 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.79 52.37 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.734 1.159 . . . . 10.0 113.375 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 -63.05 0.97 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 119.857 1.828 . . . . 10.0 107.69 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.46 -25.93 14.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.406 1.482 . . . . 10.0 110.517 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.53 167.12 31.15 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.275 -0.891 . . . . 10.0 111.789 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.0 115.98 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.775 1.23 . . . . 10.0 108.968 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.41 20.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.908 -1.745 . . . . 10.0 110.457 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.29 124.64 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.238 1.015 . . . . 10.0 108.822 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.28 -9.5 41.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.86 0.864 . . . . 10.0 113.197 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 m -129.32 74.52 80.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 10.0 108.633 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.63 -179.09 2.62 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 125.095 3.863 . . . . 10.0 112.217 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.82 33.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.716 1.206 . . . . 10.0 107.928 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.97 179.13 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.406 2.071 . . . . 10.0 112.616 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.48 168.2 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 126.926 2.09 . . . . 10.0 108.906 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.76 1.73 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.785 2.034 . . . . 10.0 110.503 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.86 165.32 21.32 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.37 2.268 . . . . 10.0 105.435 163.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.8 -164.72 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.631 2.221 . . . . 10.0 110.249 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.18 -112.72 2.46 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.277 -2.729 . . . . 10.0 106.277 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.37 133.66 45.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.142 0.977 . . . . 10.0 108.739 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.62 140.84 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.355 -1.72 . . . . 10.0 106.355 169.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.27 139.14 35.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.53 130.42 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.828 -1.916 . . . . 10.0 105.828 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 63' ' ' LEU . 11.2 t -131.16 108.07 14.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.335 . . . . 10.0 107.394 -172.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.99 143.37 54.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.292 1.037 . . . . 10.0 108.568 162.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.77 131.05 53.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.898 -0.779 . . . . 10.0 108.898 158.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.475 1.11 . . . . 10.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.79 11.78 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.111 1.364 . . . . 10.0 109.533 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.46 -73.15 0.1 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.694 1.198 . . . . 10.0 112.891 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.96 52.02 4.54 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.813 1.197 . . . . 10.0 110.307 -171.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.57 84.83 8.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.437 2.295 . . . . 10.0 106.03 -163.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.55 168.51 24.2 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.33 2.687 . . . . 10.0 109.246 171.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.1 -45.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.457 1.903 . . . . 10.0 112.091 -165.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.76 -53.14 12.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 10.0 110.577 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.86 -50.05 75.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.332 1.453 . . . . 10.0 110.824 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.7 -13.55 61.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.71 -16.92 27.64 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.764 1.625 . . . . 10.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.59 -67.3 0.4 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 120.11 1.323 . . . . 10.0 112.587 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.21 25.72 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-N 122.052 1.768 . . . . 10.0 114.469 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.9 -43.12 68.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.734 1.152 . . . . 10.0 108.765 167.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 tt -105.27 -28.48 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -164.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.7 t -46.44 -60.33 3.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.817 1.247 . . . . 10.0 109.475 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.2 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.277 1.135 . . . . 10.0 113.002 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.25 -51.61 68.66 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.356 0.663 . . . . 10.0 110.366 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.99 -39.12 80.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.091 0.472 . . . . 10.0 110.223 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.84 -25.64 64.75 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.178 -0.951 . . . . 10.0 111.431 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.01 39.77 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.607 1.163 . . . . 10.0 112.923 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.99 151.25 75.38 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 119.493 1.042 . . . . 10.0 110.938 174.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.1 169.74 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.967 3.111 . . . . 10.0 110.541 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -4.2 4.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.018 1.327 . . . . 10.0 113.428 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.39 43.34 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.705 1.602 . . . . 10.0 110.533 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.53 164.87 30.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 121.245 -0.909 . . . . 10.0 108.796 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.53 135.0 21.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.568 -1.196 . . . . 10.0 108.431 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -113.82 138.98 49.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.855 0.359 . . . . 10.0 111.733 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.23 142.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.484 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -109.09 122.34 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.186 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.7 mt -121.59 138.29 28.18 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.76 153.14 22.76 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.937 2.425 . . . . 10.0 112.211 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.69 97.78 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.433 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.12 76.78 8.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.798 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.64 20.31 1.15 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.176 1.547 . . . . 10.0 115.176 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.02 -48.13 3.43 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.937 -1.727 . . . . 10.0 112.88 168.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 -152.14 1.53 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.342 0.973 . . . . 10.0 110.737 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.82 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.154 0.982 . . . . 10.0 112.029 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.48 6.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.093 1.757 . . . . 10.0 113.347 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.88 -36.47 64.8 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.631 1.105 . . . . 10.0 110.464 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.79 -55.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -65.83 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.56 3.144 . . . . 10.0 112.237 170.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.22 -42.47 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 125.409 1.48 . . . . 10.0 111.226 173.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.62 -41.8 70.43 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.744 -1.122 . . . . 10.0 112.461 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.56 -44.26 8.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.119 1.155 . . . . 10.0 114.119 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -61.87 -45.8 92.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.568 0.622 . . . . 10.0 110.252 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.24 95.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 116.74 -1.6 . . . . 10.0 109.16 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.69 91.99 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.637 1.562 . . . . 10.0 110.775 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -60.6 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.017 1.727 . . . . 10.0 109.38 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.59 -29.02 66.47 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.962 -0.542 . . . . 10.0 111.855 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.64 -37.28 49.58 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.325 1.05 . . . . 10.0 110.669 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.6 mtp -75.74 -22.49 56.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.72 -0.657 . . . . 10.0 111.709 -170.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.44 61.85 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.844 0.735 . . . . 10.0 112.995 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.3 130.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.957 1.303 . . . . 10.0 109.314 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.59 75.95 1.38 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.572 0.749 . . . . 10.0 108.982 -165.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -5.36 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.077 2.251 . . . . 10.0 117.077 -170.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.39 51.91 7.54 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.352 1.861 . . . . 10.0 112.127 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.92 -47.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.42 -1.276 . . . . 10.0 113.419 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.78 34.84 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.589 1.541 . . . . 10.0 113.131 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.454 0 O-C-N 120.813 -1.179 . . . . 10.0 108.974 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.53 45.52 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -71.47 -65.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 117.556 -1.211 . . . . 10.0 108.698 166.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.75 74.06 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.389 1.45 . . . . 10.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.41 -40.6 82.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.478 1.511 . . . . 10.0 110.156 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.18 4.58 5.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.719 1.608 . . . . 10.0 112.871 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.08 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.56 -61.35 2.0 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.678 0.791 . . . . 10.0 112.671 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.2 64.8 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.045 0.839 . . . . 10.0 112.152 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.63 3.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.614 1.166 . . . . 10.0 108.772 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.55 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.543 1.537 . . . . 10.0 110.647 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.61 15.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.421 1.088 . . . . 10.0 113.331 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.0 -64.19 0.36 Allowed 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 128.266 2.626 . . . . 10.0 109.513 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.8 mt 54.52 44.58 28.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.764 1.625 . . . . 10.0 112.498 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.65 14.56 20.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.324 1.45 . . . . 10.0 114.224 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.42 29.11 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 127.984 2.514 . . . . 10.0 107.629 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.2 -44.92 10.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.551 2.167 . . . . 10.0 110.038 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.35 67.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.229 1.012 . . . . 10.0 111.133 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.48 -42.14 70.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.027 1.331 . . . . 10.0 110.333 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.86 -48.57 18.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.155 0.982 . . . . 10.0 108.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.24 84.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 123.402 0.439 . . . . 10.0 111.292 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.03 -46.9 78.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.378 1.471 . . . . 10.0 112.565 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.2 -41.69 61.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.556 0.742 . . . . 10.0 111.489 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.0 -14.72 59.8 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.367 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.76 30.65 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.86 0.864 . . . . 10.0 110.135 172.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.06 54.19 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 117.969 -1.462 . . . . 10.0 114.906 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.74 6.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.355 2.577 . . . . 10.0 112.674 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.95 49.35 4.08 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.67 132.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.138 -2.171 . . . . 10.0 105.138 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.26 133.7 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.63 0.772 . . . . 10.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.57 -37.0 86.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.375 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.76 66.87 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.721 0.691 . . . . 10.0 111.721 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.65 -57.1 4.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.796 1.238 . . . . 10.0 112.201 -166.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.57 -33.64 64.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.4 m -62.29 -49.5 75.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.28 92.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.522 1.129 . . . . 10.0 110.232 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.28 -48.72 45.79 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.726 1.148 . . . . 10.0 110.721 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.57 38.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.712 0.805 . . . . 10.0 111.195 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.84 172.32 8.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.361 1.464 . . . . 10.0 111.59 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.17 -40.45 86.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.824 1.25 . . . . 10.0 110.444 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.86 54.68 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.745 0.818 . . . . 10.0 110.495 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.47 -38.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.287 1.035 . . . . 10.0 111.321 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.32 63.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.07 0.948 . . . . 10.0 111.003 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.37 19.6 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.12 82.65 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.817 -0.814 . . . . 10.0 109.608 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -33.98 76.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.729 -1.129 . . . . 10.0 111.46 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.41 1.58 38.53 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.627 0.649 . . . . 10.0 112.136 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 11.7 mmtt -96.89 -47.14 5.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 10.0 110.91 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.13 -6.04 58.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -79.44 -44.96 20.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.923 0.392 . . . . 10.0 110.751 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -74.53 -21.21 59.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 37.8 mt . . . . . 0 C--O 1.225 -0.208 0 CA-C-N 116.207 -0.452 . . . . 10.0 111.1 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.1 mtm . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.763 0.316 . . . . 10.0 111.582 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.93 78.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.612 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.0 5.05 1.73 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 113.49 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.3 36.78 26.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.897 2.079 . . . . 10.0 112.127 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 32' ' ' LEU . 89.9 t -69.36 135.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.33 -16.04 4.01 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.701 2.0 . . . . 10.0 110.255 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.48 -170.92 33.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.892 1.71 . . . . 10.0 112.72 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.45 153.01 61.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.242 2.217 . . . . 10.0 108.309 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.53 152.67 71.37 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.599 -1.0 . . . . 10.0 113.07 -6.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.1 m -145.86 144.26 30.12 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.351 1.46 . . . . 10.0 108.634 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.94 158.39 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.823 1.649 . . . . 10.0 108.204 163.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.14 136.48 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.7 t -104.06 135.06 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.123 -1.436 . . . . 10.0 107.123 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.08 10.96 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.148 4.579 . . . . 10.0 117.561 171.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.57 20.28 60.34 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.803 -1.554 . . . . 10.0 115.52 -170.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.9 -41.4 1.03 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.962 1.881 . . . . 10.0 114.346 -170.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.69 107.58 16.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.553 1.941 . . . . 10.0 106.765 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.59 169.54 17.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.141 -1.429 . . . . 10.0 107.141 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.8 1.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.585 0.354 . . . . 10.0 110.193 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.26 -50.1 5.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 128.569 2.748 . . . . 10.0 107.717 160.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.13 16.57 4.48 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.834 1.683 . . . . 10.0 114.4 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -128.28 -51.21 1.3 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.793 1.297 . . . . 10.0 109.692 168.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.59 72.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.037 1.335 . . . . 10.0 112.298 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.54 -5.98 9.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 118.496 -1.169 . . . . 10.0 114.754 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.36 35.26 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 119.75 1.775 . . . . 10.0 110.046 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 -52.62 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.354 2.036 . . . . 10.0 111.724 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.27 -28.7 69.9 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.999 -1.063 . . . . 10.0 111.539 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.12 66.81 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.07 0.548 . . . . 10.0 110.409 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.69 -42.9 32.92 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.014 -1.054 . . . . 10.0 110.939 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.76 -31.83 73.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.91 0.777 . . . . 10.0 111.04 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.56 -56.4 8.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.502 1.921 . . . . 10.0 108.053 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.33 93.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 116.917 -1.516 . . . . 10.0 111.509 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.65 69.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.996 1.725 . . . . 10.0 111.729 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.58 -47.04 64.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.863 0.465 . . . . 10.0 110.58 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.45 -42.63 96.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.608 0.763 . . . . 10.0 111.256 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.08 -37.38 83.89 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 120.94 -1.1 . . . . 10.0 111.266 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.31 -51.89 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.261 0.937 . . . . 10.0 108.582 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.06 63.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.543 1.137 . . . . 10.0 110.064 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.63 -0.46 33.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 117.145 -1.407 . . . . 10.0 113.123 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.418 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.03 -33.37 9.29 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.627 1.571 . . . . 10.0 114.429 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -55.8 4.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.372 -1.344 . . . . 10.0 107.372 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.32 66.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.159 -0.928 . . . . 10.0 111.795 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.41 6.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 130.122 3.369 . . . . 10.0 113.73 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.16 13.51 34.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.653 1.181 . . . . 10.0 113.153 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.977 2.111 . . . . 10.0 109.819 -163.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.085 1.754 . . . . 10.0 108.787 -179.16 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.292 0 N-CA-C 109.203 -1.559 . . . . 10.0 109.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.66 0.15 Allowed 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 127.081 2.152 . . . . 10.0 110.423 -175.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.2 11.9 0.66 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 112.45 -2.159 . . . . 10.0 112.997 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.41 157.75 43.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.028 1.731 . . . . 10.0 108.009 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.25 132.81 44.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.48 49.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.187 -1.042 . . . . 10.0 108.187 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.6 13.73 52.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.713 1.149 . . . . 10.0 113.423 -166.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.03 0.98 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.858 1.829 . . . . 10.0 107.853 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -26.07 14.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.427 1.491 . . . . 10.0 110.45 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.5 167.14 31.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.25 -0.906 . . . . 10.0 111.702 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.91 115.98 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.802 1.241 . . . . 10.0 109.036 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.41 167.25 20.42 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.927 -1.733 . . . . 10.0 110.534 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.62 40.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.213 1.005 . . . . 10.0 108.835 172.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 m -67.32 -9.39 40.61 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.228 0.825 . . . . 10.0 113.228 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -129.35 74.39 81.0 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.14 0.976 . . . . 10.0 108.574 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.53 -179.08 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 125.095 3.864 . . . . 10.0 112.246 -172.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.91 34.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.681 1.193 . . . . 10.0 107.932 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.08 179.08 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.457 2.105 . . . . 10.0 112.601 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.48 168.23 20.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.801 2.04 . . . . 10.0 108.931 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.0 -61.8 1.71 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.808 2.043 . . . . 10.0 110.531 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.03 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.321 2.248 . . . . 10.0 105.34 163.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.9 -164.62 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.576 2.184 . . . . 10.0 110.229 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.67 2.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.323 -2.711 . . . . 10.0 106.323 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.51 133.79 46.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.075 0.95 . . . . 10.0 108.697 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.76 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.16 35.3 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.5 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.962 -1.866 . . . . 10.0 105.962 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.12 108.16 14.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -172.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.14 143.37 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.305 1.042 . . . . 10.0 108.463 162.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.73 131.14 53.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 158.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.42 176.82 7.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 10.0 110.381 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.82 11.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.0 109.464 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.47 -73.22 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.66 1.184 . . . . 10.0 112.842 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.06 4.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.778 1.18 . . . . 10.0 110.326 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.52 84.76 8.23 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 127.464 2.306 . . . . 10.0 106.111 -163.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.5 168.49 24.2 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.339 2.693 . . . . 10.0 109.239 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.07 -45.7 0.28 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.431 1.892 . . . . 10.0 112.081 -165.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.87 -53.09 12.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.767 2.027 . . . . 10.0 110.518 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.05 -49.87 76.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.423 1.489 . . . . 10.0 110.796 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.47 61.63 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -171.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.85 27.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.69 1.596 . . . . 10.0 112.046 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.6 -67.31 0.4 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.174 1.352 . . . . 10.0 112.56 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.0 -9.18 25.67 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 121.986 1.745 . . . . 10.0 114.425 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.2 69.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.812 1.187 . . . . 10.0 108.837 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.22 -28.49 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 113.874 1.065 . . . . 10.0 113.874 -164.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.43 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.746 1.218 . . . . 10.0 109.48 173.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.85 -35.39 78.65 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.273 1.133 . . . . 10.0 112.897 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.24 -51.66 68.47 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.431 0.693 . . . . 10.0 110.304 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.89 -39.22 80.79 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.169 0.509 . . . . 10.0 110.25 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.79 -25.71 64.84 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.096 -1.002 . . . . 10.0 111.415 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.07 39.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.513 1.125 . . . . 10.0 112.923 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.86 151.17 74.5 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 119.485 1.039 . . . . 10.0 110.971 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.07 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.987 3.125 . . . . 10.0 110.49 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.12 -4.19 4.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.011 1.324 . . . . 10.0 113.395 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.62 8.34 43.45 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.743 1.617 . . . . 10.0 110.627 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.52 164.94 30.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 O-C-N 121.189 -0.945 . . . . 10.0 108.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -146.08 137.07 24.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.402 -1.272 . . . . 10.0 108.444 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -117.3 135.64 53.68 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.804 0.335 . . . . 10.0 111.725 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.92 138.67 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.81 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -104.42 118.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.02 138.44 27.01 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.88 152.89 25.32 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.028 2.485 . . . . 10.0 112.4 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 96.96 8.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.271 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.1 76.8 8.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.363 -0.38 . . . . 10.0 111.776 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.22 1.16 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.132 1.53 . . . . 10.0 115.132 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.11 -48.18 3.42 Favored Glycine 0 N--CA 1.467 0.723 0 O-C-N 119.933 -1.729 . . . . 10.0 112.752 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.39 -152.13 1.52 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.389 0.995 . . . . 10.0 110.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.86 -30.75 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.077 0.951 . . . . 10.0 112.081 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.34 -27.52 6.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.049 1.74 . . . . 10.0 113.396 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.86 -36.46 64.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.66 1.118 . . . . 10.0 110.478 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.88 -55.14 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.94 31.91 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.519 3.128 . . . . 10.0 112.137 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 125.332 1.444 . . . . 10.0 111.196 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.47 -41.86 70.0 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.53 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.32 8.45 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.121 1.156 . . . . 10.0 114.121 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.89 -45.67 92.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.503 0.592 . . . . 10.0 110.335 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.38 -45.33 94.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.786 -1.578 . . . . 10.0 109.251 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.63 92.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.592 1.542 . . . . 10.0 110.829 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.6 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.99 1.716 . . . . 10.0 109.483 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.64 -29.03 66.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.919 -0.562 . . . . 10.0 111.789 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.57 -37.24 48.79 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.362 1.065 . . . . 10.0 110.701 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.8 -22.46 56.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.695 -170.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.46 61.83 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.871 0.748 . . . . 10.0 112.986 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.41 130.32 26.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 124.916 1.286 . . . . 10.0 109.277 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.87 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.605 0.762 . . . . 10.0 109.022 -165.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -5.39 54.26 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.103 2.26 . . . . 10.0 117.103 -170.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 51.96 7.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.313 1.845 . . . . 10.0 112.114 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.93 -47.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.455 -1.26 . . . . 10.0 113.381 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.93 34.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.576 1.535 . . . . 10.0 113.199 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.41 -44.57 0.61 Allowed 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.832 -1.167 . . . . 10.0 108.84 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.48 44.7 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.605 1.335 . . . . 10.0 114.605 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -71.53 -65.49 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 117.518 -1.23 . . . . 10.0 108.695 166.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.72 74.04 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.407 1.458 . . . . 10.0 112.048 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.49 -40.48 82.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.388 1.475 . . . . 10.0 110.241 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.3 4.65 5.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.818 1.647 . . . . 10.0 112.826 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.29 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.991 -2.225 . . . . 10.0 104.991 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.62 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.713 0.805 . . . . 10.0 112.625 -173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.26 -21.22 64.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.093 0.86 . . . . 10.0 112.189 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.42 -53.51 3.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.58 1.152 . . . . 10.0 108.831 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.38 88.03 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 10.0 110.656 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.63 15.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.382 1.073 . . . . 10.0 113.325 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.01 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 128.217 2.607 . . . . 10.0 109.57 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 41.0 mt 54.43 44.71 28.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.815 1.646 . . . . 10.0 112.436 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.6 20.63 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.284 1.434 . . . . 10.0 114.189 -173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 155.39 29.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 127.933 2.493 . . . . 10.0 107.643 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.2 -45.01 10.7 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.576 2.184 . . . . 10.0 109.937 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.36 67.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.208 1.003 . . . . 10.0 111.161 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.15 70.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.981 1.313 . . . . 10.0 110.322 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.53 18.03 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.165 0.986 . . . . 10.0 108.909 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.25 -37.16 84.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.461 0.476 . . . . 10.0 111.349 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.11 -46.89 78.95 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.324 1.45 . . . . 10.0 112.51 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.62 60.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.549 0.74 . . . . 10.0 111.412 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.95 -14.71 59.82 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.36 -0.838 . . . . 10.0 110.418 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.52 -41.73 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.814 0.846 . . . . 10.0 110.098 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.07 10.1 54.52 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.0 -1.445 . . . . 10.0 114.845 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.32 8.79 6.59 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.313 2.556 . . . . 10.0 112.64 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.16 4.15 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.696 -1.362 . . . . 10.0 109.696 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.54 132.88 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.165 -2.161 . . . . 10.0 105.165 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -92.26 133.76 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.561 0.744 . . . . 10.0 110.022 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.63 -36.96 85.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.768 -0.634 . . . . 10.0 110.37 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.09 -26.79 66.89 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.637 0.653 . . . . 10.0 111.719 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.06 4.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.334 -1.728 . . . . 10.0 106.334 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.776 1.23 . . . . 10.0 112.241 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.51 -33.65 64.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.3 m -62.34 -49.37 75.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.76 -41.33 92.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.555 1.142 . . . . 10.0 110.207 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.1 -48.73 44.18 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.768 1.167 . . . . 10.0 110.83 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.65 38.84 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.714 0.806 . . . . 10.0 111.116 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.461 1.504 . . . . 10.0 111.657 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.18 -40.35 86.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.782 1.233 . . . . 10.0 110.521 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.82 55.38 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.723 0.809 . . . . 10.0 110.489 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.49 -38.78 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.241 1.016 . . . . 10.0 111.324 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.31 63.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.995 0.918 . . . . 10.0 111.016 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.46 19.72 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.851 -0.899 . . . . 10.0 110.851 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.35 -36.21 82.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.751 -0.852 . . . . 10.0 109.53 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -33.63 75.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.751 -1.118 . . . . 10.0 111.542 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.6 -0.87 34.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.581 0.628 . . . . 10.0 112.373 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 54.2 mmtt -95.26 -44.92 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 10.0 110.8 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.34 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.584 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -79.24 -45.75 19.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.692 0.282 . . . . 10.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -16.58 60.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 45.8 mt . . . . . 0 C--O 1.227 -0.093 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.293 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.763 0.315 . . . . 10.0 111.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.89 78.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.69 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.0 5.02 1.75 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.148 1.779 . . . . 10.0 113.524 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.4 36.8 26.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.885 2.074 . . . . 10.0 112.075 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 172.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.17 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.793 2.037 . . . . 10.0 110.319 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.39 -170.96 33.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 126.024 1.773 . . . . 10.0 112.865 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.38 152.99 62.04 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 127.316 2.246 . . . . 10.0 108.341 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.63 152.71 71.76 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.569 -1.013 . . . . 10.0 113.103 -6.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 57.2 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.325 1.45 . . . . 10.0 108.538 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.6 mmm -123.94 158.44 31.99 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.733 1.613 . . . . 10.0 108.225 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.16 136.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.862 -1.533 . . . . 10.0 106.862 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.0 135.2 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.091 -1.448 . . . . 10.0 107.091 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 46.99 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 133.151 4.58 . . . . 10.0 117.53 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.67 20.08 60.57 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.778 -1.568 . . . . 10.0 115.552 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.41 1.04 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.954 1.877 . . . . 10.0 114.333 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.72 107.57 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.53 24.55 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.471 1.908 . . . . 10.0 106.79 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.63 169.58 17.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.304 -1.497 . . . . 10.0 107.09 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.91 -178.76 1.29 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.36 -50.08 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 128.482 2.713 . . . . 10.0 107.724 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.54 4.5 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.963 1.744 . . . . 10.0 114.377 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.9 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 118.726 1.263 . . . . 10.0 109.651 168.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.065 1.346 . . . . 10.0 112.247 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.49 -5.68 9.99 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 118.57 -1.128 . . . . 10.0 114.83 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.74 174.25 35.07 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.639 1.719 . . . . 10.0 109.963 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.88 -52.6 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.407 2.072 . . . . 10.0 111.766 -169.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.015 -1.053 . . . . 10.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.41 -27.2 66.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.138 0.575 . . . . 10.0 110.38 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.64 -43.04 32.67 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.097 -1.002 . . . . 10.0 110.822 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.71 -31.87 73.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.965 0.802 . . . . 10.0 111.036 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.48 8.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.537 1.935 . . . . 10.0 108.074 168.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.5 -41.37 93.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.896 -1.526 . . . . 10.0 111.496 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.952 1.705 . . . . 10.0 111.735 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.15 64.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.934 0.494 . . . . 10.0 110.591 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.43 -42.52 96.24 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.584 0.754 . . . . 10.0 111.301 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.18 -37.38 83.61 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.93 -1.106 . . . . 10.0 111.242 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.18 -52.0 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.232 0.924 . . . . 10.0 108.583 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.96 -43.06 63.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.596 1.158 . . . . 10.0 110.016 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.7 -0.4 33.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.154 -1.403 . . . . 10.0 113.139 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.477 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.08 -33.25 9.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.637 1.575 . . . . 10.0 114.466 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -55.73 4.99 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.763 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.5 6.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 130.244 3.418 . . . . 10.0 113.638 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.12 13.43 35.19 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.717 1.207 . . . . 10.0 113.117 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.33 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.872 2.069 . . . . 10.0 109.845 -163.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.039 1.736 . . . . 10.0 108.768 -179.272 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.296 0 N-CA-C 109.284 -1.526 . . . . 10.0 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.7 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 127.087 2.155 . . . . 10.0 110.406 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.24 11.86 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.07 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.012 1.725 . . . . 10.0 108.081 -175.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.32 132.75 44.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 148.42 49.48 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.7 13.61 52.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.623 1.106 . . . . 10.0 113.42 -167.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -63.04 0.98 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 119.871 1.835 . . . . 10.0 107.769 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.348 1.459 . . . . 10.0 110.521 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.68 167.02 31.57 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.271 -0.893 . . . . 10.0 111.719 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.82 115.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.836 1.254 . . . . 10.0 109.023 -171.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.45 167.32 20.31 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 119.993 -1.692 . . . . 10.0 110.497 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.69 41.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.29 1.036 . . . . 10.0 108.823 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.44 -9.36 41.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.768 0.827 . . . . 10.0 113.116 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.29 74.34 81.06 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.254 1.022 . . . . 10.0 108.647 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.43 -179.11 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 125.121 3.881 . . . . 10.0 112.29 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.92 34.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.769 1.227 . . . . 10.0 107.948 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.14 179.14 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.427 2.085 . . . . 10.0 112.538 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.54 168.18 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.78 2.032 . . . . 10.0 108.938 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -47.0 -61.87 1.67 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.851 2.06 . . . . 10.0 110.44 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.05 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 127.228 2.211 . . . . 10.0 105.301 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.91 -164.56 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.585 2.19 . . . . 10.0 110.304 173.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.07 -112.7 2.46 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.36 -2.696 . . . . 10.0 106.36 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.48 133.71 45.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.07 0.948 . . . . 10.0 108.785 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.64 140.82 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.305 -1.739 . . . . 10.0 106.305 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.31 139.22 35.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.8 t -128.54 130.43 69.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.901 -1.888 . . . . 10.0 105.901 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.15 108.09 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -172.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.11 143.39 54.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.236 1.014 . . . . 10.0 108.544 162.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.14 53.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 158.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.36 176.87 7.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.391 1.076 . . . . 10.0 110.365 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.05 175.82 11.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.049 1.34 . . . . 10.0 109.555 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.673 1.189 . . . . 10.0 112.882 172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.98 52.11 4.56 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.78 1.181 . . . . 10.0 110.293 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.57 84.83 8.38 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 127.371 2.268 . . . . 10.0 106.147 -163.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.56 168.55 24.08 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.32 2.68 . . . . 10.0 109.253 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.0 -45.68 0.28 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.482 1.913 . . . . 10.0 112.06 -164.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.81 -53.17 12.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.745 2.018 . . . . 10.0 110.556 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.81 76.41 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.349 1.459 . . . . 10.0 110.91 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.52 61.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.63 -16.86 27.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.793 1.637 . . . . 10.0 112.118 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.73 -67.25 0.41 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 120.064 1.302 . . . . 10.0 112.557 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.23 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.066 1.774 . . . . 10.0 114.431 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.85 -43.2 68.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.83 1.195 . . . . 10.0 108.774 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.16 -28.56 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 t -46.35 -60.42 3.68 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.668 1.187 . . . . 10.0 109.492 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.79 -35.42 79.18 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 CA-C-N 120.244 1.123 . . . . 10.0 112.908 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.18 -51.67 68.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.422 0.689 . . . . 10.0 110.362 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -58.92 -39.08 80.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.128 0.489 . . . . 10.0 110.291 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.52 64.61 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.15 -0.969 . . . . 10.0 111.441 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.08 39.81 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.563 1.145 . . . . 10.0 112.834 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.93 151.28 74.72 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 119.52 1.055 . . . . 10.0 110.982 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.13 169.67 21.59 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.985 3.124 . . . . 10.0 110.537 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.05 -4.19 4.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.969 1.308 . . . . 10.0 113.461 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.72 8.46 43.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.706 1.602 . . . . 10.0 110.6 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.56 165.56 29.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 121.213 -0.929 . . . . 10.0 108.798 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -146.63 135.79 22.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.573 -1.194 . . . . 10.0 108.458 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.87 136.81 52.47 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 t -140.02 139.57 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.022 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -106.33 120.2 41.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.044 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG11 ' A' ' 30' ' ' VAL . 10.8 mt -118.23 136.45 23.93 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.73 154.64 26.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.502 2.135 . . . . 10.0 112.307 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.78 96.74 7.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.247 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.41 76.77 8.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.757 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.55 20.23 1.15 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.204 1.557 . . . . 10.0 115.204 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.04 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.863 -1.773 . . . . 10.0 112.827 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.54 -152.11 1.58 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.351 0.977 . . . . 10.0 110.759 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.201 1.0 . . . . 10.0 112.002 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.36 -27.44 6.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.123 1.769 . . . . 10.0 113.346 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.96 -36.4 64.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 119.589 1.086 . . . . 10.0 110.498 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.8 -55.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.031 -1.1 . . . . 10.0 108.031 174.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.532 3.133 . . . . 10.0 112.182 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.12 -42.56 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 125.405 1.479 . . . . 10.0 111.296 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.5 -41.86 70.09 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.768 -1.11 . . . . 10.0 112.499 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.5 -44.33 8.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 114.137 1.162 . . . . 10.0 114.137 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.84 -45.77 92.38 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.514 0.597 . . . . 10.0 110.3 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.2 mt -61.39 -45.26 95.1 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 116.744 -1.598 . . . . 10.0 109.209 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -45.7 91.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.652 1.569 . . . . 10.0 110.771 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.005 1.722 . . . . 10.0 109.474 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.66 -29.03 66.4 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 118.955 -0.545 . . . . 10.0 111.767 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.22 49.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.325 1.05 . . . . 10.0 110.748 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 31.0 mtp -75.77 -22.49 56.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.644 -0.693 . . . . 10.0 111.632 -170.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.32 14.54 61.87 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.914 0.768 . . . . 10.0 112.985 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.39 130.28 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.012 1.325 . . . . 10.0 109.272 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.56 76.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.955 -0.758 . . . . 10.0 108.955 -165.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.35 -5.33 54.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.092 2.256 . . . . 10.0 117.092 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 44.35 51.99 7.45 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.284 1.833 . . . . 10.0 112.11 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.97 -47.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.448 -1.263 . . . . 10.0 113.364 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.85 34.81 1.29 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.627 1.558 . . . . 10.0 113.159 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.46 0.62 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 120.835 -1.165 . . . . 10.0 108.898 172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.51 45.49 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.542 1.312 . . . . 10.0 114.542 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.42 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 117.67 -1.157 . . . . 10.0 108.756 166.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.48 -46.93 73.5 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.378 1.444 . . . . 10.0 112.033 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.32 -40.65 82.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.473 1.509 . . . . 10.0 110.194 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.07 4.51 5.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.808 1.643 . . . . 10.0 112.899 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.31 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.3 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.683 0.793 . . . . 10.0 112.615 -173.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.33 -21.16 64.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.149 0.886 . . . . 10.0 112.171 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.48 -53.46 3.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.519 1.127 . . . . 10.0 108.781 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.43 88.07 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.541 1.536 . . . . 10.0 110.626 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.39 13.83 15.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.395 1.078 . . . . 10.0 113.267 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.91 -64.24 0.36 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 128.206 2.602 . . . . 10.0 109.591 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.46 44.63 28.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.734 1.614 . . . . 10.0 112.534 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.63 20.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.228 1.411 . . . . 10.0 114.179 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 155.25 28.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.944 2.498 . . . . 10.0 107.676 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.1 -45.01 10.96 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.525 2.15 . . . . 10.0 109.955 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.22 67.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.193 0.997 . . . . 10.0 111.212 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.13 70.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.02 1.328 . . . . 10.0 110.327 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.51 18.07 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.211 1.004 . . . . 10.0 108.93 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.09 84.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.405 0.441 . . . . 10.0 111.367 -172.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.09 -46.94 78.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.307 1.443 . . . . 10.0 112.536 172.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.7 t80 -74.2 -41.78 60.87 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.597 0.759 . . . . 10.0 111.406 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.86 -14.79 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.35 -0.844 . . . . 10.0 110.39 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.39 -41.79 29.97 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.801 0.84 . . . . 10.0 110.18 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.0 10.12 54.13 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 117.931 -1.483 . . . . 10.0 114.846 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.38 8.84 6.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.367 2.583 . . . . 10.0 112.615 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.25 4.13 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.672 -1.371 . . . . 10.0 109.672 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.49 132.94 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.134 -2.173 . . . . 10.0 105.134 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.41 133.72 35.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.608 0.763 . . . . 10.0 109.915 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.96 85.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.8 -0.619 . . . . 10.0 110.406 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.96 -26.86 67.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.748 0.704 . . . . 10.0 111.719 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.69 -57.03 4.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.378 -1.712 . . . . 10.0 106.378 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.87 -59.51 4.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.85 1.26 . . . . 10.0 112.164 -166.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.55 -33.67 64.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.5 m -62.28 -49.43 75.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.327 -0.62 . . . . 10.0 109.327 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.73 -41.33 92.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.645 1.178 . . . . 10.0 110.237 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.694 1.133 . . . . 10.0 110.883 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.682 0.793 . . . . 10.0 111.178 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.392 1.477 . . . . 10.0 111.716 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.1 -40.44 86.92 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.911 1.284 . . . . 10.0 110.523 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.9 54.69 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.754 0.822 . . . . 10.0 110.484 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.48 -38.8 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.158 0.983 . . . . 10.0 111.274 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.28 63.73 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.002 0.921 . . . . 10.0 110.99 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.34 19.88 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.861 -0.896 . . . . 10.0 110.861 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.38 -36.21 82.96 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.712 -0.875 . . . . 10.0 109.583 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.36 77.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.767 -1.111 . . . . 10.0 111.517 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -94.95 -15.05 23.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.607 0.639 . . . . 10.0 112.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 72.3 mmtt -86.9 -47.25 9.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 10.0 110.845 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.79 -9.4 59.01 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.11 -42.47 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.684 0.278 . . . . 10.0 110.989 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -19.45 57.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 68.8 mt . . . . . 0 C--O 1.227 -0.094 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.118 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.852 0.358 . . . . 10.0 111.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.29 -43.87 80.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.664 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.08 5.05 1.77 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.142 1.777 . . . . 10.0 113.477 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 54.38 36.77 26.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.875 2.07 . . . . 10.0 112.142 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.1 t -69.39 135.04 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.682 -1.229 . . . . 10.0 107.682 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.2 -16.14 4.05 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.766 2.026 . . . . 10.0 110.31 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.91 33.64 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.968 1.747 . . . . 10.0 112.769 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.51 152.99 61.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 127.216 2.206 . . . . 10.0 108.283 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.65 71.41 Favored 'Cis proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.646 -0.981 . . . . 10.0 113.07 -6.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.1 m -145.86 144.3 30.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.331 1.452 . . . . 10.0 108.59 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.94 158.38 32.14 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.792 1.637 . . . . 10.0 108.211 163.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.08 136.41 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.943 -1.502 . . . . 10.0 106.943 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.4 t -104.05 135.21 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.054 -1.462 . . . . 10.0 107.054 168.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.0 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.132 4.573 . . . . 10.0 117.582 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.1 60.58 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.844 -1.531 . . . . 10.0 115.568 -170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.85 -41.26 1.04 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.931 1.866 . . . . 10.0 114.348 -170.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.76 107.61 16.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 -171.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.97 113.4 24.46 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.522 1.929 . . . . 10.0 106.8 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.51 169.57 17.48 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 120.408 -1.433 . . . . 10.0 107.141 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.95 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.587 0.355 . . . . 10.0 110.11 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.34 -50.01 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 128.466 2.707 . . . . 10.0 107.764 160.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.56 4.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.881 1.705 . . . . 10.0 114.429 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.28 -51.2 1.3 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.724 1.262 . . . . 10.0 109.667 168.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.66 72.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.102 1.361 . . . . 10.0 112.202 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.64 -5.92 9.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.796 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.31 35.23 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.693 1.747 . . . . 10.0 109.96 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.93 -52.57 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.359 2.039 . . . . 10.0 111.758 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.46 -28.58 69.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.977 -1.077 . . . . 10.0 111.486 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.45 -27.1 66.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.101 0.56 . . . . 10.0 110.392 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.96 32.67 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.959 -1.088 . . . . 10.0 110.904 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.7 -31.88 73.19 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.922 0.783 . . . . 10.0 111.026 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.51 -56.4 8.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.557 1.943 . . . . 10.0 108.075 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.54 -41.36 93.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 116.883 -1.532 . . . . 10.0 111.494 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.75 -48.73 69.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.985 1.721 . . . . 10.0 111.728 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.05 65.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.975 0.51 . . . . 10.0 110.613 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.57 -42.47 96.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.592 0.757 . . . . 10.0 111.263 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.27 -37.32 83.27 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 120.946 -1.096 . . . . 10.0 111.236 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.3 -51.87 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.28 0.945 . . . . 10.0 108.654 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.08 63.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.573 1.149 . . . . 10.0 110.016 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.71 -0.34 33.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.08 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.33 9.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.671 1.589 . . . . 10.0 114.42 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.74 4.99 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.33 -1.359 . . . . 10.0 107.33 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.37 -20.3 66.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.743 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 130.183 3.393 . . . . 10.0 113.639 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.21 13.45 35.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.667 1.187 . . . . 10.0 113.114 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.87 0.27 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.903 2.081 . . . . 10.0 109.799 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.079 1.751 . . . . 10.0 108.805 -179.276 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.293 0 N-CA-C 109.154 -1.578 . . . . 10.0 109.154 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.71 0.15 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.116 2.166 . . . . 10.0 110.357 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.01 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.081 2.153 . . . . 10.0 113.029 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.46 157.69 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.013 1.725 . . . . 10.0 108.047 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.19 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.7 148.45 49.23 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.63 52.08 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.702 1.144 . . . . 10.0 113.437 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 -63.04 0.98 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.788 1.794 . . . . 10.0 107.817 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.44 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.5 mp0 -98.42 -25.95 14.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.405 1.482 . . . . 10.0 110.506 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.58 167.06 31.38 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.254 -0.904 . . . . 10.0 111.687 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.86 115.91 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.848 1.259 . . . . 10.0 109.054 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.39 20.27 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 119.895 -1.753 . . . . 10.0 110.479 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.56 40.64 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.254 1.022 . . . . 10.0 108.83 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.29 -9.47 41.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.794 0.838 . . . . 10.0 113.19 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 m -129.27 74.4 81.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.163 0.985 . . . . 10.0 108.646 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.58 -179.07 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 125.073 3.849 . . . . 10.0 112.221 -172.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.61 138.88 34.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.698 1.199 . . . . 10.0 107.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -73.01 179.1 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.481 2.121 . . . . 10.0 112.598 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.5 168.27 20.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.804 2.042 . . . . 10.0 108.937 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.809 2.044 . . . . 10.0 110.488 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.83 165.4 21.08 Favored Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 127.315 2.246 . . . . 10.0 105.359 163.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.89 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.55 2.167 . . . . 10.0 110.24 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.58 2.43 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 106.338 -2.705 . . . . 10.0 106.338 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.53 133.71 46.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.116 0.966 . . . . 10.0 108.718 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.25 139.2 35.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.521 -1.288 . . . . 10.0 107.521 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.0 t -128.57 130.39 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.15 108.1 14.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.426 -1.324 . . . . 10.0 107.426 -172.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.01 143.36 54.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.271 1.028 . . . . 10.0 108.533 162.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.72 131.12 53.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 158.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.37 176.81 7.15 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.417 1.087 . . . . 10.0 110.398 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.82 11.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.098 1.359 . . . . 10.0 109.511 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.51 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.607 1.163 . . . . 10.0 112.879 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.89 51.99 4.53 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.775 1.178 . . . . 10.0 110.38 -171.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.45 84.8 8.13 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 127.457 2.303 . . . . 10.0 106.098 -163.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.58 23.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.308 2.672 . . . . 10.0 109.253 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.476 1.911 . . . . 10.0 112.083 -165.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.78 -53.14 12.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.704 2.001 . . . . 10.0 110.572 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.91 -49.9 76.05 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.327 1.451 . . . . 10.0 110.884 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -13.47 61.62 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.713 0.635 . . . . 10.0 112.713 -171.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.74 -16.76 27.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.722 1.609 . . . . 10.0 112.118 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.24 0.41 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 120.094 1.315 . . . . 10.0 112.593 -172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.04 -9.2 25.7 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.988 1.746 . . . . 10.0 114.403 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.87 -43.15 69.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.797 1.18 . . . . 10.0 108.813 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.27 -28.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 -164.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 t -46.46 -60.35 3.82 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.711 1.205 . . . . 10.0 109.471 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.77 -35.42 79.4 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.272 1.133 . . . . 10.0 112.945 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.9 t90 -57.17 -51.66 68.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.418 0.687 . . . . 10.0 110.367 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.94 -39.13 80.68 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.182 0.515 . . . . 10.0 110.258 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.94 -25.54 64.62 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.117 -0.99 . . . . 10.0 111.418 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.68 10.05 39.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.568 1.147 . . . . 10.0 112.897 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.7 mt -60.97 151.26 75.17 Favored Pre-proline 0 C--O 1.236 0.385 0 CA-C-N 119.513 1.051 . . . . 10.0 110.922 174.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.13 169.71 21.52 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 124.042 3.161 . . . . 10.0 110.471 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.11 -4.26 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.004 1.322 . . . . 10.0 113.397 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.58 8.35 43.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.744 1.618 . . . . 10.0 110.653 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.48 164.71 31.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 O-C-N 121.161 -0.962 . . . . 10.0 108.834 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -145.98 134.65 22.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.534 -1.212 . . . . 10.0 108.448 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -114.48 135.52 54.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.854 0.359 . . . . 10.0 111.621 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.71 138.91 41.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 10.0 109.685 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -104.91 118.5 36.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.49 HD12 HG11 ' A' ' 30' ' ' VAL . 15.8 mt -118.75 138.51 26.03 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 112.726 0.639 . . . . 10.0 112.726 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.28 152.86 24.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.933 2.422 . . . . 10.0 112.188 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 97.47 8.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.391 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.88 76.79 8.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.389 -0.369 . . . . 10.0 111.861 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.53 20.16 1.15 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.165 1.542 . . . . 10.0 115.165 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.11 3.42 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 119.939 -1.725 . . . . 10.0 112.793 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.53 -152.08 1.57 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.327 0.965 . . . . 10.0 110.779 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.84 -30.81 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.077 0.951 . . . . 10.0 112.047 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.38 -27.43 6.33 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.079 1.752 . . . . 10.0 113.327 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.95 -36.35 64.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.656 1.116 . . . . 10.0 110.515 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.9 -55.1 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.93 31.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.545 3.138 . . . . 10.0 112.186 170.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.16 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.33 1.443 . . . . 10.0 111.217 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.57 -41.82 70.3 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.476 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.33 8.46 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 114.181 1.178 . . . . 10.0 114.181 -173.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.85 -45.78 92.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 123.639 0.587 . . . . 10.0 110.241 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.38 -45.24 95.17 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 116.7 -1.619 . . . . 10.0 109.197 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -45.6 92.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.61 1.55 . . . . 10.0 110.778 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -60.59 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.082 1.753 . . . . 10.0 109.415 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.71 -29.0 66.29 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.796 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.16 48.86 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.365 1.066 . . . . 10.0 110.703 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.9 -22.42 56.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.663 -170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.44 61.9 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.867 0.746 . . . . 10.0 112.97 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.31 130.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 124.929 1.292 . . . . 10.0 109.337 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.55 75.95 1.37 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.47 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.091 2.256 . . . . 10.0 117.091 -170.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 52.0 7.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.329 1.852 . . . . 10.0 112.086 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.93 -47.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 117.452 -1.261 . . . . 10.0 113.403 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.83 1.31 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.57 1.532 . . . . 10.0 113.084 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.4 -44.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.447 0 O-C-N 120.762 -1.211 . . . . 10.0 108.891 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.55 45.41 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.56 1.318 . . . . 10.0 114.56 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.43 -65.64 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 117.601 -1.19 . . . . 10.0 108.671 166.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.53 -46.81 73.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.324 1.42 . . . . 10.0 112.025 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.56 82.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.479 1.511 . . . . 10.0 110.182 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.22 4.57 5.5 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.774 1.63 . . . . 10.0 112.867 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.28 2.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.706 0.803 . . . . 10.0 112.635 -173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.19 64.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.112 0.869 . . . . 10.0 112.171 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.47 3.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.557 1.143 . . . . 10.0 108.79 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.4 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.544 1.538 . . . . 10.0 110.666 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.25 13.74 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.362 1.065 . . . . 10.0 113.34 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.03 -64.27 0.36 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 128.166 2.586 . . . . 10.0 109.57 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.4 mt 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.73 1.612 . . . . 10.0 112.522 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.49 20.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.282 1.433 . . . . 10.0 114.192 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.07 155.41 29.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 127.888 2.475 . . . . 10.0 107.643 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.18 -44.96 10.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.532 2.155 . . . . 10.0 110.012 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.34 67.49 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.259 1.024 . . . . 10.0 111.19 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.08 70.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.965 1.306 . . . . 10.0 110.344 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.56 17.91 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.16 0.984 . . . . 10.0 108.875 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.19 -37.25 84.57 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 122.761 0.425 . . . . 10.0 111.36 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.86 78.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.279 1.432 . . . . 10.0 112.605 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.69 60.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.609 0.763 . . . . 10.0 111.423 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.376 -0.827 . . . . 10.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.46 -41.73 30.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.788 0.835 . . . . 10.0 110.15 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.08 54.46 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.953 -1.471 . . . . 10.0 114.811 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.33 8.87 6.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.394 2.597 . . . . 10.0 112.604 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.9 49.26 4.12 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.678 -1.369 . . . . 10.0 109.678 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.53 132.89 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.167 -2.16 . . . . 10.0 105.167 169.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.66 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.666 0.786 . . . . 10.0 110.03 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.804 -0.617 . . . . 10.0 110.416 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.14 -26.73 66.81 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.682 0.674 . . . . 10.0 111.706 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.09 4.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.359 -1.719 . . . . 10.0 106.359 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.9 -59.44 4.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.819 1.248 . . . . 10.0 112.169 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.56 -33.7 64.8 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.254 -0.276 . . . . 10.0 110.254 -170.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.25 -49.48 75.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.38 92.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.592 1.157 . . . . 10.0 110.23 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.1 -48.77 44.17 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 119.701 1.137 . . . . 10.0 110.845 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.9 1.02 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.637 0.775 . . . . 10.0 111.181 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.3 8.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.387 1.475 . . . . 10.0 111.69 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.13 -40.4 86.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.262 . . . . 10.0 110.487 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.82 54.94 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.718 0.807 . . . . 10.0 110.505 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.4 mm -69.57 -38.78 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.23 1.012 . . . . 10.0 111.268 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.26 63.78 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.002 0.921 . . . . 10.0 110.963 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.39 19.59 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.837 -0.905 . . . . 10.0 110.837 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.07 82.52 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.762 -0.846 . . . . 10.0 109.611 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.0 76.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.771 -1.109 . . . . 10.0 111.495 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.69 -2.24 35.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.557 0.617 . . . . 10.0 111.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -93.48 -48.32 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.622 0.248 . . . . 10.0 110.953 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.65 58.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.407 . . . . 10.0 111.793 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 66' ' ' LEU . 11.3 tmtt? -79.17 -45.05 20.7 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.818 0.342 . . . . 10.0 110.597 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -18.64 60.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.004 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.72 -40.23 63.72 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.146 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.19 79.06 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.055 0.391 . . . . 10.0 112.055 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.44 -30.03 66.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.366 -0.379 . . . . 10.0 111.511 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.86 79.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.649 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 4.97 1.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.1 1.76 . . . . 10.0 113.545 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.45 36.8 26.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.888 2.075 . . . . 10.0 112.077 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.7 t -69.37 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.679 -1.23 . . . . 10.0 107.679 172.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.13 4.05 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.757 2.023 . . . . 10.0 110.316 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.32 -170.83 33.52 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.933 1.73 . . . . 10.0 112.777 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.53 153.0 61.54 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 127.286 2.234 . . . . 10.0 108.304 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.58 152.7 71.59 Favored 'Cis proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.6 -1.0 . . . . 10.0 113.087 -6.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.0 m -145.89 144.24 30.07 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.264 1.425 . . . . 10.0 108.537 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.98 158.4 32.15 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.77 1.628 . . . . 10.0 108.174 163.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.05 135.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.04 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 1 C-N-CA 133.17 4.588 . . . . 10.0 117.552 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.19 60.38 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.807 -1.552 . . . . 10.0 115.526 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.88 -41.27 1.04 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.967 1.883 . . . . 10.0 114.349 -170.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.77 107.55 16.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.98 113.45 24.52 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 126.528 1.931 . . . . 10.0 106.738 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.57 169.62 17.41 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.333 -1.479 . . . . 10.0 107.154 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.94 -178.8 1.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.631 0.373 . . . . 10.0 110.191 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.27 -50.16 5.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 128.527 2.731 . . . . 10.0 107.715 160.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.07 16.53 4.45 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.856 1.693 . . . . 10.0 114.435 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.32 -51.11 1.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.735 1.267 . . . . 10.0 109.628 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.56 72.58 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.076 1.351 . . . . 10.0 112.251 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.57 -5.88 9.89 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.443 -1.199 . . . . 10.0 114.752 174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.85 174.32 35.22 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.71 1.755 . . . . 10.0 109.93 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.98 -52.53 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.397 2.065 . . . . 10.0 111.752 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.31 -28.71 69.92 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.965 -1.084 . . . . 10.0 111.526 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.39 -27.24 66.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.144 0.578 . . . . 10.0 110.333 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.65 -42.84 33.36 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.051 -1.031 . . . . 10.0 110.961 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.83 -31.82 73.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.923 0.783 . . . . 10.0 111.014 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.49 -56.4 8.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.59 1.956 . . . . 10.0 108.076 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.32 93.1 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 116.928 -1.51 . . . . 10.0 111.542 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.72 69.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.931 1.696 . . . . 10.0 111.698 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.07 65.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.905 0.482 . . . . 10.0 110.637 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.48 -42.61 96.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.605 0.762 . . . . 10.0 111.272 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.1 mt -67.04 -37.42 84.06 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 120.881 -1.137 . . . . 10.0 111.278 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.28 -51.93 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 119.239 0.927 . . . . 10.0 108.574 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.01 -43.08 63.49 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.573 1.149 . . . . 10.0 110.021 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.65 -0.32 33.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.144 -175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.538 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.32 9.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.672 1.589 . . . . 10.0 114.461 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -55.75 4.98 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.37 -1.344 . . . . 10.0 107.37 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.28 -20.34 66.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.121 -0.945 . . . . 10.0 111.811 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.73 -35.46 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 130.087 3.355 . . . . 10.0 113.712 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.17 13.48 34.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.701 1.2 . . . . 10.0 113.145 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.82 0.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.92 2.088 . . . . 10.0 109.823 -163.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.294 0 C-N-CA 126.058 1.743 . . . . 10.0 108.788 -179.276 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.234 -1.546 . . . . 10.0 109.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.23 73.64 0.16 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.046 2.138 . . . . 10.0 110.379 -175.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.25 11.97 0.65 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 112.429 -2.169 . . . . 10.0 113.011 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -146.41 157.74 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.033 1.733 . . . . 10.0 108.052 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 m -131.25 132.8 44.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.47 49.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.56 51.91 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.632 1.11 . . . . 10.0 113.432 -167.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.09 0.98 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 119.863 1.832 . . . . 10.0 107.727 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.363 1.465 . . . . 10.0 110.488 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.6 167.07 31.36 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.231 -0.918 . . . . 10.0 111.623 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.85 116.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.879 1.272 . . . . 10.0 109.064 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.34 20.33 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.869 -1.77 . . . . 10.0 110.478 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.56 40.72 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.312 1.045 . . . . 10.0 108.864 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.38 40.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.808 0.843 . . . . 10.0 113.215 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 m -129.3 74.38 81.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.209 1.003 . . . . 10.0 108.62 -176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.62 -179.1 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 125.114 3.876 . . . . 10.0 112.198 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.54 138.87 34.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.732 1.213 . . . . 10.0 107.993 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.09 179.08 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.456 2.104 . . . . 10.0 112.626 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.5 168.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.862 2.065 . . . . 10.0 108.947 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.06 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.778 2.031 . . . . 10.0 110.514 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.77 165.39 21.2 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 10.0 105.388 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.94 -164.63 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.585 2.19 . . . . 10.0 110.248 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.12 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.343 -2.703 . . . . 10.0 106.343 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.46 133.66 45.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.081 0.952 . . . . 10.0 108.758 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.55 140.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.335 -1.728 . . . . 10.0 106.335 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.3 139.23 35.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.855 -1.905 . . . . 10.0 105.855 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 63' ' ' LEU . 11.4 t -131.19 108.13 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 -172.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.07 143.35 54.26 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.305 1.042 . . . . 10.0 108.515 162.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.69 131.03 53.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 158.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.3 176.77 7.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.438 1.095 . . . . 10.0 110.427 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.05 175.81 11.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.965 1.306 . . . . 10.0 109.479 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.44 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.688 1.195 . . . . 10.0 112.903 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.0 4.53 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.873 1.225 . . . . 10.0 110.379 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.52 84.83 8.3 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 127.427 2.291 . . . . 10.0 106.101 -163.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.56 168.53 24.14 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.365 2.71 . . . . 10.0 109.215 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.03 -45.74 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.538 1.935 . . . . 10.0 112.046 -165.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.82 -53.06 12.81 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.69 1.996 . . . . 10.0 110.618 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.9 76.05 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.368 1.467 . . . . 10.0 110.865 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.44 61.57 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.732 0.642 . . . . 10.0 112.732 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.8 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.709 1.604 . . . . 10.0 112.031 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.83 -67.18 0.41 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 120.124 1.329 . . . . 10.0 112.581 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.94 -9.26 25.84 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 122.141 1.8 . . . . 10.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.21 68.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.795 1.18 . . . . 10.0 108.774 167.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.88 1.067 . . . . 10.0 113.88 -164.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.45 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.799 1.24 . . . . 10.0 109.499 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.88 -35.42 78.17 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.277 1.135 . . . . 10.0 112.928 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.8 t90 -57.11 -51.64 68.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.407 0.683 . . . . 10.0 110.389 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.14 80.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.126 0.489 . . . . 10.0 110.252 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.64 64.67 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.11 -0.993 . . . . 10.0 111.375 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.1 39.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.487 1.115 . . . . 10.0 112.948 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.9 151.23 74.7 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 119.467 1.031 . . . . 10.0 111.002 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.09 169.64 21.67 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.013 3.142 . . . . 10.0 110.505 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 -4.22 4.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.994 1.318 . . . . 10.0 113.452 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.72 8.43 43.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.687 1.595 . . . . 10.0 110.606 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.78 31.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 O-C-N 121.19 -0.944 . . . . 10.0 108.865 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -146.13 134.86 22.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.551 -1.204 . . . . 10.0 108.399 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -114.38 139.9 49.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.869 0.366 . . . . 10.0 111.538 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.45 143.54 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.692 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.368 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 30' ' ' VAL . 16.3 mt -124.21 138.66 31.21 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.66 152.76 22.86 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.069 2.513 . . . . 10.0 112.207 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.67 98.2 9.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.405 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.4 mt -87.92 76.75 8.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.449 -0.341 . . . . 10.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.13 1.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.11 1.522 . . . . 10.0 115.11 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.14 3.42 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 119.97 -1.706 . . . . 10.0 112.824 168.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.02 1.52 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.335 0.969 . . . . 10.0 110.766 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.96 -30.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.14 0.976 . . . . 10.0 111.976 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.32 -27.54 6.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.103 1.761 . . . . 10.0 113.331 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.86 -36.4 64.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.679 1.127 . . . . 10.0 110.501 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.95 -55.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.923 -1.14 . . . . 10.0 107.923 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.84 31.89 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.495 3.118 . . . . 10.0 112.257 170.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.14 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 125.314 1.435 . . . . 10.0 111.173 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.44 -41.95 70.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.81 -1.091 . . . . 10.0 112.463 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.45 8.37 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -173.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.77 -45.8 92.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 123.639 0.587 . . . . 10.0 110.3 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.39 -45.23 95.23 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.738 -1.601 . . . . 10.0 109.226 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.65 92.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.611 1.55 . . . . 10.0 110.874 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.977 1.711 . . . . 10.0 109.48 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.75 -28.95 66.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 118.922 -0.561 . . . . 10.0 111.768 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.19 49.72 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.38 1.072 . . . . 10.0 110.655 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.79 -22.56 56.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.621 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.43 61.63 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.82 0.724 . . . . 10.0 112.871 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.34 130.26 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.973 1.309 . . . . 10.0 109.313 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.5 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 -165.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.52 54.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.118 2.266 . . . . 10.0 117.118 -170.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.42 52.03 7.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.348 1.859 . . . . 10.0 112.064 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.04 -47.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 117.444 -1.265 . . . . 10.0 113.355 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.95 34.8 1.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.628 1.558 . . . . 10.0 113.079 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.56 0.62 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 120.758 -1.214 . . . . 10.0 108.845 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.49 44.89 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.547 1.314 . . . . 10.0 114.547 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.49 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.549 -1.215 . . . . 10.0 108.661 166.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.57 -46.83 73.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.397 1.453 . . . . 10.0 112.031 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.43 -40.66 83.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.433 1.493 . . . . 10.0 110.135 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.06 4.5 5.43 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.683 1.593 . . . . 10.0 112.888 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.22 -57.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.0 -2.222 . . . . 10.0 105.0 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.56 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.664 0.786 . . . . 10.0 112.716 -173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.31 -21.22 64.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.099 0.863 . . . . 10.0 112.199 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.49 3.9 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.535 1.134 . . . . 10.0 108.81 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 58.42 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.517 1.527 . . . . 10.0 110.695 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.31 13.71 15.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.357 1.063 . . . . 10.0 113.28 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.95 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 128.223 2.609 . . . . 10.0 109.546 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.0 mt 54.52 44.61 28.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.729 1.612 . . . . 10.0 112.542 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.75 14.59 20.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.299 1.44 . . . . 10.0 114.154 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.045 2.538 . . . . 10.0 107.704 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.16 -45.0 10.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.539 2.16 . . . . 10.0 109.973 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.03 -29.34 67.47 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.263 1.025 . . . . 10.0 111.119 -174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.52 -42.16 70.5 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.022 1.329 . . . . 10.0 110.292 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.5 18.02 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.169 0.988 . . . . 10.0 108.877 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 123.387 0.43 . . . . 10.0 111.369 -172.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.12 -46.83 79.0 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.262 1.425 . . . . 10.0 112.569 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.3 -41.59 60.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.6 0.76 . . . . 10.0 111.439 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.99 -14.8 59.8 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.357 -0.839 . . . . 10.0 110.384 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.42 -41.85 30.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.827 0.851 . . . . 10.0 110.114 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.15 53.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.944 -1.475 . . . . 10.0 114.883 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.39 8.85 6.56 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.333 2.567 . . . . 10.0 112.625 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 49.3 4.12 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.67 -1.372 . . . . 10.0 109.67 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.6 132.94 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.144 -2.169 . . . . 10.0 105.144 169.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.69 35.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.673 0.789 . . . . 10.0 110.009 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.59 -37.01 86.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.788 -0.625 . . . . 10.0 110.352 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.04 -26.75 66.92 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.707 0.685 . . . . 10.0 111.772 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.66 -57.07 4.01 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.36 -1.719 . . . . 10.0 106.36 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.94 -59.42 4.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.821 1.249 . . . . 10.0 112.154 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.58 -33.73 64.77 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.205 -0.294 . . . . 10.0 110.205 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -62.27 -49.41 75.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.284 -0.636 . . . . 10.0 109.284 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.76 -41.29 92.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.524 1.13 . . . . 10.0 110.216 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.21 -48.71 45.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.686 1.13 . . . . 10.0 110.773 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.63 38.82 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.709 0.804 . . . . 10.0 111.147 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.28 8.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.426 1.49 . . . . 10.0 111.701 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.08 -40.41 87.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.842 1.257 . . . . 10.0 110.54 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.85 55.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.695 0.798 . . . . 10.0 110.495 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.6 mm -69.49 -38.77 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.224 1.009 . . . . 10.0 111.322 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.28 63.8 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 10.0 111.018 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.39 19.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.16 82.79 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.806 -0.82 . . . . 10.0 109.569 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.34 -33.64 75.97 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.749 -1.119 . . . . 10.0 111.527 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.67 -0.89 33.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.592 0.633 . . . . 10.0 112.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.37 -48.41 5.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.701 0.286 . . . . 10.0 110.709 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.86 -5.98 59.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.815 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.5 tmtt? -81.35 -43.81 18.51 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.874 0.369 . . . . 10.0 110.891 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -17.77 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.124 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 69.3 mt -75.89 -38.55 57.71 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.96 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.26 80.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.6 mtm -71.2 -29.2 64.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.91 81.12 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.595 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -69.97 5.0 1.74 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.175 1.79 . . . . 10.0 113.539 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 54.37 36.81 26.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.877 2.071 . . . . 10.0 112.146 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 32' ' ' LEU . 90.5 t -69.37 135.13 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.717 -1.216 . . . . 10.0 107.717 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.37 -16.09 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.717 2.007 . . . . 10.0 110.254 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.37 -170.88 33.61 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.954 1.74 . . . . 10.0 112.821 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 152.99 61.76 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.262 2.225 . . . . 10.0 108.359 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.59 152.65 71.56 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.592 -1.003 . . . . 10.0 113.078 -6.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.7 m -145.86 144.22 30.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 125.294 1.438 . . . . 10.0 108.562 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.93 158.35 32.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.847 1.659 . . . . 10.0 108.208 163.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.06 136.53 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.955 -1.498 . . . . 10.0 106.955 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.2 t -104.07 135.13 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.1 10.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 133.159 4.584 . . . . 10.0 117.542 171.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.6 20.19 60.47 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 117.806 -1.552 . . . . 10.0 115.601 -169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -131.88 -41.28 1.04 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.916 1.858 . . . . 10.0 114.38 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.81 107.53 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.99 113.39 24.46 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 126.506 1.922 . . . . 10.0 106.808 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.45 169.65 17.34 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 120.393 -1.442 . . . . 10.0 107.172 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.84 1.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.617 0.367 . . . . 10.0 110.123 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.31 -50.09 5.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 128.469 2.708 . . . . 10.0 107.771 160.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.08 16.56 4.44 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.946 1.736 . . . . 10.0 114.368 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.0 m -128.38 -51.16 1.29 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.814 1.307 . . . . 10.0 109.609 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.62 72.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.143 1.377 . . . . 10.0 112.274 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 118.529 -1.151 . . . . 10.0 114.73 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.3 35.22 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.738 1.769 . . . . 10.0 110.015 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.437 2.092 . . . . 10.0 111.72 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.33 -28.65 69.89 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.904 -1.122 . . . . 10.0 111.523 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.15 66.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.058 0.543 . . . . 10.0 110.333 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.67 -43.01 32.65 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.062 -1.024 . . . . 10.0 110.905 -169.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.91 73.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.889 0.768 . . . . 10.0 111.076 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.5 8.0 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.65 1.98 . . . . 10.0 108.018 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.56 -41.29 93.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 116.959 -1.496 . . . . 10.0 111.538 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 120.946 1.703 . . . . 10.0 111.74 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.49 -47.12 64.89 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.898 0.479 . . . . 10.0 110.635 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.46 -42.55 96.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.616 0.767 . . . . 10.0 111.251 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.45 83.97 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 120.917 -1.114 . . . . 10.0 111.257 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.0 mt -58.15 -51.98 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.217 0.917 . . . . 10.0 108.647 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.05 -43.03 63.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.483 1.113 . . . . 10.0 110.018 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.69 -0.36 33.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.12 -1.419 . . . . 10.0 113.072 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.14 -33.26 9.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.618 1.567 . . . . 10.0 114.458 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -55.69 5.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.413 -1.329 . . . . 10.0 107.413 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.38 66.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.177 -0.919 . . . . 10.0 111.738 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 130.053 3.341 . . . . 10.0 113.741 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.19 13.51 34.9 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.677 1.191 . . . . 10.0 113.113 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.35 76.84 0.27 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.895 2.078 . . . . 10.0 109.816 -163.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.135 1.774 . . . . 10.0 108.822 -179.291 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.267 0 N-CA-C 109.166 -1.573 . . . . 10.0 109.166 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.18 73.72 0.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 127.088 2.155 . . . . 10.0 110.359 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.38 12.01 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.094 2.158 . . . . 10.0 112.981 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.46 157.72 43.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.029 1.731 . . . . 10.0 108.086 -175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m -131.2 132.79 44.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.63 148.37 49.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.186 -1.042 . . . . 10.0 108.186 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.68 52.35 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.731 1.158 . . . . 10.0 113.415 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -63.07 0.98 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.825 1.813 . . . . 10.0 107.854 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.9 14.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.369 1.467 . . . . 10.0 110.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.1 31.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.242 -0.911 . . . . 10.0 111.718 -171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.95 115.98 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.819 1.248 . . . . 10.0 108.99 -171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -80.43 167.39 20.24 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 119.963 -1.71 . . . . 10.0 110.489 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.24 124.61 40.79 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.309 1.044 . . . . 10.0 108.839 172.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.42 41.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.806 0.842 . . . . 10.0 113.176 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.198 0.999 . . . . 10.0 108.664 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.63 -179.11 2.63 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.987 3.792 . . . . 10.0 112.235 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 138.91 34.1 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.723 1.209 . . . . 10.0 107.948 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.99 179.12 5.67 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.453 2.102 . . . . 10.0 112.643 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.51 168.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.824 2.049 . . . . 10.0 108.946 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 m -47.08 -61.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.855 2.062 . . . . 10.0 110.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.35 21.34 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 127.385 2.274 . . . . 10.0 105.433 163.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.83 -164.73 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.676 2.25 . . . . 10.0 110.248 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.6 2.44 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.71 45.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.138 0.975 . . . . 10.0 108.706 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.66 140.78 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 169.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.24 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.523 -1.288 . . . . 10.0 107.523 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.59 130.32 68.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.89 -1.892 . . . . 10.0 105.89 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.09 108.12 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.06 143.42 54.26 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.292 1.037 . . . . 10.0 108.516 162.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 150' ' ' VAL . 4.9 mp -121.84 131.11 53.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 158.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.31 176.81 7.14 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.465 1.106 . . . . 10.0 110.472 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.04 175.84 11.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.063 1.345 . . . . 10.0 109.498 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.53 -73.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.63 1.172 . . . . 10.0 112.905 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.99 52.0 4.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.76 1.171 . . . . 10.0 110.376 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.46 84.77 8.12 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 127.452 2.301 . . . . 10.0 106.118 -163.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.53 168.51 24.18 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.306 2.671 . . . . 10.0 109.234 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.07 -45.73 0.28 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.409 1.883 . . . . 10.0 112.064 -165.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.09 12.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.774 2.029 . . . . 10.0 110.564 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.9 -49.93 75.92 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.36 1.464 . . . . 10.0 110.888 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.78 -13.52 61.55 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.744 0.646 . . . . 10.0 112.744 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.69 -16.82 27.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.712 1.605 . . . . 10.0 112.038 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 120.122 1.328 . . . . 10.0 112.576 -172.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.03 -9.22 25.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 CA-C-N 122.063 1.773 . . . . 10.0 114.358 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.22 69.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.832 1.196 . . . . 10.0 108.829 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.18 -28.47 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.825 1.046 . . . . 10.0 113.825 -164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -46.48 -60.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.713 1.205 . . . . 10.0 109.448 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.38 79.04 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-N 120.299 1.142 . . . . 10.0 113.004 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.9 t90 -57.17 -51.6 68.65 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.322 0.649 . . . . 10.0 110.421 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.24 80.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.186 0.517 . . . . 10.0 110.211 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.55 64.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.1 -1.0 . . . . 10.0 111.427 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.67 10.02 39.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.563 1.145 . . . . 10.0 112.862 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.91 151.26 74.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 119.52 1.054 . . . . 10.0 111.029 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.14 169.68 21.57 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.067 3.178 . . . . 10.0 110.419 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 -4.24 4.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.044 1.338 . . . . 10.0 113.473 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.67 8.38 43.39 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.737 1.615 . . . . 10.0 110.642 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.45 164.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 121.212 -0.93 . . . . 10.0 108.824 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -145.56 135.75 23.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.445 -1.252 . . . . 10.0 108.335 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -115.46 134.57 54.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.904 0.383 . . . . 10.0 111.573 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.64 140.42 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.548 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.0 mtt85 -107.74 123.36 48.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.298 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 63' ' ' LEU . 19.7 mt -124.99 138.76 32.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 112.916 0.71 . . . . 10.0 112.916 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.27 152.95 24.13 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.06 2.507 . . . . 10.0 112.339 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.68 98.47 9.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.369 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.92 76.76 8.61 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.791 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.62 20.28 1.15 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.07 -48.1 3.42 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 119.879 -1.763 . . . . 10.0 112.808 168.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.13 1.55 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.316 0.96 . . . . 10.0 110.74 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.071 0.948 . . . . 10.0 112.089 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.3 -27.52 6.28 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.098 1.759 . . . . 10.0 113.319 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.9 -36.39 64.74 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 119.693 1.133 . . . . 10.0 110.513 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.88 -55.21 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.93 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.459 3.104 . . . . 10.0 112.193 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.2 -42.46 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 125.346 1.451 . . . . 10.0 111.26 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.65 -41.77 70.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.774 -1.108 . . . . 10.0 112.462 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -44.33 8.52 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.91 -45.69 92.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.639 0.587 . . . . 10.0 110.275 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.34 -45.33 94.84 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 116.784 -1.579 . . . . 10.0 109.211 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -45.57 92.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.609 1.55 . . . . 10.0 110.812 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -60.61 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.988 1.715 . . . . 10.0 109.399 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.64 -28.92 66.31 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 118.966 -0.54 . . . . 10.0 111.825 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.7 -37.18 49.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.318 1.047 . . . . 10.0 110.699 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.85 -22.42 56.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.671 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.38 14.51 61.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.874 0.749 . . . . 10.0 113.016 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.28 130.28 26.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.95 1.3 . . . . 10.0 109.324 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.58 75.9 1.37 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.977 -0.749 . . . . 10.0 108.977 -165.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.22 -5.42 54.27 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.038 2.236 . . . . 10.0 117.038 -170.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.35 51.95 7.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.312 1.845 . . . . 10.0 112.118 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.94 -47.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.417 -1.277 . . . . 10.0 113.398 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.89 34.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.628 1.558 . . . . 10.0 113.095 -176.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.52 0.62 Allowed 'General case' 0 C--O 1.22 -0.468 0 O-C-N 120.814 -1.179 . . . . 10.0 108.901 172.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 -16.54 44.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 10.0 114.569 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.53 -65.51 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 117.478 -1.249 . . . . 10.0 108.676 166.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.58 -46.88 73.81 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 120.42 1.464 . . . . 10.0 112.031 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.451 1.5 . . . . 10.0 110.244 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.14 4.49 5.53 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.776 1.63 . . . . 10.0 112.853 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -115.19 -57.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 105.03 -2.211 . . . . 10.0 105.03 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.6 -61.26 2.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.694 0.798 . . . . 10.0 112.63 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.32 -21.22 64.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.086 0.857 . . . . 10.0 112.199 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.43 -53.6 3.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.601 1.16 . . . . 10.0 108.795 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.01 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.587 1.555 . . . . 10.0 110.659 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.23 13.73 15.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 10.0 113.306 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.96 -64.28 0.36 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 128.239 2.616 . . . . 10.0 109.479 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.55 44.55 28.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.746 1.618 . . . . 10.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.65 20.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.208 1.403 . . . . 10.0 114.184 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 155.33 28.98 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 127.897 2.479 . . . . 10.0 107.679 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.22 -44.89 10.93 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.537 2.158 . . . . 10.0 110.003 -173.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.33 67.49 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.191 0.996 . . . . 10.0 111.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.55 -42.07 70.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.965 1.306 . . . . 10.0 110.361 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.61 17.76 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.2 1.0 . . . . 10.0 108.884 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.2 84.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 123.426 0.453 . . . . 10.0 111.432 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.06 -46.93 78.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.318 1.447 . . . . 10.0 112.542 172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.16 -41.81 60.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.601 0.761 . . . . 10.0 111.382 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.9 -14.74 59.84 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.401 -0.812 . . . . 10.0 110.421 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.76 30.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.871 0.868 . . . . 10.0 110.143 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.09 54.51 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 117.926 -1.486 . . . . 10.0 114.836 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.27 8.75 6.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.386 2.593 . . . . 10.0 112.649 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.0 49.26 4.1 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.65 132.84 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.176 -2.157 . . . . 10.0 105.176 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.71 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.679 0.791 . . . . 10.0 110.0 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.68 -36.9 85.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.738 -0.649 . . . . 10.0 110.367 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.8 66.88 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.744 0.702 . . . . 10.0 111.673 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.59 -57.09 4.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.363 -1.718 . . . . 10.0 106.363 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.9 -59.45 4.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.795 1.238 . . . . 10.0 112.161 -166.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.53 -33.7 64.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 -170.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 m -62.36 -49.31 76.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.75 -41.33 92.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.557 1.143 . . . . 10.0 110.269 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -49.09 -48.78 44.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.673 1.124 . . . . 10.0 110.809 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.88 1.02 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.678 0.791 . . . . 10.0 111.179 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.78 172.32 8.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.474 1.509 . . . . 10.0 111.658 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.42 86.71 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.825 1.25 . . . . 10.0 110.487 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.82 54.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.757 0.823 . . . . 10.0 110.501 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.53 -38.85 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.23 1.012 . . . . 10.0 111.213 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.61 -33.2 63.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.026 0.93 . . . . 10.0 110.987 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.26 -48.39 19.43 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.872 -0.891 . . . . 10.0 110.872 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.4 -36.03 82.38 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.792 -0.828 . . . . 10.0 109.656 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -34.14 77.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.663 -1.16 . . . . 10.0 111.45 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.01 7.23 41.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.613 0.642 . . . . 10.0 112.045 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -101.09 -48.26 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.645 0.259 . . . . 10.0 110.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.48 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.7 tmtt? -77.16 -44.28 30.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.878 0.371 . . . . 10.0 110.829 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -16.88 57.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 10.0 111.298 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.4 mt -74.97 -37.63 61.87 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.233 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.34 82.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.974 0.361 . . . . 10.0 111.974 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 57.7 mtm -71.59 -28.89 64.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.86 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.688 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.07 5.09 1.75 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.081 1.752 . . . . 10.0 113.53 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 54.34 36.85 26.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.99 2.116 . . . . 10.0 112.082 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.698 -1.223 . . . . 10.0 107.698 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.25 -16.2 4.02 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.779 2.032 . . . . 10.0 110.295 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.982 1.753 . . . . 10.0 112.802 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.45 153.06 61.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.192 2.197 . . . . 10.0 108.27 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.7 71.46 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.535 -1.027 . . . . 10.0 113.109 -6.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.5 m -145.91 144.22 30.04 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.287 1.435 . . . . 10.0 108.534 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.9 mmm -123.86 158.41 31.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.844 1.657 . . . . 10.0 108.221 163.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.936 -1.505 . . . . 10.0 106.936 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.0 135.18 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.065 -1.457 . . . . 10.0 107.065 168.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 1 C-N-CA 133.131 4.572 . . . . 10.0 117.471 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.18 60.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 117.752 -1.582 . . . . 10.0 115.498 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.37 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.975 1.887 . . . . 10.0 114.373 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -112.7 107.61 16.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.4 24.41 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.51 1.924 . . . . 10.0 106.768 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.59 17.44 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 120.316 -1.49 . . . . 10.0 107.087 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.78 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.601 0.36 . . . . 10.0 110.184 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.29 -50.15 5.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 128.615 2.766 . . . . 10.0 107.689 160.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.06 16.48 4.48 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.92 1.724 . . . . 10.0 114.412 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.1 m -128.32 -51.14 1.29 Allowed 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.768 1.284 . . . . 10.0 109.654 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.37 -34.62 72.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.04 1.336 . . . . 10.0 112.252 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.87 9.87 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.416 -1.213 . . . . 10.0 114.741 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.78 174.27 35.12 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.717 1.758 . . . . 10.0 110.017 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.419 2.079 . . . . 10.0 111.753 -169.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.63 69.86 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.9 -1.125 . . . . 10.0 111.58 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.46 -27.14 66.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 123.069 0.548 . . . . 10.0 110.368 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.59 -43.05 32.93 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.014 -1.054 . . . . 10.0 110.894 -169.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.3 mt -63.71 -31.86 73.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.937 0.79 . . . . 10.0 111.066 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.52 -56.5 8.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.628 1.971 . . . . 10.0 107.984 168.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.43 -41.42 93.53 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 116.905 -1.522 . . . . 10.0 111.503 176.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.8 -48.66 69.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.965 1.712 . . . . 10.0 111.705 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.51 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.964 0.505 . . . . 10.0 110.617 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.41 -42.68 96.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.585 0.754 . . . . 10.0 111.257 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.03 -37.44 84.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.948 -1.095 . . . . 10.0 111.251 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.32 -51.92 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.99 -43.03 63.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.577 1.151 . . . . 10.0 110.037 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.73 -0.31 33.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.144 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.21 9.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.614 1.566 . . . . 10.0 114.399 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -55.79 4.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.345 -1.354 . . . . 10.0 107.345 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.29 66.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.766 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 130.082 3.353 . . . . 10.0 113.679 175.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.03 13.33 35.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.759 1.224 . . . . 10.0 113.153 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.4 tttm 56.42 76.78 0.28 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.939 2.096 . . . . 10.0 109.855 -163.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.122 1.769 . . . . 10.0 108.815 -179.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 109.135 -1.586 . . . . 10.0 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.12 73.72 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.144 2.178 . . . . 10.0 110.313 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.428 -2.169 . . . . 10.0 113.023 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.42 157.77 43.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.964 1.706 . . . . 10.0 107.991 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.29 132.76 44.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.671 -1.233 . . . . 10.0 107.671 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.57 148.43 49.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.21 -1.033 . . . . 10.0 108.21 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.65 13.69 52.11 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.767 1.175 . . . . 10.0 113.398 -167.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -62.98 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.767 1.783 . . . . 10.0 107.78 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.52 -25.89 14.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.353 1.461 . . . . 10.0 110.46 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.55 167.12 31.16 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.249 -0.907 . . . . 10.0 111.694 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.88 115.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.781 1.232 . . . . 10.0 109.002 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.31 167.32 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.001 -1.687 . . . . 10.0 110.508 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.67 40.98 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.271 1.028 . . . . 10.0 108.853 172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.37 -9.4 41.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.21 0.819 . . . . 10.0 113.21 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -129.26 74.4 81.05 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.195 0.998 . . . . 10.0 108.676 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.53 -179.08 2.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 125.047 3.831 . . . . 10.0 112.266 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.87 34.04 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.739 1.215 . . . . 10.0 107.944 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.1 179.04 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.415 2.076 . . . . 10.0 112.58 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.8 m -127.35 168.3 20.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 126.866 2.067 . . . . 10.0 108.949 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.11 -61.8 1.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.812 2.045 . . . . 10.0 110.493 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.85 165.37 21.14 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 127.305 2.242 . . . . 10.0 105.394 163.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.91 -164.61 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.608 2.206 . . . . 10.0 110.201 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.75 2.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 106.347 -2.701 . . . . 10.0 106.347 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.45 133.76 45.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.01 0.924 . . . . 10.0 108.77 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.79 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 169.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.24 139.08 35.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.47 130.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.939 -1.874 . . . . 10.0 105.939 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.13 108.06 14.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.94 143.32 54.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.303 1.041 . . . . 10.0 108.58 162.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.8 131.1 53.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 158.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.34 176.86 7.11 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.376 1.07 . . . . 10.0 110.391 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.06 175.79 11.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.028 1.331 . . . . 10.0 109.525 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.47 -73.14 0.1 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.563 1.145 . . . . 10.0 112.937 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.95 4.53 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 124.858 1.218 . . . . 10.0 110.336 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.49 84.74 8.15 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.532 2.333 . . . . 10.0 106.102 -163.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.54 168.58 24.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.296 2.664 . . . . 10.0 109.217 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 63.93 -45.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.538 1.935 . . . . 10.0 112.064 -164.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.88 -53.03 13.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.754 2.022 . . . . 10.0 110.569 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.96 -49.94 75.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.472 1.509 . . . . 10.0 110.784 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.43 61.6 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.73 -16.85 27.74 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.727 1.611 . . . . 10.0 112.074 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.81 -67.21 0.41 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.115 1.325 . . . . 10.0 112.559 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.02 -9.17 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 122.076 1.777 . . . . 10.0 114.518 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.16 68.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.766 1.167 . . . . 10.0 108.806 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.17 -28.59 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.348 1.059 . . . . 10.0 113.85 -164.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.36 -60.29 3.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.79 1.236 . . . . 10.0 109.544 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.89 -35.38 78.34 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 CA-C-N 120.243 1.122 . . . . 10.0 112.918 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.28 -51.54 68.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.412 0.685 . . . . 10.0 110.34 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -59.01 -39.17 81.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.128 0.49 . . . . 10.0 110.231 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.81 -25.63 64.77 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.153 -0.967 . . . . 10.0 111.445 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.66 9.99 39.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.625 1.17 . . . . 10.0 112.868 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.405 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.0 mt -60.94 151.17 75.3 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 119.488 1.04 . . . . 10.0 110.994 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.07 169.7 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.982 3.121 . . . . 10.0 110.484 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.1 -4.1 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.024 1.33 . . . . 10.0 113.372 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.8 8.37 43.26 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.765 1.626 . . . . 10.0 110.532 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.44 164.33 32.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 O-C-N 121.164 -0.96 . . . . 10.0 108.863 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.93 140.91 28.59 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.435 -1.257 . . . . 10.0 108.29 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -120.84 134.13 55.3 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.759 0.314 . . . . 10.0 111.549 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.25 136.94 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.803 -0.635 . . . . 10.0 109.66 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -103.66 119.71 39.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.402 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD21 ' CAA' ' A' ' 201' ' ' 1YO . 22.9 mt -121.26 138.45 28.08 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.859 0.688 . . . . 10.0 112.859 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.5 152.81 23.38 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.027 2.485 . . . . 10.0 112.222 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.07 97.22 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -87.94 76.77 8.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.827 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.52 20.15 1.15 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.1 -48.1 3.41 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 119.903 -1.748 . . . . 10.0 112.787 168.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.51 -152.12 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.294 0.949 . . . . 10.0 110.783 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.81 -30.83 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.074 0.95 . . . . 10.0 112.003 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.4 -27.44 6.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.068 1.747 . . . . 10.0 113.367 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.86 -36.42 64.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.629 1.104 . . . . 10.0 110.485 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.93 -55.21 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.81 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.492 3.117 . . . . 10.0 112.21 170.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.21 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.352 1.453 . . . . 10.0 111.176 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.53 -41.81 70.13 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 117.789 -1.101 . . . . 10.0 112.535 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.53 -44.33 8.61 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.136 1.161 . . . . 10.0 114.136 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.8 -45.78 92.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.528 0.604 . . . . 10.0 110.304 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.32 -45.35 94.79 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 116.836 -1.554 . . . . 10.0 109.234 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -45.69 92.14 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.552 1.523 . . . . 10.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.978 1.711 . . . . 10.0 109.413 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.7 -28.91 66.24 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 118.881 -0.58 . . . . 10.0 111.806 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.72 -37.15 49.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.347 1.059 . . . . 10.0 110.699 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.5 56.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.653 -0.689 . . . . 10.0 111.634 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.6 61.71 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.974 0.797 . . . . 10.0 113.023 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.35 130.28 26.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.997 1.319 . . . . 10.0 109.315 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.57 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.981 -0.748 . . . . 10.0 108.981 -165.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -5.4 54.19 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 117.137 2.273 . . . . 10.0 117.137 -170.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.37 51.97 7.49 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.284 1.834 . . . . 10.0 112.113 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.91 -47.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.487 -1.244 . . . . 10.0 113.461 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.77 34.92 1.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.532 1.514 . . . . 10.0 113.067 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.749 -1.219 . . . . 10.0 108.929 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.2 -16.42 44.7 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.576 1.325 . . . . 10.0 114.576 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.52 -65.65 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.552 -1.213 . . . . 10.0 108.625 166.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.57 -46.78 73.77 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.391 1.451 . . . . 10.0 111.997 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.39 -40.62 82.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.459 1.503 . . . . 10.0 110.207 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.1 4.46 5.53 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.736 1.615 . . . . 10.0 112.884 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.23 -57.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.049 -2.204 . . . . 10.0 105.049 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -80.68 -61.28 2.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.704 0.801 . . . . 10.0 112.618 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.26 64.8 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.06 0.845 . . . . 10.0 112.147 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.43 3.91 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.591 1.157 . . . . 10.0 108.802 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.41 87.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.476 1.51 . . . . 10.0 110.698 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.79 15.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.408 1.083 . . . . 10.0 113.372 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.97 -64.2 0.36 Allowed 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 128.226 2.61 . . . . 10.0 109.581 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.9 mt 54.52 44.63 28.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.789 1.635 . . . . 10.0 112.449 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.69 14.64 20.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 10.0 114.148 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.2 155.38 28.98 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 127.907 2.483 . . . . 10.0 107.643 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.27 -44.88 10.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.543 2.162 . . . . 10.0 109.972 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.09 -29.32 67.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.222 1.009 . . . . 10.0 111.124 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.53 -42.1 70.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.945 1.298 . . . . 10.0 110.353 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.93 -48.54 17.87 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.071 0.948 . . . . 10.0 108.901 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.16 -37.2 84.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 123.45 0.469 . . . . 10.0 111.412 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.95 78.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.285 1.434 . . . . 10.0 112.532 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.21 -41.66 61.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.559 0.744 . . . . 10.0 111.443 -177.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -76.96 -14.78 59.81 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.38 -0.825 . . . . 10.0 110.411 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.75 30.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.766 0.826 . . . . 10.0 110.102 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.06 10.14 54.36 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.958 -1.468 . . . . 10.0 114.827 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.75 6.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.327 2.563 . . . . 10.0 112.604 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.98 49.24 4.11 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.54 132.93 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.177 -2.157 . . . . 10.0 105.177 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.34 133.76 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.642 0.777 . . . . 10.0 109.983 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.64 -37.04 86.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.732 -0.651 . . . . 10.0 110.375 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.92 -26.86 67.06 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.681 0.673 . . . . 10.0 111.732 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.7 -57.05 4.02 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.375 -1.713 . . . . 10.0 106.375 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.8 -59.56 4.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.846 1.258 . . . . 10.0 112.172 -166.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.55 -33.66 64.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -49.38 75.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.8 m -65.8 -41.3 92.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.587 1.155 . . . . 10.0 110.229 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.668 1.122 . . . . 10.0 110.831 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -92.68 38.98 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.674 0.789 . . . . 10.0 111.129 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.92 172.3 8.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.396 1.479 . . . . 10.0 111.569 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.2 -40.4 86.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.814 1.246 . . . . 10.0 110.439 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.5 -49.91 54.32 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.765 0.826 . . . . 10.0 110.445 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.49 -38.84 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.256 1.022 . . . . 10.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 1.7 mtmt -55.52 -33.34 63.68 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.025 0.93 . . . . 10.0 111.017 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.11 -48.47 19.8 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.854 -0.898 . . . . 10.0 110.854 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.42 -36.14 82.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.702 -0.881 . . . . 10.0 109.502 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.693 -1.146 . . . . 10.0 111.478 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 12.7 pt-20 -104.29 10.65 35.48 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.72 0.637 . . . . 10.0 111.853 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.3 tmtt? -102.65 -51.02 3.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.686 0.279 . . . . 10.0 110.495 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.74 -4.81 59.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.844 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HB2' HD12 ' A' ' 66' ' ' LEU . 14.4 tmtt? -77.79 -45.38 24.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.852 0.358 . . . . 10.0 110.848 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.84 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.324 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 36.7 mt -75.14 -38.57 60.97 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.38 -0.373 . . . . 10.0 110.856 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.69 83.75 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.083 0.401 . . . . 10.0 112.083 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 63.6 mtm -69.35 -30.1 68.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 10.0 111.436 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.86 79.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.623 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.05 5.03 1.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.125 1.77 . . . . 10.0 113.493 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.43 36.75 26.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.93 2.092 . . . . 10.0 112.12 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 32' ' ' LEU . 90.4 t -69.35 135.04 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.24 -16.18 4.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.737 2.015 . . . . 10.0 110.277 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.3 -170.86 33.54 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.928 1.727 . . . . 10.0 112.772 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.54 152.97 61.44 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 127.253 2.221 . . . . 10.0 108.308 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.59 152.68 71.58 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.585 -1.006 . . . . 10.0 113.035 -6.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.87 144.27 30.11 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.272 1.429 . . . . 10.0 108.551 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.95 158.35 32.21 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.906 1.682 . . . . 10.0 108.218 163.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.934 -1.506 . . . . 10.0 106.934 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.0 t -104.06 135.16 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.17 10.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 133.175 4.59 . . . . 10.0 117.505 171.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.23 60.26 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.667 -1.629 . . . . 10.0 115.446 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.89 -41.28 1.04 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.989 1.895 . . . . 10.0 114.315 -170.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -112.78 107.62 16.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.315 -0.995 . . . . 10.0 108.315 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.07 113.42 24.55 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.495 1.918 . . . . 10.0 106.764 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.48 169.59 17.44 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 120.277 -1.514 . . . . 10.0 107.198 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.98 -178.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.62 0.368 . . . . 10.0 110.171 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.35 -50.09 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 128.552 2.741 . . . . 10.0 107.733 160.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 16.52 4.48 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.868 1.699 . . . . 10.0 114.373 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.27 -51.16 1.3 Allowed 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.825 1.313 . . . . 10.0 109.656 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.54 72.46 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.072 1.349 . . . . 10.0 112.174 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.62 -6.03 9.83 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.535 -1.147 . . . . 10.0 114.802 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.27 35.22 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.667 1.733 . . . . 10.0 109.929 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.92 -52.52 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.355 2.037 . . . . 10.0 111.736 -169.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -28.6 69.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.946 -1.096 . . . . 10.0 111.568 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.16 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.095 0.558 . . . . 10.0 110.351 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.71 -42.86 32.96 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.014 -1.054 . . . . 10.0 110.898 -169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.93 -31.77 73.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.908 0.776 . . . . 10.0 110.985 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.46 8.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.589 1.956 . . . . 10.0 108.103 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.47 -41.33 93.47 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 116.945 -1.502 . . . . 10.0 111.58 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.69 69.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.902 1.683 . . . . 10.0 111.746 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.06 65.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.902 0.481 . . . . 10.0 110.619 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.55 -42.57 96.82 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 10.0 111.217 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.14 -37.38 83.72 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.877 -1.139 . . . . 10.0 111.26 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.23 -51.94 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.284 0.947 . . . . 10.0 108.561 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.02 -43.06 63.53 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.618 1.167 . . . . 10.0 110.052 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.7 -0.27 33.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.173 -1.394 . . . . 10.0 113.188 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.487 ' HB3' HD12 ' A' ' 27' ' ' ILE . 15.9 mm-40 -103.17 -33.25 9.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.679 1.591 . . . . 10.0 114.436 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -55.69 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.35 -20.32 66.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.115 -0.948 . . . . 10.0 111.772 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.46 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.108 3.363 . . . . 10.0 113.707 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.06 13.38 35.36 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.732 1.213 . . . . 10.0 113.151 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.92 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.942 2.097 . . . . 10.0 109.78 -163.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.138 1.775 . . . . 10.0 108.82 -179.321 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . 0.422 ' CAA' HD21 ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.194 -1.563 . . . . 10.0 109.194 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.08 73.77 0.15 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 127.131 2.172 . . . . 10.0 110.357 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.37 12.06 0.66 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 112.459 -2.155 . . . . 10.0 112.998 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.47 157.7 43.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.984 1.714 . . . . 10.0 108.041 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.18 132.82 44.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.735 -1.209 . . . . 10.0 107.735 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.38 49.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.62 52.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.67 1.128 . . . . 10.0 113.423 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -63.0 0.98 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.763 1.782 . . . . 10.0 107.77 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.38 -25.97 14.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 10.0 110.501 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -154.59 167.02 31.51 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.27 -0.894 . . . . 10.0 111.624 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.89 115.97 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.797 1.239 . . . . 10.0 108.996 -171.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.38 167.36 20.31 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 119.948 -1.72 . . . . 10.0 110.473 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.27 124.66 40.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.168 0.987 . . . . 10.0 108.815 172.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 m -67.25 -9.46 40.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.832 0.853 . . . . 10.0 113.219 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 m -129.32 74.37 81.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.195 0.998 . . . . 10.0 108.612 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.49 -179.12 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 125.139 3.892 . . . . 10.0 112.213 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.57 138.96 34.21 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.729 1.211 . . . . 10.0 107.934 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.13 179.17 5.67 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.369 2.046 . . . . 10.0 112.569 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.5 168.3 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.832 2.053 . . . . 10.0 108.947 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.89 1.67 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.834 2.054 . . . . 10.0 110.457 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.74 165.43 21.11 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.283 2.233 . . . . 10.0 105.397 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.99 -164.61 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.571 2.181 . . . . 10.0 110.213 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.15 -112.68 2.45 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.269 -2.733 . . . . 10.0 106.269 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.47 133.79 45.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.137 0.975 . . . . 10.0 108.723 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.73 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.348 -1.723 . . . . 10.0 106.348 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.15 139.16 35.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.55 130.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.906 -1.887 . . . . 10.0 105.906 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.5 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.2 108.11 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.393 -1.336 . . . . 10.0 107.393 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.04 143.39 54.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.275 1.03 . . . . 10.0 108.583 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.528 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 158.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.27 176.85 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.433 1.093 . . . . 10.0 110.459 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.89 11.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.071 1.349 . . . . 10.0 109.502 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HD1' ' CG2' ' A' ' 98' ' ' ILE . 40.2 t80 -61.59 -73.09 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.615 1.166 . . . . 10.0 112.912 172.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.01 4.54 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.828 1.204 . . . . 10.0 110.392 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.9 t -113.57 84.8 8.37 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 127.471 2.308 . . . . 10.0 106.086 -163.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.56 168.6 23.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.279 2.653 . . . . 10.0 109.203 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.03 -45.75 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.46 1.904 . . . . 10.0 112.093 -165.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.79 -53.14 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.672 1.989 . . . . 10.0 110.597 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.88 -49.93 75.91 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.471 1.508 . . . . 10.0 110.817 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.83 -13.54 61.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.68 -16.85 27.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.687 1.595 . . . . 10.0 112.071 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.2 0.41 Allowed Pre-proline 0 N--CA 1.469 0.502 0 CA-C-N 120.09 1.314 . . . . 10.0 112.621 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.09 -9.11 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 CA-C-N 121.994 1.748 . . . . 10.0 114.45 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.88 -43.18 68.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.772 1.169 . . . . 10.0 108.827 167.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.23 -28.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.33 1.052 . . . . 10.0 113.816 -164.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 t -46.48 -60.25 3.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.763 1.225 . . . . 10.0 109.483 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.88 -35.35 78.57 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.348 1.16 . . . . 10.0 112.918 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.5 t90 -57.29 -51.59 68.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.349 0.659 . . . . 10.0 110.372 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.12 80.69 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.168 0.509 . . . . 10.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.89 -25.6 64.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.094 -1.004 . . . . 10.0 111.39 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.13 39.65 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.535 1.134 . . . . 10.0 112.908 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.97 151.25 75.17 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 119.45 1.023 . . . . 10.0 110.968 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.1 169.69 21.57 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 124.053 3.169 . . . . 10.0 110.458 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.09 -4.16 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.024 1.33 . . . . 10.0 113.457 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.76 8.39 43.29 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.622 1.569 . . . . 10.0 110.587 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.46 164.85 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 O-C-N 121.117 -0.989 . . . . 10.0 108.884 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -145.66 136.18 24.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.477 -1.238 . . . . 10.0 108.413 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -115.4 137.65 51.82 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.778 0.323 . . . . 10.0 111.572 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.98 140.24 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.692 -0.686 . . . . 10.0 109.832 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -106.34 120.87 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.5 HD12 HG11 ' A' ' 30' ' ' VAL . 14.9 mt -121.83 138.76 29.05 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 112.692 0.627 . . . . 10.0 112.692 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.69 152.82 22.81 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.911 2.407 . . . . 10.0 112.287 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.16 98.05 9.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.5 mt -88.21 76.8 8.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.751 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.17 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.161 1.541 . . . . 10.0 115.161 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.09 -48.09 3.41 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 119.897 -1.752 . . . . 10.0 112.801 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.52 -152.06 1.56 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.317 0.961 . . . . 10.0 110.75 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.83 -30.76 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.108 0.963 . . . . 10.0 112.12 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.46 -27.39 6.42 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.064 1.745 . . . . 10.0 113.374 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.9 -36.48 64.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.606 1.094 . . . . 10.0 110.472 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.83 -55.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.495 3.118 . . . . 10.0 112.148 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.15 -42.53 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 125.407 1.479 . . . . 10.0 111.294 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.59 -41.84 70.37 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 117.757 -1.116 . . . . 10.0 112.457 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.43 -44.32 8.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 114.186 1.18 . . . . 10.0 114.186 -173.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.93 -45.71 92.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.685 0.615 . . . . 10.0 110.272 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.2 95.32 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 116.702 -1.618 . . . . 10.0 109.204 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.7 91.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.628 1.558 . . . . 10.0 110.764 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 126.004 1.722 . . . . 10.0 109.42 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.71 -28.89 66.21 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 118.887 -0.578 . . . . 10.0 111.8 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.78 -37.1 50.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.329 1.052 . . . . 10.0 110.625 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.89 -22.43 56.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.802 -0.618 . . . . 10.0 111.702 -170.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.33 14.55 61.84 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.897 0.761 . . . . 10.0 113.0 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.962 1.305 . . . . 10.0 109.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.94 1.37 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.36 -5.35 54.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 117.059 2.244 . . . . 10.0 117.059 -170.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.28 52.05 7.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.347 1.859 . . . . 10.0 112.092 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.98 -47.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 117.425 -1.274 . . . . 10.0 113.328 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.9 34.79 1.3 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.586 1.539 . . . . 10.0 113.175 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.33 -44.51 0.62 Allowed 'General case' 0 C--O 1.221 -0.44 0 O-C-N 120.805 -1.185 . . . . 10.0 108.948 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.51 45.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.541 1.311 . . . . 10.0 114.541 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.5 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.6 -1.19 . . . . 10.0 108.637 166.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.6 -46.78 73.88 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.347 1.43 . . . . 10.0 112.006 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.37 -40.51 82.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.468 1.507 . . . . 10.0 110.24 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.24 4.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.766 1.626 . . . . 10.0 112.847 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.4 ' CG2' ' HD1' ' A' ' 35' ' ' TYR . 61.4 mt -115.26 -57.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.033 -2.21 . . . . 10.0 105.033 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.62 -61.37 1.99 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.694 0.798 . . . . 10.0 112.6 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.12 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.073 0.851 . . . . 10.0 112.157 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.52 -53.5 3.88 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.508 1.123 . . . . 10.0 108.758 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.545 1.538 . . . . 10.0 110.614 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.68 15.67 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.367 1.067 . . . . 10.0 113.322 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.5 tttm 70.07 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 128.17 2.588 . . . . 10.0 109.557 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.47 44.59 28.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.768 1.627 . . . . 10.0 112.475 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.59 20.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.295 1.438 . . . . 10.0 114.177 -173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 155.36 29.0 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 127.959 2.503 . . . . 10.0 107.655 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.15 -44.96 10.95 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 10.0 110.017 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.0 -29.36 67.54 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.191 0.997 . . . . 10.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.51 -42.15 70.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.983 1.313 . . . . 10.0 110.314 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.9 -48.58 17.84 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.145 0.978 . . . . 10.0 108.876 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.15 -37.16 84.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 123.408 0.443 . . . . 10.0 111.4 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.13 -46.85 79.04 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.328 1.451 . . . . 10.0 112.558 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.57 60.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.537 0.735 . . . . 10.0 111.466 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.3 mt -77.02 -14.74 59.79 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.414 -0.804 . . . . 10.0 110.365 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.79 30.77 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.777 0.831 . . . . 10.0 110.115 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.99 10.12 54.07 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 117.981 -1.455 . . . . 10.0 114.847 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.31 8.71 6.59 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.365 2.583 . . . . 10.0 112.673 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.97 49.23 4.11 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.68 -1.368 . . . . 10.0 109.68 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.53 132.88 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.233 -2.136 . . . . 10.0 105.233 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -92.32 133.64 35.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.63 0.772 . . . . 10.0 110.021 173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.59 -36.88 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.811 -0.614 . . . . 10.0 110.445 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.83 66.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.694 0.679 . . . . 10.0 111.687 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.64 -57.02 4.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.88 -59.54 4.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.826 1.25 . . . . 10.0 112.093 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.56 -33.64 64.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 -170.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 m -62.35 -49.38 75.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -65.68 -41.36 92.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.554 1.141 . . . . 10.0 110.212 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.17 -48.8 44.76 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.691 1.132 . . . . 10.0 110.789 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.58 38.97 1.02 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.639 0.776 . . . . 10.0 111.202 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.83 172.24 8.6 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.474 1.51 . . . . 10.0 111.666 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.36 86.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.837 1.255 . . . . 10.0 110.512 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.57 -49.88 55.05 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.719 0.808 . . . . 10.0 110.477 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.52 -38.79 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 124.209 1.004 . . . . 10.0 111.262 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.58 -33.23 63.73 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.009 0.923 . . . . 10.0 111.029 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.47 19.33 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.831 -0.908 . . . . 10.0 110.831 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.3 -36.16 82.77 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.703 -0.88 . . . . 10.0 109.616 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -33.87 76.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.661 -1.162 . . . . 10.0 111.488 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.59 -5.46 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.619 0.645 . . . . 10.0 112.127 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.1 mmtt -92.0 -48.74 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.52 0.2 . . . . 10.0 111.01 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.48 -9.02 59.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.818 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' HB2' HD12 ' A' ' 66' ' ' LEU . 12.4 tmtt? -79.36 -45.01 20.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.672 0.273 . . . . 10.0 110.629 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -19.43 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.203 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 51.4 mt -74.02 -40.57 62.79 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.12 78.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.949 0.352 . . . . 10.0 111.949 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.08 -29.99 65.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 10.0 111.482 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.85 80.28 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.929 -0.578 . . . . 10.0 109.666 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.02 5.04 1.75 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.093 1.757 . . . . 10.0 113.5 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.38 36.82 26.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.935 2.094 . . . . 10.0 112.029 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 32' ' ' LEU . 91.4 t -69.31 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.769 -1.197 . . . . 10.0 107.769 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.26 -16.16 4.02 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 126.783 2.033 . . . . 10.0 110.267 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.35 -170.86 33.57 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.979 1.752 . . . . 10.0 112.791 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.57 152.98 61.37 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 127.282 2.233 . . . . 10.0 108.325 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.55 152.66 71.42 Favored 'Cis proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.61 -0.996 . . . . 10.0 113.082 -6.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.3 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.282 1.433 . . . . 10.0 108.581 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.92 158.39 32.08 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.779 1.632 . . . . 10.0 108.146 163.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.11 136.55 29.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.3 t -104.14 135.19 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.085 -1.45 . . . . 10.0 107.085 168.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.13 10.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.142 4.577 . . . . 10.0 117.517 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.73 20.1 60.42 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 117.753 -1.582 . . . . 10.0 115.531 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.84 -41.35 1.04 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.998 1.899 . . . . 10.0 114.365 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.81 107.58 16.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.277 -1.009 . . . . 10.0 108.277 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 126.511 1.924 . . . . 10.0 106.741 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.54 169.56 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.362 -1.461 . . . . 10.0 107.22 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.96 -178.79 1.28 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.606 0.362 . . . . 10.0 110.14 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.3 mt -46.23 -50.11 4.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 128.528 2.731 . . . . 10.0 107.778 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.1 16.52 4.49 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.927 1.727 . . . . 10.0 114.352 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.29 -51.16 1.3 Allowed 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.851 1.326 . . . . 10.0 109.692 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.5 72.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.068 1.347 . . . . 10.0 112.3 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.53 -5.9 9.92 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-O 118.542 -1.144 . . . . 10.0 114.774 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.81 174.24 35.11 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 119.672 1.736 . . . . 10.0 109.945 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.86 -52.65 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.397 2.065 . . . . 10.0 111.73 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.06 -1.025 . . . . 10.0 111.561 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.16 66.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.094 0.558 . . . . 10.0 110.342 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.99 32.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.969 -1.082 . . . . 10.0 110.89 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.4 mt -63.77 -31.86 73.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.876 0.762 . . . . 10.0 110.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.45 -56.44 8.24 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.636 1.974 . . . . 10.0 108.036 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.59 -41.3 92.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 116.922 -1.513 . . . . 10.0 111.555 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.78 69.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 120.984 1.72 . . . . 10.0 111.7 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.47 -47.06 65.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.939 0.496 . . . . 10.0 110.643 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.55 -42.54 96.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.513 0.725 . . . . 10.0 111.228 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.02 -37.49 84.23 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 120.899 -1.126 . . . . 10.0 111.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.27 -51.89 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.234 0.925 . . . . 10.0 108.589 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.0 -43.09 63.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.567 1.147 . . . . 10.0 110.045 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.61 -0.37 33.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.11 -1.424 . . . . 10.0 113.164 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -103.17 -33.3 9.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.62 1.568 . . . . 10.0 114.392 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.82 4.93 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.35 66.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.154 -0.93 . . . . 10.0 111.759 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.74 -35.47 6.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 130.172 3.389 . . . . 10.0 113.689 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.11 13.34 35.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.724 1.21 . . . . 10.0 113.166 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.38 76.9 0.27 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.973 2.109 . . . . 10.0 109.806 -163.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.126 1.77 . . . . 10.0 108.834 -179.27 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.232 0 N-CA-C 109.179 -1.568 . . . . 10.0 109.179 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.16 73.69 0.15 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 127.152 2.181 . . . . 10.0 110.355 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.32 12.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 112.392 -2.185 . . . . 10.0 113.039 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.43 157.76 43.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.944 1.698 . . . . 10.0 108.057 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 m -131.25 132.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.64 148.39 49.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 13.57 52.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.67 1.129 . . . . 10.0 113.43 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 -63.02 0.98 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.86 1.83 . . . . 10.0 107.768 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -25.88 14.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.409 1.483 . . . . 10.0 110.572 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.68 167.0 31.64 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.234 -0.916 . . . . 10.0 111.614 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -132.82 115.98 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.816 1.246 . . . . 10.0 109.01 -171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.4 167.33 20.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.948 -1.72 . . . . 10.0 110.435 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.2 124.64 40.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.254 1.022 . . . . 10.0 108.883 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -67.35 -9.48 41.69 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.816 0.846 . . . . 10.0 113.216 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 m -129.19 74.43 81.07 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.222 1.009 . . . . 10.0 108.667 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.57 -179.07 2.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 125.111 3.874 . . . . 10.0 112.261 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.91 34.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 124.716 1.207 . . . . 10.0 107.898 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.08 179.11 5.71 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.38 2.054 . . . . 10.0 112.665 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 m -127.52 168.26 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.828 2.051 . . . . 10.0 108.902 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.6 m -47.1 -61.8 1.71 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.834 2.053 . . . . 10.0 110.45 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.4 21.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 127.37 2.268 . . . . 10.0 105.39 163.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.97 -164.59 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.576 2.184 . . . . 10.0 110.206 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.09 -112.66 2.45 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 106.382 -2.687 . . . . 10.0 106.382 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.44 133.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.15 0.98 . . . . 10.0 108.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.55 140.75 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.323 -1.732 . . . . 10.0 106.323 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -99.19 139.13 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -128.51 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.858 -1.905 . . . . 10.0 105.858 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 11.2 t -131.13 108.03 14.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.475 -1.305 . . . . 10.0 107.475 -172.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.93 143.32 54.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.316 1.046 . . . . 10.0 108.573 162.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.0 mp -121.76 131.03 53.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 158.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.13 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.419 1.088 . . . . 10.0 110.396 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.02 175.84 11.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.969 1.308 . . . . 10.0 109.471 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.51 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.625 1.17 . . . . 10.0 112.884 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.03 4.54 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.823 1.201 . . . . 10.0 110.312 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.58 84.81 8.4 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.412 2.285 . . . . 10.0 106.087 -163.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.47 168.49 24.18 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.4 2.733 . . . . 10.0 109.25 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.06 -45.69 0.28 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.447 1.899 . . . . 10.0 112.051 -165.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.86 -53.13 12.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.764 2.026 . . . . 10.0 110.572 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.84 -49.98 75.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.389 1.476 . . . . 10.0 110.874 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.8 -13.49 61.57 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.7 -16.91 27.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.775 1.63 . . . . 10.0 112.045 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.7 -67.28 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.083 1.31 . . . . 10.0 112.554 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.92 -9.32 25.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.063 1.773 . . . . 10.0 114.466 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.1 69.24 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.746 1.157 . . . . 10.0 108.851 167.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.26 -28.58 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.846 1.054 . . . . 10.0 113.846 -164.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 t -46.37 -60.31 3.84 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.782 1.233 . . . . 10.0 109.524 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.44 78.62 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 120.266 1.131 . . . . 10.0 112.917 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.19 -51.65 68.46 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.382 0.673 . . . . 10.0 110.378 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.95 -39.1 80.63 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.154 0.502 . . . . 10.0 110.265 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.97 -25.45 64.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.124 -0.985 . . . . 10.0 111.453 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.74 10.07 39.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.576 1.15 . . . . 10.0 112.887 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.95 151.23 75.1 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.511 1.05 . . . . 10.0 110.977 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.04 169.62 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 124.054 3.17 . . . . 10.0 110.477 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.03 -4.2 4.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.02 1.328 . . . . 10.0 113.434 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.66 8.43 43.36 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.688 1.595 . . . . 10.0 110.63 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.52 164.66 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 O-C-N 121.241 -0.912 . . . . 10.0 108.827 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -145.6 136.82 24.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.501 -1.227 . . . . 10.0 108.507 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -114.65 135.88 53.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.96 0.41 . . . . 10.0 111.704 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 1.4 t -139.26 139.81 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.425 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -108.8 121.62 45.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.191 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 18.7 mt -121.76 138.21 28.24 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 112.787 0.662 . . . . 10.0 112.787 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.71 152.85 22.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.0 2.467 . . . . 10.0 112.395 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.37 98.08 9.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.502 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -88.0 76.74 8.56 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.913 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.54 20.23 1.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.04 -48.12 3.43 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.879 -1.763 . . . . 10.0 112.827 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.48 -152.06 1.54 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.279 0.943 . . . . 10.0 110.791 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.79 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.04 0.936 . . . . 10.0 112.07 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.49 6.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.093 1.757 . . . . 10.0 113.336 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -73.85 -36.43 64.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.642 1.11 . . . . 10.0 110.573 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.89 -55.17 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.9 31.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.49 3.116 . . . . 10.0 112.192 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 125.383 1.468 . . . . 10.0 111.23 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.55 -41.87 70.29 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 117.721 -1.133 . . . . 10.0 112.45 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.4 -44.44 8.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 114.129 1.159 . . . . 10.0 114.129 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.87 -45.71 92.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.525 0.602 . . . . 10.0 110.26 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.45 -45.24 95.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 116.71 -1.614 . . . . 10.0 109.257 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.67 92.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 120.628 1.558 . . . . 10.0 110.835 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.54 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.029 1.732 . . . . 10.0 109.448 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.72 -28.94 66.23 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 118.909 -0.567 . . . . 10.0 111.805 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 t -51.68 -37.2 49.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.33 1.052 . . . . 10.0 110.677 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.88 -22.44 56.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.647 -0.692 . . . . 10.0 111.63 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.43 14.47 61.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.85 0.738 . . . . 10.0 112.955 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.32 130.23 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.994 1.318 . . . . 10.0 109.261 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.54 75.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.574 0.75 . . . . 10.0 109.011 -165.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.29 -5.4 54.35 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 117.067 2.247 . . . . 10.0 117.067 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.99 7.49 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.332 1.853 . . . . 10.0 112.072 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.96 -47.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 117.413 -1.28 . . . . 10.0 113.431 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.84 34.85 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.599 1.545 . . . . 10.0 113.183 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.44 -44.43 0.61 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.814 -1.179 . . . . 10.0 108.938 172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.57 45.68 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.484 1.291 . . . . 10.0 114.484 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.47 -65.57 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 117.588 -1.196 . . . . 10.0 108.654 166.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.63 -46.75 73.96 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.368 1.44 . . . . 10.0 111.98 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.53 -40.54 83.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.458 1.503 . . . . 10.0 110.14 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.12 4.49 5.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 112.883 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.24 -57.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.002 -2.221 . . . . 10.0 105.002 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.57 -61.29 2.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.764 0.825 . . . . 10.0 112.621 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.36 -21.27 64.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.09 0.859 . . . . 10.0 112.136 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.41 -53.48 3.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.571 1.148 . . . . 10.0 108.799 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.46 88.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.556 1.542 . . . . 10.0 110.618 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.29 13.73 15.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.411 1.084 . . . . 10.0 113.328 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.3 tttm 69.96 -64.29 0.36 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.26 2.624 . . . . 10.0 109.537 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.54 44.73 28.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.768 1.627 . . . . 10.0 112.417 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.73 14.51 21.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.267 1.427 . . . . 10.0 114.137 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.05 155.45 29.21 Favored Pre-proline 0 N--CA 1.466 0.357 0 C-N-CA 127.983 2.513 . . . . 10.0 107.679 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.27 -44.99 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 10.0 109.936 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.97 -29.41 67.62 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.175 0.99 . . . . 10.0 111.182 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.08 70.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.981 1.313 . . . . 10.0 110.386 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.98 -48.52 17.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.15 0.98 . . . . 10.0 108.895 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.2 -37.21 84.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 123.396 0.435 . . . . 10.0 111.357 -172.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.12 -46.9 79.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.235 1.414 . . . . 10.0 112.506 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.2 -41.73 60.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.543 0.737 . . . . 10.0 111.388 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.89 -14.75 59.84 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.31 -0.869 . . . . 10.0 110.378 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.78 30.72 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.766 0.827 . . . . 10.0 110.1 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.97 10.14 53.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.93 -1.483 . . . . 10.0 114.85 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.41 8.88 6.56 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.389 2.595 . . . . 10.0 112.601 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 49.3 4.12 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.638 -1.385 . . . . 10.0 109.638 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.6 132.96 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.39 133.73 35.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.615 0.766 . . . . 10.0 109.993 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.66 -36.96 85.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.729 -0.653 . . . . 10.0 110.375 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.01 -26.81 66.97 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.692 0.678 . . . . 10.0 111.75 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.04 4.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.328 -1.73 . . . . 10.0 106.328 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -51.9 -59.48 4.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.831 1.252 . . . . 10.0 112.156 -166.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.57 -33.63 64.74 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.296 -0.261 . . . . 10.0 110.296 -170.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 m -62.32 -49.43 75.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.34 92.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.571 1.148 . . . . 10.0 110.264 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.24 -48.71 45.46 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.658 1.117 . . . . 10.0 110.837 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.61 38.92 1.02 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.66 0.784 . . . . 10.0 111.278 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.29 8.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.372 1.469 . . . . 10.0 111.694 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.15 -40.31 86.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.775 1.23 . . . . 10.0 110.562 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.92 54.54 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.677 0.791 . . . . 10.0 110.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.44 -38.83 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.191 0.997 . . . . 10.0 111.269 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.26 63.72 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.059 0.944 . . . . 10.0 110.974 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.3 -48.38 19.3 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.17 82.8 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.766 -0.844 . . . . 10.0 109.582 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 117.802 -1.094 . . . . 10.0 111.557 178.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.78 3.86 37.28 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.698 0.624 . . . . 10.0 112.09 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -99.06 -45.95 5.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.714 0.292 . . . . 10.0 110.697 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.63 -8.69 55.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.738 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -77.28 -44.31 30.22 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.753 0.311 . . . . 10.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -18.27 58.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.157 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.9 mt -74.08 -36.88 64.33 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.201 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.01 -46.53 82.24 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 mtm -71.86 -28.86 63.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.535 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.7 -43.91 78.95 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.984 -0.553 . . . . 10.0 109.615 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -69.98 4.96 1.77 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.142 1.777 . . . . 10.0 113.518 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.5 36.73 26.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.976 2.11 . . . . 10.0 112.064 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.39 135.06 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 172.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.23 -16.08 4.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.672 1.989 . . . . 10.0 110.284 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.34 -170.89 33.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.959 1.742 . . . . 10.0 112.744 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.5 153.02 61.67 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.329 2.252 . . . . 10.0 108.336 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.56 152.74 71.52 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.57 -1.012 . . . . 10.0 113.086 -6.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.9 m -145.95 144.22 30.0 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.281 1.432 . . . . 10.0 108.562 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.86 158.42 31.91 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.832 1.653 . . . . 10.0 108.294 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.975 -1.491 . . . . 10.0 106.975 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.5 t -103.97 135.2 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 168.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 t30 47.02 10.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 1 C-N-CA 133.145 4.578 . . . . 10.0 117.546 171.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.66 20.13 60.48 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.839 -1.534 . . . . 10.0 115.605 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.81 -41.31 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.897 1.849 . . . . 10.0 114.353 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -112.87 107.59 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.46 24.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 126.54 1.936 . . . . 10.0 106.713 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.58 169.61 17.42 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.297 -1.502 . . . . 10.0 107.162 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.81 1.28 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.643 0.377 . . . . 10.0 110.175 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.25 -50.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 128.557 2.743 . . . . 10.0 107.687 160.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.04 16.53 4.43 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.952 1.739 . . . . 10.0 114.354 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.772 1.286 . . . . 10.0 109.689 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.47 -34.49 72.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.098 1.359 . . . . 10.0 112.283 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.5 -5.9 9.95 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-O 118.554 -1.137 . . . . 10.0 114.852 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.9 174.28 35.23 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.614 1.707 . . . . 10.0 109.913 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.54 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.378 2.052 . . . . 10.0 111.816 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.39 -28.63 69.92 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.006 -1.059 . . . . 10.0 111.488 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.47 -27.15 66.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.104 0.562 . . . . 10.0 110.344 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.7 -42.84 33.05 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.971 -1.081 . . . . 10.0 110.928 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.8 -31.91 73.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.926 0.784 . . . . 10.0 110.975 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.45 8.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.637 1.975 . . . . 10.0 108.079 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.6 -41.3 92.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 116.898 -1.525 . . . . 10.0 111.53 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.74 69.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.987 1.721 . . . . 10.0 111.693 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.04 65.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 10.0 110.592 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -60.45 -42.63 96.54 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.604 0.762 . . . . 10.0 111.254 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.12 -37.43 83.86 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.958 -1.089 . . . . 10.0 111.219 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.7 mt -58.23 -51.93 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.265 0.939 . . . . 10.0 108.604 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.97 -43.08 63.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.579 1.151 . . . . 10.0 110.07 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.64 -0.37 33.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.183 -1.389 . . . . 10.0 113.157 -175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.521 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.05 -33.33 9.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.656 1.582 . . . . 10.0 114.442 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -55.72 5.02 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.445 -1.317 . . . . 10.0 107.445 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.34 -20.32 66.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 10.0 111.756 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.81 -35.36 6.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.08 3.352 . . . . 10.0 113.694 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 13.39 35.29 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.729 1.212 . . . . 10.0 113.111 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.31 76.93 0.27 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.886 2.075 . . . . 10.0 109.827 -163.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.13 1.772 . . . . 10.0 108.878 -179.272 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 109.175 -1.57 . . . . 10.0 109.175 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.22 73.71 0.15 Allowed 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 127.046 2.138 . . . . 10.0 110.324 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.33 12.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 112.467 -2.151 . . . . 10.0 113.053 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.47 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.995 1.718 . . . . 10.0 108.063 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.18 132.82 44.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.44 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.71 13.66 52.29 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.67 1.129 . . . . 10.0 113.405 -167.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.11 0.97 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.794 1.797 . . . . 10.0 107.745 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.37 -25.94 14.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.383 1.473 . . . . 10.0 110.528 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.59 167.08 31.3 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.345 -0.847 . . . . 10.0 111.694 -171.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.87 115.85 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.874 1.27 . . . . 10.0 109.07 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.33 167.37 20.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 119.924 -1.735 . . . . 10.0 110.5 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.64 40.88 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.261 1.024 . . . . 10.0 108.9 172.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.29 -9.55 41.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.816 0.846 . . . . 10.0 113.22 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.1 m -129.23 74.39 81.07 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.255 1.022 . . . . 10.0 108.692 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.53 -179.0 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 125.084 3.856 . . . . 10.0 112.231 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.69 138.91 34.13 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.685 1.194 . . . . 10.0 107.905 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.05 179.12 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.474 2.116 . . . . 10.0 112.593 176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.57 168.24 21.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.845 2.058 . . . . 10.0 108.902 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -46.99 -61.88 1.67 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.817 2.047 . . . . 10.0 110.489 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.78 165.37 21.27 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 127.319 2.248 . . . . 10.0 105.378 163.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.91 -164.64 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.524 2.149 . . . . 10.0 110.237 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.16 -112.64 2.44 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.355 -2.698 . . . . 10.0 106.355 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.49 133.76 46.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.03 0.932 . . . . 10.0 108.744 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.72 140.78 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.312 -1.736 . . . . 10.0 106.312 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.16 139.14 35.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.3 t -128.5 130.35 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.11 108.13 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.484 -1.302 . . . . 10.0 107.484 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.42 54.36 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.219 1.008 . . . . 10.0 108.524 162.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.86 131.1 53.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 158.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -127.28 176.78 7.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.515 1.126 . . . . 10.0 110.414 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -151.0 175.83 11.7 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.008 1.323 . . . . 10.0 109.469 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -61.48 -73.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 10.0 112.905 172.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.94 52.08 4.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.824 1.202 . . . . 10.0 110.322 -171.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.55 84.73 8.26 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 127.472 2.309 . . . . 10.0 106.115 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.5 168.6 23.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.281 2.654 . . . . 10.0 109.252 171.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.73 0.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.446 1.898 . . . . 10.0 112.068 -165.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.73 -53.22 12.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.736 2.015 . . . . 10.0 110.542 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.89 -49.88 76.13 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.349 1.46 . . . . 10.0 110.877 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.88 -13.4 61.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.683 0.623 . . . . 10.0 112.683 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.83 -16.73 27.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.659 1.584 . . . . 10.0 112.029 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.72 -67.26 0.41 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.081 1.309 . . . . 10.0 112.569 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.08 -9.13 25.49 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 122.031 1.761 . . . . 10.0 114.411 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.8 -43.29 68.97 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 10.0 108.781 167.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.21 -28.46 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.906 1.076 . . . . 10.0 113.906 -164.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -46.37 -60.39 3.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 10.0 109.505 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.18 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.255 1.127 . . . . 10.0 112.996 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.6 t90 -57.18 -51.64 68.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.407 0.683 . . . . 10.0 110.367 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.9 -39.2 80.74 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.171 0.51 . . . . 10.0 110.279 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.53 64.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.211 -0.931 . . . . 10.0 111.393 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.7 10.13 39.62 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.613 1.165 . . . . 10.0 112.905 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.409 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.99 151.25 75.4 Favored Pre-proline 0 C--O 1.237 0.416 0 CA-C-N 119.483 1.038 . . . . 10.0 110.953 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.13 169.75 21.44 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.003 3.135 . . . . 10.0 110.509 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -4.14 4.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.973 1.309 . . . . 10.0 113.394 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.41 43.33 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.671 1.588 . . . . 10.0 110.61 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.49 164.97 30.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 121.141 -0.974 . . . . 10.0 108.809 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -145.81 137.25 24.94 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.497 -1.229 . . . . 10.0 108.402 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -115.45 137.07 52.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.913 0.387 . . . . 10.0 111.553 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.08 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.468 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -109.17 126.75 53.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.255 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -127.07 139.19 34.42 Favored Pre-proline 0 N--CA 1.462 0.172 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.23 153.16 21.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.974 2.449 . . . . 10.0 112.241 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.87 99.02 10.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.296 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 142' ' ' LYS . 22.6 mt -88.18 76.9 8.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.757 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.69 20.26 1.17 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.122 1.527 . . . . 10.0 115.122 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.1 3.43 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 119.886 -1.759 . . . . 10.0 112.852 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.46 -152.08 1.53 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.292 0.949 . . . . 10.0 110.78 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.83 -30.78 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.088 0.955 . . . . 10.0 112.057 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.43 -27.44 6.45 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.124 1.77 . . . . 10.0 113.337 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.87 -36.37 64.81 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.661 1.119 . . . . 10.0 110.588 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.88 -55.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.533 3.133 . . . . 10.0 112.171 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.13 -42.5 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 125.336 1.446 . . . . 10.0 111.239 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.59 -41.9 70.43 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.778 -1.106 . . . . 10.0 112.471 -175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.38 -44.34 8.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 114.183 1.179 . . . . 10.0 114.183 -173.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.9 -45.77 92.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.49 0.586 . . . . 10.0 110.201 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.35 -45.31 94.95 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 116.761 -1.59 . . . . 10.0 109.205 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.7 92.0 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.601 1.546 . . . . 10.0 110.789 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -60.59 3.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.015 1.726 . . . . 10.0 109.35 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.7 -28.92 66.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 118.963 -0.542 . . . . 10.0 111.767 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.63 -37.22 49.24 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.401 1.081 . . . . 10.0 110.71 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.7 mtp -75.86 -22.46 56.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.686 -0.674 . . . . 10.0 111.606 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.34 14.54 61.84 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.906 0.765 . . . . 10.0 113.0 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.37 130.28 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.932 1.293 . . . . 10.0 109.326 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -123.54 75.96 1.37 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -165.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.27 -5.37 54.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.11 2.263 . . . . 10.0 117.11 -170.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.32 52.02 7.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.343 1.857 . . . . 10.0 112.071 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 117.484 -1.246 . . . . 10.0 113.368 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.83 34.91 1.3 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.565 1.529 . . . . 10.0 113.14 -176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.42 -44.5 0.61 Allowed 'General case' 0 C--O 1.219 -0.505 0 O-C-N 120.822 -1.174 . . . . 10.0 108.899 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.44 44.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.45 -65.62 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 117.654 -1.165 . . . . 10.0 108.673 166.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.61 -46.81 73.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.255 1.389 . . . . 10.0 111.98 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.56 82.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.406 1.482 . . . . 10.0 110.186 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.11 4.5 5.47 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.76 1.624 . . . . 10.0 112.896 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.21 -57.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.071 -2.196 . . . . 10.0 105.071 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.65 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.706 0.802 . . . . 10.0 112.615 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.34 -21.1 64.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.115 0.87 . . . . 10.0 112.217 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.52 -53.48 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.591 1.157 . . . . 10.0 108.772 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.44 87.92 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.571 1.548 . . . . 10.0 110.671 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.18 13.75 15.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.399 1.08 . . . . 10.0 113.389 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.94 -64.25 0.36 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.207 2.603 . . . . 10.0 109.567 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.7 mt 54.61 44.53 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.764 1.626 . . . . 10.0 112.504 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.64 14.56 20.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.269 1.428 . . . . 10.0 114.208 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.33 28.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 127.921 2.488 . . . . 10.0 107.682 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.11 -45.04 10.87 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.575 2.183 . . . . 10.0 109.968 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.3 67.39 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.232 1.013 . . . . 10.0 111.175 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.56 -42.08 70.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.941 1.297 . . . . 10.0 110.336 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.403 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.92 -48.55 17.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.208 1.003 . . . . 10.0 108.886 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.2 84.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 122.76 0.424 . . . . 10.0 111.418 -172.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.05 -46.93 78.75 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.279 1.432 . . . . 10.0 112.569 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.23 -41.65 61.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.535 0.734 . . . . 10.0 111.448 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.98 -14.7 59.81 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.371 -0.83 . . . . 10.0 110.366 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.43 -41.79 30.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.893 0.877 . . . . 10.0 110.095 172.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.04 10.09 54.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.917 -1.49 . . . . 10.0 114.773 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.84 6.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 121.358 2.579 . . . . 10.0 112.652 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.25 4.12 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.629 -1.388 . . . . 10.0 109.629 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.57 132.95 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 105.161 -2.163 . . . . 10.0 105.161 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.33 133.65 35.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.611 0.764 . . . . 10.0 110.005 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.53 -37.03 86.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.791 -0.623 . . . . 10.0 110.366 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.06 -26.8 66.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.733 0.697 . . . . 10.0 111.717 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.03 4.03 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.95 -59.45 4.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.829 1.252 . . . . 10.0 112.192 -166.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.56 -33.69 64.79 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.226 -0.287 . . . . 10.0 110.226 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.9 m -62.2 -49.49 75.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.75 -41.27 92.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.518 1.127 . . . . 10.0 110.255 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -49.15 -48.71 44.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.723 1.147 . . . . 10.0 110.84 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.66 38.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.697 0.799 . . . . 10.0 111.191 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.31 8.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.413 1.485 . . . . 10.0 111.624 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.19 -40.36 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.852 1.261 . . . . 10.0 110.473 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.84 55.59 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.682 0.793 . . . . 10.0 110.46 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.5 -38.84 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 124.244 1.018 . . . . 10.0 111.261 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.23 63.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 10.0 111.001 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.41 19.48 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.2 82.93 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.732 -0.863 . . . . 10.0 109.553 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.421 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.32 -34.15 77.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.74 -1.124 . . . . 10.0 111.432 178.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.12 1.76 39.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.749 0.704 . . . . 10.0 111.922 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.9 tmtt? -96.5 -52.91 3.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.587 0.232 . . . . 10.0 110.533 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.31 -5.88 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.137 0.421 . . . . 10.0 112.137 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 66' ' ' LEU . 4.0 tmmt? -79.1 -45.92 19.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.938 0.399 . . . . 10.0 110.821 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -19.59 59.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.164 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 54.6 mt -71.87 -37.82 70.14 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.605 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.47 80.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.015 0.376 . . . . 10.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.39 -29.37 64.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.74 0.305 . . . . 10.0 111.464 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.87 82.97 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.631 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -70.0 5.04 1.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.158 1.783 . . . . 10.0 113.558 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.41 36.74 26.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.916 2.086 . . . . 10.0 112.077 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.442 HG21 HD22 ' A' ' 32' ' ' LEU . 90.6 t -69.3 135.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.729 -1.211 . . . . 10.0 107.729 172.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.6 p -129.2 -16.08 4.06 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.637 1.975 . . . . 10.0 110.261 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -170.89 33.64 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.036 1.779 . . . . 10.0 112.853 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.49 153.02 61.71 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.271 2.228 . . . . 10.0 108.299 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.57 152.65 71.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.561 -1.016 . . . . 10.0 113.152 -6.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.6 m -145.81 144.3 30.19 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.317 1.447 . . . . 10.0 108.583 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.96 158.39 32.15 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.837 1.655 . . . . 10.0 108.19 163.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.09 136.5 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.6 t -104.08 135.16 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 107.117 -1.438 . . . . 10.0 107.117 168.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.09 10.97 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 133.19 4.596 . . . . 10.0 117.463 171.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.11 60.57 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.77 -1.572 . . . . 10.0 115.57 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.89 -41.31 1.04 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.976 1.888 . . . . 10.0 114.325 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.77 107.58 16.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -89.01 113.37 24.46 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 126.549 1.94 . . . . 10.0 106.765 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.53 169.62 17.39 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 120.344 -1.473 . . . . 10.0 107.159 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.92 -178.82 1.3 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.603 0.361 . . . . 10.0 110.171 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.28 -50.06 5.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 128.483 2.713 . . . . 10.0 107.811 160.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.53 4.5 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.849 1.69 . . . . 10.0 114.365 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.6 m -128.25 -51.25 1.3 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.759 1.28 . . . . 10.0 109.697 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -34.6 72.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.1 1.36 . . . . 10.0 112.238 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.51 -5.87 9.94 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.489 -1.173 . . . . 10.0 114.844 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.79 174.31 35.17 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.699 1.749 . . . . 10.0 110.012 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.86 -52.57 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.391 2.061 . . . . 10.0 111.81 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.37 -28.66 69.92 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.907 -1.121 . . . . 10.0 111.478 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.44 -27.16 66.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.044 0.538 . . . . 10.0 110.406 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.8 m -77.63 -42.94 33.08 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.079 -1.013 . . . . 10.0 110.938 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.67 -31.96 73.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.941 0.791 . . . . 10.0 111.01 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.47 8.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.604 1.962 . . . . 10.0 108.057 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.61 -41.27 92.94 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 116.888 -1.53 . . . . 10.0 111.508 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.77 -48.81 69.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 121.017 1.735 . . . . 10.0 111.663 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.46 -47.01 65.33 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.844 0.458 . . . . 10.0 110.661 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.5 -42.64 96.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.581 0.752 . . . . 10.0 111.245 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.07 -37.39 83.94 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.922 -1.111 . . . . 10.0 111.247 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.8 mt -58.26 -51.92 65.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 119.265 0.939 . . . . 10.0 108.553 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.03 -43.1 63.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.622 1.169 . . . . 10.0 109.972 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.69 -0.29 33.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 117.15 -1.405 . . . . 10.0 113.15 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.38 9.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.647 1.579 . . . . 10.0 114.425 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -55.77 4.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.833 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.71 -35.54 6.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 130.174 3.389 . . . . 10.0 113.65 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.08 13.42 35.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.682 1.193 . . . . 10.0 113.105 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.34 76.87 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.93 2.092 . . . . 10.0 109.837 -163.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.113 1.765 . . . . 10.0 108.797 -179.227 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . 0.452 ' CAA' ' SAK' ' A' ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.254 0 N-CA-C 109.17 -1.572 . . . . 10.0 109.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.15 73.76 0.15 Allowed 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 127.166 2.186 . . . . 10.0 110.312 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.96 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 112.4 -2.182 . . . . 10.0 113.047 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -146.44 157.68 43.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.09 1.756 . . . . 10.0 108.037 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -131.21 132.85 44.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.676 -1.231 . . . . 10.0 107.676 -174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 148.41 49.34 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.148 -1.056 . . . . 10.0 108.148 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.79 52.37 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.734 1.159 . . . . 10.0 113.375 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 -63.05 0.97 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 119.857 1.828 . . . . 10.0 107.69 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.46 -25.93 14.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.406 1.482 . . . . 10.0 110.517 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -154.53 167.12 31.15 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.275 -0.891 . . . . 10.0 111.789 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.0 115.98 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.775 1.23 . . . . 10.0 108.968 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.39 167.41 20.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.908 -1.745 . . . . 10.0 110.457 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.29 124.64 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.238 1.015 . . . . 10.0 108.822 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.28 -9.5 41.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.86 0.864 . . . . 10.0 113.197 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 m -129.32 74.52 80.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 10.0 108.633 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.63 -179.09 2.62 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 125.095 3.863 . . . . 10.0 112.217 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.82 33.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.716 1.206 . . . . 10.0 107.928 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.97 179.13 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.406 2.071 . . . . 10.0 112.616 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.48 168.2 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 126.926 2.09 . . . . 10.0 108.906 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -47.08 -61.76 1.73 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.785 2.034 . . . . 10.0 110.503 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.86 165.32 21.32 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 127.37 2.268 . . . . 10.0 105.435 163.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.8 -164.72 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.631 2.221 . . . . 10.0 110.249 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.18 -112.72 2.46 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.277 -2.729 . . . . 10.0 106.277 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.37 133.66 45.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.142 0.977 . . . . 10.0 108.739 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.62 140.84 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.355 -1.72 . . . . 10.0 106.355 169.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.27 139.14 35.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.6 t -128.53 130.42 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.828 -1.916 . . . . 10.0 105.828 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 63' ' ' LEU . 11.2 t -131.16 108.07 14.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.335 . . . . 10.0 107.394 -172.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -68.99 143.37 54.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.292 1.037 . . . . 10.0 108.568 162.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.77 131.05 53.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.898 -0.779 . . . . 10.0 108.898 158.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.28 176.82 7.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.475 1.11 . . . . 10.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.79 11.78 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.111 1.364 . . . . 10.0 109.533 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.46 -73.15 0.1 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.694 1.198 . . . . 10.0 112.891 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.96 52.02 4.54 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.813 1.197 . . . . 10.0 110.307 -171.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.6 t -113.57 84.83 8.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 127.437 2.295 . . . . 10.0 106.03 -163.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.55 168.51 24.2 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.33 2.687 . . . . 10.0 109.246 171.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 64.1 -45.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.457 1.903 . . . . 10.0 112.091 -165.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.76 -53.14 12.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 10.0 110.577 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.86 -50.05 75.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.332 1.453 . . . . 10.0 110.824 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.7 -13.55 61.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.71 -16.92 27.64 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.764 1.625 . . . . 10.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.59 -67.3 0.4 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 120.11 1.323 . . . . 10.0 112.587 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.21 25.72 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-N 122.052 1.768 . . . . 10.0 114.469 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.9 -43.12 68.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.734 1.152 . . . . 10.0 108.765 167.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 tt -105.27 -28.48 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -164.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.7 t -46.44 -60.33 3.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.817 1.247 . . . . 10.0 109.475 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.83 -35.34 79.2 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.277 1.135 . . . . 10.0 113.002 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.25 -51.61 68.66 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.356 0.663 . . . . 10.0 110.366 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.99 -39.12 80.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.091 0.472 . . . . 10.0 110.223 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.84 -25.64 64.75 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.178 -0.951 . . . . 10.0 111.431 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.01 39.77 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.607 1.163 . . . . 10.0 112.923 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.8 mt -60.99 151.25 75.38 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 119.493 1.042 . . . . 10.0 110.938 174.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.1 169.74 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.967 3.111 . . . . 10.0 110.541 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -4.2 4.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.018 1.327 . . . . 10.0 113.428 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -100.7 8.39 43.34 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.705 1.602 . . . . 10.0 110.533 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.53 164.87 30.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 O-C-N 121.245 -0.909 . . . . 10.0 108.796 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.53 135.0 21.99 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.568 -1.196 . . . . 10.0 108.431 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -113.82 138.98 49.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.855 0.359 . . . . 10.0 111.733 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.23 142.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.484 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -109.09 122.34 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.186 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 15.7 mt -121.59 138.29 28.18 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.76 153.14 22.76 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.937 2.425 . . . . 10.0 112.211 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.69 97.78 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.433 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.12 76.78 8.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.798 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.64 20.31 1.15 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.176 1.547 . . . . 10.0 115.176 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.02 -48.13 3.43 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.937 -1.727 . . . . 10.0 112.88 168.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 -152.14 1.53 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.342 0.973 . . . . 10.0 110.737 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.2 tp -46.84 -30.82 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.154 0.982 . . . . 10.0 112.029 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.33 -27.48 6.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.093 1.757 . . . . 10.0 113.347 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.88 -36.47 64.8 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.631 1.105 . . . . 10.0 110.464 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.79 -55.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -65.83 31.86 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 129.56 3.144 . . . . 10.0 112.237 170.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.22 -42.47 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 125.409 1.48 . . . . 10.0 111.226 173.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.62 -41.8 70.43 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.744 -1.122 . . . . 10.0 112.461 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.56 -44.26 8.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.119 1.155 . . . . 10.0 114.119 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -61.87 -45.8 92.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.568 0.622 . . . . 10.0 110.252 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.42 -45.24 95.15 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 116.74 -1.6 . . . . 10.0 109.16 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.69 91.99 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.637 1.562 . . . . 10.0 110.775 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -60.6 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.017 1.727 . . . . 10.0 109.38 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.59 -29.02 66.47 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.962 -0.542 . . . . 10.0 111.855 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.64 -37.28 49.58 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.325 1.05 . . . . 10.0 110.669 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.6 mtp -75.74 -22.49 56.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.72 -0.657 . . . . 10.0 111.709 -170.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.44 61.85 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.844 0.735 . . . . 10.0 112.995 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.3 130.3 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.957 1.303 . . . . 10.0 109.314 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.59 75.95 1.38 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.572 0.749 . . . . 10.0 108.982 -165.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -5.36 54.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.077 2.251 . . . . 10.0 117.077 -170.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.39 51.91 7.54 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.352 1.861 . . . . 10.0 112.127 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.92 -47.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.42 -1.276 . . . . 10.0 113.419 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.78 34.84 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.589 1.541 . . . . 10.0 113.131 -176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.42 0.62 Allowed 'General case' 0 C--O 1.22 -0.454 0 O-C-N 120.813 -1.179 . . . . 10.0 108.974 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.15 -16.53 45.52 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -71.47 -65.54 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 117.556 -1.211 . . . . 10.0 108.698 166.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.75 74.06 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.389 1.45 . . . . 10.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.41 -40.6 82.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.478 1.511 . . . . 10.0 110.156 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.18 4.58 5.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.719 1.608 . . . . 10.0 112.871 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.29 -57.08 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.56 -61.35 2.0 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.678 0.791 . . . . 10.0 112.671 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.28 -21.2 64.8 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.045 0.839 . . . . 10.0 112.152 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.43 -53.63 3.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.614 1.166 . . . . 10.0 108.772 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.55 87.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.543 1.537 . . . . 10.0 110.647 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.26 13.61 15.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.421 1.088 . . . . 10.0 113.331 -176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.0 -64.19 0.36 Allowed 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 128.266 2.626 . . . . 10.0 109.513 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.8 mt 54.52 44.58 28.53 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.764 1.625 . . . . 10.0 112.498 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.65 14.56 20.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.324 1.45 . . . . 10.0 114.224 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.42 29.11 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 127.984 2.514 . . . . 10.0 107.629 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.2 -44.92 10.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.551 2.167 . . . . 10.0 110.038 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.35 67.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.229 1.012 . . . . 10.0 111.133 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.48 -42.14 70.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.027 1.331 . . . . 10.0 110.333 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.86 -48.57 18.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.155 0.982 . . . . 10.0 108.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.21 -37.24 84.59 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 123.402 0.439 . . . . 10.0 111.292 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.03 -46.9 78.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.378 1.471 . . . . 10.0 112.565 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.9 t80 -74.2 -41.69 61.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.556 0.742 . . . . 10.0 111.489 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -77.0 -14.72 59.8 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.256 -0.903 . . . . 10.0 110.367 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.76 30.65 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.86 0.864 . . . . 10.0 110.135 172.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.95 10.06 54.19 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 117.969 -1.462 . . . . 10.0 114.906 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.3 8.74 6.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.355 2.577 . . . . 10.0 112.674 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.95 49.35 4.08 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.67 132.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 105.138 -2.171 . . . . 10.0 105.138 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.26 133.7 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.63 0.772 . . . . 10.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.57 -37.0 86.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.375 174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.1 -26.76 66.87 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.721 0.691 . . . . 10.0 111.721 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.65 -57.1 4.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.351 -1.722 . . . . 10.0 106.351 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.796 1.238 . . . . 10.0 112.201 -166.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.57 -33.64 64.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.4 m -62.29 -49.5 75.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.65 -41.28 92.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.522 1.129 . . . . 10.0 110.232 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.28 -48.72 45.79 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.726 1.148 . . . . 10.0 110.721 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -92.57 38.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.712 0.805 . . . . 10.0 111.195 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.84 172.32 8.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.361 1.464 . . . . 10.0 111.59 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.17 -40.45 86.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.824 1.25 . . . . 10.0 110.444 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.53 -49.86 54.68 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.745 0.818 . . . . 10.0 110.495 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.8 mm -69.47 -38.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.287 1.035 . . . . 10.0 111.321 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.32 63.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.07 0.948 . . . . 10.0 111.003 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -48.37 19.6 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.817 -0.913 . . . . 10.0 110.817 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.37 -36.12 82.65 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.817 -0.814 . . . . 10.0 109.608 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -63.43 -33.98 76.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.729 -1.129 . . . . 10.0 111.46 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.41 1.58 38.53 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.627 0.649 . . . . 10.0 112.136 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 11.7 mmtt -96.89 -47.14 5.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.646 0.26 . . . . 10.0 110.91 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.13 -6.04 58.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 138' ' ' MET . 14.8 tmtt? -79.44 -44.96 20.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.923 0.392 . . . . 10.0 110.751 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -74.53 -21.21 59.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 37.8 mt -71.93 -37.89 69.95 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.207 -0.452 . . . . 10.0 111.1 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.33 78.0 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.001 0.371 . . . . 10.0 112.001 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.1 mtm -72.79 -28.64 62.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.582 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.93 78.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.612 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.0 5.05 1.73 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 113.49 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 54.3 36.78 26.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.897 2.079 . . . . 10.0 112.127 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 32' ' ' LEU . 89.9 t -69.36 135.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 p -129.33 -16.04 4.01 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.701 2.0 . . . . 10.0 110.255 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.48 -170.92 33.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.892 1.71 . . . . 10.0 112.72 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 m -142.45 153.01 61.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.242 2.217 . . . . 10.0 108.309 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.53 152.67 71.37 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.599 -1.0 . . . . 10.0 113.07 -6.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.1 m -145.86 144.26 30.12 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.351 1.46 . . . . 10.0 108.634 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.7 mmm -123.94 158.39 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.823 1.649 . . . . 10.0 108.204 163.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.14 136.48 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.901 -1.518 . . . . 10.0 106.901 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.7 t -104.06 135.06 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.123 -1.436 . . . . 10.0 107.123 168.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.08 10.96 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.148 4.579 . . . . 10.0 117.561 171.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.57 20.28 60.34 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.803 -1.554 . . . . 10.0 115.52 -170.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.9 -41.4 1.03 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.962 1.881 . . . . 10.0 114.346 -170.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -112.69 107.58 16.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -88.95 113.47 24.52 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.553 1.941 . . . . 10.0 106.765 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.59 169.54 17.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.141 -1.429 . . . . 10.0 107.141 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.93 -178.8 1.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.585 0.354 . . . . 10.0 110.193 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.6 mt -46.26 -50.1 5.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 128.569 2.748 . . . . 10.0 107.717 160.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.13 16.57 4.48 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.834 1.683 . . . . 10.0 114.4 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -128.28 -51.21 1.3 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.793 1.297 . . . . 10.0 109.692 168.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.59 72.97 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.037 1.335 . . . . 10.0 112.298 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.54 -5.98 9.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 118.496 -1.169 . . . . 10.0 114.754 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.36 35.26 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 119.75 1.775 . . . . 10.0 110.046 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 -52.62 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.354 2.036 . . . . 10.0 111.724 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.27 -28.7 69.9 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.999 -1.063 . . . . 10.0 111.539 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.42 -27.12 66.81 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.07 0.548 . . . . 10.0 110.409 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.6 m -77.69 -42.9 32.92 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.014 -1.054 . . . . 10.0 110.939 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.76 -31.83 73.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.91 0.777 . . . . 10.0 111.04 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.56 -56.4 8.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.502 1.921 . . . . 10.0 108.053 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.56 -41.33 93.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 116.917 -1.516 . . . . 10.0 111.509 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.65 69.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.996 1.725 . . . . 10.0 111.729 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.58 -47.04 64.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.863 0.465 . . . . 10.0 110.58 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.45 -42.63 96.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.608 0.763 . . . . 10.0 111.256 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.08 -37.38 83.89 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 120.94 -1.1 . . . . 10.0 111.266 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.31 -51.89 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.261 0.937 . . . . 10.0 108.582 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.06 63.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.543 1.137 . . . . 10.0 110.064 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.63 -0.46 33.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 117.145 -1.407 . . . . 10.0 113.123 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.418 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.03 -33.37 9.29 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.627 1.571 . . . . 10.0 114.429 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -55.8 4.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.372 -1.344 . . . . 10.0 107.372 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -20.32 66.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.159 -0.928 . . . . 10.0 111.795 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.41 6.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 130.122 3.369 . . . . 10.0 113.73 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.16 13.51 34.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.653 1.181 . . . . 10.0 113.153 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.977 2.111 . . . . 10.0 109.819 -163.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.085 1.754 . . . . 10.0 108.787 -179.16 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.292 0 N-CA-C 109.203 -1.559 . . . . 10.0 109.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.66 0.15 Allowed 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 127.081 2.152 . . . . 10.0 110.423 -175.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.2 11.9 0.66 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 112.45 -2.159 . . . . 10.0 112.997 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -146.41 157.75 43.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.028 1.731 . . . . 10.0 108.009 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 m -131.25 132.81 44.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.68 148.48 49.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.187 -1.042 . . . . 10.0 108.187 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.6 13.73 52.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.713 1.149 . . . . 10.0 113.423 -166.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 -63.03 0.98 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.858 1.829 . . . . 10.0 107.853 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.4 -26.07 14.6 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.427 1.491 . . . . 10.0 110.45 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.5 167.14 31.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.25 -0.906 . . . . 10.0 111.702 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.91 115.98 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.802 1.241 . . . . 10.0 109.036 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.41 167.25 20.42 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.927 -1.733 . . . . 10.0 110.534 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 124.62 40.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.213 1.005 . . . . 10.0 108.835 172.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 m -67.32 -9.39 40.61 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.228 0.825 . . . . 10.0 113.228 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -129.35 74.39 81.0 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.14 0.976 . . . . 10.0 108.574 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.53 -179.08 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 125.095 3.864 . . . . 10.0 112.246 -172.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.61 138.91 34.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.681 1.193 . . . . 10.0 107.932 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -73.08 179.08 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.457 2.105 . . . . 10.0 112.601 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 m -127.48 168.23 20.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.801 2.04 . . . . 10.0 108.931 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.8 m -47.0 -61.8 1.71 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.808 2.043 . . . . 10.0 110.531 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.03 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.321 2.248 . . . . 10.0 105.34 163.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.9 -164.62 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.576 2.184 . . . . 10.0 110.229 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.13 -112.67 2.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.323 -2.711 . . . . 10.0 106.323 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -54.51 133.79 46.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.075 0.95 . . . . 10.0 108.697 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.65 140.76 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.371 -1.715 . . . . 10.0 106.371 169.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.23 139.16 35.3 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.5 130.39 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.962 -1.866 . . . . 10.0 105.962 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.12 108.16 14.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -172.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.14 143.37 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.305 1.042 . . . . 10.0 108.463 162.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.73 131.14 53.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 158.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.42 176.82 7.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 10.0 110.381 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.08 175.82 11.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.0 109.464 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.47 -73.22 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.66 1.184 . . . . 10.0 112.842 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.9 52.06 4.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.778 1.18 . . . . 10.0 110.326 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.52 84.76 8.23 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 127.464 2.306 . . . . 10.0 106.111 -163.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.5 168.49 24.2 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.339 2.693 . . . . 10.0 109.239 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.07 -45.7 0.28 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.431 1.892 . . . . 10.0 112.081 -165.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.87 -53.09 12.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.767 2.027 . . . . 10.0 110.518 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.05 -49.87 76.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.423 1.489 . . . . 10.0 110.796 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.47 61.63 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -171.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -90.73 -16.85 27.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.69 1.596 . . . . 10.0 112.046 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.6 -67.31 0.4 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.174 1.352 . . . . 10.0 112.56 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.0 -9.18 25.67 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 121.986 1.745 . . . . 10.0 114.425 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.84 -43.2 69.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.812 1.187 . . . . 10.0 108.837 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.22 -28.49 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 113.874 1.065 . . . . 10.0 113.874 -164.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -46.43 -60.33 3.84 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.746 1.218 . . . . 10.0 109.48 173.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.85 -35.39 78.65 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 CA-C-N 120.273 1.133 . . . . 10.0 112.897 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.24 -51.66 68.47 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.431 0.693 . . . . 10.0 110.304 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.6 t -58.89 -39.22 80.79 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.169 0.509 . . . . 10.0 110.25 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.79 -25.71 64.84 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.096 -1.002 . . . . 10.0 111.415 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.59 10.07 39.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.513 1.125 . . . . 10.0 112.923 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 35.1 mt -60.86 151.17 74.5 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 119.485 1.039 . . . . 10.0 110.971 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.07 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.987 3.125 . . . . 10.0 110.49 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.12 -4.19 4.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.011 1.324 . . . . 10.0 113.395 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.62 8.34 43.45 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.743 1.617 . . . . 10.0 110.627 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.52 164.94 30.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 O-C-N 121.189 -0.945 . . . . 10.0 108.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -146.08 137.07 24.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.402 -1.272 . . . . 10.0 108.444 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -117.3 135.64 53.68 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.804 0.335 . . . . 10.0 111.725 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.92 138.67 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.81 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -104.42 118.09 35.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.02 138.44 27.01 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.88 152.89 25.32 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.028 2.485 . . . . 10.0 112.4 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.21 96.96 8.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.271 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.1 76.8 8.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.363 -0.38 . . . . 10.0 111.776 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.61 20.22 1.16 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.132 1.53 . . . . 10.0 115.132 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.11 -48.18 3.42 Favored Glycine 0 N--CA 1.467 0.723 0 O-C-N 119.933 -1.729 . . . . 10.0 112.752 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.39 -152.13 1.52 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.389 0.995 . . . . 10.0 110.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.86 -30.75 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.077 0.951 . . . . 10.0 112.081 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.34 -27.52 6.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.049 1.74 . . . . 10.0 113.396 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -73.86 -36.46 64.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.66 1.118 . . . . 10.0 110.478 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.88 -55.14 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.94 31.91 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.519 3.128 . . . . 10.0 112.137 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.19 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 125.332 1.444 . . . . 10.0 111.196 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -54.47 -41.86 70.0 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.753 -1.118 . . . . 10.0 112.53 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.32 8.45 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.121 1.156 . . . . 10.0 114.121 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -61.89 -45.67 92.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.503 0.592 . . . . 10.0 110.335 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.38 -45.33 94.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.786 -1.578 . . . . 10.0 109.251 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -45.63 92.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.592 1.542 . . . . 10.0 110.829 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.9 -60.6 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.99 1.716 . . . . 10.0 109.483 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.64 -29.03 66.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.919 -0.562 . . . . 10.0 111.789 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.57 -37.24 48.79 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.362 1.065 . . . . 10.0 110.701 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.8 -22.46 56.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.695 -170.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.41 14.46 61.83 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.871 0.748 . . . . 10.0 112.986 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 m -62.41 130.32 26.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 124.916 1.286 . . . . 10.0 109.277 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.51 75.87 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.605 0.762 . . . . 10.0 109.022 -165.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -5.39 54.26 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 117.103 2.26 . . . . 10.0 117.103 -170.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.36 51.96 7.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.313 1.845 . . . . 10.0 112.114 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.93 -47.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.455 -1.26 . . . . 10.0 113.381 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.93 34.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.576 1.535 . . . . 10.0 113.199 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.41 -44.57 0.61 Allowed 'General case' 0 C--O 1.22 -0.471 0 O-C-N 120.832 -1.167 . . . . 10.0 108.84 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.12 -16.48 44.7 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.605 1.335 . . . . 10.0 114.605 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -71.53 -65.49 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 117.518 -1.23 . . . . 10.0 108.695 166.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.66 -46.72 74.04 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.407 1.458 . . . . 10.0 112.048 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.49 -40.48 82.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.388 1.475 . . . . 10.0 110.241 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.3 4.65 5.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.818 1.647 . . . . 10.0 112.826 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.29 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.991 -2.225 . . . . 10.0 104.991 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -80.62 -61.33 2.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.713 0.805 . . . . 10.0 112.625 -173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.26 -21.22 64.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.093 0.86 . . . . 10.0 112.189 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.42 -53.51 3.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.58 1.152 . . . . 10.0 108.831 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.38 88.03 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 10.0 110.656 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.21 13.63 15.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.382 1.073 . . . . 10.0 113.325 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 70.01 -64.21 0.36 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 128.217 2.607 . . . . 10.0 109.57 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 111' ' ' MET . 41.0 mt 54.43 44.71 28.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.815 1.646 . . . . 10.0 112.436 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.68 14.6 20.63 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.284 1.434 . . . . 10.0 114.189 -173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.17 155.39 29.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 127.933 2.493 . . . . 10.0 107.643 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.2 -45.01 10.7 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.576 2.184 . . . . 10.0 109.937 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.02 -29.36 67.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.208 1.003 . . . . 10.0 111.161 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 -42.15 70.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.981 1.313 . . . . 10.0 110.322 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.53 18.03 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.165 0.986 . . . . 10.0 108.909 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.25 -37.16 84.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.461 0.476 . . . . 10.0 111.349 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.11 -46.89 78.95 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.324 1.45 . . . . 10.0 112.51 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.1 t80 -74.3 -41.62 60.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.549 0.74 . . . . 10.0 111.412 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.95 -14.71 59.82 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.36 -0.838 . . . . 10.0 110.418 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.52 -41.73 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.814 0.846 . . . . 10.0 110.098 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.07 10.1 54.52 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.0 -1.445 . . . . 10.0 114.845 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.32 8.79 6.59 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.313 2.556 . . . . 10.0 112.64 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.92 49.16 4.15 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.696 -1.362 . . . . 10.0 109.696 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.54 132.88 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.165 -2.161 . . . . 10.0 105.165 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -92.26 133.76 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.561 0.744 . . . . 10.0 110.022 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.7 mtpt -64.63 -36.96 85.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.768 -0.634 . . . . 10.0 110.37 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.09 -26.79 66.89 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.637 0.653 . . . . 10.0 111.719 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.67 -57.06 4.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.334 -1.728 . . . . 10.0 106.334 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.79 -59.5 4.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.776 1.23 . . . . 10.0 112.241 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.51 -33.65 64.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.3 m -62.34 -49.37 75.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.76 -41.33 92.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.555 1.142 . . . . 10.0 110.207 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -49.1 -48.73 44.18 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.768 1.167 . . . . 10.0 110.83 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.65 38.84 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.714 0.806 . . . . 10.0 111.116 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.82 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.461 1.504 . . . . 10.0 111.657 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.18 -40.35 86.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.782 1.233 . . . . 10.0 110.521 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.82 55.38 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.723 0.809 . . . . 10.0 110.489 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.49 -38.78 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.241 1.016 . . . . 10.0 111.324 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.59 -33.31 63.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.995 0.918 . . . . 10.0 111.016 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.14 -48.46 19.72 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.851 -0.899 . . . . 10.0 110.851 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.35 -36.21 82.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.751 -0.852 . . . . 10.0 109.53 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -33.63 75.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.751 -1.118 . . . . 10.0 111.542 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.6 -0.87 34.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.581 0.628 . . . . 10.0 112.373 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 54.2 mmtt -95.26 -44.92 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 10.0 110.8 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.34 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.584 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -79.24 -45.75 19.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.692 0.282 . . . . 10.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -16.58 60.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 45.8 mt -75.76 -40.41 55.4 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.293 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.42 77.34 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.1 0.407 . . . . 10.0 112.1 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 60.0 mtm -70.46 -29.72 66.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.763 0.315 . . . . 10.0 111.556 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.89 78.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.69 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.0 5.02 1.75 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.148 1.779 . . . . 10.0 113.524 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.4 36.8 26.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.885 2.074 . . . . 10.0 112.075 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.3 t -69.4 135.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 172.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.21 -16.17 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.793 2.037 . . . . 10.0 110.319 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.39 -170.96 33.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 126.024 1.773 . . . . 10.0 112.865 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.38 152.99 62.04 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 127.316 2.246 . . . . 10.0 108.341 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.63 152.71 71.76 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.569 -1.013 . . . . 10.0 113.103 -6.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 57.2 m -145.9 144.22 30.05 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.325 1.45 . . . . 10.0 108.538 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.6 mmm -123.94 158.44 31.99 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.733 1.613 . . . . 10.0 108.225 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.16 136.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.862 -1.533 . . . . 10.0 106.862 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.7 t -104.0 135.2 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.091 -1.448 . . . . 10.0 107.091 168.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 46.99 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 133.151 4.58 . . . . 10.0 117.53 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.67 20.08 60.57 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.778 -1.568 . . . . 10.0 115.552 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -131.81 -41.41 1.04 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.954 1.877 . . . . 10.0 114.333 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -112.72 107.57 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.91 113.53 24.55 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.471 1.908 . . . . 10.0 106.79 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.63 169.58 17.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.304 -1.497 . . . . 10.0 107.09 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.91 -178.76 1.29 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.083 -0.34 . . . . 10.0 110.083 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.36 -50.08 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 128.482 2.713 . . . . 10.0 107.724 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.12 16.54 4.5 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.963 1.744 . . . . 10.0 114.377 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.9 m -128.31 -51.18 1.29 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 118.726 1.263 . . . . 10.0 109.651 168.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.59 72.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.065 1.346 . . . . 10.0 112.247 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.49 -5.68 9.99 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 118.57 -1.128 . . . . 10.0 114.83 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.74 174.25 35.07 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.639 1.719 . . . . 10.0 109.963 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.88 -52.6 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.407 2.072 . . . . 10.0 111.766 -169.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.3 -28.66 69.89 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.015 -1.053 . . . . 10.0 111.566 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.41 -27.2 66.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.138 0.575 . . . . 10.0 110.38 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.64 -43.04 32.67 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.097 -1.002 . . . . 10.0 110.822 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.71 -31.87 73.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.965 0.802 . . . . 10.0 111.036 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.4 -56.48 8.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.537 1.935 . . . . 10.0 108.074 168.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -65.5 -41.37 93.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.896 -1.526 . . . . 10.0 111.496 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.67 69.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.952 1.705 . . . . 10.0 111.735 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.15 64.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.934 0.494 . . . . 10.0 110.591 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.43 -42.52 96.24 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.584 0.754 . . . . 10.0 111.301 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.18 -37.38 83.61 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.93 -1.106 . . . . 10.0 111.242 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.18 -52.0 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.232 0.924 . . . . 10.0 108.583 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.96 -43.06 63.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.596 1.158 . . . . 10.0 110.016 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.7 -0.4 33.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 117.154 -1.403 . . . . 10.0 113.139 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.477 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.08 -33.25 9.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.637 1.575 . . . . 10.0 114.466 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -55.73 4.99 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.28 66.34 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.763 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.82 -35.5 6.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 130.244 3.418 . . . . 10.0 113.638 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.12 13.43 35.19 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.717 1.207 . . . . 10.0 113.117 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 56.33 76.88 0.27 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.872 2.069 . . . . 10.0 109.845 -163.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.039 1.736 . . . . 10.0 108.768 -179.272 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.296 0 N-CA-C 109.284 -1.526 . . . . 10.0 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.09 73.7 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 127.087 2.155 . . . . 10.0 110.406 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.24 11.86 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.07 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.012 1.725 . . . . 10.0 108.081 -175.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.32 132.75 44.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.54 148.42 49.48 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.7 13.61 52.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.623 1.106 . . . . 10.0 113.42 -167.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -63.04 0.98 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 119.871 1.835 . . . . 10.0 107.769 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.3 mp0 -98.47 -25.85 14.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.348 1.459 . . . . 10.0 110.521 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.68 167.02 31.57 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.271 -0.893 . . . . 10.0 111.719 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.82 115.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.836 1.254 . . . . 10.0 109.023 -171.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.45 167.32 20.31 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 119.993 -1.692 . . . . 10.0 110.497 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.21 124.69 41.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.29 1.036 . . . . 10.0 108.823 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -67.44 -9.36 41.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.768 0.827 . . . . 10.0 113.116 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.29 74.34 81.06 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.254 1.022 . . . . 10.0 108.647 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.43 -179.11 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 125.121 3.881 . . . . 10.0 112.29 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.63 138.92 34.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.769 1.227 . . . . 10.0 107.948 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.14 179.14 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.427 2.085 . . . . 10.0 112.538 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 m -127.54 168.18 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.78 2.032 . . . . 10.0 108.938 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -47.0 -61.87 1.67 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.851 2.06 . . . . 10.0 110.44 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.84 165.41 21.05 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 127.228 2.211 . . . . 10.0 105.301 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.91 -164.56 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.585 2.19 . . . . 10.0 110.304 173.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.07 -112.7 2.46 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 106.36 -2.696 . . . . 10.0 106.36 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -54.48 133.71 45.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.07 0.948 . . . . 10.0 108.785 172.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.64 140.82 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.305 -1.739 . . . . 10.0 106.305 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.31 139.22 35.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.512 -1.292 . . . . 10.0 107.512 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.8 t -128.54 130.43 69.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.901 -1.888 . . . . 10.0 105.901 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 63' ' ' LEU . 11.3 t -131.15 108.09 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -172.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.11 143.39 54.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.236 1.014 . . . . 10.0 108.544 162.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.76 131.14 53.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 158.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.36 176.87 7.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.391 1.076 . . . . 10.0 110.365 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.05 175.82 11.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.049 1.34 . . . . 10.0 109.555 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.673 1.189 . . . . 10.0 112.882 172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.98 52.11 4.56 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.78 1.181 . . . . 10.0 110.293 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.57 84.83 8.38 Favored Pre-proline 0 N--CA 1.449 -0.523 0 C-N-CA 127.371 2.268 . . . . 10.0 106.147 -163.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.56 168.55 24.08 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.32 2.68 . . . . 10.0 109.253 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 64.0 -45.68 0.28 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.482 1.913 . . . . 10.0 112.06 -164.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.81 -53.17 12.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.745 2.018 . . . . 10.0 110.556 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.81 76.41 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.349 1.459 . . . . 10.0 110.91 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -13.52 61.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.63 -16.86 27.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.793 1.637 . . . . 10.0 112.118 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.73 -67.25 0.41 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 120.064 1.302 . . . . 10.0 112.557 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.01 -9.23 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.066 1.774 . . . . 10.0 114.431 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.85 -43.2 68.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.83 1.195 . . . . 10.0 108.774 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.16 -28.56 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 t -46.35 -60.42 3.68 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.668 1.187 . . . . 10.0 109.492 173.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.79 -35.42 79.18 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 CA-C-N 120.244 1.123 . . . . 10.0 112.908 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -57.18 -51.67 68.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.422 0.689 . . . . 10.0 110.362 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -58.92 -39.08 80.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.128 0.489 . . . . 10.0 110.291 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.93 -25.52 64.61 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.15 -0.969 . . . . 10.0 111.441 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.73 10.08 39.81 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.563 1.145 . . . . 10.0 112.834 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 34.9 mt -60.93 151.28 74.72 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 119.52 1.055 . . . . 10.0 110.982 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.13 169.67 21.59 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.985 3.124 . . . . 10.0 110.537 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.05 -4.19 4.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.969 1.308 . . . . 10.0 113.461 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.72 8.46 43.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.706 1.602 . . . . 10.0 110.6 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.56 165.56 29.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 O-C-N 121.213 -0.929 . . . . 10.0 108.798 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -146.63 135.79 22.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.573 -1.194 . . . . 10.0 108.458 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -113.87 136.81 52.47 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.944 0.35 . . . . 10.0 111.944 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 t -140.02 139.57 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.022 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -106.33 120.2 41.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.044 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG11 ' A' ' 30' ' ' VAL . 10.8 mt -118.23 136.45 23.93 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.73 154.64 26.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.502 2.135 . . . . 10.0 112.307 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.78 96.74 7.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.247 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.41 76.77 8.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.757 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.55 20.23 1.15 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.204 1.557 . . . . 10.0 115.204 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -48.04 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 119.863 -1.773 . . . . 10.0 112.827 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.54 -152.11 1.58 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.351 0.977 . . . . 10.0 110.759 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.201 1.0 . . . . 10.0 112.002 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.36 -27.44 6.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.123 1.769 . . . . 10.0 113.346 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.96 -36.4 64.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 119.589 1.086 . . . . 10.0 110.498 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.8 -55.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.031 -1.1 . . . . 10.0 108.031 174.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.91 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.532 3.133 . . . . 10.0 112.182 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.12 -42.56 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 125.405 1.479 . . . . 10.0 111.296 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.5 -41.86 70.09 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.768 -1.11 . . . . 10.0 112.499 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.5 -44.33 8.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 114.137 1.162 . . . . 10.0 114.137 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.84 -45.77 92.38 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.514 0.597 . . . . 10.0 110.3 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.2 mt -61.39 -45.26 95.1 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 116.744 -1.598 . . . . 10.0 109.209 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -45.7 91.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.652 1.569 . . . . 10.0 110.771 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -60.57 3.02 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.005 1.722 . . . . 10.0 109.474 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.66 -29.03 66.4 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 118.955 -0.545 . . . . 10.0 111.767 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.62 -37.22 49.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.325 1.05 . . . . 10.0 110.748 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 31.0 mtp -75.77 -22.49 56.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.644 -0.693 . . . . 10.0 111.632 -170.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.32 14.54 61.87 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.914 0.768 . . . . 10.0 112.985 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.39 130.28 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.012 1.325 . . . . 10.0 109.272 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -123.56 76.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.955 -0.758 . . . . 10.0 108.955 -165.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.35 -5.33 54.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.092 2.256 . . . . 10.0 117.092 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 44.35 51.99 7.45 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.284 1.833 . . . . 10.0 112.11 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.97 -47.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 117.448 -1.263 . . . . 10.0 113.364 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.85 34.81 1.29 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.627 1.558 . . . . 10.0 113.159 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.38 -44.46 0.62 Allowed 'General case' 0 C--O 1.221 -0.415 0 O-C-N 120.835 -1.165 . . . . 10.0 108.898 172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.18 -16.51 45.49 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.542 1.312 . . . . 10.0 114.542 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.42 -65.56 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 117.67 -1.157 . . . . 10.0 108.756 166.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.48 -46.93 73.5 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.378 1.444 . . . . 10.0 112.033 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.32 -40.65 82.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.473 1.509 . . . . 10.0 110.194 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.07 4.51 5.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.808 1.643 . . . . 10.0 112.899 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -115.31 -57.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.62 -61.3 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.683 0.793 . . . . 10.0 112.615 -173.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.33 -21.16 64.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.149 0.886 . . . . 10.0 112.171 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -94.48 -53.46 3.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.519 1.127 . . . . 10.0 108.781 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.43 88.07 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.541 1.536 . . . . 10.0 110.626 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.39 13.83 15.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.395 1.078 . . . . 10.0 113.267 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.91 -64.24 0.36 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 128.206 2.602 . . . . 10.0 109.591 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.2 mt 54.46 44.63 28.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.734 1.614 . . . . 10.0 112.534 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.63 20.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.228 1.411 . . . . 10.0 114.179 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 155.25 28.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 127.944 2.498 . . . . 10.0 107.676 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.1 -45.01 10.96 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.525 2.15 . . . . 10.0 109.955 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.07 -29.22 67.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.193 0.997 . . . . 10.0 111.212 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.57 -42.13 70.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.02 1.328 . . . . 10.0 110.327 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.89 -48.51 18.07 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.211 1.004 . . . . 10.0 108.93 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.09 84.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.405 0.441 . . . . 10.0 111.367 -172.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.09 -46.94 78.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.307 1.443 . . . . 10.0 112.536 172.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.7 t80 -74.2 -41.78 60.87 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.597 0.759 . . . . 10.0 111.406 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.86 -14.79 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.35 -0.844 . . . . 10.0 110.39 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.39 -41.79 29.97 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.801 0.84 . . . . 10.0 110.18 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.0 10.12 54.13 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 117.931 -1.483 . . . . 10.0 114.846 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -127.38 8.84 6.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.367 2.583 . . . . 10.0 112.615 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.25 4.13 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.672 -1.371 . . . . 10.0 109.672 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.49 132.94 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.134 -2.173 . . . . 10.0 105.134 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.41 133.72 35.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.608 0.763 . . . . 10.0 109.915 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.63 -36.96 85.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.8 -0.619 . . . . 10.0 110.406 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.96 -26.86 67.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.748 0.704 . . . . 10.0 111.719 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.69 -57.03 4.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.378 -1.712 . . . . 10.0 106.378 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -51.87 -59.51 4.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.85 1.26 . . . . 10.0 112.164 -166.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.55 -33.67 64.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.305 -0.257 . . . . 10.0 110.305 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.5 m -62.28 -49.43 75.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.327 -0.62 . . . . 10.0 109.327 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.0 m -65.73 -41.33 92.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.645 1.178 . . . . 10.0 110.237 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -49.16 -48.72 44.76 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.694 1.133 . . . . 10.0 110.883 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.6 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.682 0.793 . . . . 10.0 111.178 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.81 172.32 8.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.392 1.477 . . . . 10.0 111.716 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.1 -40.44 86.92 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.911 1.284 . . . . 10.0 110.523 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.54 -49.9 54.69 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.754 0.822 . . . . 10.0 110.484 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.48 -38.8 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.158 0.983 . . . . 10.0 111.274 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.56 -33.28 63.73 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.002 0.921 . . . . 10.0 110.99 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.34 19.88 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.861 -0.896 . . . . 10.0 110.861 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.38 -36.21 82.96 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.712 -0.875 . . . . 10.0 109.583 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.36 77.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.767 -1.111 . . . . 10.0 111.517 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -94.95 -15.05 23.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.607 0.639 . . . . 10.0 112.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 72.3 mmtt -86.9 -47.25 9.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 10.0 110.845 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.79 -9.4 59.01 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.98 0.363 . . . . 10.0 111.98 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.11 -42.47 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.684 0.278 . . . . 10.0 110.989 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -19.45 57.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 68.8 mt -72.5 -44.18 62.59 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.118 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.75 -46.86 77.76 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 67.3 mtm -69.76 -30.88 68.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 10.0 111.498 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.29 -43.87 80.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.664 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -70.08 5.05 1.77 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.142 1.777 . . . . 10.0 113.477 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 54.38 36.77 26.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.875 2.07 . . . . 10.0 112.142 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.1 t -69.39 135.04 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.682 -1.229 . . . . 10.0 107.682 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.2 -16.14 4.05 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.766 2.026 . . . . 10.0 110.31 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.91 33.64 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.968 1.747 . . . . 10.0 112.769 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.51 152.99 61.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 127.216 2.206 . . . . 10.0 108.283 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.55 152.65 71.41 Favored 'Cis proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.646 -0.981 . . . . 10.0 113.07 -6.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.1 m -145.86 144.3 30.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.331 1.452 . . . . 10.0 108.59 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.94 158.38 32.14 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.792 1.637 . . . . 10.0 108.211 163.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.08 136.41 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.943 -1.502 . . . . 10.0 106.943 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 164' ' ' PHE . 29.4 t -104.05 135.21 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.054 -1.462 . . . . 10.0 107.054 168.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.0 10.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.132 4.573 . . . . 10.0 117.582 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.63 20.1 60.58 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.844 -1.531 . . . . 10.0 115.568 -170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -131.85 -41.26 1.04 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.931 1.866 . . . . 10.0 114.348 -170.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.76 107.61 16.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 -171.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.97 113.4 24.46 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.522 1.929 . . . . 10.0 106.8 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.4 p90 -136.51 169.57 17.48 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 120.408 -1.433 . . . . 10.0 107.141 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -174.95 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.587 0.355 . . . . 10.0 110.11 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.34 -50.01 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 128.466 2.707 . . . . 10.0 107.764 160.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.56 4.53 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.881 1.705 . . . . 10.0 114.429 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.28 -51.2 1.3 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.724 1.262 . . . . 10.0 109.667 168.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.66 72.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.102 1.361 . . . . 10.0 112.202 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.64 -5.92 9.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.796 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.87 174.31 35.23 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.693 1.747 . . . . 10.0 109.96 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.93 -52.57 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.359 2.039 . . . . 10.0 111.758 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.46 -28.58 69.91 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.977 -1.077 . . . . 10.0 111.486 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.45 -27.1 66.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.101 0.56 . . . . 10.0 110.392 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.9 m -77.69 -42.96 32.67 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.959 -1.088 . . . . 10.0 110.904 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.7 -31.88 73.19 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.922 0.783 . . . . 10.0 111.026 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.51 -56.4 8.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.557 1.943 . . . . 10.0 108.075 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.54 -41.36 93.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 116.883 -1.532 . . . . 10.0 111.494 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.75 -48.73 69.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.985 1.721 . . . . 10.0 111.728 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.5 -47.05 65.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.975 0.51 . . . . 10.0 110.613 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.57 -42.47 96.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.592 0.757 . . . . 10.0 111.263 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.27 -37.32 83.27 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 120.946 -1.096 . . . . 10.0 111.236 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -58.3 -51.87 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.28 0.945 . . . . 10.0 108.654 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -51.98 -43.08 63.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.573 1.149 . . . . 10.0 110.016 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.2 tttt -79.71 -0.34 33.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 117.14 -1.409 . . . . 10.0 113.08 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.13 -33.33 9.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.671 1.589 . . . . 10.0 114.42 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -55.74 4.99 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.33 -1.359 . . . . 10.0 107.33 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.37 -20.3 66.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.743 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.78 -35.42 6.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 130.183 3.393 . . . . 10.0 113.639 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.21 13.45 35.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.667 1.187 . . . . 10.0 113.114 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.36 76.87 0.27 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.903 2.081 . . . . 10.0 109.799 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.079 1.751 . . . . 10.0 108.805 -179.276 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . 0.446 ' CAA' ' SAK' ' A' ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_